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12 A recipe for better medicine 
Patients in different settings may receive very different 
treatments for the same condition. A push is on to 
standardize care and to use those standards to measure 
the best health and cost outcomes for medical services. 
By Karen Baar 
A new prescription for Puerto Rico 
Puerto Rico’s popular governor and controversial statehood 
advocate, Pedro J. Rossello, M.D. ’70, has advanced pediatric surgery 
and the health care system serving his island of 3.2 million people. 
But statehood, a goal he has pursued since his days at Yale, has 
so far eluded him. 
By John Curtis 
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Mapping the landscape of asthma 
With a series of landmark advances, Yale researchers are unlocking the biological 
secrets that could explain why so many Americans are having trouble breathing. 
Recent findings lend support to a controversial immune system theory. 
By Marc Wortman 
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A welcome to medicine, page 43 
X-ray crystallography reveals the 
structure of an enzyme involved in 
the replication of hepatitis delta virus. 
See Findings in Scope, page 10. 
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LETTERS 
Wake up and smell the herbs 
To the Editor: 
With considerable hope and anticipa¬ 
tion, I read your articles on vision 
research and treatment at Yale (A 
Closer Look at Sight, Fall 1998) in the 
last issue. My hope and anticipation 
were dashed. 
You admit you’re not doing any¬ 
thing for wet or dry macular degen¬ 
eration except using the laser blunder¬ 
buss, which doesn’t do the job at all. 
Why doesn’t such a lofty research in¬ 
stitution explore all potential thera¬ 
pies, including the use oi herbs for 
both types of macular degeneration? 
I am 83 and in excellent health; five 
years ago I developed wet macular de¬ 
generation in my left eye. A highly re¬ 
garded ophthalmologist blinded that 
eye with a laser. Knowing the danger 
to my good eye, I applied to two es¬ 
teemed clinics for treatment. One re¬ 
fused me because my bad eye was too 
bad, and my good eye too good, for 
their FDA protocol. The other turned 
me down because I was taking 
Coumadin. So what was I to do? 
I wrote about my plight in a Wall 
Street Journal article. Immediately 
I received about 200 letters and 
calls, one from a technical journalist 
in California. He encouraged me to 
try herbs to strengthen the walls of 
the little capillaries and to prevent 
the growth of unwanted capillaries. 
I have now been on herbs for three 
years, going on four. My own ophthal¬ 
mologist in New York says my good 
eye is just as good as ever: I read with¬ 
out glasses, drive anywhere day or 
night and use distance glasses for goll 
four times a week. 
Even though orthodox medicine 
frowns on much oi alternative medi¬ 
cine, I would encourage Yale to ex¬ 
plore herbal approaches in treating 
macular degeneration. It might open 
your eyes and help you help thou¬ 
sands, even millions, oi other people 
keep their eyes open. 
Woodrow Wirsig 
Palm City, Fla. 
Bruce Shields, Department chair 
responds: Although ophthalmology has 
made great strides in the preservation of 
vision with regard to many disease pro¬ 
cesses, macular degeneration remains one 
for which we still have very little to offer 
our patients. The good news, however, is 
that this is one of the areas in which the 
greatest amount of research is being con¬ 
centrated. I fully agree that our efforts 
should leave no stone unturned. At the 
Yale Eye Center, we have identified 
macular degeneration and related retinal 
disorders among our primary research tar¬ 
gets, and we have both research scientists 
and clinician-scientists working diligently 
toward this goal. 
Peters was vindicated 
but dismayed by decision 
To the Editor: 
The article on the symposium honor¬ 
ing John P. Peters, M.D., (Fall 1998) 
omitted the lact that his loyalty 
case was taken up by the United 
States Supreme Court. Dr. Peters 
was exonerated personally, and his 
position at the National Institutes 
of Health was reinstated. This narrow 
decision did not deal with the broader 
issue of the constitutionality of the 
loyalty hearings and was deeply 
disappointing to him. 
Sylvia Axelrod, M.D. ’50, HS '50-52 
Valley Stream, N.Y. 
Shame and grief over 
a matter of words 
To the Editor: 
1 read with interest the note about 
Howard Spiro and the quotation from 
his address in Vienna [Faculty Notes, 
Summer 1998). Dr. Spiro is quoted as 
saying, “The shame that has no vent 
in words makes other organs weep." 
There are various ways to translate, 
and attribution to original sources is 
sometimes difficult, but when 1 
passed through the pathology depart¬ 
ment as a medical student, I thought 
it was Virchow who had said, “Griel 
that has no vent in tears makes other 
organs weep.” Perhaps Dr. Spiro 
modified Virchow’s statement to fit 
the direction of his address, and, 
perhaps with the full address before 
me, I would not be carping like this. 
The way I learned it seems somewhat 
more appropriate, especially given 
that we used to believe that stress 
was responsible for various gas¬ 
trointestinal problems. 
Robert C. Wallach, M.D. '60 
New York, N.Y. 
From Howard Spiro: I am grateful to 
Dr. Wallach for providing the source of 
the original quotation that I often repeat, 
even in my textbook. I had long ascribed 
it to the psychiatrist Maudsley but, on 
assurance that he had never said, “ The 
sorrow that has no vent in tears makes 
other organs weep, ” I have usually just 
put it in quotes. Perhaps I was overly 
subtle in switching “shame ”for “sorrow ” 
and “words"for “tears”but, in the context 
of what the Austrians were finally confess- j 
ing, I thought I was making a point. I 
will trade a copy of my published remarks i 
for the specific reference to Virchow. 
Fair enough? 
How to reach us Yale Medicine 
welcomes news and commentary. Please 
send letters to the editor and news items 
to Yale Medicine, P.0. Box 7612, New 
Haven, CT 06519-0612, or via electronic 
mail to ymm@yale.edu, and include a day¬ 
time telephone number. Submissions may 
be edited for length, style and content. 
COME HOME TO NEW HAVEN 
A dozen reasons to attend 
Alumni Reunion Weekend 
June 4 and 5 
1 . Take a stroll down Cedar and College 
streets—and memory lane 
2 . Hear about plans for the new research and 
teaching building on Congress Avenue 
3 . Learn about cutting-edge research from Yale faculty 
4. Hear from the former director 
of the World Health Organization 
5. Celebrate 30 years of the Downs Fellowship 
6. Have dessert with the EPH faculty 
7 Have a burger at Louis's (smuggle in your own ketchup) 
8. See if the Blue Room is still serving tea 
9. Take a last look at Harkness dorm before renovations 
10. Visit the newly reopened British Art Center 
11 
SAVE THE DATES 
FRIDAY JUNE 4 
50 Years of Yale Surgery 
EPH Focus on Global Health 
Dean’s Reception 
New England Clambake 
Alumni and Downs Fellowship 
Celebration Dinner 
Stock up on YSM lapel pins 
12 . Stand in line at Pepe's 
SATURDAY JUNE 5 
Research at Yale 
AYAM Annual Meeting 
Luncheon, Guided Tours, Class Dinners 
INFORMATION 
Full program will be mailed in early spring 
Office of Alumni Affairs 203 785.4674 
info.med.yale.edu/ayam 
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First-year class brings more than smarts to school 
It took more than academic credentials to gain admission to the class of 2002. Life experience 
helping others counted as well. The class gathered during the white-coat ceremony. 
Gaining entry to the School of 
Medicine remains among the 
academic world’s most competi¬ 
tive selection processes. With more than 
3,000 applicants for the approximately 
ioo slots in each first-year class at Yale, 
being smart and well-prepared are givens. 
It takes more than that to get in. “We re 
looking for people who have shown that 
they are truly concerned about other 
people and have done something in their 
lives that really illustrates that spirit,” 
says Deputy Dean for Education Robert 
H. Giiford, M.D., HS ’67. The 102 
members of the Class of 2002 arrived in 
New Haven at summer’s end with just 
that experience. 
The 57 men and 45 women represent 
a broad cross section of backgrounds and 
interests. They include 21 Yale graduates, 
15 Harvard graduates, at least one lawyer, 
a mother of three, and two children of faculty members. 
The mean age of the class is 24. About half the class is 
Hispanic, African-American or Asian-American. As for the 
assessment of those more humane qualities, Dean Gifford 
says, “they needn’t have anything to do with medicine. 
We look for people who have given of themselves to others, 
such as working with kids, or as camp counselors, or with 
the disadvantaged in the community.” 
Among the entering students, Vivek Murthy organized 
a program while in college that sent American college 
students to India to conduct HIV prevention workshops 
for teenagers. Alison Norris developed school libraries in 
Zanzibar and helped restore overgrazed land in Kenya 
before working on public health issues at Harvard and the 
Rockefeller Institute. Patricia Diaz traded an apartment on 
Central Park South and a successful career as a lawyer in 
New York City for a dormitory room in Harkness and a full 
schedule as a medical student. She finds that she’s not alone 
in having an unexpected background for a medical student. 
“Everyone here,” she says, “has an exceptional and fascinat¬ 
ing story of their own.” 
A clean room for gene 
therapy and stem cell 
transplantation 
In 1989 leukemia patient Richard D. 
Frisbee III became the first child in 
Connecticut to receive a bone marrow 
transplant. He died later that year, 
but were he alive today he might be 
a candidate for a stem cell transplant, 
which has emerged as a promising 
way to halt leukemia and other can¬ 
cers. To help pursue new treatments 
and honor this young patient, the 
Richard D. Frisbee III Laboratory 
of Stem Cell Transplantation and 
Hematopoietic Graft Engineering 
opened in October at Yale-New 
Haven Hospital’s Blood Bank in the 
Department of Laboratory Medicine. 
A “clean room” laboratory for gene 
therapy and stem cell manipulations, 
the Frisbee Laboratory will be used for 
both clinical applications and basic 
science research by a number of medi¬ 
cal school departments and the Yale 
Christine Frisbee helped establish the new 
stem cell lab in memory of her son, Richard. 
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Cancer Center. “It is literally a bio¬ 
logical manufacturing facility,” says 
Edward L. Snyder, M.D., the blood 
bank’s director and a professor of labo¬ 
ratory medicine. “This unique labora¬ 
tory provides an opportunity to link 
together the Yale Cancer Center, Yale- 
New Haven Hospital and the School 
of Medicine in a three-pronged attack 
against cancer.” 
In the new Class 10,000 labora¬ 
tory—so named because it has fewer 
than 10,000 dust particles per cubic 
foot of air—Yale physicians and scien¬ 
tists will have a cleaner environment 
in which to process stem cells from 
the blood or bone marrow of both 
patients and donors. After chemo¬ 
therapy, a patient’s previously 
collected stem cells are reinfused and 
migrate to the bone marrow, where 
they reproduce and differentiate, 
creating blood cells that commit to 
specific functions in the body. For 
stem cell transplants for patients 
who do not have a “matched” donor, 
T cells can be removed from donor 
blood or bone marrow to prevent 
graft-versus-host disease in recipients. 
“We need to be in a special environ¬ 
ment with purified air so that we do 
no harm to the cells when we are do¬ 
ing our manipulation,” says Diane 
Krause, M.D., Ph.D., assistant 
professor ol laboratory medicine 
and director of stem cell processing 
at the Blood Bank at Yale-New 
Haven Hospital. 
Stem cell therapy is especially 
promising because “rather than trying 
to beat the disease to death with che¬ 
motherapy, it allows us to step back 
and apply a more gentle treatment,” 
says Dennis Cooper, M.D., HS ’82, 
clinical director of stem cell transplan¬ 
tation at the Yale Cancer Center. He 
says that work by investigators includ¬ 
ing Joseph P. McGuirk, D.O., and 
Stuart E. Seropian, M.D., is pushing 
the limits of existing therapies. By ma¬ 
nipulating stem cells to attack tumor 
cells through an immunologic re¬ 
sponse, these new therapies give pa¬ 
tients a much better chance of surviv¬ 
ing after being diagnosed with cancer. 
“The most exciting area in the next 10 
years,” Dr. Cooper says, “is going to 
be in identifying the different cell 
types that can attack the tumor with¬ 
out harming the patient. The Frisbee 
lab is where many of these cell ma¬ 
nipulation studies will be done.” 
As the field of gene therapy ma¬ 
tures over the next five to 10 years, 
the laboratory will provide a facility 
for testing newly designed vectors, the 
altered viruses that are used to deliver 
therapeutic genes in the treatment of 
cancers and other diseases. (Yale has 
another Class 10,000 clean room in 
the Sterling Hall of Medicine that is 
also used for basic research in gene 
therapy, under the directorship of 
Albert Deisseroth, M.D., Ph.D.) 
Creation of the Frisbee Faboratory 
was made possible through the fund¬ 
raising efforts of Christine Frisbee, 
Richard’s mother and former adminis¬ 
trator of the stem cell transplant unit 
at Yale. In 1990, she launched a foun¬ 
dation named for her son, which, 
since then, has raised and distributed 
more than $1 million. The new labo¬ 
ratory is the foundation’s largest un¬ 
dertaking to date. “We want to fund 
things that other people won’t fund, 
that we think are innovative and 
that bring the field of transplantation 
forward,” she says. 
The foundation also provided 
support for the First Annual Frisbee 
Foundation Stem Cell Symposium, 
held in October to coincide with the 
opening of the Frisbee Faboratory. 
Speakers discussed cord blood process¬ 
ing and its effect on stem cell trans¬ 
plantations, advances in breast cancer 
research and graft-versus-host disease. 
“Our aim,” says Ms. Frisbee, “is to 
get people who are doing the most 
advanced research to educate other 
health care professionals with the 
hope that more people will use this 
knowledge to help find cures.” 
Lessons of healing: 
Exploring the link between 
spirituality and health 
Throughout the ages, men and 
women have thanked deities for 
favors bestowed. Such blessings may 
be good health, fortune or romance, 
and their commemoration has taken 
the form of sculptures, paintings, 
carvings and pilgrimages. Artists 
Melinda Bridgman and Ana Flores 
traced the history of ex-votos, also 
known as milagros, the Spanish word 
for miracles, as part of a two-day 
symposium on Health and Spirituality 
held in October at the medical school. 
The conference brought together 
health professionals and academic 
researchers from mainstream and 
alternative medical worlds. Talks and 
workshops covered topics such as the 
relationship between health and the 
environment in a talk by William 
Foege, M.D., professor at the Rollins 
School of Public Health at Emory 
University, and the value of religion 
for health in a lecture by Dale 
Matthews, associate professor of 
medicine at Georgetown University. 
“We all had much to think about,” 
says Howard M. Spiro, M.D., 
professor of medicine and director 
of the Program for Humanities in 
Medicine, one of the sponsors, 
“but my conclusion was that main¬ 
stream doctors have got to take the 
lessons of alternative medicine, the 
lessons of healing, more to heart 
than they do. We should consider 
mind and spirit as well as the body.” 
YALE MEDICINE 5 
SCOPE 
With a mechanical heart, 
a patient goes home— 
and waits 
Everywhere Robert Kenyon goes these 
days a bundle of electrical wires con¬ 
nects him to a battery pack that pow¬ 
ers an artificial heart embedded in the 
walls ol his abdomen. His life literally 
depends on the device, a left ventricu¬ 
lar assist system, or LVAS, designed to 
sustain heart patients until a donor 
heart becomes available. When Mr. 
Kenyon, who suffers from cardiomy¬ 
opathy, a fatal degenerative heart dis¬ 
ease, leh Yale-New Haven Hospital in 
September, he became the first patient 
in New England and one of only 
about 20 around the country to return 
home with this type of device. With¬ 
out it, his chances of surviving the 
wait for a scarce donor heart would be 
small. Since leaving the hospital, the 
life-sustaining booster for his diseased 
heart has allowed him to resume many 
aspects of a normal life. 
“I’m fully employed,” says Mr. 
Kenyon, 60, a reinsurance broker 
who lives in Darien. “I work from 
a computer in my house, which I have 
been doing for the last 15 months. 
I’m still developing new business lor 
my company.” 
His need for a dependable power 
supply keeps him close to home, and 
his status at the top of the heart re¬ 
cipient waiting list keeps him no more 
than an hour’s drive away Irom New 
Haven. The batteries and backups he 
carries in a bag over his right shoulder 
have become his inseparable compan¬ 
ions. His wife, Kathy, also carries 
spares in a backpack, and at home he 
plugs the artificial heart into a moni¬ 
tor that provides direct current. 
The LVAS keeps Mr. Kenyon alive 
by providing support to the diseased 
left side of his heart, which pumps 
blood to the body. “The left heart has 
a real heavy load,” says John A. 
Elefteriades, M.D. ’76, HS ’76-83, 
professor and chief ol cardiothoracic 
surgery. Working with George 
Tellides, M.D., Dr. Elefteriades im¬ 
planted the device. 
Some 28 years in the making, the 
LVAS is the latest generation of artifi¬ 
cial hearts. Made by Novacor, a Cali¬ 
fornia-based division of Baxter Health 
Care Corporation, the LVAS received 
approval in September from the Food 
and Drug Administration as a bridge 
to transplant. In Europe, where the 
LVAS was approved for use several 
years ago, some patients have already 
lived up to three years connected to 
the device. 
Mr. Kenyon received his LVAS 
under an experimental protocol dur¬ 
ing a five-hour operation that required 
the services of a dozen surgeons, 
anesthesiologists and nurses and an 
engineer from Novacor. After a month 
in the hospital, Mr. Kenyon went 
home. “I’m glad this technology is 
available," he says, “but I’ll be glad 
when I can get rid of it.'This thing 
allows me to live at about 50 percent 
of where I was 10 years ago. I want to 
be at 90 percent.” 
Yale epidemiologist leads 
study of risks from radon 
in drinking water 
Radon in Connecticut’s drinking 
water poses a minimal health risk, 
primarily when it is released into 
household air, according to a recent 
study by experts convened by the 
Connecticut Academy of Science 
and Engineering. The state Depart¬ 
ment of Public Utility Control 
requested the study after receiving 
reports of radon in drinking water 
and requests for treatment of public 
drinking water supplies to reduce 
radon content. 
The panel, chaired by Jan A. 
Stolwijk, Ph.D., Susan Dwight Bliss 
Professor Emeritus of Epidemiology, 
found that the major adverse health 
effect of radon is a possible increase 
in lung cancer risk resulting from 
inhalation. According to the report, 
some adverse health effects, primarily 
in the stomach, may result also 
from the ingestion of drinking water 
containing radon, although the 
effect is “expected to be less than 
for inhalation.” 
With a battery pack powering his left ventricular assist system (LVAS), Robert Kenyon receives 
a routine checkup at the Yale Physicians Building. One of the first in the country to leave the 
hospital with an LVAS, Mr. Kenyon relies upon the mechanical booster until a donor heart for 
transplant becomes available. 
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From cough medicine to deadly addiction, 
a century of heroin and drug-abuse policy 
A century ago, scientists at a 
German pharmaceutical firm 
investigated a chemical modifi¬ 
cation to morphine that made it more 
palatable as a cough suppressant. The 
Bayer Co., predecessor to today’s 
pharmaceutical giant, marketed its 
popular new remedy as “Heroin.” 
Although it worked against coughs 
caused by serious and then-common 
diseases such as tuberculosis and 
pneumonia, physicians and pharma¬ 
cists soon noticed an unhappy side 
effect—patients required ever larger 
doses and were becoming increasingly 
dependent on the elixir. By 1912 it had 
emerged as a recreational drug among 
young men in New York City. Two 
years later, addicts were knocking at 
the doors of New York and Philadel¬ 
phia hospitals in search of treatment. 
The history of the drug’s use and 
abuse was the topic of One Hundred 
Years of Heroin, a conference held at 
Yale in late September. It brought 
together some of the nation’s leading 
thinkers on the drug problem, such as 
U.S. Sen. Daniel Patrick Moynihan 
of New York; Egil Krogh Jr., who 
directed drug policies during the 
Nixon administration; and Jerome H. 
Jaffe, M.D., who, under President 
Nixon, became the nation’s first 
so-called drug czar. 
Organized by David F. Musto, 
M.D., professor in the Child Study 
Center and the Section of the History 
of Medicine and a leading historian of 
drug abuse and drug-abuse policy, the 
conference focused largely on the 
Nixon years because, according to Dr. 
Musto, it was then that the modern 
federal drug program was created. 
Social and political issues drove many 
developments in drug policy. Spurred 
in part by a desire to show a drop in 
crime before the 1972 elections, the 
Nixon administration began a pilot 
program in the District of Columbia, 
where half the inmates in local jails 
tested positive for opiates. Mr. Krogh, 
now a lawyer in private practice in 
Seattle, told the conference audience, 
“If we could get results in the District, 
we could use them across the coun¬ 
try.” As treatment, including metha¬ 
done, became available in the capital, 
crime did indeed drop, he says. 
Another impetus for solutions to 
drug use started half a world away, 
in Vietnam, where studies found that 
up to a fifth of the American soldiers 
were addicted to heroin. On a trip to 
Vietnam Mr. Krogh told soldiers, 
“I’m here from the White House to 
find out about the drug problem.” 
Then, Mr. Krogh recalls, a soldier 
took a drag of marijuana and replied, 
“I’m from Mars, man.” 
Dr. Jaffe, who was director of the 
Special Action Office for Drug Abuse 
Prevention at the time, introduced 
programs that reduced the addiction 
rate among returning Vietnam veter¬ 
ans. He also tried to expand treatment 
programs, create a research base and 
develop a national strategy for drugs. 
Money became available in greater 
amounts than ever before, for both 
treatment of addiction and training in 
substance-abuse treatment. “We devel¬ 
oped more federal support in treat¬ 
ment capacity in the first two years 
than had been developed in the pre¬ 
ceding 50,” says Dr. Jaffe. 
A century after its introduction, 
heroin continues to pose complex 
medical, legal, social and public health 
questions and to resist efforts at con¬ 
trol. “We seem to have a peak in 
heroin use every 20 to 25 years,” says 
Dr. Musto. “Some have explained this 
as ‘generational forgetting.’ Whatever 
the explanation, heroin will remain a 
problem indefinitely for those who 
become addicted. However, it is, in 
part because of methadone, more 
treatable than uncontrolled cocaine.” 
Conferees Sen. Daniel 
Patrick Moynihan, left, 
and Egil Krogh Jr. initiated 
modern federal drug policy 
during the Nixon administra¬ 
tion. Below: Bayer marketed 
heroin as a cough suppres¬ 
sant until its addictive prop¬ 
erties were recognized. 
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Improving public health from the ground up Faculty in epidemiology and pub¬ 
lic health are joining forces with 
Griffin Hospital in Derby to 
create an innovative program to 
improve health in Connecticut’s 
Naugatuck River Valley region 
northwest of New Haven. The hospi¬ 
tal will house a new prevention 
research center focusing on cardiovas¬ 
cular disease, the area’s leading cause 
of death, with programs in smoking 
cessation, obesity management and 
cardiac screening. The center will 
design future interventions based on 
health surveys in six Naugatuck Valley 
towns and discussions with commu¬ 
nity representatives. The federal 
Centers for Disease Control and 
Prevention have provided $2.9 million 
for the efforts and follow-up studies 
to determine which interventions 
should be maintained. 
“It is a major philosophical shift 
in public health—the notion that 
experts can’t simply go into a commu¬ 
nity and tell people what they need,” 
says David L. Katz, M.D., M.P.H. 
’93, director of preventive medicine 
at the hospital and assistant clinical 
professor of public health and 
medicine. “It just doesn't work. 
You need community buy-in. The 
best way to get it is to ask people 
what they want.” 
Dr. Katz will serve as director of 
the center, which will be staffed at 
Griffin Hospital. Physicians from 
the hospital will collaborate on the 
project with Yale faculty and students. 
A community advisory committee 
will work with center staff, faculty, 
community leaders and citizens to 
identify health needs and recommend 
initiatives. Each project will have a 
community action team to target 
public health priorities. “Whatever 
the community asks us to do over 
the next five years, we will find 
someone who has that expertise,” 
says Dr. Katz. “This new center,” 
adds Michael H. Merson, M.D., 
dean of public health, “has great 
potential for improving the health 
of the population living in the lower 
Naugatuck Valley.” 
School, government 
settle suit over 
credit balances 
A federal investigation into the medi¬ 
cal school’s billing practices ended in 
September with a $5.6 million settle¬ 
ment over credit balances accrued 
during the last 20 years. The school 
has also agreed to abide by a four-year 
corrective action plan that includes 
annual audits, establishment of a 
credit balance department and 
biannual instruction programs for 
those involved in resolution of credit 
balances. The settlement includes no 
admission of liability on the part of 
the School of Medicine. 
The U.S. Attorney’s office in 
New Haven had contended that the 
medical school improperly handled a 
significant number of credit balances, 
billing insurers and individuals more 
than once for the same procedure. 
“As the government recognized in 
the settlement, the complexity of 
health insurance payment systems 
makes credit balances unavoidable,” 
says Irwin M. Birnbaum, the medical 
school’s chief operating officer. 
“Nevertheless, in past years Yale failed 
to have adequate administrative and 
billing systems in place to process all 
payments properly.” The disputed 
credit balances accrued prior to the 
installation of a new computer billing 
system in 1995. They represent a small 
fraction of the payments for clinical 
services made to the school during the 
period in question. Payments are ex¬ 
pected to reach $120 million in this 
academic year alone. 
The $5.6 million settlement 
includes a $500,000 refund to the 
federal government for Medicare 
and other federal health programs. 
In addition, Yale will provide $1.8 
million to certain health care carriers, 
$2.5 million to individuals and other 
entities, and $700,000 to the federal 
government to resolve all claims. 
As part of an overall modernization 
of accounting and information 
systems, Yale has completed a 
$15 million upgrade of its systems 
and management, including 
major improvements to its computer 
billing and information systems. 
State-of-the-art imaging 
for neurovascular disease 
One of the nation’s most advanced 
diagnostic neuroangiography suites 
for diagnosis and treatment of neu¬ 
rovascular system disease opened re¬ 
cently at Yale-New Haven Hospital. 
The $2.3 million suite is the only one 
of its type in the country outside the 
National Institutes of Health and is 
considered the most advanced any¬ 
where. It features a Philips biplane 
imaging system that offers radiologists 
simultaneous front and side views of 
vascular images, along with ultra¬ 
sound and CT scanning. This mark¬ 
edly decreases the time it takes to 
perform complex examinations and 
allows performance of life-saving 
embolization procedures. A table-side 
module provides on-the-spot process¬ 
ing of results and image analysis. “The 
combination of all these features in 
the neuroangiography suite represents 
the pinnacle of today’s medical imag¬ 
ing technology,” says Barbara Maione, 
manager of special procedures and 
intervention services. 
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New research clinic 
seeking to identify 
schizophrenia earlier 
While traditional treatment of schizo¬ 
phrenia, or psychosis, seeks to reduce 
symptoms after they have affected 
people’s lives, the psychiatry 
department’s new PRIME Research 
Clinic is launching the first study in 
the country to explore the prevention, 
delay or reduction of serious symp¬ 
toms. Through early identification 
and treatment, the clinic hopes to 
address the disease before it becomes 
debilitating. 
The PRIME clinic, which stands 
for Prevention through Risk Identifi¬ 
cation, Management and Education, 
will study individuals who, while in 
the prime of their lives, show signs of 
being at risk for developing a debili¬ 
tating mental illness. It includes 
people from ages 14 to 45 who are 
concerned with a recent change in 
their thoughts or feelings. 
Possible signs that someone may 
be at risk for mental illness include 
a sudden decline in work or school 
performance, social withdrawal, 
trouble concentrating or thinking 
clearly, feelings of suspicion or worry 
about the intentions of other people 
without apparent justification, and 
bizarre changes in the way things look 
or sound. These experiences may be 
accompanied by mood shifts such as 
depression, anxiety or angry outbursts, 
explains Thomas H. McGlashan, 
M.D., professor of psychiatry, execu¬ 
tive director of the Yale Psychiatric 
Institute and leader of the study. 
Dr. McGlashan and the PRIME 
clinic plan to provide those 
entering the study with preventive 
counseling as well as participation 
in a medication trial. The experimen¬ 
tal program will offer treatment 
for one year followed by one year 
of monitoring. 
Preliminary results from research 
conducted in Australia indicate 
that early intervention may prevent 
symptoms from developing or may 
significantly reduce symptoms of 
psychosis. “Most people diagnosed 
A pediatrician’s frank talk about fibs Long before Independent Coun¬ 
sel Kenneth Starr’s report and 
possible presidential lies were the 
topic of the day, Diane M. Komp, 
M.D., professor of pediatrics, decided 
to explore the issue of lying: why 
people do it and whether lies are ever 
justified. Her book on that topic, The 
Anatomy of a Lie: The Truth About Lies 
and Why Good People Tell Them, 
makes only one small mention of 
President Clinton and the Lewinsky 
affair, yet the coincidence of the 
book’s release and the release of Inde¬ 
pendent Counsel Kenneth Starr’s re¬ 
port couldn’t have been more appro¬ 
priate, according to its author. 
Her own soul searching inspired 
Dr. Komp to write her book, which 
was published in the fall by 
Zondervan, a HarperCollins imprint. 
Dr. Komp, a pediatric oncologist, 
has written five other books, including 
A Window to Heaven and Children Are 
... Images of Grace. She began to ex¬ 
amine her personal standards of hon¬ 
esty after she came upon a memoir by 
American Civil War veteran H. Clay 
Trumbull titled A Lie Never Justifiable. 
Trumbull, a Yankee chaplain, de¬ 
scribes how he would rather kill one 
of his Confederate captors than lie to 
him to cover an escape attempt. 
Perplexed by Trumbull’s reasoning, 
Dr. Komp began to question whether 
there are, at times, good reasons for 
lying. She devotes a chapter to a 
Dutch family who sheltered Jews 
during the Holocaust and asks 
whether lying to the Gestapo is 
justifiable. She questions her own lie 
Pediatric oncologist and author Diane 
Komp explores the ethics and reasons 
for lying in her new book. 
of omission to the mother of a child 
stricken with cancer. The cancer, she 
told the mother, had not progressed. 
But, seeing the mother’s need for 
hope, she left out the bad news—the 
cancer was not going away either. 
While examining other people’s 
dishonesty and tracking her own 
“white lies” in a journal, she couldn’t 
help noting that while we condemn 
dishonesty in political leaders, police 
officers, doctors and others we expect 
to trust, many of us pay little heed to 
the impact of our own falsehoods. 
“There may be a personal price to pay 
in downsizing duplicity, but we can’t 
afford not to pay it,” Dr. Komp writes 
in her book. 
with serious mental disorders encoun¬ 
ter sometimes irreversible reduction 
in quality of life, including failure 
at work or school, loss of sense of 
self, social estrangement, or distrac¬ 
tions from persistent voices and fear of 
persecution,” Dr. McGlashan 
says. “Because of its early onset— 
typically in the late teens and early 
twenties—schizophrenia robs society 
of its victims’ intellectual and 
physical productivity.” 
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FINDINGS 
Imaging RNA enzyme a step toward understanding hepatitis 
Using X-ray crystallography, researchers have solved the three-dimensional struc¬ 
ture of an RNA enzyme that plays a role in the replication of the hepatitis delta 
virus. It is the only example of an RNA catalyst found in a human pathogen and 
the second example of a fully visualized RNA enzyme. Jennifer Doudna, Ph.D., profes¬ 
sor of molecular biophysics and biochemistry and an investigator with the Howard 
Hughes Medical Institute (HHMI), led the research. Hepati¬ 
tis delta, a secondary infection that sometimes occurs in 
patients with hepatitis B, is a significant prob¬ 
lem in developing countries, where it is often 
fatal. “It is known that this RNA enzyme is 
essential for replication of the virus,” says 
Dr. Doudna. “Using our knowledge of its 
molecular structure, it may be possible to design 
pharmaceuticals that interfere with its function and 
stop the progression of the disease.” 
A three-dimensional image of 
an RNA enzyme involved in the 
hepatitis delta virus. 
‘Jumping DNA' may 
help explain evolution 
of immune system 
A bit of DNA that has the 
ability, heretofore unseen in 
humans, to “jump” from one 
organism to another may 
have given rise to the hu¬ 
man immune system, ac¬ 
cording to Yale researchers. 
A team led by David G. 
Schatz, Ph.D., associate 
professor of immunobiology 
and an HHMI investigator, 
has found evidence that tiny 
gene particles vital to the 
task of producing millions of 
different kinds of antibodies 
in humans act like a gene 
segment that can "jump" 
into foreign DNA. Their find¬ 
ings were published in the 
Aug. 20 issue of the journal 
Nature. Although such 
genes abound in lower or¬ 
ganisms, the “jumping DNA” 
is the first cut-and-paste 
“transposase" ever found in 
humans. Dr. Schatz theo¬ 
rizes that such a jump may 
have happened within the 
mammalian genome some 
450 million years ago. 
“This helps explain why 
the jawed vertebrates—in¬ 
cluding humans—are the 
only species that have a 
second, adaptive immune 
system in addition to the 
innate immune system that 
all other species have,” says 
Dr. Schatz. Any clinical appli¬ 
cations of this knowledge 
are speculative, he says, al¬ 
though there may be implica¬ 
tions for the diagnosis or 
prevention of lymphoma. 
Early study suggests 
new way to treat 
schizophrenia 
A drug under development 
for anxiety has been found 
to reverse schizophrenia-like 
effects of “angel dust" in 
rats without apparent side 
effects, according to a 
School of Medicine study. 
The drug, designated 
LY354740, offers a possible 
alternative to current schizo¬ 
phrenia therapies, which 
affect the brain’s dopamine 
system and may cause side 
effects such as Parkinso¬ 
nian-like tremors. LY354740 
acts by lowering levels of 
the chemical glutamate, one 
of the neurotransmitters re¬ 
sponsible for relaying mes¬ 
sages between neurons. 
Bita Moghaddam, Ph.D., 
associate professor of 
psychiatry and neurobiology, 
who led the study, cautions 
that the new drug has only 
worked in animal models. 
"This is just rats, which do 
not get complex cognitive 
disorders like schizophrenia,” 
she says. She and research 
associate Barbara W. Adams 
reported their findings in the 
Aug. 28 issue of the journal 
Science. Clinical trials for the 
drug’s use in treatment of 
schizophrenia are expected 
to begin later this year. 
Women under 75 
fare worse than men 
after heart attacks 
Many clinicians have long 
believed that men were 
more prone to death from 
heart attack than women. 
Evidence from a Yale study 
suggests that age, as well 
as sex, determines the out¬ 
come. “We found that the 
younger the age of the pa¬ 
tient, the worse the outcome 
for women compared with 
men,” says Viola Vaccarino, 
M.D., assistant professor of 
epidemiology and public 
health, who led the study. 
In the 1,000 cases studied, 
women under 75 were al¬ 
most twice as likely as men 
to die in the hospital follow¬ 
ing a heart attack, according 
to findings published in the ( 
Oct. 12 issue of Archives of 
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Internal Medicine. Con¬ 
versely, women 75 or older 
had a significantly lower risk 
of death than men that age. 
Dr. Vaccarino said the age 
75 cut-off was chosen only 
for description of the results. 
However, no clear dividing 
line at age 75 was found. 
On the contrary, there was 
a gradual increase of risk of 
dying for women compared 
with men going from older 
ages to younger ages. A fol¬ 
low-up study that reviewed 
about 400,000 cases con¬ 
firmed the original findings, 
she says. Further investiga¬ 
tions are being planned to 
look at the reasons for the 
relatively poor prognosis 
after heart attacks for 
younger female patients. 
A little testosterone 
may aid estrogen 
replacement therapy 
A dose of testosterone may 
be a good thing for post¬ 
menopausal women under¬ 
going hormone replacement 
therapy. Estrogen mixed with 
an equal amount of methyl- 
testosterone, also known as 
androgen, improved sexual 
desire and response in 
women who were dissatis¬ 
fied with estrogen alone, 
according to a study in the 
October issue of The Journal 
of Reproductive Medicine. 
“Giving estrogen alone to 
menopausal women helped 
a little bit, but gradually over 
time the effectiveness was 
j lost,” says Philip Sarrel, M.D., 
professor of obstetrics and 
gynecology and of psychia¬ 
try, and principal investigator 
for the study. “What we found 
in our study was the missing 
part—the lack of androgen 
replacement." Side effects 
and failure of the treatment 
to meet the patient’s needs 
are the most common rea¬ 
sons women give for 
discontinuing hormone 
replacement therapy. 
Many heart-failure 
patients would rather 
not be revived 
Nearly one-quarter of all pa¬ 
tients hospitalized for severe 
congestive heart failure say 
they do not wish to be re¬ 
suscitated if their hearts 
stop beating, according to a 
study authored by Harlan M. 
Krumholz, M.D., associate 
professor of medicine and 
epidemiology, in the Aug. 18 
issue of Circulation, the jour¬ 
nal of the American Heart 
Association. Another 69 per¬ 
cent definitely wanted resus¬ 
citation and 8 percent were 
uncertain. Patients who per¬ 
ceived that they would live 
less than two more months 
were the most likely to reject 
the prospect of resuscita¬ 
tion, researchers found. Pa¬ 
tients who were older, 
wealthier and less able to 
take care of their own basic 
needs in the two weeks 
before hospitalization also 
were more likely to reject 
resuscitation. The study, 
Dr. Krumholz says, points up 
the need for discussions of 
end-of-life care. “We, as a 
profession, need to develop 
approaches so we can talk 
about these issues without 
extinguishing hope,” says 
Dr. Krumholz. “In many 
cases these discussions 
are not happening." 
The Program for Humanities in Medicine 
1998-1999 LECTURE SERIES 
Lectures, free and open to the public, begin at 5 p.m. in the Beaumont Room, 
333 Cedar Street. Refreshments at 4:30 p.m. For information call Howard Spiro 
or Clara Gyorgyey at (203) 785-5494. 
FEBRUARY 25 
Match Day: Stories of Adoption & Reunion 
Morris A. Wessel, M.D. 
Clinical Professor Emeritus of Pediatrics 
Yale University School of Medicine 
Diana K.R. Jowdy, MA 
Ph.D. Candidate 
American Culture 
University of Michigan 
MARCH 4 
Cultural Competence? 
Immigrant Patients American Doctors 
The Robert Penn Warren Lecture 
Anne Fadiman, BA 
Editor of The American Scholar 
MARCH 18 
Eye of Doctors: Enhancing Observational 
Skills With Fine Arts 
Irwin M. Braverman, M.D. 
Professor of Dermatology 
Yale University School of Medicine 
APRIL 1 
Meeting the Challenge of 
Alternative Medicine 
Joseph J. Jacobs M.D., MBA 
Former Director 
Office of Alternative Medicine at NIH 
APRIL 15 
When a Patient Wants to Die 
Charles F. McKhann, M.D. 
Professor of Surgery 
Yale University School of Medicine 
APRIL 29 
Forty Years of Medical Education at Yale 
Howard Levitin, M.D. 
Professor of Internal Medicine 
Yale University School of Medicine 
MAY 6 
Carlo Levi, MD & the Italian 
Anti-Fascist Movement 
Harvey Mandell, M.D. 
Retired Internist 
David Ward, Ph.D. 
Associate Professor of Italian 
Wellesley College 
MAY 13 
A Surprise 
Jacques Pepin, MA 
Master Chef, Columnist, Author, Teacher 
PBS-TV Host 
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CLINICAL RESEARCH 
A recipe for 
better medicine 
Rapid advances in technology and the rise of managed care have raised questions about the 
cost and benefits of medical care. Outcomes research aims to define just what optimal care 
should include. But, when it comes to health, how do you define a happy outcome? 
Is there a formula for the best medical care? Physicians 
will tell you that for most maladies the same treat¬ 
ment that works in one case is very likely to work in 
the next. If it doesn’t, the physician will pull out the next 
arrow in the medical quiver. In more cases than physi¬ 
cians might care to admit, however, the treatment ap¬ 
plied to two patients with the same disorder can vary 
enormously from region to region, among hospitals 
and even among clinicians within the same hospital. Re¬ 
searchers investigating quality of care and insurers who 
pay for enormously different forms of care for the same 
ailment are beginning to ask why such variations exist. 
As a result, hospitals and some clinical researchers are 
striving to develop standards of care to make sure that, 
no matter who or where, a patient’s treatment will not 
deviate from accepted norms—at least not without a 
good reason. At the same time, many are asking whether 
such a drive for statistically objective standards of care 
won’t turn medicine into a computer-driven system that 
will ultimately undercut the individual and human ele¬ 
ment at its core. 
With the increasing pace of medical advances and 
the explosion of new information available to both pa¬ 
tients and health care professionals, academic health cen¬ 
ters are looking ever more closely at health outcomes. 
The drive to hold the line on costs and to bring the most 
effective treatments to bear has put medical centers on 
notice that they must establish care guidelines. The chal¬ 
lenge is to develop logical methods for determining what 
works best without removing physician experience and 
individual judgment from the art of medicine. 
Karen Baar is a writer based in Woodbridge, Conn. 
Outcomes research, a relatively recent field of in¬ 
quiry, hopes to do just that by studying which ap¬ 
proaches to patient care make the patient healthiest and 
happiest when all is said and done. Outcomes research 
strives to match the best care with the most patients, all 
the while keeping an eye on costs. 
Such research is also one of those relatively uncom¬ 
mon occasions when the interests of academic investiga¬ 
tors and practitioners coincide. “Academic research 
is methodologically rigorous, slower, more nuanced; 
it results in publications, not action,” says cardiologist 
Harlan M. Krumholz, M.D., an associate professor of 
medicine and epidemiology and a leader in the field. He 
is one of a number of School of Medicine faculty at the 
Center for Outcomes Research and Evaluation (CORE) 
at Yale-New Haven Hospital working to evaluate the 
quality and outcomes of health care from many perspec¬ 
tives—the patient, health care professionals, hospitals, 
managed care organizations and employers. “Hospital 
staff,” he notes, “typically don’t have the time or back¬ 
ground to take the academic approach. They are respon¬ 
sible for actually taking care of people; they also have to 
make policy and business decisions to keep the organiza¬ 
tion running. CORE offers a wonderful synergism be¬ 
tween projects to improve care and academic inquiries 
about finding the best opportunities to do that.” 
BEYOND MORBIDITY AND MORTALITY 
“Outcomes research is really a catch-all phrase,” explains 
Dr. Krumholz. “Traditionally, the measures were morbid¬ 
ity and mortality. Now we are looking at newer and 
sometimes less tangible domains, including cost, satisfac¬ 
tion, functional status and quality of life.” 
Outcomes research, or evidence-based medicine, strives to improve care 
by examining which treatments work best and by defining accepted 
norms for the care of patients in any number of clinical areas. Yale-New 
i Haven Hospital has documented close to 60 such clinical pathways, 
giving both patients and care-givers a roadmap for treatment. The overall 
goal—from diagnosis and treatment to early recovery in the hospital and 
discharge home, to the patient’s return to daily activities—is to ensure 
the right things are done for the right people at the right time. 
Early recovery 
jWffv 
One common area of- medical care, treatment of 
heart attack, has already benefited from Dr. Krumholz’s 
studies of treatment-related outcomes and the develop¬ 
ment of clinical pathways aimed at improving outcomes. 
“A heart attack is a heart attack,” says Dr. Cadman. 
“ There is no reason why we shouldn't as a country expect 
the same therapy for a routine myocardial infarction 
whether it happens in Connecticut or California, but 
there is amazing variability.” 
A recent study by Dr. Krumholz and his colleagues, 
published in the Aug. 19 issue of the Journal of the Ameri¬ 
ca}! Medical Association (JAMA), found that patients who 
received beta-blocker therapy had a 14 percent lower risk 
of death at one year after discharge. Despite its docu¬ 
mented benefit, only half of 45,000 patients who were 
ideal candidates for beta-blockers, a possibly life-prolong¬ 
ing treatment, were prescribed the drug when they were 
released from the hospital. “Given that mortality after 
acute myocardial infarction is high in the elderly and that 
beta-blockers reduce mortality in this group, our findings 
reveal an ample opportunity to improve the care and out¬ 
comes for such patients,” says Dr. Krumholz. Not only 
were large numbers of patients not getting a potentially 
beneficial drug, patients in certain regions of the country 
were far less likely to get the drug. Use of beta-blockers 
ranged from a low of 30 percent in Mississippi to a high 
of 77 percent in Connecticut. 
On Jan. 28 The New England Journal of Medicine 
published a follow-up study by Dr. Krumholz and 
colleagues including CORE’s deputy director, Martha 
J. Radford, M.D., and medical student Jersey Chen. 
They showed that much of the better performance by 
top U.S. hospitals in acute myocardial infarction could 
be explained by their greater use of two inexpensive but 
highly effective drugs, beta blockers and aspirin. 
Yale’s outcomes researchers are helping to establish 
benchmarks for care, thereby decreasing such wide vari¬ 
ability. “Harlan’s work on congestive heart failure in the 
elderly has changed our thinking about how to work up 
and manage a group of patients. It’s having a national 
impact,” says Ralph Horwitz, M.D., chair of the Depart¬ 
ment of Internal Medicine. 
, 
, 
Harlan Krumholz’s studies of outcomes from treatment of heart 
attacks have helped to standardize and improve care nationwide. 
For clinicians, it means working through guidelines 
developed to assure that each of their patients gets com¬ 
prehensive, optimal care. Yale-New Haven Hospital has 
developed 57 clinical pathways for inpatients, for prob¬ 
lems such as coronary artery bypass surgery, hip replace¬ 
ment, pneumonia, strokes and chemotherapy of standard 
diseases, says Edwin Cadman, M.D., a professor of medi¬ 
cine and chief of staff at YNHH. “We wanted to docu¬ 
ment that we were improving quality of care and the out¬ 
come of care.” 
Clinical pathways and outcomes research are ideas 
brought over from engineering and business management 
theory. A clinical—sometimes called critical—pathway is 
a predefined set of instructions that takes a clinician 
through each day—sometimes through each few hours— 
of treating a patient with a particular diagnosis. Usually, 
a physician tracks progress by initialing various boxes on 
the chart; the pathway typically includes nursing care, 
medications, nutrition, rehabilitation, education and 
discharge planning. 
Going home 
Dr. Krumholz has also published research that links 
emotional support to recovery for coronary patients, de¬ 
monstrating that those with social networks are far more 
likely to recover quickly. This has led to more direct 
efforts by hospitals to ensure that patients, who may not 
have family or friends to assist them after discharge, re¬ 
ceive more than a prescription upon leaving the hospital. 
DEFINING A GOOD OUTCOME 
While cost efficiency and the effort to develop state-of- 
the-art care motivate outcomes research, the goal of phy¬ 
sicians lies elsewhere. “The system should be for pa¬ 
tients,” says Dr. Krumholz. “The question is how to 
configure it in a way we can afford.” 
To be sure they are getting accurate and complete in¬ 
formation, then, is a challenge for CORE staff. “We try 
to use a combination of standardized, validated 
surveys that have been used in the field, ” says Jennifer 
Mattera, M.P.H. ’95, CORE’s assistant director. “And 
we include a few open-ended questions, what I would 
call common-sense questions, like ‘How do you feel? 
Do you feel you’ve recovered? Do you feel better now 
than before you came to the hospital?’ Both are useful 
in different ways.” 
What complicates matters is that patients may not 
value the same things as their doctors. What, for ex¬ 
ample, determines if a hip replacement procedure is a 
success? A surgeon may focus on technical achievement: 
Did the patient leave the hospital alive and well? But this 
explains only a small part of the outcome. Researchers 
want to know: What percentage of patients who had hip 
replacement feel they are better off as a result six months 
later? And how do they measure “better off,” which can 
vary from returning to the game of golf they love to just 
getting out of bed in the morning without pain? Linking 
perceptions of benefit with real cost reductions can help 
physicians formulate the optimal approaches to treat¬ 
ment and follow-up care. 
Another question researchers are asking is why some 
people do better than others, even when the severity of 
their medical conditions is the same. “It may have to do 
with whether and where they had rehabilitation or if they 
have a family member invested in their recovery,” says Dr. 
Krumholz. “If we can isolate these factors, we can then 
identify people at risk and develop interventions for them.” 
The YNHH Congestive Heart Failure Continuity of 
Care (C-Care) Program, a study developed by Dr. Krumholz 
and Joan Amatruda, R.N., B.S.N., along with a team of 
nurses, physicians, epidemiologists and social workers, ex¬ 
emplifies this approach. C-Care is designed to improve 
outcomes for people with heart failure, thereby decreas¬ 
ing their hospital readmission rates. “Our idea is to de- 
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Staff at the Center for Outcomes Research at Yale-New Haven Hospi¬ 
tal pore through patient data for evidence of which approaches to 
treatment are the most effective. From left, Joan Amatruda, R.N., Sally 
Roumanis, R.N., Martha Radford, M.D., and Jennifer Mattera, M.P.H. 
sign a strategy that will improve patients’ quality of life 
and allow them to get control over their illness,” says Ms. 
Amatruda, C-Care’s director of clinical nursing services. 
For the study, patients have been randomly assigned 
to two groups. On leaving the hospital, one group gets 
the standard care and a set of written instructions for 
what to expect and how to respond to problems. With 
the second or “intervention” group, Ms. Amatruda and 
other staff go to extra lengths to follow up and educate 
the patients. During home visits, Ms. Amatruda teaches 
patients about their illness, medications, and lifestyle and 
health behaviors that play a significant role in the condi¬ 
tion. She also teaches them the early signs and signals of 
a problem and makes sure that patients know how to get 
the help they need. And she gives patients a book she 
wrote which summarizes the necessary information and 
lists community resources and how to get access to them. 
With one patient in the C-Care program, part of the 
intervention was teaching him to negotiate the system. 
When heart attack-sufferer George Sholes was discharged 
from the hospital for a second time, he recalls that his at¬ 
tending physician told him, ‘“When you notice or sus¬ 
pect you’ve got this, that or the other thing, call me.’” 
Mr. Sholes wasn’t clear just what that meant in practical 
terms. “I was pretty sure he didn’t mean simply, get in 
touch with me, since that’s what I thought I had been 
trying to do by going through the usual chain-of-com- 
mand from my primary care person at my HMO.” Nor 
did he think he should page the physician, as a ward 
nurse suggested. He was feeling adrift as he was preparing 
to go home until Ms. Amatruda made sense of the “cul¬ 
tural fog.” She told him that, in the event of a problem, 
he was to call his attending physician’s nurses, who would 
contact the doctor if it were necessary. Moreover, she 
supplied the necessary telephone numbers. 
“It’s no magic formula but absolute common sense,” 
explains Ms. Amatruda. Researchers will follow both 
groups and compare their readmission rates. If the pro- 
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gram is successful, it can be adapted to any number of 
other diseases. 
THE SUBJECTIVE ANIMAL 
One of the challenges facing outcomes researchers is as¬ 
sessing patient satisfaction and quality of life in a scien¬ 
tifically acceptable way. Some researchers hold that only 
standardized tools that have been proven reliable and 
valid when used in large populations are legitimate. But 
others argue that instruments such as checklists lose sight 
of the individual and miss important information. More¬ 
over, some physicians view this work as a challenge to 
their authority and interference with their practice. They 
are suspicious that managed care and cost considerations 
are driving the research. Detractors say that medicine is 
an art and that clinical pathways are “cookbook medi¬ 
cine” that will stifle innovation. 
Predicting who will benefit 
most from surgery The majority of people with epilepsy have 
what is called localization-related epilepsy; 
their seizures are triggered in one area of 
the brain. Of these people, about 20 percent have 
seizures that cannot be controlled. 
Susan Spencer, M.D., professor of neurology at 
the School of Medicine, is principal investigator of 
the Multi-Center Study of Epilepsy Surgery, a major investigation 
funded by the National Institutes of Health to predict who will benefit 
most from surgery used to treat this condition. The procedure is de¬ 
cades old, but as diagnostic technology, such as magnetic reso¬ 
nance imaging, has improved, so has the ability to identify and define 
the responsible area in the brain. 
“We are now using the treatment more and more,” says Dr. Spen¬ 
cer, “but no one has rigorously studied what are the best predictors 
of success in terms of quality of life. And it appears, looking at our 
patients, that some have remarkable improvement and some do not.” 
Over the next two years, Dr. Spencer and colleagues will be re¬ 
cruiting at least 400 patients at six medical centers. Researchers will 
periodically assess the patients’ quality of life for two years after their 
surgery. 
“The quality-of-life issue has never figured into patient selection, 
but it may begin to figure as much as seizure control,” says Dr. Spen¬ 
cer. “We need to know who are the patients for whom we can make 
the biggest difference.” For example, even when their seizures are 
eliminated, only some patients go on to hold jobs or drive. “We may 
begin to study what prevents people from improving and whether we 
should be providing counseling or vocational training. We’ll perform 
the same service much better.” 
Susan Spencer 
Evaluation of 
quality of life 
“It’s troublesome that the psychometric academic 
Mafia think that they can tell you the quality of your life 
from some sort of checklist,” says Alvan Feinstein, M.D., 
Sterling Professor of Medicine and Epidemiology. “Creat¬ 
ing these checklists for measuring health describes a sta¬ 
tus, but not quality of life. Suppose we consider someone 
who has had paralysis in both legs and has to walk with 
braces and crutches. Does that person have good quality 
of life? If you say no, you are denying that Itzhak 
Perlman has a good quality of life. There’s a difference 
between someone’s health status and their reaction to 
that status and the only way to measure that in my opin¬ 
ion is to ask someone directly.” To critics who dismiss 
such a technique as subjective, he replies: “If you want to 
deal with wholly objective data, study rats; it’s the subjec¬ 
tive stuff that distinguishes people as people.” 
Ms. Amatruda’s home visits for the C-Care Program 
demonstrate how misleading any patient-supplied infor¬ 
mation may potentially be. “One gentleman looked good 
on his profile,” she says, “but when I visited, he was liv¬ 
ing alone and was unable to get up to his second-floor 
bedroom. He had set up an old broken Barcalounger in 
the kitchen to elevate his legs so that he could sleep. 
There was nothing in the refrigerator and his stomach 
was growling.” Ms. Amatruda sent in a social worker; he 
now has a home health aide several times a week and has 
accepted Meals on Wheels. 
On the other hand, Ms. Amatruda visited a woman 
whose husband had just died and who, based on her pro¬ 
file, looked like she was in trouble. But the home visit re¬ 
vealed that she was 
appropriately grieving 
and had plenty of 
support. 
PUTTING DATA 
TO WORK 
The rise of outcomes 
research has been 
powered in part by 
the increasing use of 
computers to collect 
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Edwin Cadman 
“There is no reason why we 
shouldn’t expect the same 
therapy for a routine myocardial 
infarction whether it happens in 
Connecticut or California, but 
there is amazing variability.” 
Ralph Horwitz 
“Work [at Yale] on congestive 
heart failure in the elderly 
has changed our thinking 
about how to work up and 
manage a group of patients. 
It’s having a national impact.” 
and maintain data about patient care. Physician-to-physi- 
cian comparisons can be made, as well as studies of 
across-the board care of similar conditions. “Every order 
at our hospital is computerized,” says Dr. Cadman. “You 
cannot hand write an order and haven’t been able to do 
that for five years. That sets us apart from probably 95 
percent of other medical centers. Because everything is 
retained in the database we can ask ‘How many times 
does Physician X order such a test?’ or ‘How many times 
is this test ordered in heart attack cases?’” 
Having such information is invaluable. When hospi¬ 
tal administrators learned, for example, that surgeons 
were ordering a daily chest X-ray for patients undergoing 
a particular surgical procedure—and that the X-ray al¬ 
most never showed any change—they were able to report 
back to the surgeons and eliminate the practice. 
“In a case like that, there’s no diminution in quality of 
care and you can reduce costs substantially,” says Dr. 
Cadman. It can also be used as a teaching aid. For ex¬ 
ample, cardiac surgeons discuss how they treat patients, 
debate the merits of various practices and come up with a 
consensus, which then becomes the “Yale” standard of 
care. Once developed, the standards are available on the 
computer system. “It’s a great teaching tool for interns 
and residents,” says Dr. Cadman. 
In addition to individual patients and clinical treat¬ 
ments, CORE staff look at the bigger picture: “How 
should resources be allocated?” asks Dr. Krumholz. 
“Where are the gaps? What care ought to be delivered 
and how?” 
Outcomes research can help to fill in holes in medi¬ 
cal care. For example, says Dr. Krumholz, “People with 
Return to daily activities 
a condition called atrial fibrillation can be treated with 
blood thinners to prevent strokes. But the number of 
people getting this treatment is small. Why?” The aim 
of outcomes researchers in this instance is to identify 
the gap and to increase the number of patients being 
treated appropriately. 
Although Dr. Krumholz and colleagues acknowledge 
the potential for problems, they argue that the clinical 
pathways are not static. Rather, they represent the opti¬ 
mal suggested practices based on current knowledge. In 
the case of Yale-New Haven Hospital, teams of local ex¬ 
pert clinicians worked exhaustively over several years to 
come up with the 47 existing pathways, a process coordi¬ 
nated by Dr. Cadman and colleagues Leo Cooney, M.D., 
and Victor Morris, M.D. Are those pathways now com¬ 
plete? No, says Dr. Krumholz, and they never will be. 
“We have to continually reevaluate the best practices and 
new treatments,” he says. 
Besides, a physician is free to depart from the stan¬ 
dard. “But if he or she deviates there must be a reason,” 
says Dr. Cadman. “Maybe that particular patient is sicker 
or there is another complicating feature.” And because 
any variation must be documented and justified on the 
patient’s chart, physicians and the hospital gain a measure 
of legal protection in the event of a malpractice claim. 
While deviations from the standard may need to be 
justified, they aren’t necessarily bad. “Not offering a 
blood thinner to someone with atrial fibrillation because 
no one thought about it is the variation we aim to get rid 
of,” says Dr. Krumholz. “But tailoring an intervention to 
an individual patient’s preferences—we never want to ex¬ 
tinguish that kind of variation. ” EE) 
PROFILE 
A new 
prescription fi 
Puerto Rico 
Puerto Rico's popular and controversial governor, a Yale-educated 
physician bent on health care reform and statehood, 
has taken island politics by storm. 
By John Curtis 
On a chilly evening last March, Pedro J. Rossello 
strode to a podium at the Yale Law School to 
argue that Puerto Rico, the U.S. island-com¬ 
monwealth he has governed since 1993, should become 
the nation’s 51st state. In the audience at this symposium 
on the island’s political status were members of the 
issue’s three dominant political camps—advocates either 
of statehood, independence or continued common¬ 
wealth status. While the governor doubted that his re¬ 
marks would change any minds, it was an important 
speech. He would deliver essentially the same message a 
lew days later to the U.S. Senate, where he was sched¬ 
uled to testify in support of the United States-Puerto 
Rico Political Status Act, which proposed placing the 
long-debated question of status in the hands of Puerto 
Rican voters. 
For Governor Rossello, a Yale-educated physician 
and public health expert, the Law School symposium 
was a homecoming of sorts. A successful pediatric sur¬ 
geon and former health director for the city of San Juan, 
he spent four years in New Haven, graduating cum 
laude from the School of Medicine as president of the 
Pedro J. Rossello Jr., M.D. ’70, 
celebrates his second gubernatorial 
victory in Puerto Rico on Election 
Day 1996. 
John Curtis is a staff writer. 
class of 1970. Since his election 
as governor six years ago in 
the first of two landslides, he 
has pursued major structural 
change in Puerto Rico with 
enormous energy. Topping the 
list: health care reform, which 
has created a single-payer sys¬ 
tem for almost half the island’s population during the 
last four years; and statehood, a highly charged issue 
with a still uncertain future. In a December referendum 
on self-determination, 50.2 percent of the voters 
chose “none of the above,” widely seen as both a 
protest against the vote and support of commonwealth 
status. But Dr. Rossello took comfort in the showing 
for statehood, which garnered 46.5 percent of the vote. 
“Today the people spoke and they said statehood is the 
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future of Puerto Rico,” he insists in the face of the am¬ 
biguous results. 
“Puerto Rican statehood,” Dr. Rossello told the 
Law School audience last spring, “will create a bilingual, 
bicultural bridge, linking the American continents. It 
will spur trade, investment, and greater prosperity for 
peoples all around our hemisphere.” He added: “It will 
convert our island from a disenfranchised outpost to an 
evermore valuable asset as the Americas team up to com¬ 
pete as a single trading bloc in the global marketplace.” 
His advocacy of political and economic causes does 
not end at his home borders. To avoid crossing a labor 
picket line, he asked that the venue for his speech move 
to the Law School from New Haven’s Omni Hotel, 
where workers were locked in a unionization dispute 
with management. As he entered the hall, he received a 
standing ovation, even from those on other sides of the 
most important debate in Puerto Rico. 
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It is clear that, as governor, he incites strong passions. 
His constituents have twice given him overwhelming 
victories—and they have erupted in fury at some of his 
policies, with unions nearly shutting down the island for 
several days last summer, for example, over his proposal 
to privatize the government-owned telephone industry. 
Undeterred, Dr. Rossello seems capable of pressing 
forward with issues that he considers important, 
regardless of the uproar from various quarters. 
“Any change will create controversy because you 
alter the status quo,” he said during an interview in 
Connecticut last spring as he prepared for his Yale 
speech. Possessing an easygoing charm and, at 54, still 
showing the trim figure of the nationally ranked tennis 
player he was in his youth, he arrived fresh from an 
afternoon jog and shower and deftly fielded questions 
about health care reform, statehood and his time at Yale. 
Since Puerto Rico became a commonwealth in 1952, 
with the island’s political destiny in the hands of Con¬ 
gress, nothing has inflamed and divided islanders more 
than their political status. In a nonbinding 1993 referen¬ 
dum, the commonwealth option prevailed in a narrow 
victory over statehood, 48.6 percent to 46.3 percent. 
Now, not only as governor, but also as last year’s 
president of the U.S. Council of State Governments and 
chair of both the Democratic and Southern Governors’ 
Associations, Dr. Rossello has secured a platform for a 
goal he has pursued since his medical school days. 
During much of 1998, however, other events competed 
for his attention. The year began with a rebuke from the 
Inter-American Press Association, which accused him of 
abusing his office by withdrawing government advertis¬ 
ing from a newspaper critical of his administration. 
Dr. Rossello responded that the government was simply 
seeking a more effective advertising medium. In July, 
50 unions struck for two days over the telephone 
privatization plan. And in September, Hurricane Georges 
killed 11 people in Puerto Rico, caused an estimated 
$2 billion in damage and left 17,000 homeless. 
AN EYE ON HEALTH CARE 
His 1996 reelection by the largest margin of any Puerto 
Rican governor in 32 years attests to an administration 
distinguished by more than discord, dissent and disaster. 
Since his inauguration in 1993, access to health care has 
increased, the crime rate has dropped by half, taxes have 
gone down nearly 20 percent, community schools have 
replaced a centralized education bureaucracy, and public 
servants have received major salary hikes and the right to 
unionize. Eager to wean the island’s economy from de¬ 
pendence on federal tax exemptions, he has modernized 
the industrial infrastructure, streamlined permit require¬ 
ments and created incentives for tourism and exports. 
While Dr. Rossello’s health plan has angered some, 
almost everyone in Puerto Rico agrees that change was 
sorely needed. Before health care reform, only about 
half the island’s population had private insurance or the 
means to pay for medical services. The other half, the 1.7 
million islanders considered medically indigent, relied 
on Medicaid and a government health system hampered 
by bureaucracy, inadequate funding and political parti¬ 
sanship. The island has the highest infant mortality rate 
and the lowest average infant birth weight among all 
U.S. states and territories. It also had the frightening 
distinction of being home to seven of the 10 hospitals 
with the highest death rates in the United States. 
Despite those deficiencies, many Puerto Ricans were 
simply too poor to seek medical care outside the govern¬ 
ment-run clinics. Of the 3.8 million islanders, 58 percent 
live at or below poverty level. The per capita income in 
1996 was $8,403, about half that of the poorest of the 
50 states, Mississippi. 
Dr. Rossello has resolved to replace the parallel, 
but unequal, health systems with a single, managed 
care system. “The government is redefining its role,’’ 
Dr. Rossello says. “Instead of being the direct provider, 
it is using its resources to buy insurance for people. 
The goal is a transition from two separate systems, one 
public and one private, into one system, which is ac¬ 
cessed through health insurance.” Why was change 
needed? “The problem of the previous system,” the 
governor says, “was that the outcomes were very differ¬ 
ent.” Infant mortality, for example, was shown to be 
higher in the public system than in the private. 
In 1993, Dr. Rossello signed a bill passed by the 
island’s legislative assembly that created the Puerto Rico 
Health Insurance Administration. The PRHIA immedi¬ 
ately launched a pilot program in Fajardo, a city on the 
island’s northeastern coast with high infant mortality 
and teen pregnancy. By the end of 1998, health reform 
had enrolled 1.5 million people. Since the reform began, 
more physicians, pharmacies, clinics, hospitals and 
health care centers have become accessible to the medi¬ 
cally indigent. The island’s infant mortality rate declined 
from 12.7 per thousand in 1995 to 10.5 per thousand in 
1996. Outcomes studies are also under way to measure 
the reform plan’s impact on people’s health. The cost of 
delivering health care has not gone down, but it has not 
increased as rapidly as before the reform. “If we had con¬ 
tinued the old system, it would not have gone down,” Dr. 
Rossello says. “It would have gone up at a steeper rate.” 
No longer providing direct medical care, the govern¬ 
ment health department is concentrating on preventive 
measures, such as vaccinations. It is also selling its hospi- 
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The mechanics of reform 
In 1993, during his first term as governor, Pedro J. Rossello, 
M.D. '70, sought to eliminate the two-tiered health care de¬ 
livery in Puerto Rico that divided care into public and pri¬ 
vate systems. His health reform has given 1.5 million of the 
1.7 million medically indigent islanders insurance cards that 
provide access to managed care services throughout Puerto 
Rico. The government health system—understaffed, under¬ 
funded and overburdened—is to be dismantled, and the local 
government and Medicaid funds that supported it are to be 
diverted to the health reform. 
In 1993, the Puerto Rico Health Insurance Administration 
was created as the supervisory agency of health reform, 
authorized to organize regional health alliances and contract 
with insurers for coverage. Blue Cross of Puerto Rico received 
a $30.2 million contract to serve the small northeastern city 
of Fajardo, the pilot program for the health reform, chosen for 
its high infant mortality, high rate of teen pregnancy and low 
life expectancy. Since then, three other insurance companies 
have joined the reform plan, providing coverage to 1.5 million 
Puerto Ricans. By June 1999,1.6 million people are expected 
to receive coverage. 
In Fajardo in January 1994, Dr. Rossello distributed the 
first 400 personal health insurance cards, known as la 
tarjetita, the little card, which give holders access to basic 
medical services such as vaccinations and checkups. By the 
time it is fully implemented, in June 2000, the reform plan is 
expected to cover about 55 percent of the island’s popula¬ 
tion, including everyone at or below 200 percent of the pov¬ 
erty level and all government employees. 
Before health reform about 1.2 million people, 34 percent 
of the island’s population, had partial medical coverage 
through Medicaid and another 450,000 people, or 11 
percent, depended on public health systems provided by the 
island or municipal governments. They will be covered by the 
reform plan, which also includes Medicare subscribers who 
cannot afford supplementary care. 
Gov. Pedro Rossello, at left, has made health care reform a center- 
piece of his administration. He presents a family from the northeast¬ 
ern town of Loiza with the government health insurance card. 
The impact of the pilot program in Fajardo was immediate. 
Within 17 days of the start of health reform, the ratio of 
patients to primary care providers went from 1,325-to-l to 
484-to-l. Participation by physicians is voluntary, but as 
health reform spread across the island, many physicians 
saw the number of fee-for-service patients decline. In addi¬ 
tion, an increased number of health care centers and 
pharmacies became available. 
“Of the total resources that we invested in health, about 
15 percent were federal, mostly Medicaid funds, and 85 
percent were state,” says Dr. Rossello. “Instead of using this 
to run our own hospitals and pay public service doctors and 
nurses, we are using those resources to buy insurance. It’s 
using those resources we had before. We are using them in 
a different way.” 
tals and clinics to pay off the debt for the construction 
of those facilities. Support for the health reform, 
however, has not been unanimous. Although Dr. 
Rossello cites studies showing a patient satisfaction 
rate of 90 percent, a report prepared by the College of 
Physicians and Surgeons of Puerto Rico in 1996 gave 
the reform mixed reviews. For the medically indigent, 
the report noted better and faster access to primary care, 
laboratories, medications, emergency rooms and 
hospitals. But it also found widespread discontent over 
reimbursement among physicians, who struck in protest 
for 10 days in 1996. 
Doctors who participate in the reform plan receive 
a capitation payment of $46 per patient per month. 
Physicians say it is too low because medical coverage 
is broad and because physicians have no control over 
ancillary services, such as those provided by laboratories, 
pharmacies and emergency rooms. Doctors are working 
more, earning less and spending less time with their 
patients. “The problem with the reform,” says Jose 
Roman de Jesus, M.D., a former president of the Puerto 
Rico Medical Association who led the study, “is that 
they have done it too fast, without stopping to analyze 
problems that exist, look for alternatives and then 
move ahead.” 
Dr. Rossello responds that physicians must simply 
adapt to new incentives under the health reform. 
“Before,” he says, “you made more money the sicker 
the patient was. The new paradigm is you make more 
money the healthier your patient is.” 
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San Juan 
Fajardo 
Puerto Rico at a glance 
1998 population: 3.8 million 
Annual health budget: $1.75 billion 
Number enrolled in health reform: 1.5 million 
Per capita income (1996): $8,403 (United States, $18,552) 
Infant mortality: 10.5 per 1000 live births in 1997 
(United States, 6.5/1000) 
Life expectancy: 76.6 years (United States, 76 years) 
Unemployment rate: 12.5% (United States, 5.4%) 
Poverty rate (1997): 58% (United States, 13.3%) 
Poverty level (1990): $12,674 for a family of four 
Literacy rate: 89% (United States, 97%) 
Sources: Pan American Health Organization, Puerto Rico Department 
of Health, Puerto Rico Department of Economic Development and 
Commerce, Department of Labor and Human Resources of Puerto 
Rico and the U.S. Census Bureau. 
THE PATH TO POLITICS 
Dr. Rossello’s route to a political career began in 
medicine. After his graduation from Yale, he went on 
to residency at Beth Israel Hospital in Boston, where he 
trained with renowned Harvard cancer specialist Judah 
Folkman, M.D. (While at Yale, Dr. Rossello married 
his wife, Maga, the former Irma Margarita Nevares, 
with whom he has three sons, one a Yale College 
graduate.) In 1976, he returned to Puerto Rico to start 
the academic career he had contemplated while in 
New Haven—a pediatric surgery practice and a 
teaching post at the University of Puerto Rico (where 
he remains on the faculty). But back at home he saw his 
surroundings with new eyes. “What I encountered on 
the island was sobering,” Dr. Rossello wrote in his 1993 
proposal for health reform. “Our health service delivery 
system fell far short of the standard to which we aspired: 
that is, quality care for all, regardless of the patient’s 
economic circumstances.” 
In 1981 he earned a master’s degree in public health 
from the University of Puerto Rico and, four years 
later, became director of health in San Juan, the island’s 
2 2 
Political status 
1898: Spain cedes Puerto Rico to the United States at the 
close of the Spanish-American War through the Treaty of Paris. 
1902: The United States declares Puerto Rico a territory. 
1917: The Jones Act gives Puerto Ricans U.S. citizenship and a 
locally elected legislature; executive authority remains in the 
hands of a governor appointed by the U.S. president. 
1947: Congress permits Puerto Ricans to elect their governor, 
effective in 1948. 
1952: Congress ratifies a local constitution for Puerto Rico, 
subordinate to and compatible with the U.S. Constitution; the 
territory is denominated a commonwealth. 
1967: In the first plebiscite on the island's status, Puerto 
Ricans endorse commonwealth over statehood, 60 percent to 
39 percent. Independence garners 1 percent of the vote. 
1993: In a second plebiscite, the commonwealth polls 48.6 
percent to statehood’s 46.3 percent, with independence at 
4.4 percent. 
1998: A third plebiscite, offering four options based on legisla¬ 
tion approved earlier that year by the U.S. House of Represen¬ 
tatives, generates 46.5 percent backing for statehood; nearly t 
all of the remaining votes (50.2 percent) are cast for “none of 
the above” in a protest led by commonwealth advocates. 
] ru 
Sources: Time Almanac 1999 and the Office of the Governor of 
Puerto Rico. 
ilt 
capital. He chaired the pro-statehood New Progressive 
Party’s 1988 platform committee, which called for health 
care reform. Of his decision to enter politics, he says, 
“The triggering factor was my desire to improve health 
care delivery in Puerto Rico. I did not expect to be in 
the public health field and even less in the political arena 
when I made my career choice initially.” 
The unexpected transition from a surgeon to a 
nationally prominent political figure is in keeping with 
his character, say medical school friends who recall his 
prowess both with a scalpel and a tennis racket. He had 
been captain of the tennis team during his undergraduate 
days at Notre Dame, and he brought some of that same 
leadership and competitive drive to his medical studies. 
“He made a number of important contributions to the 
field of pediatric surgery,” says Robert J. Touloukian, 
M.D., a Yale professor of surgery and pediatrics and 
one of his instructors. Among his accomplishments, 
Dr. Rossello originated an esophageal lengthening 
procedure that is now used all over the world. 
Robert Rosa, M.D. ’70, met Rossello as a first-year 
student and was his anatomy class partner. “What led 
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him into politics, I think, was a great concern for Puerto 
Rico and its people,” says Dr. Rosa. “That was probably 
the motivating factor, that he could provide the kind of 
leadership and direction that he felt Puerto Rico 
needed.” Another classmate, W. Romney Burke, M.D. 
’70, recalls long conversations in Spanish in which his 
friend spoke in favor of statehood. “I would not have 
predicted his becoming governor,” says Dr. Burke, now 
a urologist in Oregon. “But I’m not surprised.” 
Speaking at Yale last March, Dr. Rossello ticked off 
reasons why statehood would be good for Puerto Rico 
and dismissed the standard objections. Proponents of 
English as the nation’s official language worry about ad¬ 
mitting a state where the majority speak Spanish. Bilin¬ 
gualism, answers Dr. Rossello, is a cornerstone of Puerto 
Rico’s role as “midwife” to the commercial integration of 
the hemisphere. Political delegations from certain small 
states believe the admission of Puerto Rico will cost 
them seats in the House of Representatives. A 1911 act 
of Congress limiting House membership to 435 seats, 
Dr. Rossello says, could be amended to increase the size 
of the House. To those who argue that the current com¬ 
monwealth status offers the best of both worlds, confer¬ 
ring U.S. citizenship without federal income taxes, he 
countered that the status quo perpetuates the congres¬ 
sional oversight that has ruled the island since 1898. 
Although the House of Representatives approved 
the bill in March 1998, the Senate adjourned last year 
President of his medical school class, Gov. Rossello returned to Yale in 
March 1998 to push for statehood for Puerto Rico during a speech at 
the law school before traveling to Washington to speak to Congress. 
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without addressing it. The Senate did pass a resolution 
recognizing the right of Puerto Rican voters to express 
their views in a referendum and make them known to 
the president and Congress. Puerto Rican officials then 
scheduled for December 13 a nonbinding referendum 
offering five choices: commonwealth, statehood, free 
association, independence and none of the above. 
With the bulk of the vote divided between statehood 
and “none of the above,” the next step is unclear. Dr. 
Rossello’s opponents, who urged voters to cast their 
ballots for “none of the above” to protest the plebiscite, 
saw the results as an affirmation of the status quo. But 
the governor vowed to press his campaign to make 
Puerto Rico the 51st state. “It’s a watershed moment,” 
he says. “For the first time there is a consensus in Puerto 
Rico that there has to be a change in political status.” 
Among the beneficial effects of statehood, Dr. 
Rossello believes, would be a redistribution of wealth as 
the more affluent become, for the first time, subject to 
federal income tax. “We have to recognize that statehood 
for Puerto Rico does have an internal impact of having 
wealth redistributed from the top level to the bottom 
level,” he says. “That is a goal that I am very much 
in favor of.” 
His political goals might appear to conflict with 
his own interests as a physician and a member of the 
island's higher social ranks. Dr. Rossello and his three 
sisters grew up in a household rich in political and 
social connections. Their father, a prominent psychiatrist 
who had held high government and university posts, 
inspired Dr. Rossello to become a physician by his 
example. The family’s roots in Puerto Rico go back 
several generations, to ancestors who migrated from 
Mallorca, a Spanish island in the Mediterranean. 
Dr. Rossello insists his own interests, however, 
are secondary to the social benefits of the policies he 
endorses. “They represent the common good, the best 
options for our people.” Statehood also would prove a 
boon to health care, Dr. Rossello believes. It would 
invert the present funding formula so that federal 
funds would provide 83 percent, rather than the current 
15 percent, of the island’s health budget. 
“In a very conscious way we have tried to make 
this big change. It has not been without difficulties and 
it still has some resistance,” he says, adding that he 
borrowed ideas from President Clinton’s 1993 national 
health reform proposal. “Eventually it will serve at least 
as a discussion model. As a health advocate, this is 
central to me. I think Puerto Rico is on the verge of 
establishing a principle that is dear to health advocates, 
that health care is not the privilege of some, but the 
right of everyone.” H2] 
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Inhaled steroids have dramatically improved 
the management of asthma, decreasing both 
the frequency and severity of episodes by 
reducing inflammation. Tara DellaCamera, 
above, uses an inhaler during a visit to 
the Yale Physicians Building. To study the 
molecular underpinnings of the disease, Yale 
researchers have implanted human genes 
implicated in asthma into mice. The purple 
stain in the image at left is mucus accumu¬ 
lating in the airway of a transgenic mouse. 
of Asthma 
Asthma was once thought to he on the wane, 
but in recent decades its incidence has 
soared. Yale scientists have solved a piece 
of the puzzle and hope their findings will 
lead to new ways to treat and even prevent 
the disease. 
by Marc Wortman 
nyone who visited East Germany prior to the fall 
of the Berlin Wall in 1989 remembers a heavy pall 
of gray and yellow smoke that hung over much 
of the landscape. The widespread burning of soft coal 
for heat and energy and the lack of pollution controls 
for motor vehicle exhaust and heavy industry made for 
some of the worst air pollution and general environmen¬ 
tal quality in the world. An ecological nightmare, it was 
also a disaster for the lungs of East Germans, who suf¬ 
fered extremely high rates of respiratory problems like 
emphysema and bronchitis. Public health officials, who 
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were already contending with the skyrocketing increase 
in asthma rates throughout Western Europe, feared a 
veritable tidal wave of patients arriving from the East 
with severe asthma problems when the wall came down. 
They were in lor a shock. 
Airborne pollutants like coal dust, auto exhaust and 
chemical emissions from industrial smokestacks are 
among the most potent triggers of the chronic coughing, 
mucous production, wheezing and dangerously con¬ 
stricted airways that typify asthma. According to most 
standard theories about its causes, chronic, high-level 
exposure to pollutants, dust and other environmental 
stimuli should increase the likelihood that a person will 
develop the disease and suller frequent attacks. That and 
the generally limited health care system and medications 
available in East Germany appeared to create fertile 
ground for an asthma problem of monumental propor¬ 
tions. Yet just the opposite proved true. While East 
Germans did have very high levels of other respiratory 
infections, they were afflicted with dramatically lower 
rates of asthma than their Western brethren. Much of 
the medical community was baffled. 
Isolating asthma Asthma most often arises dur¬ 
ing childhood, but adults 
exposed regularly to certain 
industrial chemicals are also at risk 
for developing the disease. Figuring 
out why children get asthma can be 
enormously complex, but the cause 
of the disease when it develops in 
the workplace can sometimes be 
identified. Yale researchers hope 
that studying work-related asthma 
may lead to new ways of preventing 
it from developing in exposed work¬ 
ers, as well as to a better under¬ 
standing of the mechanisms under¬ 
lying other types of asthma. 
Certain adults develop asthma 
due to workplace exposure to spe¬ 
cific chemicals. These can include 
doctors, dentists and nurses, who 
are exposed to latex in gloves, and 
beauty salon workers, who are ex¬ 
posed to hair sprays and nail pol¬ 
ishes. One of the most common 
causes of workplace asthma is ex¬ 
posure to isocyanates. These chemi¬ 
cals are found in the hard, shiny 
spray paints and lacquers used in 
auto-body shops and in numerous 
polyurethane foam and plastic prod¬ 
ucts such as mattresses and boat 
hulls. Somewhere between 5 and 
20 percent of workers who are ex¬ 
posed to isocyanates develop 
asthma. “It’s a problem in industry,” 
says Carrie Redlich, M.D., who is di¬ 
recting studies of work-related 
asthma. “Once you get asthma you 
need to get away from the chemi¬ 
cals. You can lose your livelihood." 
Working with small auto-body 
shops around New Haven, Dr. 
Redlich, an associate professor of 
medicine, has been investigating the 
allergy process, as well as who is in 
danger of getting the disease and, 
when they do get asthma, what ac¬ 
tually happens in the lungs. Dr. 
Redlich gives asthmatic workers 
controlled doses of isocyanates in 
an exposure chamber—the only one 
of its kind in the U.S.—and then 
studies the physiologic and immuno¬ 
logic responses. She can also ex¬ 
pose human lung cells to isocyan¬ 
ates to better understand how the 
chemicals cause asthma. 
Eventually she hopes to develop 
a test to see who among industrial 
workers have begun to develop the 
disease. “If we can identify them 
early enough,” Dr. Redlich says, “and 
get them away from exposure, we 
may be able to prevent the 
development of asthma. 
But if you miss them, they 
may go on to develop 
chronic asthma that could 
be with them—and possi¬ 
bly disable them—for the 
rest of their lives.” 
Workers in autobody shops are 
exposed to chemicals that can 
lead to career-ending asthma. 
Some scientists, including many at Yale, now believe 
they have a plausible explanation for why this happened. 
These researchers suspect that improved hygiene and 
pollution control, immunization, antibiotics and early 
diagnosis and treatment of diseases may have paradoxi¬ 
cally made Western Europeans and Americans more 
prone to developing asthma. Our immune systems, they 
contend, evolved to deal with a pathogen-fdled world. 
With fewer pathogens around to defend against, power¬ 
ful immune responses have instead focused on otherwise 
benign inhaled allergens, setting off a cascade of changes 
to lung tissue resulting in asthma. While the theory 
remains controversial, epidemologists have found addi¬ 
tional anecdotal evidence in other population groups 
around the world to support it, and Yale researchers have 
recently discovered molecular evidence to back it up. 
That research is part of a concerted effort at Yale to 
tackle the disease. The designation by the National 
Heart, Lung and Blood Institute of the National Insti¬ 
tutes of Health (NHLBI, NIH) in January 1997 of Yale 
as one of the nation’s seven Specialized Centers of Re¬ 
search (SCOR) for the study of asthma underscored the 
strength of the work being done by the researchers. If 
their efforts to parse out the genetic and molecular path- 
jack Elias, above, directs one of the nation's seven NIH-funded 
Specialized Centers for Research for the study of asthma. 
A hallmark of the Yale program is to introduce human genes 
believed to be associated with asthma into the lungs of mice 
and observe the resulting changes. Above top: A normal mouse 
airway and, below, that of a transgenic mouse with scar tissue 
caused by asthma, stained green. 
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ways that lead to asthma ultimately bear fruit, they— 
along with their clinical colleagues applying these basic 
science concepts to health care practices—will raise 
hopes of finding new means to prevent and even halt the 
chronic and sometimes fatal disease. 
AN EPIDEMIC OF WHEEZING 
There is an enormous need for improved understanding 
of asthma and for better diagnostic tools, prevention 
methods and treatments. While some have insisted that 
the rise in asthma rates reflects improved recognition of 
the disease by clinicians and better reporting by the 
health care industry, there is little evidence that this can 
account for the across-the-board size of the increase. 
Jack Elias, M.D., a professor of medicine at Yale and 
chief of the section of pulmonary and critical care 
medicine is head of the asthma SCOR. He says, “In the 
1970s, asthma was actually getting less common. Then 
something happened. We’ve seen a documented increase, 
a doubling of its prevalence and severity.” According to 
the U.S. Centers for Disease Control and Prevention 
(CDC) statistics, asthma rates have risen enormously 
by all measures. There were about 6.8 million cases of 
asthma in 1980. That number rose to more than 15 
million in 1998, encompassing about 5 percent of 
the population. 
The highest proportion of cases is seen among chil¬ 
dren ages 5 to 14. According to the NHLBI, somewhere 
between 5 and 6 million children suffer from asthma, 
making it the most prevalent chronic childhood disease. 
It causes more missed school days—well over 10 million 
annually—than any other chronic disease. It is also 
among the top three causes of hospital admission in the 
country for all age groups and the leading cause for chil¬ 
dren. The annual cost of treating asthma jumped from 
around $6 billion in 1990 to more than $10.2 billion 
by 1997- The severity of asthma attacks has increased 
alarmingly as well. In the 1970s, death from asthma was 
uncommon. Unrelieved asthma suffocated somewhere 
between 5,000 and 7,000 people last year. 
Although high asthma rates now affect all 
segments of American society, it has reached epidemic 
proportions among inner-city minorities. For instance, 
in Connecticut non-whites make up only 13 percent 
of the total population but account for nearly 50 percent 
of all asthma hospitalizations. The death rate among 
non-whites from asthma is three times higher than that 
for whites. 
It is only in the past decade that researchers have 
begun to gain a clearer understanding of the disease. 
Asthma is a chronic disease characterized clinically by 
recurring episodes of spasms, or muscle contractions, of 
the bronchial tubes, constricting and closing off airways. 
Pathologically, the tissue of an 
asthmatic’s airways is constantly raw 
and inflamed, leading to frequent 
coughing and wheezing. Those in¬ 
flamed airways are hyper-responsive to 
a wide variety of stimuli. In the large 
majority of cases, asthma attacks result 
from viral infection. In many others, 
asthma is worsened by allergic-type re¬ 
actions to allergens, or triggers, like 
pollen, foods, dust mites, mold, ani¬ 
mal dander and feathers. (Most often, 
these asthmatics have other types of 
allergic reactions as well, such as rashes 
and food allergies.) Once asthma be¬ 
comes chronic, the triggers that can set off an attack em¬ 
brace more and more environmental stimuli and can in¬ 
clude colds and other upper-respiratory-tract infections, 
cigarette smoke, heavy exercise and even rapid swings in 
weather conditions. 
A polluted industrial landscape in Russia. 
Researchers suspect that improved hygiene 
and pollution control, immunization and 
antibiotics may have paradoxically made 
Western Europeans and Americans more prone 
to developing asthma. 
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Brian Leaderer, at 
left, heads a large 
study designed to 
understand what 
home conditions may 
cause children to 
develop asthma. 
Below: an apparatus 
he designed to 
collect gases in 
the home. 
Collecting dust for science 
Why do 15 percent of all 
American children—and an 
even higher proportion 
among inner-city minority groups— 
develop asthma? No one knows. 
There is clearly a genetic predisposi¬ 
tion, because parents with asthma 
are significantly more likely to have 
a child with asthma; a child whose 
older sibling has asthma is more 
likely to develop the disease as well. 
It’s also known that exposure to 
allergens, such as dust mites, 
cockroach droppings and dog and 
cat dander, raises the likelihood of 
developing asthma. But nobody 
knows when, and at what levels, ex¬ 
posure proves critical to developing 
the disease. Yale researchers have 
j started vacuuming hundreds of 
; houses and collecting tens of 
thousands of dust samples to try 
to answer these questions. 
With the help of a $3.7 million, 
I five-year grant from the National 
Institute of Environmental Health 
Sciences, a team led by Brian 
! Leaderer, Ph.D., professor of epide- 
i miology, has been going into the 
homes of around 1,000 infants living 
in and around Bridgeport, Hartford, 
New Haven and Springfield, Mass., 
to study how the home environment 
affects the development of asthma. 
The infants were selected at birth by 
finding mothers who already had a 
child with asthma in the home. 
After taking lengthy medical and 
family histories and gathering infor¬ 
mation about the families’ houses, 
the teams then visit the homes 
and, using special vacuum cleaners, 
collect dust samples from critical 
spaces, including infant bedrooms, 
crib bedding, the room of the older 
asthmatic child, the main living 
room and kitchen. The dust is then 
checked for the presence of known 
allergens. Air is also sampled for 
fungi and mold and a passive moni¬ 
tor is placed in the home to mea¬ 
sure gaseous pollutants, such as 
sulfur dioxide and tobacco smoke. 
Periodically, the team returns to col¬ 
lect additional samples and mea¬ 
sure the airborne pollutants. Four 
times annually, the team gathers in¬ 
formation about the infants’ respira¬ 
tory health. 
Dr. Leaderer hopes that his study 
will provide the first data that pin¬ 
point which allergens at which point 
in early life can cause asthma to 
develop. “You have to understand 
the factors that cause asthma first,” 
he says, “and then you can develop 
effective mitigation strategies. We 
don’t know what exposure at what 
level over what period of time im¬ 
pacts the development of asthma.” 
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For reasons that aren’t entirely understood, the seri¬ 
ousness of asthma can range widely. Low-level asthma 
problems can be limited to occasional wheezing and 
shortness ol breath. (Moreover, children will sometimes 
“outgrow” their asthma, like other allergies.) During a 
lull-blown asthma attack, however, the airways undergo 
a condition similar to what takes place in nasal passages 
during a bad cold: The walls of the airways produce ex¬ 
cess mucus, become swollen and lurther inflamed, and 
their muscles spasm and contract. An attack may be 
brief or can last several days or more. Lack of early treat¬ 
ment of asthma can have grave consequences down the 
line, because the damage can accumulate until the air¬ 
ways lose their ability to recover from the spasms. Delay¬ 
ing treatment of a severe attack can have deadly conse¬ 
quences because the inflamed airways may not respond 
to medications. 
Historically, inhalers—bronchodilators—that relax 
the muscles ol the airways and open them up were the 
main weapon in treating asthma. By 1990, investigators 
had identified the condition that causes asthma: chronic 
inflammation ol the airways. Controlling that inflam¬ 
mation is now recognized as the key to preventing 
asthma attacks and reducing their severity. While 
bronchodilators are used for symptomatic relief, the only 
medications with proven effectiveness in controlling air¬ 
way inflammation are corticosteroids. Generally the ste¬ 
roids are inhaled or, in severe cases, taken in pill form. 
There has been a huge rise in the use of steroids as a 
result of the increase in asthma and improved under¬ 
standing of the etiology ol the disease. Many pediatri¬ 
cians and pulmonary specialists now recommend that 
very young children, even inlants, receive steroids at 
the first signs of asthma to prevent the inflammation 
from becoming chronic. However, the use of steroids, 
especially by children, is controversial because ol their 
immune-system-suppressing side effects and because, 
at very high doses, they have the potential to thwart 
growth. Robert Biondi, M.D., assistant clinical professor 
3 o 
ol pediatrics and co-director ol the pediatric allergy 
and asthma clinic ol the Yale-New Haven Hospital 
Primary Care Center, says, “Like any medication, 
you pay a price. The benefits in this case definitely 
outweigh the side eflects. Studies show that many adults 
who develop chronic pulmonary disease had untreated 
asthma as kids. Moreover, persistent inflammation 
remodels the airways—they get stiff. Eventually, they 
don’t budge with bronchodilators.” Ramsay Fuleihan, 
associate research scientist in pediatrics and clinic co¬ 
director, says, “Early treatment, medical management 
and patient education are absolutely vital for preventing 
lilelong problems.” 
SEARCHING FOR A CAUSE 
There are many theories about the causes behind the 
huge increase in asthma rates. Most are environmental 
and none is proven. Speaking at an American Medical 
Association briefing last year, Dr. Stephen Redd of the 
CDC expressed the general bafflement ol the medical 
community: “The genetic makeup of 
the population couldn't have changed 
enough to see the increases in asthma 
that are being seen in many devel¬ 
oped countries. So there’s got to be 
some kind of environmental expo¬ 
sure, but exactly what that is really 
isn’t known.” Environment-related 
theories include population concen¬ 
tration in urban centers, more en¬ 
ergy-efficient, airtight homes that 
don’t recirculate fresh air and more 
sedentary lifestyles, especially among 
inner-city children, all resulting in higher exposure to 
dust mites, cockroach droppings, air pollution, animal 
dander, cigarette smoke and other common allergens. 
“No one answer seems to explain everything,” says Yale 
pulmonary medicine chief Dr. Elias. “It may end up that 
a lot of little things are going on that add together to in¬ 
crease the rate.” 
Researchers lace a complex puzzle that doesn’t lit 
neatly into any single discipline. Laboratory scientists 
and clinicians from a half dozen separate departments at 
Yale are looking at the full disease phenomenon, Irom 
the genetic and cellular cascade that results in chronic 
airway inflammation to the environmental and genetic 
factors that may combine to trigger the disease to new 
clinical interventions aimed at preventing the disease 
from developing and, when it does, reducing the current 
great demand for hospital treatment of asthma attacks. 
A major breakthrough in the understanding of the 
molecular mechanism behind the disease came through 
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“No one answer seems to explain everything,” 
says Yale pulmonary medicine chief Jack Elias. 
“It may end up that a lot of little things are 
going on that add together to increase the rate.” 
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the work of basic scientists, including some at Yale. 
When it occurred, no one even realized the work they 
were doing had anything to do with asthma. In the mid- 
1980s, Kim Bottomly, Ph.D., professor of immunobiol¬ 
ogy and investigator in the Howard Hughes Medical 
Institute, showed that one of the basic components of 
the immune system, the CD4+ T lymphocyte cells, dif¬ 
ferentiate when activated into two different effector cell 
lines. She found that the two types of effector T cells 
have distinctly separate immune functions. Shortly after 
her finding, Tim Mosmann, Ph.D., an immunobiologist 
at the University of Rochester, made an epochal discov¬ 
ery: he found that the two types of effector T cells se¬ 
creted unique panels of small molecules called cytokines 
that accounted for their distinct functions. The two 
types of lymphocytes were designated Thi and Phi. 
The Thx and Th2 lymphocytes use a variety of 
mechanisms to rid the body of pathogens such as viruses 
and parasites. Thi cells secrete cytokines that induce cells 
containing disease-causing microbes to kill them, 
clearing the body of pathogens that live inside 
cells. Th2 cells deal with pathogens that are too 
large to be engulfed by cells or replicate them- 1 selves outside of body cells, such as worms. TI12 
cells induce the production of a variety of small 
molecules that bind to the pathogen and facilitate 
clearing it from the body. SAn overarching evolutionary economy seems 
to govern the immune system. Researchers specu¬ 
late that the immune response to the continuous pres- 
Kim Bottomly, above 
left, and Lauren Cohn 
have been exploring 
the role of Th2 cells 
in the development of 
asthma by activating 
them in transgenic 
mice. Left: A normal 
mouse airway followed 
by the airway of a 
mouse in which the 
Th2 cells have been 
activated resulting 
in increased produc¬ 
tion of mucus in the 
airways. 
“Early treatment, medical management 
and patient education are absolutely 
vital for preventing lifelong problems.” 
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ence of pathogens is normally kept in balance by Thi 
and Th2 cells working in a dynamic system that recipro¬ 
cally regulates each other’s activities. The body needs to 
have enough of both kinds of cells and not too many 
of either one. “It’s important,” says Dr. Bottomly, “that 
the immune system make the right kind of response to 
a pathogen. Mostly it does because we’re all alive in a 
world filled with germs and parasites.” Sometimes, 
though, the immune response goes haywire and it at¬ 
tacks the body’s own cells. Many diseases that plague 
humans, including rheumatoid arthritis, diabetes and 
possibly multiple sclerosis, are autoimmune disorders 
that are now believed to be caused by an inappropriate 
Thi response. 
Researchers suspect that other categories of disease 
may be caused by overactive Th2 cells, including allergic 
disorders. One unrealized side effect of successful immu¬ 
nization programs and the widespread use of antibiotics 
to eradicate childhood diseases may be that the lack of 
childhood infections leads to a reciuction in Thi cell re¬ 
sponses. The pathogens that induce their activation sim¬ 
ply aren’t there anymore. While the health benefits of 
immunization and antibiotics have been beyond calcula¬ 
tion, the consequences for the body in some cases are 
not entirely positive. “ The lack ofThi immunity allows 
Thz activity to go unchecked,’’ says Dr. Bottomly. “In a 
world without the worms and other large parasites Th2 
cells evolved to respond to, they’re left to become acti¬ 
vated by the benign environmental substances present in 
chronic, low-dose amounts.” One extremely common 
source of low-dose environmental substances is air 
breathed through the nose. The “immune distraction” or 
“immune deviation” model of asthma holds that asthma 
results from a chronically exaggerated response to pollen, 
dust mites and other allergens in the absence of infec¬ 
tious diseases leading to Thi immunity and in the ab¬ 
sence of worms leading to Th2 immunity. 
Retrospective studies of populations such as those 
that lived behind the wall in East Germany have lent 
support to the theory. Other studies have found that 
children in Japan who responded strongly to a skin test 
indicating that they had been exposed to tuberculosis are 
Speaking the language of asthma 
Asthma is the most frequent 
cause of hospital admission 
for children in the U.S. The 
damage of all sorts done to the 
children who suffer from asthma is 
great, including the health effects, 
social isolation and school days 
missed. The cost of caring for them 
mounts well into the billions of dol¬ 
lars annually. However, minorities 
require hospitalization for asthma 
and die from the disease at much 
higher rates than whites. The differ¬ 
ences between the two groups are 
significant in Connecticut. Asthma 
rates are generally comparable 
between whites and non-whites in 
Connecticut, yet non-whites, who 
form 13 percent of the state’s 
population, account for 48 percent 
of hospital admissions for asthma. 
Moreover, non-white Hispanics, 
wno make up only 6 percent of 
Connecticut’s population, compose 
close to a quarter of all hospital 
admissions for asthma in the state. 
Differences in environmental ex¬ 
posures to allergens or population 
genetics cannot completely account 
for these heavily skewed rates. 
Studies show that cultural barriers 
to proper understanding and treat¬ 
ment of asthma may underlie the 
higher rates. Developing an inte¬ 
grated approach that will allow 
physicians to address all of these 
issues represents a complex 
challenge for Yale’s Pediatric Asthma 
Program. In addition to providing 
educational tools and activities for 
both primary care providers and 
families with asthma, last fall the 
program established the Pediatric 
Asthma Clinic to reach out to 
minority populations in the New 
Haven region. 
The clinic combines the exper¬ 
tise of pediatric pulmonologists and 
allergists, and it is geared toward 
providing children with asthma and 
their families with comprehensive 
care without the need for several 
clinic visits. As part of the clinic’s 
work, Spanish-speaking health care 
providers teach non-English-speak¬ 
ing Hispanic patients how to avoid 
asthma triggers and how to use 
medications properly to prevent 
attacks. Program director Jose 
Calderon, M.D., assistant 
professor of pediatrics, who is origi¬ 
nally from Colombia, believes that 
such “culturally and linguistically 
attuned” clinics and outreach 
programs could decrease the 
number of emergency room visits 
and hospital admissions in the tar¬ 
geted populations by as much as 
70 percent. Says Dr. Calderon: 
“We want to educate, to speak their 
language, understand their concerns 
and establish a partnership." 
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Asthmatic children are the single largest patient group seen by Yale 
pediatricians. By unifying interdisciplinary services, Yale clinicians 
hope to reduce hospital admissions for asthma. Alia Bazzy-Asaad, 
... co-director of the Pediatric Asthma Care Team, listens to patient 
less likely to suffer from asthma or other allergic dis- Anthony Papaie’s lungs. 
eases. Similarly, in a study of Italian soldiers, those who 
tested positive for antibodies to hepatitis A virus—a sign 
of more childhood infections in gen¬ 
eral—had significantly fewer allergies. 
Armed with promising new direc¬ 
tions for the study of molecular mecha¬ 
nisms for asthma, in the early 1990s Dr. 
Elias set out to expand research in the 
field at Yale. The first challenge he en¬ 
countered, however, wasn’t scientific at 
all. Instead, he needed to convince his 
colleagues to devote valuable time and 
resources to understanding the disease. 
uIn a world without the worms and other 
large parasites Th2 cells evolved to respond to, 
they’re left to become activated by the benign 
environmental substances present in chronic, 
low-dose amounts.” 
BUILDING THE ASTHMA TEAM 
He faced an uphill struggle. At the time, 
Yale had very little presence in the study 
of asthma. “Yale has a great tradition in 
biology and immunology,” says Dr. Elias, “but lacks 
much of a tradition in the asthma and allergy fields.” 
He wanted to bring that great tradition to bear on a new 
and pressing problem. “I literally went door to door.” 
His enthusiasm for the possibilities opening up in the 
field drew a strong response and soon about 75 scientists 
from all over campus, including the departments of 
pathology, public health, occupational medicine, 
immunobiology, pediatrics, the Boyer Center for 
Molecular Medicine and his own pulmonary medicine 
section, were looking into the disease. The Yale Asthma 
Working Group, as the loose confederation of research¬ 
ers was designated, has now been gathering once a 
month for more than five years. At first, the educators 
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needed an education. “We spent the first years having 
clinicians teach basic scientists what asthma was and 
the basic scientists explaining to the clinicians what 
could be happening at the cellular and molecular level, 
recalls Dr. Elias. 
The efiorts to build an organization paid off hand¬ 
somely. With Dr. Elias as principal investigator, the 
asthma working group achieved a major coup when it 
was awarded a five-year, $10.2 million grant in January 
1997 from the NHLBI to support multidisciplinary re¬ 
search. That prestigious award established Yale as one of 
only seven Specialized Centers of Research (SCOR) 
focusing on asthma in the country. The SCOR group 
has since added more than a half dozen other substantial 
federal grants as it pursues its general goal of ferreting 
out the molecular causes of asthma and moving those 
basic science discoveries rapidly to clinical testing. “The 
vision in creating this group has been an outstanding 
success,” says Anuradha Ray, Ph.D., who, along with 
her husband Prabir Ray, Ph.D., both associate professors 
of pulmonary medicine, studies the genetics underlying 
asthma. “Jack has shown that with the right vision, 
you can do tremendous things. Now, the goal is 
landmark observations.” 
From basic science to clinical care, the landmarks 
have started to pile up. 
One of the biggest challenges to understanding 
asthma has been the lack of an adequate animal model 
to study the development of the disease. Dr. Elias has 
been working closely with Dr. Bottomly and Richard 
Flavell, Ph.D., chair of the Section of Immunobiology 
and investigator in the Howard Hughes Medical Insti¬ 
tute, to create transgenic mice. They have succeeded 
spectacularly over the past year. “It’s so exciting how 
powerful this is,” says Dr. Elias. “We’re the only people 
in the world who have put a human asthma gene in a 
mouse lung and turned it on and off, even in utero. This 
mouse is as close as we’ve come to human asthma. It al¬ 
lows us to study asthma in neonates and the adult 
mouse, and to see the difference in how the disease af¬ 
fects each." With this new mouse model, researchers can 
go back to study how the gene is produced in humans 
on the one hand and how to block its production in the 
mouse on the other. Eventually, the asthma team hopes 
to figure out how to modulate the genetic activity—to 
prevent asthma in humans from oc¬ 
curring or possibly to develop a cure. 
To that end, Dr. Anuradha Ray’s 
studies in mouse models of asthma 
have recently identified the transcrip¬ 
tion factors that explain how Th2 
gene expression results in the cascade 
of signals that bring eosinophils, a 
type of white blood cell, into the 
lungs. When compared with normal 
lungs, asthmatic lungs have hugely 
higher numbers of eosinophils. Once 
in the airways, eosinophils release a 
group of proteins that injure tissues, 
causing the inflammation that makes the airways of 
asthmatics so hypersensitive. Working with colleagues 
at Yale and at McGill University in Montreal, Dr. 
Anuradha Ray is now looking for ways to target the early 
genetic expression leading to the proliferation of eosino¬ 
phils with medications. “It would be like steroids,” she 
says, “but steroids affect many other things. We would 
hope that this would have more specific action and 
fewer side effects.” 
BREATHING EASIER 
While the study of animal models provides excellent 
clues about the nature of the disease in humans, only 
clinical study can provide a true understanding. Other 
members of the SCOR group have been attempting to 
Yale asthma researchers gather monthly to review progress. 
“Were the only people in the world who have 
put a human asthma gene in a mouse lung and 
turned it on and off, even in utero. This mouse 
is as close as we’ve come to human asthma.” 
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take the knowledge learned in the laboratory and bring 
it to clinical research. “There’s a great marriage between 
M.D.s and Ph.D.s,” says Dr. Ray. Clinicians have been 
studying industrial workers who contracted asthma as 
adults as a result of exposure to workplace chemicals to 
examine the disease process. (See Isolating asthma.) 
Epidemiologists are looking closely at how home envi¬ 
ronment might affect the development of the disease 
in children. (See Collecting dust for science.) 
Efforts to understand and improve treatment of 
asthma are taking place in many different disciplines. 
For instance, researchers in the section of pediatric respi¬ 
ratory medicine are studying the effects of hypoxia 
(low oxygen in the blood)—a common consequence of 
an asthma attack—on brain function in the young as 
well as how the muscles of respiration respond to the 
increased work of breathing imposed by acute and 
, chronic airway obstruction. 
Physicians from the section have also come together 
with primary care physicians in the community as the 
Pediatric Asthma Care Team (PACT) to coordinate care 
for children with severe asthma. According to Alia 
Bazzy-Asaad, M.D., an associate professor of pediatrics 
who is co-director of PACT along with Gabriel Haddad, 
M.D., chief of the section of respiratory medicine, the 
Department of Pediatrics now treats more than 500 
children each year, making it the single largest patient 
group in the department. “Patients often get seen in 
many different places,” she says. “We get everyone 
around the table and ask how we can do this in a 
coordinated way.” PACT members are also developing 
In her laboratory, Anuradha 
Ray studies how Th2 gene 
expression in transgenic 
mice precipitates a cas¬ 
cade of events resulting 
in the accumulation of 
eosinophils in the airways. 
The presence of increased 
eosinophil cells in the 
airways, shown at left, 
underlies the tissue 
damage that eventually 
leads to asthma. 
innovative programs to reach out to the minority com¬ 
munity to reduce epidemic asthma rates. (See Speaking 
the language of asthma) 
These many different approaches to asthma raise 
hopes that the skyrocketing increase can be slowed. At 
the same time, the very recent breakthroughs in under¬ 
standing the biological basis of the disease have created 
guarded optimism that prevention and perhaps a cure 
may one day be possible. The researchers still have a 
long way to go before they can get a handle on the 
disease. “Were making headway in understanding the 
disease mechanism,” says Dr. Bottomly, “but we don’t 
know much about interfering with it.” 
They recognize just how important it is to figure 
that out. “For some people,” says Dr. Elias, “asthma 
dictates everything about their everyday life. It can be 
a life-threatening event every time they get a cold or 
walk into a room filled with animal hair or sleep in a 
dusty bed.” For the first time since asthma rates began 
their upward climb, though, there’s hope that one day 
asthma sufferers may no longer need to worry about 
losing their breath. EED 
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Perfecting the Faculty Practice 
New associate dean will keep an eye on 
quality of care, as well as the bottom line. 
David J. Leffell, M.D., medical director of the Yale 
Faculty Practice for the past three years and a profes¬ 
sor of surgery and dermatology, has been appointed 
the medical school’s associate dean for clinical affairs and 
director of the Faculty Practice. He will have oversight of all 
clinical and business activity lor the practice, which repre¬ 
sents more than 650 Yale physicians and provides tertiary 
care to thousands of patients throughout the region. 
1 he appointment by Dean David A. Kessler, M.D., 
effective Jan. 1, comes at a time when academic medical 
centers across the United States are responding to major 
economic forces affecting their operation. Lower reimburse¬ 
ments under managed care, along with changes in the way 
attending and resident physicians must account for their 
time, have prompted medical schools to re-examine the way 
they do business in the clinical sphere. Dr. Leffell’s primary 
task. Dean Kessler said, will be to help define the Faculty 
Practice as an efficient organization that facilitates the 
research and educational missions of the school. 
“Our mandate is to be efficient, responsive and avail¬ 
able,” Dr. Leffell said in an interview. “We can’t serve any 
of our constituencies, not least of all our patients, unless 
were on a sound economic footing. And without patients, 
there is no medical school.” 
A native of Montreal, Dr. Leffell is a 1977 Yale College 
graduate who received his medical degree from the McGill 
University Faculty of Medicine in 1981. He completed a 
AAAS elects seven fellows 
from ranks of faculty HI AAAS 
Seven medical school faculty members were elected to the 
rank of fellow by the American Association for the Advance¬ 
ment of Science (AAAS) in September. They include Vincent 
A. Andriole. M.D ’57, professor of medicine; Joseph E. Craft, 
M.D., professor of medicine; Richard L. Edelson, M.D. ’70, 
professor of dermatology and in the Cancer Center; Maurice 
J. Mahoney, M.D., professor of genetics, pediatrics, and ob¬ 
stetrics and gynecology; Stephen E. Malawista, M.D., pro¬ 
fessor of medicine; I. George Miller Jr., M.D., John F. Enders 
Professor of Pediatrics, Epidemiology, Molecular Biophysics 
and Biochemistry; Edward L. Snyder, M.D., professor of labo¬ 
ratory medicine. The awards were presented in January dur¬ 
ing the AAAS Fellows Forum at the association’s annual 
meeting in Anaheim, Calif. 
David J. Leffell 
is the new 
associate dean 
for clinical affairs 
and director of 
the Yale Faculty 
Practice. 
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residency in internal medicine at Cornell Cooperating 
Hospitals in 1984 then spent two years as a dermatology 
resident at Yale and one as an NIH-sponsored fellow, also 
in New Haven. He became a Yale faculty member in 1988 
after a fellowship in dermatologic surgery at the University 
of Michigan. 
The Faculty Practice, originally established as a billing 
and collection unit for the clinical services of Yale profes¬ 
sors, has evolved into a complex organization responsible 
for negotiating contracts, marketing its services, and 
planning strategically in a changing health care environ¬ 
ment. For the year ending June 30, the Faculty Practice 
logged more than 400,000 patient encounters and collected 
revenues exceeding $100 million for clinical activity at the 
Yale Physicians Building, Yale-New Haven Hospital, the 
Yale Sports Medicine Center and other offsite locations. 
Its operation had been complicated by flaws in the 
school’s APS computerized billing system, which has been 
phased out with the successful implementation of a new 
IDX system. 
Dean Kessler cited Dr. Leffell, an authority in the 
genetics of skin cancer and an expert in the management 
of the disease, for “his strong administrative skills and an 
outstanding record of scholarly achievement.” The dean 
added; “I have every confidence that, under his direction, 
the Faculty Practice will achieve an even higher standard 
of excellence.” The school’s chief operating officer, Irwin 
Birnbaum, was similarly enthusiastic: “David has the 
professional experience and the vision to help the 
Faculty Practice truly become a multi-specialty academic 
group practice.” 
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Expert in genetics 
of hypertension is 
named chair 
Richard P. Lifton, M.D., Ph.D., 
a Howard Hughes Medical 
Institute investigator whose 
research in hypertension has led to the 
identification of more than a dozen 
genes that regulate blood pressure, has 
been appointed chair of the Depart¬ 
ment of Genetics. 
Dr. Lifton will preside over a 
department of 28 full-time faculty 
members, 58 postdoctoral fellows and 
associates, and 45 graduate students, 
including a number of the most dis¬ 
tinguished scientists in modern genet¬ 
ics. “What makes Rick an outstanding 
choice for this job is his great ability 
to bridge the worlds of basic science 
and clinical medicine,” said Dean 
David A. Kessler, M.D. “That is in¬ 
creasingly important in an era when 
laboratory discoveries are being trans¬ 
lated for the benefit of patients more 
quickly than ever before.” 
A native of Washington, D.C., 
Dr. Lifton is a 1975 graduate of 
Dartmouth College and holds M.D. 
and Ph.D. degrees from Stanford 
University, where he worked in the 
laboratory of molecular geneticist 
David Hogness. While at Stanford, he 
and fellow graduate student Michael 
Goldberg discovered a short DNA 
sequence, known as the TATA box, 
that regulates the initiation of gene 
transcription in all higher organisms. 
Dr. Lifton spent four years as resident 
and chief resident in medicine at 
Brigham and Women’s Hospital, then 
three years with Howard Hughes in¬ 
vestigator Jean-Marc Lalouel, M.D., 
D.Sc., in Utah, where he identified 
the first known gene affecting the 
regulation of human blood pressure. 
Since then, Dr. Lifton and mem¬ 
bers of his research team have identi¬ 
fied a dozen genes that either raise or 
lower blood pressure by influencing 
how the kidney handles salt. He came 
to the Yale faculty, from Harvard, as 
an assistant professor of medicine in 
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New genetics chair Richard Lifton 
1993 and was promoted to associate 
professor in 1994 and professor in 
1997. His discoveries in the genetics 
ol hypertension may lay the ground¬ 
work for safer, more effective medica¬ 
tions for a disease affecting more 
than 50 million people in the United 
States alone. 
The department was established 
at Yale in 1972 as the Department 
of Human Genetics with Leon E. 
Rosenberg, M.D., as chair. Its focus is 
unusually broad, with strength in a 
wide range ol disciplines including 
studies of simple model organisms, 
inherited metabolic disorders, and the 
genetics of common human diseases, 
increasingly believed to have a com¬ 
plex genetic component. 
When Dr. Rosenberg became dean 
of the School of Medicine in 1984, 
Sterling Professor Carolyn W. 
Slayman, Ph.D., was appointed to 
lead the department. After Dr. 
Slayman’s selection as deputy dean for 
academic and scientific affairs in 1995, 
faculty member David C. Ward, 
Ph.D., inventor of the gene-mapping 
technique known as fluorescence in 
situ hybridization, served for two 
years as acting chair. Daniel DiMaio, 
M.D., Ph.D., led the department as 
interim chair last year as a national 
search was conducted. 
Dr. DiMaio said Dr. Lifton’s selec¬ 
tion as chair “was an outstanding 
choice. He’s someone who is inter¬ 
ested in the genetics of common dis¬ 
ease, which most people agree is the 
future of human genetics. He knows 
his way around Yale,” he added, “and 
his work is superb.” 
Bov! 
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Faculty honored 
with endowed 
professorships 
Joan A. Steitz, Ph.D. Joan A. Steitz, Ph.D., internation¬ 
ally renowned for her contribu¬ 
tions to the field of molecular 
genetics, has been named Sterling 
Professor of Molecular Biophysics 
and Biochemistry by vote of the 
Yale Corporation. 
Dr. Steitz’s studies have defined the 
roles of small nuclear ribonucleopro- 
tein particles in RNA processing in 
mammals. She has focused her re¬ 
search on the structure and function 
of these cellular complexes, which 
play a key role in some of the most 
basic biological processes that convert 
information in the DNA to the active 
protein molecules of the living cell. 
She discovered the important roles 
that cellular particles known as small 
nuclear ribonucleoproteins, or snurps, 
play in the activity of cells. In addition 
to providing new understandings of 
the mechanics of gene expression, 
Dr. Steitz’s research also has implica¬ 
tions for improved diagnosis and 
treatment of autoimmune diseases, 
particularly rheumatic diseases that 
occur when a person’s own antibodies 
attack snurps. 
A member of the Yale faculty since 
1970 and chair of her department, 
Dr. Steitz has led the molecular 
genetics program in the Boyer Center 
for Molecular Medicine and is also an 
investigator with the Howard Hughes 
Medical Institute. Prior to her Yale 
appointment, she did postdoctoral 
work at the Medical Research Council 
Laboratory of Molecular Biology in 
Cambridge, England, where she 
worked with Nobel laureate Francis 
Crick. She earned her B.S. in chemis¬ 
try from Antioch College and her 
Ph.D. from Harvard University, 
where she worked with another Nobel 
laureate, James D. Watson. Drs. 
Watson and Crick elucidated the 
Joan A. Steitz Paul B. Sigler 
structure of DNA, the genetic mate¬ 
rial of living organisms. 
Dr. Steitz was appointed a full 
professor at Yale in 1978 and became 
the Henry Ford II Professor of 
Molecular Biophysics and Biochemis¬ 
try in 1992. At Yale, she established a 
laboratory dedicated to the study of 
RNA structure and function. Dr. 
Steitz’s achievements have earned her 
many honors, including the National 
Medal of Science and the Christopher 
Columbus Discovery Award in Bio¬ 
medical Research. She was the first 
woman to win the Warren Triennial 
Prize, which is often described as 
the “Nobel Prize predictor” because 
so many of its recipients have gone on 
to win the latter award, and was also 
the first woman to be presented 
Israel’s Weizmann Women & Science 
Award. Steitz is a member of the 
American Academy of Arts and 
Sciences and the National Academy 
of Sciences. 
Paul B. Sigler, M.D., Ph.D. 
aul B. Sigler, M.D., Ph.D., a 
specialist on the chemical 
mechanisms in cell regulatory 
processes, has been named the Henry 
Ford II Professor of Molecular Bio¬ 
physics and Biochemistry by vote of 
the Yale Corporation. 
Dr. Sigler is engaged in the study 
of two cell regulatory processes, con¬ 
trolled gene expression and transmem¬ 
brane signaling. Specifically, he has in¬ 
vestigated the interactions of proteins 
and nucleic acids and how genetic 
code is transcribed through selective 
binding of regulatory proteins to tar¬ 
get DNA sequences. In addition, 
he recently led a team that received 
national attention for visualizing in 
atomic detail (three-dimensional 
computerized “snapshots”) how two 
female sex hormones, progesterone 
and estrogen, bind to their receptors. 
Fhe team was also the first to solve 
the structure of progesterone bound 
to the human receptor. 
In his research, Dr. Sigler uses 
X-ray crystallography to determine 
the three-dimensional structure of 
molecules and how they link together. 
His work has also revealed for the 
first time how genes in cells through¬ 
out the body respond to a large 
family of hormones that include the 
adrenal and sex steroids, vitamin D, 
thyroid hormone and retinoic acid, 
which is crucial in embryonic devel¬ 
opment. Among his current projects 
is an analysis of the structure and 
function of chaperonin-assisted 
protein folding. 
Dr. Sigler, who is also an investiga¬ 
tor at the Howard Hughes Medical 
Institute, joined the Yale faculty in 
1989. Prior to coming to Yale, he 
was a professor of molecular and 
theoretical biology, biophysics and 
biochemistry for 21 years at the 
University of Chicago. 
A graduate of Princeton University, 
Dr. Sigler earned his medical degree 
from Columbia University in 1959 
and was an intern and resident in 
medicine at the Columbia-Presbyte- 
rian Medical Center in New York. 
He received a Ph.D. in biochemistry 
in 1968 from the University of 
Cambridge’s Medical Research 
Council Laboratory of Molecular 
Biology, where he was a Helen Hay 
Whitney Fellow. 
Dr. Sigler is the recipient of nu¬ 
merous honors, including a 
Guggenheim Fellowship, a U.S. Pub¬ 
lic Health Service Research Career 
Development Award and a Merit 
Award from the National Institute of 
General Medical Sciences. He is a 
member of the National Academy of 
Sciences and a fellow of the American 
Academy of Arts and Sciences. 
FACULTY N April 1999. The APS, made up of 
nearly 10,000 professionals in science 
and medicine, is a nonprofit society 
devoted to fostering education, 
scientific research and the dissemina¬ 
tion of knowledge in the physiologi¬ 
cal sciences. 
Michael J. Caplan, M.D., Ph.D. 87, 
professor of cellular and molecular 
physiology, was presented the 1998 
Young Investigator Award by the 
American Society for Nephrology in 
October. The award, which recog¬ 
nizes excellence and creativity in 
nephrologic research, includes a grant 
to the winner’s laboratory. Dr. Caplan 
presented a talk at the award ceremo¬ 
nies entitled Playing in Traffic: Sorting 
of Ion Transport Proteins in Polarized 
Cells. He is also the recipient ol the 
1998 Bowditch Young Investigator 
Award from the American Physiologi¬ 
cal Society. 
Michael D. Ezekowitz, M.B.Ch.B., 
Ph.D., professor of medicine (cardiol¬ 
ogy), was an invited speaker for the 
North American Society of Pacing 
Two from faculty join Institute of Medicine 
ric J. Nestler, M.D. ’83, Ph.D. 
'82, HS '83-87, the Elizabeth 
Mears and House Jameson 
Professor of Psychiatry, Pharmacol¬ 
ogy and Neurobiology, and Sally E. 
Shaywitz, M.D., professor of pediat¬ 
rics and co-director of the Yale 
Center for the Study of Learning and 
Attention, have been elected to the 
Institute of Medicine. Both were 
chosen for their major contributions 
to health and medicine and for the 
significant amount of volunteer time 
they devote on committees engaged 
in a broad range of studies on 
health policy issues. 
Dr. Nestler, who directs the division 
of molecular psychiatry and Abraham 
Ribicoff Research Facilities in the De¬ 
partment of Psychiatry, has con¬ 
ducted groundbreaking studies in the 
Eric J. Nestler Sally E. Shaywitz 
biology of addiction, unraveling the 
function of certain genes in the 
mesolimbic dopamine system. 
Dr. Shaywitz and her husband, 
pediatric neurologist Bennett A. 
Shaywitz, M.D., lead a team that 
has conducted groundbreaking stud¬ 
ies in the neurobiology of reading 
and dyslexia, identifying the neural 
circuitry of reading, its functional 
disruption in dyslexia, and gender 
differences in brain organization 
for reading. 
Stephan Ariyan, M.D., clinical pro¬ 
fessor of surgery (plastic), was honored 
by the Armenian-American Profes¬ 
sionals Organization in September at 
its Third Annual Ball in Teaneck, N.J., 
for his efforts following the Decem¬ 
ber 1988 earthquake in Armenia. 
Robert S. Baltimore, M.D., profes¬ 
sor of pediatrics and epidemiology, 
participated in the Consensus 
Development Conference on Diagno¬ 
sis and Treatment of Attention Deficit 
Hyperactivity Disorder (ADHD) in 
November at the National Institutes 
of Health in Bethesda, Md. The 
consensus panel concluded that 
children with ADHD often receive an 
inconsistent level of care from a 
fragmented system that consumes a 
large share of health care dollars. 
Walter F. Boron, M.D., Ph.D., HS 
’78-80, professor of cellular and 
molecular physiology, has been 
elected president of the American 
Physiological Society (APS), effective 
Vov! 
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tax 
benefits. 
and Electrophysiology in May in San 
Diego, nth International Congress 
Cardiostim 1998 Meeting in June in 
France, and the XXth Congress ol the 
European Society ol Cardiology in 
August in Vienna. He was also a 
participant in the Fifth American 
College ol Chest Physicians 
Antithrombotic Therapy Consensus 
Conlerence in June in Tucson, Ariz. 
Alvan R. Feinstein, M.D., HS 
’52-54, Sterling Professor ol Medicine 
and Epidemiology, received the Oscar 
B. Hunter Award from the American 
Society for Clinical Pharmacology and 
Therapeutics at its annual meeting last 
March for his contributions to the 
field. Past recipients include Jonas E. 
Salk, M.D., and Albert B. Sabin, 
M.D., and lormer Yale faculty 
members Paul Calabresi, M.D. 55, 
and Louis S. Goodman, M.D. 
Rosemarie L. Fisher, 
M.D., HS 74-75, 
prolessor ol medi¬ 
cine, has been 
appointed director 
of graduate medical 
education (GME) 
lor both the School 
ol Medicine and Yale-New Haven 
Hospital. The new joint position was 
created to oversee the medical center’s 
68 residency and fellowship programs, 
which may fall under the aegis of 
either the hospital or medical school. 
The medical center currently has 599 
residents and 182 fellows participating 
in training programs. 
Dr. Fisher, who directed the 
residency program in the Department 
of Internal Medicine from 1987 to 
1998, also was selected to participate 
in the fourth class of the Hedwig van 
Ameringen Executive Leadership in 
Academic Medicine Program for 
Women, based at Allegheny Univer¬ 
sity of the Health Sciences. 
Ralph E. Hoffman, M.D., associate 
professor of psychiatry, was among 
investigators at 22 U.S. and five 
international universities to receive 
a total of 40 prestigious, two-year 
grants of $50,000 per year from 
the National Alliance lor Research 
on Schizophrenia and Depression. 
The grant will support his research 
on transcranial magnetic stimulation 
in patients reporting auditory 
hallucinations. 
Margaret K. 
Hostetter, M.D., 
has been named 
professor ol pediat¬ 
rics and chief of the 
section of pediatric 
immunology and 
director ol the Yale 
Child Health Research Center. Dr. 
Hostetter received her medical degree 
from Baylor College of Medicine and 
was a resident and fellow in inlectious 
diseases at Boston Children’s Hospi¬ 
tal. She comes to Yale from the 
University of Minnesota, where she 
held the American Legion Heart 
Research Chair in Pediatrics. Her 
research locuses on virulence factors 
in two important pathogens: Strepto¬ 
coccus pneumoniae, the leading cause 
of death from respiratory infections, 
and Candida albicans, the predomi¬ 
nant cause of latal lungal infections in 
patients with compromised immune 
function. Twelve years ago in Minne¬ 
sota, Dr. Hostetter co-founded the 
first clinic specializing in the medical 
and developmental evaluation of 
internationally adopted children 
and has transplanted this model to 
Yale. Dr. Hostetter holds three 
R-01 awards from the National 
Institutes of Health and is a new 
appointee to the Council of the 
National Institute for Child Health 
and Human Development. 
Charles A. Janeway Jr., M.D., 
professor of immunobiology and 
biology, was presented the Irvington 
Institute’s Leadership Award for 
outstanding scientific leadership in 
immunology in October in New York 
City. Dr. Janeway also recently 
completed a one-year term as presi¬ 
dent of the American Association of 
Immunologists. 
Michael Kashgarian, M.D. ’58, HS 
’59-63, professor of pathology and 
biology, was lauded by the Gesellshaft 
fur Nephrologie (the German Society 
of Nephrology) for his outstanding 
contributions to the fields of renal 
pathology and physiology. He was 
made an honorary member of the 
society at its meeting in September. 
He is the second Yale faculty member 
to receive this honor; Robert W. 
Berliner, M.D., received the award 
in 1986. 
Ilona S. Kickbusch, 
Ph.D., has joined the 
faculty of Epidemiol¬ 
ogy and Public 
Health as professor of 
public health and 
head of the division 
of international 
health. She succeeds Lowell Levin, 
M.P.H. ’60, who retired in June. Dr. 
Kickbusch comes to Yale from the 
World Health Organization, where 
for the past four years she was director 
of the Division of Health Promotion, 
Education and Communication. She 
began her work at WHO as a consult¬ 
ant in 1980 and previously held a Yale 
appointment as lecturer in public 
health, in 1985. Her research interests 
focus on the effects of globalization of 
health, global health governance and 
strategies for health promotion. 
John A. Kirchner, M.D., professor 
emeritus of otolaryngology, was 
conferred an honorary membership 
in the European Laryngological 
Society in Rome in September. 
Dr. Kirchner is the first American 
member of the organization. 
i 
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Kathryn E. McGoldrick, M.D., 
professor of anesthesiology and 
medical director of ambulatory 
surgery, was elected in June to a two- 
year term as president of the Con¬ 
necticut State Society of Anesthesi¬ 
ologists. She also was recently elected 
vice president ol the board of trustees 
of the Wood Library-Museum of 
Anesthesiology in Park Ridge, Ill., 
and was appointed chair of the 
American Society of Anesthesiologists 
subcommittee on ambulatory and 
geriatric anesthesia. 
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Irvin M. Modlin, 
M.D., Ph.D., 
professor of 
surgery, was 
awarded the 
Huntarian Profes¬ 
sorship in Surgery 
in September by 
the Royal College 
of Surgeons of 
England. This 
award, named for 
John Hunter, 
provides a fellow¬ 
ship and the 
delivery of the 
Huntarian lecture at the College. 
John Hunter was the original great 
surgical scientist and doyen of the 
scientific evolution of the disci¬ 
pline. Three years ago, Dr. Modlin 
was awarded the Arris and Gale 
Lecture by the Royal College. In the 
250-year period that these lectures 
have been given, only six individu¬ 
als have received both. 
Irvin M. Modlin 
Linda Z. Mowad, R.N., director of 
the Cancer Information Service tor 
New England at the Yale Comprehen¬ 
sive Cancer Center, has been chosen 
to receive the American Cancer 
Society’s National Divisional Award, 
the prestigious St. George Medal. 
Joseph M. Piepmeier, M.D., HS 
’76-82, professor of neurosurgery and 
vice chair tor clinical affairs, has been 
selected as editor-in-chief of the 
Journal of NeuroOncology. His five- 
year term began in January. 
Shachar Tauber, M.D., director of 
the Yale School of Medicine’s new 
Laser Vision Correction Service and 
assistant clinical professor of ophthal¬ 
mology and visual science, was 
invited to teach laser skills at the 
Global Chinese Ophthalmology 
Congress in August to a special 
symposium of 150 refractive surgeons 
in Beijing. 
Joseph B. Warshaw, M.D., deputy 
dean for clinical affairs and chair 
of the Department of Pediatrics, 
received special recognition for 
.. 
YALE MEDICINE 
lifetime career accomplishment 
from ConnectiCare, Inc., as part 
of the health insurer’s 1998 
Children’s Health and Well-Being 
Awards program. 
Bruce E. Wexler, M.D., associate 
professor of psychiatry, participated 
in the consensus development 
conlerence on rehabilitation of 
persons with traumatic brain injury 
in October at the National Insti¬ 
tutes of Health in Bethesda, Md. 
William D. White, Ph D ., associate 
professor of epidemiology and 
public health (health policy and 
administration) and head of the 
Health Management Program, was 
awarded the National Institute for 
Health Care Management’s Fifth 
Annual Research Award in Novem¬ 
ber for a paper he co-authored, 
Medicaid Dependent Hospitals and 
Their Patients: How Have They 
Fared? Dr. White joined the faculty 
this year. Previously he taught at the 
University of Illinois at Chicago. 
His research focuses on the impact 
of managed care on health care 
markets. Other areas of research 
include the design of payment 
systems for health care services and 
the regulation ol health care 
professionals. 
Indoor Air Quality: Sources, Exposures 
and Health and Comfort Effects, a 
one-day symposium planned for April 19, 
will honor Jan A.J. Stolwijk, Ph.D., the 
Susan Dwight Bliss Professor Emeritus 
of Epidemiology. 
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International fellows travel 
the globe to learn by doing 
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Damani Piggott, who traveled to Mali on a grant from the Fogarty International Center at NIH, 
discusses his research into infectious diseases. 
Each year, students come from 
around the world to study 
medicine, nursing and public 
health at Yale. Over the past three de¬ 
cades, many have traveled far and 
wide from New Haven to increase 
their understanding of international 
health and to make contributions to a 
number of fields of study. 
Last summer 17 students worked 
abroad on projects in Africa, China, 
Russia, Latin America and Malaysia, 
among other locations. In October, they 
presented their findings during the 30th 
annual fall symposium of the Commit¬ 
tee on International Health. The major¬ 
ity of presenters were supported by the 
Wilbur Downs International Health 
Travel Fellowship Program at Yale. 
In Armenia, George Melikian, 
M.P.H. ’99, studied the prevalence of 
HIV infection among women engaged 
in prostitution. Seth Goldbarg and 
Frederick Cobey, both of the School 
of Medicine’s Class of 2001, traced the 
causes of Cryptosporidium infections 
in a village in the highlands of south¬ 
western Ethiopia. And in Romania, 
Michelle Davis, M.S.N. ’99, made an 
assessment of the conditions in which 
orphaned children live. 
Other students described studies of 
HIV transmission among pregnant 
women in Puerto Rico and HIV 
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counseling and testing in Uganda. 
Projects displayed on posters in the 
Laboratory of Epidemiology in Public 
Health building reported on organ 
transplants in Armenia, pregnancy 
outcomes and cardiovascular risk fac¬ 
tors in Cameroon, hantavirus in Ma¬ 
laysia, hookworm in China, HIV in 
Russia, the availability of contracep¬ 
tives among Cambodian refugees in 
Thailand, and gene therapy research 
in St. Kitts and Nevis. 
The program, founded in the 
1960s, began to receive regular fund¬ 
ing in the 1980s, when it was renamed 
in honor of Wilbur Downs, M.D., an 
expert on tropical and infectious dis¬ 
eases and a Yale professor who be¬ 
lieved students should learn by doing. 
One of the major lessons students 
learned was that logistical barriers are 
often the most formidable. 
In Uganda, for example, Mr. 
Cobey and Mr. Goldbarg studied a 
highlands village of 3,000 people 
where the distance to a government- 
run clinic and cost of treatment lim¬ 
ited access to health care. The Ugan¬ 
dan government’s refusal to let Mr. 
Cobey take blood samples stymied his 
efforts in a second project to gauge the 
prevalence of malaria. 
Students whose proposals are ac¬ 
cepted by a committee of about two 
dozen representatives of various disci¬ 
plines receive round-trip airfare, emer¬ 
gency medical evacuation insurance and 
a $500 stipend. In addition, the pro¬ 
gram pays for any immunizations they 
might need. Sponsors on the faculty 
help students arrange contacts in the 
host country. Acceptance into the pro¬ 
gram also allows students to seek a 
$2,500 grant from the office of student 
research. About 24 students apply each 
year and grants are awarded based on 
the amount of funding available and the 
quality of the applications. 
A reunion of past Downs Fellows is 
planned for June 4 during Alumni Re¬ 
union Weekend at the medical school. 
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Donning plain white coats, 102 students 
are welcomed to a lifetime of medicine 
Deputy dean Joseph 
Warshaw helps Nduka 
Amankulor begin his 
medical career during the 
White Coat Ceremony. 
Below: Members of the 
class of 2002 smile at the 
prospects that await. 
' 
Six years ago, alumnus Nicholas 
P.R. Spinelli, M.D. ’44, 
donated 100 starched white 
coats to the School ol Medicine, be¬ 
ginning a tradition at Yale shared by 
medical schools around the country. 
In late August, during their orien¬ 
tation as first-year medical students, 
members of the Class of 2002 picked 
up the threads of that rite of passage. 
Under a tent on Harkness lawn the 
102 entering students joined in a cer¬ 
emony that welcomed them to medi¬ 
cine and underscored the responsibil¬ 
ity that accompanies the donning of 
the white coat. One by one, faculty 
members helped them into a garment 
laden with significance—both for 
their families in the audience and for 
the patients they will encounter in the 
coming four years and beyond. 
“The white coat that you will be 
given this afternoon represents a way 
of life,” said Dean David A. Kessler, 
M.D. “You will confront real chal¬ 
lenges—life and death—in that coat. 
In essence, from today forward, you 
will always be wearing it, even if it’s 
\y ALE MEDICINE 
just hanging in the closet. It is a sym¬ 
bol of what you do.” 
Among those joining Dean Kessler 
in presenting the coats were newly ap¬ 
pointed associate dean of students 
Nancy R. Angofif, M.RH. ’81, M.D. 
’90, HS ’90-93, and Joseph Warshaw, 
M.D., deputy dean for clinical affairs. 
Chaplain Alan C. Mermann, M.D., 
and associate dean Merle Waxman de¬ 
scribed the school’s code of conduct 
and urged students to seek compan¬ 
ionship and encouragement from 
their classmates. More 
than a dozen alumni 
were in attendance. 
“For the next four 
years you will be im¬ 
mersed in learning the 
science and art ol medi¬ 
cine,” said Dr. Warshaw. 
“The Yale tradition is 
one in which the stu¬ 
dents take a large part 
ol the responsibility for 
their education. The 
goal of education at Yale 
is to provide the broad¬ 
est scientific and medical foundation 
possible to prepare you for whatever 
area you choose.” 
Deputy Dean for Education Rob¬ 
ert H. Gifford, M.D., HS ’67, called 
the ceremony “an occasion to under¬ 
score the significance of your entry 
into a profession where dedication, 
compassion and caring for others 
must be at the core of your very exist¬ 
ence. Each of you possesses those 
qualities because that is what caught 
our eye." 
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ALUMNI NEWS 
Institute of Medicine elects two alumni to its ranks 
Willard Cates, M.D. ’71, Ph.D. ’71, president of Family Health International 
in Research Triangle Park, N.C., and Joseph S. Pagano, M.D. ’57, Lineberger 
Professor of Cancer Research and professor of medicine, microbiology and immu¬ 
nology at the University of North Carolina School of Medicine, Chapel Hill, have 
been elected to the Institute of Medicine. They were chosen for their major contri¬ 
butions to health and medicine and lor the significant amount of volunteer time 
they devote on committees engaged in a broad range oi studies on health policy. 
Willard Cates Joseph S. Pagano 
CLASS N S 
’30s 
Albert W. Diddle, M.D. 30, recently 
retired irom the University of 
Tennessee Medical Center in Knox¬ 
ville, where he was the first professor 
of obstetrics and gynecology. 
’40s 
Philip B. Chase, M.D. ’43, retired 
in 1996. During his career he served 
as director ol university medicine at 
ruffs University in Medford, Mass., 
from 1963 to 1980, and as an associate 
in medicine from 1980 until 
retirement. 
Richard C. Thompson, M.D., HS 
44, developer of the Thompson 
Surgical Retractor System, is at 
Stanford, where he is researching proof 
that a new treatment for poisonous 
snakebite, proposed and published in 
Emergency Medicine, October 1995, will 
prove its usefulness. 
Vincent J. Longo, 
M.D. ’46, H.S. ’47, 
participated in the 
development of 
Viagra as a clinical 
investigator for Pfizer 
Inc., the manufac¬ 
turer of the impotence drug. Working 
out of Pfizer’s Groton, Conn., office, 
he recruited 20 men with erectile 
dysfunction and their sexual partners 
for a double-blind, randomized, 
placebo-controlled study. Pfizer’s 
clinical trials would include hundreds 
of investigators and more than 4,000 
human subjects. 
Lawrence E. Shulman, Ph.D. 45, 
M.D. ’49, retired director of the 
National Institute of Arthritis and 
Musculoskeletal and Skin Disease 
was elected to the rank of fellow by 
the American Association for the 
Advancement of Science (AAAS) 
in September. The award was 
presented in January during the 
AAAS Fellows Forum at the 
association’s annual meeting in 
Anaheim, Calif. 
’50s 
Robert L. Hill, M.D. 56, is semi- 
retired and working part time as a 
psychiatric consultant for local federal 
courts and Santa Barbara County, 
Calif. He attends the Continuing 
Medical Education Psychiatric 
Congress every year. 
Melville P. Roberts Jr., M.D. 57, 
retired in June and is now a professor 
emeritus at the University of Con¬ 
necticut School of Medicine. He lives 
on Guernsey in the Channel Islands 
in the U.K. 
Alan A. Stone, M.D. ’55, HS ’55-56, 
the Jouroff-Glveck Professor of Law 
and Psychiatry at Harvard, writes to 
say that he was delighted to see his 
former student David Kessler, M.D., 
chosen as dean. 
Vincent J. Longo 
’60s 
Malcolm A. Martin, M.D. ’62, 
of Chevy Chase, Md., was elected 
in April to the National Academy 
of Science. 
’70s 
Edward C. Halperin, M.D. 79, 
is the L.R. Prosnitz Professor and 
Chairman of the Department of 
Radiation Oncology at Duke Univer¬ 
sity Medical Center in Durham, N.C 
Jesse B. Jupiter, M.D. ’72, director 
of orthopaedic hand surgery service 
at Massachusetts General Hospital, 
where he has been practicing since 
1975, has been promoted to professor 
of orthopaedic surgery at Harvard 
Medical School. 
Jeffrey C. Faig, 
M.D. ’80, is pres¬ 
ently chief resident 
in obstetrics and 
gynecology at Kaiser 
Medical Center in 
San Francisco. He 
also completed an 
endocrinology fellowship at Stanford 
and an internal medicine residency 
at the University of California, San 
Francisco. Dr. Faig plans to practice 
obstetrics and gynecology in North¬ 
ern California next year. 
Ina S. Cusman, PA-C ’86, of 
Weymouth, Mass., has been elected 
’80s 
Jeffrey C. Faig 
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house of delegates of the American 
Academy of Physician Assistants 
(AAPA). Ms. Cushman is a senior 
physician assistant at Harvard 
Vanguard Medical Associates in 
surgical specialities. 
Thomas D. Fogel, M.D., HS 82-85, 
vice president of the Coastal Radia¬ 
tion Oncology Medical Group in 
Orange and Monterey counties, 
Calif., was elected president of the 
1998-99 Board of Directors of the 
American Cancer Society’s California 
Division. His appointment was 
announced in September at the 
organization’s 52nd Annual Meeting 
in Sacramento. Dr. Fogel has been 
actively involved with the American 
Cancer Society for 12 years. 
Alan S. Hilibrand, 
M.D. ’90, formerly 
assistant professor of 
orthopaedic surgery at 
Vanderbilt University 
School of Medicine 
and at Vanderbilt 
University Spine 
Center, has joined the Rothman 
Institute at Thomas Jefferson Univer¬ 
sity Hospital in Philadelphia. Dr. 
Hilibrand serves on the editorial 
board of the Journal of Spinal Disor¬ 
ders and on the board of directors of 
the National Spine Network. 
Timothy A. Jacobs, M.P.H. ’91, of 
Tampa, Fla., is a consultant, epidemi¬ 
ologist and international health spec¬ 
ialist for South East Asia (Vietnam). 
He is listed in the 1999 editions of 
Who’s Who in the World, Who’s Who in 
America, Who’s Who in Medicine, and 
Who’s Who in the South and Southivest. 
Steven C. Herber, M.D., HS ’90-92, 
was recently named medical director 
of St. Helena Institute for Plastic 
Surgery in the Napa Valley. Dr. 
Herber was also appointed to the 
residency review committee for plastic 
surgery by the American Medical 
Association on Medical Education. 
’90s 
Alan S. Hilibrand 
M. David Tilson, 
M.D. ’67, a vascular 
surgeon also noted 
for his expertise in 
country blues music, 
presented a lecture 
titled Call for the 
Doctor: A History 
Country Blues Piano on Thursday, 
Nov. 19, in the Beaumont Room at 
the School of Medicine. His talk was 
part of a series sponsored by the 
Program for Humanities in Medicine. 
Dr. Tilson served his internship and 
residency training at Yale from 1968 
until 1972. After a two-year military 
tour as major in the U.S. Air Force 
Medical Corps at Regional Hospital, 
Westover AFB, Mass., he returned to 
teach at the medical school until 1989 
as a professor ol surgery (tenured). 
Dr. Tilson also was chief of the 
division of vascular surgery at Yale- 
New Haven Hospital from 1983 to 
1989. He left Yale to become the Ailsa 
Mellon Bruce Professor of Surgery at 
Columbia University. 
His talk addressed how physicians 
and illness are treated in the folk blues 
tradition, and explored the origins of 
early piano and guitar blues and recent 
trends in the preservation, issues and 
conservation of piano blues music. 
NEW BOOKS 
A Time to Die: The Place for Physician 
Assistance by Charles F. McKhann, 
M.D., professor of surgery, Yale 
University Press 1999. 
The Anatomy of a Lie: 
The Truth About Lies 
and Why Good People 
Tell Them by Diane M. 
Komp, M.D., professor 
of pediatrics, Zondervan 
(Grand Rapids, Mich.) 1998. 
Little Clam by Lynn W. Reiser, M.D. 
’70, clinical professor of psychiatry, 
William Morrow & Company Inc. 
(N.Y.) 1998. 
challenged me most was learning to 
work within the social and professional 
environment of clinical medicine. All 
our energy was devoted to mastering 
the vast body of medical knowledge. 
We rarely took the time to reflect on 
what we were doing. Morning rounds 
were business only. Mealtimes were 
filled with didactic lectures in darkened 
amphitheaters. We discussed facts— 
hard data verifiable by experiment. 
We spent great energy on rounds 
to present an impenetrable facade 
which succeeded if it anticipated 
and answered all the questions of the 
senior physician. 
There was no place for vulnerability, 
exposure, uncertainty or the admission 
of incomplete knowledge. As a result, 
there was no place to address the am¬ 
biguous lorces that would make us re¬ 
luctant to convey a diagnosis such as 
cancer. We were never able to expose 
our frustration with a system that does 
not always succeed in listening to the 
suffering of patients. 
As I spoke with fellow students, I 
found that they shared my sense ol iso¬ 
lation in their own struggle to interpret 
the experience of clinical medicine. 
To address this need, I met with seven 
other fourth-year students to organize 
a series of dinner-discussions that we 
hoped would provide a forum for the 
type of open and honest reflection mis¬ 
sing from our own third-year experi¬ 
ence. So far, attendance has been sparse. 
Students explain that they are too busy. 
However, one-on-one discussions con¬ 
firm that many students recognize the 
need to reflect together on our own 
development as physicians. We are still 
feeling our way, but in the next months 
we will meet with faculty and students 
to redesign the forum. With a little 
luck, we just might find a way to cata¬ 
lyze a new type of conversation that is 
both compelling for our growth and 
convenient for our schedules. 
Daniel E. Hall, B.A. ’91, M.Div. ’96, is a 
fourth-year medical student scheduled 
to graduate in May. He will be ordained 
in the Episcopal Church in June, and he 
plans a career in surgical oncology. 
OBITUARIES 
PHILLIP G. COUCHMAN PHILIP M. LECOMPTE 
Phillip G. Couchman, M.D., died of 
cancer at his home in Rockport, 
Mass., on Aug. 15. He was 73. 
Dr. Couchman, born in Iowa, was 
a 1949 graduate ol the School of 
Medicine and later obtained an EDS 
degree from the University of Iowa. 
He did his undergraduate pre-medical 
studies at Harvard University in an 
Army Specialized Training Program. 
A veteran of World War II and the 
Korean War, he practiced medicine in 
Mount Pleasant, Iowa, for more than 
20 years. He was founding faculty 
member of the Department of Family 
Practice at the College of Medicine of 
the University of Iowa, and served as 
an associate professor for 17 years. 
During that time, Dr. Couchman 
maintained a clinical practice and 
trained physicians in the art and 
science ol medicine. He was a 
contributing editor of the Yearbook 
of Family Medicine. 
In 1987 he moved to Rockport, 
where he was a member of the Sandy 
Bay Historical Society. 
Philip M. LeCompte, M.D., formerly 
of Newton Centre, N.Y., died Sept. 15, 
in Lexington, Mass. He was 90. 
Dr. LeCompte graduated from 
the University of Minnesota and 
received his medical degree from 
Yale in 1936. He then worked at the 
Harvard Physiology Laboratory and 
in 1940 returned to teach at Yale. 
Dr. LeCompte was chief of pathology 
at Faulkner Hospital in Boston for 
more than 30 years until he retired in 
1974. In 1966 he co-authored the 
medical textbook The Pathology of 
Diabetes Mellitus. 
JOHN R. LINCOLN 
John R. Lincoln, M.D., died Aug. 16, 
in Sarasota, Fla. He was 80. 
Born in Hartford, Conn., Dr. 
Lincoln graduated from the School 
of Medicine in 1942, where he was a 
member of Alpha Omega Alpha 
honorary medical society. He served 
his internship and residency at 
Hartford Hospital. He served with 
the Marine Corps as a Naval Reserve 
officer during World War II. 
From 1948 until his retirement in 
1973, Dr. Lincoln was chief of the 
Department of Anesthesiology at the 
Maine Medical Center in Portland. 
There he established a residency 
training program in anesthesiology 
and served as its first full-time anes¬ 
thesiologist. He was the first chair of 
the center’s Patient Care Committee 
and vice president of the medical 
staff. Dr. Lincoln was also an associate 
professor at Tufts University School 
of Medicine and a consultant to 
several Maine hospitals at the time of 
his retirement. Dr. Lincoln lived in 
Casey Key and Sarasota, Fla., for the 
last several decades. 
LINCOLN OPPER 
Lincoln Opper, M.D., a former 
longtime forensic pathologist for the 
Connecticut State Police, died Sept. 1 
at home in Rockport, Maine. 
Dr. Opper received his bachelor’s 
degree from Yale in 1927 and his 
medical degree from the University of 
Munich in 1933. He did his internship 
at Yale-New Haven Hospital, where 
he was the first resident in neuropa¬ 
thology, and was an instructor in 
pathology at the School of Medicine. 
During his career, he held positions 
at the University of Arkansas and at 
Norwich State, Backus and Charlotte 
Hungerford hospitals in Connecticut, 
and at Camden Community and 
Knox County hospitals in Maine. 
DONALD A. PIOUS 
Donald A. Pious, M.D., a Univer¬ 
sity of Washington immunologist, 
died on Sept. 6 at his home in 
Seattle. He was 68. 
Born in Bridgeport, Conn., Dr. 
Pious received his bachelor’s degree 
in 1952 and his medical degree in 1956 
from the University of Pennsylvania. 
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He served his residency in pediatrics 
at Yale in 1956 and continued his 
career at the University of California 
at San Diego and the University 
of Washington. 
According to his obituary in the 
New York Times, Dr. Pious made 
important contributions to immunol¬ 
ogy by producing cell mutations that 
revealed how the body’s killer T-cells 
distinguish between foreign sub¬ 
stances, or antigens, and the body’s 
own cells. His work led to the 
discovery of how particular molecules 
appear on protein markers, like 
flagpoles, that protrude through the 
cell’s membrane and can identify a 
cell containing a virus as foreign tissue 
to be rejected. Dr. Pious’s advances 
were central to later research on 
autoimmune diseases, like rheumatoid 
arthritis and multiple sclerosis, as well 
as on the entire system of histocom¬ 
patibility, which involves the body’s 
response to transplants. 
EDWARD F. RABE 
Edward F. Rabe, M.D., died Oct. 3 at 
his home in Whitefield, Maine. 
He was 79. 
Born in Watson town, Pa., Dr. Rabe 
was a graduate of Bucknell University 
and received his medical degree from 
Yale in 1943. He served two years in 
the Army Medical Corps in Europe as 
epidemiologist in the Theatre Chief 
Surgeon’s Office. He returned to Yale 
as an instructor in pediatrics. 
In 1951 Dr. Rabe became head of 
the department of pediatrics at 
Geisinger Memorial Hospital in 
Danville, Pa., and in 1958 he was one 
of the first National Institutes of 
Health Fellows in Pediatric Neurology 
at Massachusetts General Hospital. 
Dr. Rabe then became chief of 
pediatric neurology at Boston Floating 
Hospital and professor of pediatric 
neurology at Tufts University School 
of Medicine. He also established the 
department of pediatric neurology 
at King Faisal Specialist Hospital 
and Research Center in Riyadh, 
Saudi Arabia. 
In 1989 Dr. Rabe moved to Maine 
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where he was active in Literacy Volun¬ 
teers of America and was chairman of 
its Greater Augusta affiliate. 
JOHN K. ROSE 
John Keith Rose, M.D., died July 11 in 
Cambridge, England, where he had 
lived for the past 37 years. He was 72. 
Born in Amboy, Minn., Dr. Rose 
served in the U.S. Army Air Corps 
during World War II. He earned a 
bachelor’s degree from Macalester 
College in 1950 and his medical degree 
from Yale in 1954. Dr. Rose trained at 
Johns Hopkins Hospital in Baltimore 
and then joined the staff at the 
Rockefeller Institute for Medical Re¬ 
search in New York. He studied at 
Sweden’s Karolinska Institut in the 
academic year 1960-61 and then 
joined the Cambridge University fac¬ 
ulty where he was a senior lecturer in 
the department of pathology. He was 
a fellow of Emmanuel and Pembroke 
Colleges. He retired in 1995 but con¬ 
tinued limited supervision of his de¬ 
partment thereafter. He also pursued 
research in kidney transplantation at 
the Hennepin County Medical Center 
in Minneapolis. 
CHARLES F. SCHOLHAMER, SR. 
Charles F. Scholhamer, Sr., died 
Oct. 2 in Guilford, Conn. He was 81. 
Born in New Haven, Dr. 
Scholhamer graduated in 1939 from 
Yale University and in 1942 from 
the School of Medicine. He served 
his residency at Grace-New Haven 
Hospital. 
Dr. Scholhamer was a New Haven 
pediatrician for 25 years and, betore his 
retirement, was assistant medical direc¬ 
tor for Aetna Life and Casualty Inc. 
KENNETH W. THOMPSON 
Kenneth Wade Thompson, M.D., of 
California, died July 14 after a progres¬ 
sion of disabling strokes. He was 93. 
Dr. Thompson received his medical 
degree from Harvard in 1930. He 
came to Yale in 1935 as a fellow in ex¬ 
perimental endocrinology and, from 
1937 to 1938, was the Alexander Brown 
Cox Memorial Fellow. From 1938 to 
1944, Dr. Thompson was an assistant 
professor of surgery. 
In 1944, he returned to Boston to 
develop a private surgical practice. 
During this time he was also editor 
of the New England Journal of 
Endocrinology. In 1948 he was 
appointed vice president of Organon, 
a New Jersey pharmaceutical firm, 
where he worked as director of 
research for almost 20 years. Dr. 
Thompson then served as a professor 
of obstetrics and gynecology at the 
University of Wisconsin Medical 
School. He later moved to New York 
and was elected to the presidency of 
the New York Academy of Sciences, 
where he served until his retirement 
in 1973. 
IN M E M 0 R I A M 
The School of Medicine has received 
notification of the death of the 
following persons: 
Frank R. Allen, M.D. ’51 
July 17, 1998 
Albert S. Atwood, M.D. ’45 
August 8, 1998 
Isreal E. Kirsh, M.D. ’30 
May 8, 1998 
Philip M. LeCompte, M.D. ’36 
September 15, 1998 
Robert R. McDonnell, M.D., 
HS ’50-51 
December 11, 1997 
Phong Tuan Nguyen, M.P.H. ’58 
November 15, 1995 
Trudee C. Parenteau, M.P.H. ’78 
January 10, 1997 
Kenneth C. Steele, M.D. ’45 
July 11, 1998 
Herbert Allan Wenner, M.D., 
HS ’41-45 
April 21, 1998 
John H. Wentworth, M.D. ’39 
June 21, 1998 
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Can’t talk now 
A student reflects upon life on the wards 
and looks for ways to improve communication. 
By 
Daniel E. 
I met him in the emergency room. As a third- 
year student, I now performed many basic 
procedures on a daily basis but this case was 
a first for me. The physical examination was 
unremarkable until I discovered a large, bleeding, 
irregular mass where his prostate should have 
been. From that moment, I knew the man 
had cancer. 
Subsequent work-up confirmed diagnosis, 
metastatic rectal carcinoma, but what disturbed 
me most was that, as far as I could tell, nobody informed 
the patient lor over 36 hours. Yet in that time he was sub¬ 
jected to a series of rectal exams by grave-faced physicians. 
A biopsy and CT scan were performed to confirm suspi¬ 
cions. Within 10 minutes of my discovery, we were already 
detailing his poor prognosis—but only outside the room 
and among ourselves. The hard work of informing the pa¬ 
tient was deferred, and I cringe to think how the gravity of 
our countenance and the flurry of our activity tortured his 
imagination. 
It happened every morning during “lightning rounds.” 
Sheepishly we stood by as the resident hurled questions at 
the case in the bed while jabbing her fingers into its abdo¬ 
men in a cruelly ritualized abstraction that passed for a 
physical exam. It did not matter that the case could not 
understand the questions. The case had pancreatitis and 
the resident already knew the story. It did not matter that 
the case told a different story when the resident rushed 
away. It did not matter that we all averted our eyes, afraid 
to confront the fear, confusion and suffering in the case’s 
face. It did not matter that I was guilty by association 
each time the resident transformed our “team” into a pack 
of marauding wolves. 
♦ ♦ ♦ 
The anger was palpable. It was 2 a.m.—and they all 
knew what was coming. Starting with me, they would 
spend the rest of the night answering the same questions re¬ 
peatedly as they made their way through the emergency 
room, medical admitting and finally up to the cancer unit. 
They were tired of rehearsing the story of their father’s nine- 
month decline into disseminated lymphoma with the first 
incorrect diagnosis, the second correct and devastating diag¬ 
nosis, the three less-than-perfect surgeries, and the unex- 
Hall 
plainable complications. They could not under¬ 
stand why they had to rehearse the details already 
contained in his chart. They were fed up with 
21 doctors who seemed not to listen. They were ex- 
Hl hausted by the disease. They were angry at me 
before I even entered the room. 
As a medical student, 1 had the luxury to dedi¬ 
cate 60 minutes to this family. As they vented 
their frustration, the anger started to cool, and 
they left the emergency room satisfied that at 
least one person had listened. I worry that the structure of 
post-graduate training will not permit me this luxury when 
I am a house officer. 
It puzzled me at first. It seemed odd and a little annoy¬ 
ing that a fellow medical student would publically grill me 
with detailed questions after my presentation. After inquir¬ 
ing about my topic the day before, she had apparently done 
some homework. I concluded she must be a very diligent, if 
slightly over-eager, student. 
Two weeks later I inquired about the subject of her im¬ 
pending presentation. I was dumbstruck when she said, 
“You made the mistake of telling me your topic. I’m not 
that stupid.” 
Disturbing stories such as these are rare in my experi¬ 
ence, but I suspect most physicians and medical 
students would have similar vignettes to share. 
Medical education is full of dedicated people with the best 
of intentions, but with regrettable frequency the system 
grows larger than the individuals within it, and the human 
touch is all too easily lost—if only temporarily. Each of 
these four stories is just a snapshot of many days and 
nights, but I think each illustrates a breakdown in commu¬ 
nication. As a medical student, I was disturbed by my own 
role in this broken communication, but more disturbing 
to me was that the medical team rarely discussed these 
troubling experiences. 
I never expected the third year to be easy. I was prepared 
for the long hours and the intellectual demands, but what 
Continued on page 45 
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Continuing Medical 
Education at Yale 
Feb. 26-27 
Friday-Saturday 
Workshop on Positron Coincidence Imaging 
Course Directors: Chin Ng, Ph.D., and Holly Dey, M.D. 
New Flaven Hotel, New Flaven 
Feb. 27-28 
Saturday-Sunday 
Spinal Canal Endoscopy Supercourse 
Course Director: Lloyd Saberski, M.D.; 
Co-director: James Rosser, M.D. 
Temple Medical Center, 40 Temple St., New Haven 
March 3 
Wednesday 
Intensive Workshop on the Difficult Airway 
Course Director: William Rosenblatt, M.D. 
State University of New York, Stony Brook, N.Y. 
March 6 
Saturday 
New Diagnostic, Therapeutic & Assessment 
Approaches to Epilepsy in Children and Adults 
Course Director: Susan Spencer, M.D. 
Foxwoods Resort & Conference Center, 
Ledyard, Conn. 
March 10-14 
Wednesday-Sunday 
Homelessness in the Elm City 
Course Director: Michael Rowe 
Harkness Auditorium, New Haven 
March 12-13 
Friday-Saturday 
Autism, Asperger’s Syndrome 
and Related Conditions 
Course Directors: Fred Volkmar, M.D., and 
Ami Klin, Ph.D. 
Omni Hotel, New Haven 
March 19 
Friday 
Child & Adolescent Affective and Anxiety Disorders 
Course Director: Joan Kaufman, Ph.D. 
CMHC Auditorium, New Haven 
March 19 
Friday 
Medical and Surgical Retina Symposium for the 
Specialist and the Generalist 
Yale Eye Center, Boardman Building, Room 307, 
New Haven 
April 9-10 
Friday-Saturday 
NIA Conference on Aging 
Course Director: Joanne McGloin 
Doubletree islander Hotel, Newport, R.l. 
April 30 
Friday 
New Developments in Endocrine Disease with 
Surgical Import 
Course Director: Barbara Kinder, M.D. 
Omni Hotel, New Haven 
May 8-9 
Saturday-Sunday 
Spinal Canal Endoscopy Supercourse 
Course Director: Lloyd Saberski, M.D.; 
Co-director: James Rosser, M.D. 
Temple Medical Center, 40 Temple St., New Haven 
For information, contact the Office of Postgraduate and Continuing Education, Yale University School of 
Medicine, 333 Cedar Street, P.O. Box 208052, New Haven, CT 06520-8052; Tel: (203) 785-4578 
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Venice and the Dalmatian Coast 
July 7-17, 1999 
The Maritimes and the St. Lawrence 
July 13-23, 1999 
Route of Popes and 
September 7-18, 1999 
Solar Eclipse in Eastern Europe 
August 2-12, 1999 
Voyage Around 
May 14-25, 1999 
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Emperors 
Elbe River: Berlin and Prague 
June 16-28, 1999 
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Expanded quarters 
for the Child Study Center 
Construction of the Irving and Neison Harris 
Building, a five-story addition to the Child Study 
Center facing Harkness lawn, is nearing completion 
and will be dedicated during a symposium in 
October. Designed by Centerbrook Architects, the 
building adds 22,000 square feet to the center’s 
existing facilities in Sterling Hall of Medicine and 
the Winchester building. 
The new structure includes space for programs 
in early child development, school development, 
community based interventions relating to children 
and trauma research into complex neuropsychiatric 
disorders (including autism, Tourette’s syndrome an 
obsessive-compulsive disorder) and new teaching 
facilities (including a 160-seat auditorium). The 
Harris building completes the third phase of a spat 
plan for the Child Study Center that dates to 1974. 
The first two phases were the construction of the 
Provence-Harris Child Development Unit and the 
Child Psychiatry Inpatient Service at Yale-New 
Haven Hospital. 
“The new facility will provide vital new space r 
all of the programs within the Center, and it will bi 1 
special resource for the New Haven region,” says 
center director Donald Cohen, M.D. The Harris buit 
ing will support the Center’s missions of promotin 
the health of children and families, the education 
students and fellows, and the advancement of the 
science of child development. 
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Page 12 
A running conversation about children 
What results when pediatricians and child psychiatrists carry on a 40-year dialogue about the care 
of their young patients? A deeper understanding of the psychosocial influences affecting child 
health, say the members of this unique collaboration. 
By John Curtis 
yrmmnmmc mwmmmr 
PRACTICE 
Patients, doctors and the bottom line 
Market forces and a changing world of medicine have 
prompted Yale’s 650-member physician organization to 
take a closer look at the way it does business. A greater 
emphasis on patient service, detailed practice standards 
and better ways of tracking data are emblematic of a 
changing culture within the school’s clinical enterprise. 
By John Curtis 
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23 ‘We have a remarkable community here’ 
Susan Hockfield, an accomplished neurobiologist and new dean 
of the Graduate School, talks about the future of research, 
teaching and Yale’s community of scholars. 
Interview by Michael Fitzsousa 
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An education in taste 
Start with one legendary French chef. 
Combine with Yale scientist and 
expert in the physiology of taste. 
Mix with fine food for two hours 
and record. Yields one conversation 
rich in flavor and detail, 
A conversation with Marc Wortman 
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LETTERS 
A little more candor 
in class profile 
To the Editor: 
I must comment that the 
article on the Yale medical 
school Class of 2002 [First- 
Year Class Brings More than 
Smarts to School, Winter 1999] 
does injury to the English 
language. How is it possible 
to write that the class repre¬ 
sents “a broad cross section 
of backgrounds and interests" 
when more than a third were 
undergraduates at either Yale or 
Harvard? Or when “half the class 
is Hispanic, African American or 
Asian-American”? Without reference 
to census data, it seems to me that 
together those minorities constitute 
25 percent or less of the American 
population. 
Now I could care less who you admit 
or why, but don’t try to tell me that 
such a narrow admission policy is 
“broad.” Come on, guys, this is Yale, 
not some bush-league operation. 
Tell it straight. 
Michael W.R. Davis, B.A. '53 
Royal Oak, Mich. 
Asthma model was 
a group effort 
To the Editor: 
Your article on asthma [Mapping the 
Landscape of Asthma, Winter 1999] 
explained very nicely the ever-increas¬ 
ing problem this disease represents in 
the United States and worldwide, as 
well as the efforts at Yale to address 
this pressing prob- 
1 1 • 1 “ 1 Yale Medicine 
iem. i wish, how¬ 
ever, to point out 
that the inducible 
transgenic mouse 
that was described, 
in which genes can 
be turned on and 
off at will, was not 
prepared solely in 
my laboratory. It 
was a collaborative 
effort of a number of laboratories 
including that of Prabir Ray, Ph.D., 
associate professor of medicine in the 
Department of Internal Medicine. 
Jack A. Elias, M.D. 
Professor of medicine 
Chief of pulmonary and critical care medicine 
Corrections 
The caption on page 25 of the Winter 
issue of Yale Medicine incorrectly 
described the device shown in the 
photograph. It is a peak flow meter, 
used to measure a patient’s ability to 
move air through the lungs, one 
indicator of the activity of asthma. 
Alan A. Stone, M.D. ’65, HS ’55-56, is 
the Touroff-Glueck Professor of Law 
and Psychiatry at Harvard. His title 
was incorrect in the Alumni Notes sec¬ 
tion of the Winter issue. 
How to reach us Yale Medicine 
welcomes news and commentary. Please 
send letters to the editor and news items 
to Yale Medicine, P.0. Box 7612, New 
Haven, CT 06519-0612, or via electronic 
mail to ymm@yale.edu, and include a day¬ 
time telephone number. Submissions may 
be edited for length, style and content. 
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iCOPE CONSTRUCTION UPDATE 
Congress Avenue project gains 
the backing of city officials 
Plans for a new research and teaching complex on 
Congress Avenue took several large steps forward 
over the winter, bringing the planning process 
for the proposed 440,000-square-foot structure closer 
to completion. 
New Haven’s Board of Aldermen approved the plans on 
March 15, leaving a final review by the City Plan Commis¬ 
sion in May. The Yale Corporation, which is reviewing 
the project in stages, endorsed the design development 
phase last fall. In early April, the Corporation authorized 
funding for construction documents for the building. 
“This building is about more than bricks and mortar,” 
Dean David A. Kessler, M.D., said at a press conference 
with city officials and community leaders in February. 
“It’s about people and ideas and the creation of a favorable 
environment for making medical breakthroughs. By having 
a clear focus on disease, I think we will see real advances 
that impact both individuals and the health of the public. 
Our goal is to advance the scientific basis of the practice 
of medicine.” 
Demolition of two buildings on Congress Avenue will 
begin in August, and construction of the new facility is to 
Above right The Congress Avenue building is Yale's largest project in 
several decades. The $160 million facility will be largely devoted to 
wet-bench laboratory space, a magnetic resonance center, new teach¬ 
ing facilities in anatomy and histology, an auditorium and expanded 
laboratory support. 
Below Mayor John DeStefano joined Dean David Kessler in February 
for the unveiling of plans for the new 440,000-square-foot facility. 
begin as early as October, with substantial completion in 
June of 2002. The school still must squeeze $4 million from 
construction cqsts to meet the $160 million project budget, 
develop a parking plan and relocate offices from the build¬ 
ings slated for demolition. Bruce Carmichael, who manages 
the myriad details of the process as executive director of 
major projects, admits it’s not a simple task. “This is a three- 
dimensional checkers game in the dark ph a rocking boat,” 
he observed. “But we will find a wayio make it work.” 
The new building will be about three times-the size jpf 
the Boyer Center for Molecular Medicine, which opened in 
1991 on a site diagonally across Congress 
Avenue. Much of the new space will be 
devoted to wet-bench laboratories and 
the school’s'Magnetic Resonance Cen¬ 
ter. The new building will also include 
histology and anatomy labbratories for 
medical education, meeting rooms, and 
a 140-seat auditorium and expanded 
laboratory support. 
Laboratories will have a standard 
design, with no customized fittings, 
in order to maintain flexibility. “As 
research groups grow, as program needs 
change, we expect a great deal of assign¬ 
ment and reassignment. We want a 
generic quality that can accommodate 
that,” Carmichael said. 
v/ 
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Yale-created Lyme 
vaccine hits the market 
LYMErix, a vaccine against Lyme 
disease based on Yale research licensed 
to SmithKline Beecham Pharmaceuti¬ 
cals, received Food and Drug 
Administration approval in December 
for prescription use. Yale served as 
a major study center during clinical 
trials of the compound, which is 
the first vaccine approved for 
the disease. 
l he vaccine, which became avail¬ 
able to patients in January, was de¬ 
rived from basic research performed at 
the School of Medicine by a team in¬ 
cluding Richard A. Flavell, Ph.D., 
Fred S. Kantor, M.D., Erol Fikrig, 
M.D., and Stephen W. Barthold, 
D.V.M., Ph.D. 
Lecture series gives 
public an inside look 
at drug discovery 
During the past 150 years, scientists 
and physicians first discovered that 
germs, bacteria and viruses caused 
disease, then found agents that could 
destroy, thwart and obstruct the 
pathogens. Disease and its treatments 
were the topic this winter of a five- 
part public lecture series sponsored 
by the Office of Postgraduate and 
Continuing Medical Education. This 
year’s series was tided What’s In Your 
Medicine Cabinet? 
“The past few decades have seen 
remarkable advances in pharmacology 
and the management of a large num¬ 
ber of common diseases,” said James 
D. Kenney, M.D., associate dean for 
postgraduate and continuing medical 
education and the course organizer. 
“ The effectiveness of frequently pre¬ 
scribed drugs, as well as their costs 
and interactions, are matters of public 
concern.” The Patrick and Catherine 
Weldon Donaghue Medical Research 
Foundation, based in Hartford, 
Conn., provided support for the 
series, which attracted 44 people from 
"I got Lyme disease last spring 
and I'm being treated for terioui health problemi. 
I couldn't prevent it then, but now you could.' 
The FDA approval restricted its use 
to people between 15 and 70 years old 
pending the outcome of further test¬ 
ing. “There are currently studies in 
progress to evaluate the vaccine in 
children,” said Robert T. Schoen, 
M.D., clinical professor of medicine 
and director of the Lyme Disease 
Clinic at the medical school. In addi¬ 
tion, researchers will track the need 
for booster shots beyond the three ini¬ 
tial injections. Given over the course 
of a year, the three doses of the vac¬ 
cine were found in clinical trials to 
provide 78 percent protection against 
Lyme disease. 
Schoen cautioned that other mea¬ 
sures, such as protective clothing and 
insect repellent, should be taken with 
use of the vaccine. “The vaccine is not 
100 percent protective,” he said. 
“Other tick-transmitted infections 
could also occur. It is important that 
the vaccine be part of an overall pre¬ 
vention program.” 
New Haven and surrounding towns. 
While scientists today explore the 
genetic and molecular underpinnings 
of disease and treatment, early 
chemists and physicians found medi¬ 
cations in unlikely sources. Toxic 
waste generated in the manufacture 
of coke yielded synthetic indigo, from 
which German chemists derived sulfa 
drugs that stymie the production 
of bacterial DNA. Arsenic, a heavy 
metal, became a remedy for syphilis. 
Scientists developed gramicidin as 
they exploited bacteria found in 
soil to control other bacteria. 
Speakers for the lecture series 
included Frank J. Bia, M.D., professor 
of medicine (infectious diseases), who 
discussed How We Pick and Choose 
Antibiotics; Silvio E. Inzucchi, M.D., 
assistant professor of medicine, 
Diabetes Treatment in 1998: Something 
Old, Something New; Karl L. Insogna, 
M.D., associate professor of medicine, 
Osteoporosis and Paget’s Disease of the 
Bone; John F. Setaro, M.D., associate 
professor of medicine, The Manage¬ 
ment of Hypertension; and Elena 
Citkowitz, M.D., assistant clinical 
professor of medicine, Treatment of 
Cholesterol and other Lipid Disorders. 
NCI renews Cancer Center’s 
comprehensive designation 
l he Yale Cancer Center, which is 
marking its 25th year in 1999, has again 9earned designation from the 
National Cancer Institute as 
one of the nation’s compre¬ 
hensive cancer centers. It is 
one of 37 such centers in the 
United States and the only one 
in southern New England. 
The center first received NCI des¬ 
ignation in 1974. Last August the NCI 
renewed the center’s five-year Cancer 
Center Support Grant, which supports 
research administration for the center’s 
14 research programs, shared resources 
and developmental activities. Redesigna¬ 
tion as a comprehensive cancer center 
followed in December. 
To attain comprehensive recogni¬ 
tion, an institution must pass a peer 
review and perform basic research, 
clinical research and cancer preven¬ 
tion, control and population-based re¬ 
search. The NCI designation indicates 
that Yale is a center of unusual excel¬ 
lence in research and clinical care and 
an important community resource for 
education, information and outreach. 
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A “toxic mismatch” in Havana 
For years Cuba had the distinc¬ 
tion of being the only country 
in the world to quarantine 
people who tested positive for HIV. 
One of a handful of remaining com¬ 
munist nations, Cuba took pride in 
comparing the success of its approach 
with the failures of capitalist nations 
to contain the disease. But all that is 
changing, reports Helena Hansen, an 
M.D./Ph.D. candidate at Yale who 
spent six weeks in Cuba in 1997, inter¬ 
viewing physicians, public health pro¬ 
fessionals and people with or at risk 
for HIV infection. 
She found a growing recognition 
among health care professionals that 
a new strategy is needed as tourism 
becomes the leading industry and 
Cubans flock to the cities to become 
entrepreneurs in a new, dollar-based 
economy. “There are many social 
changes taking place because the 
economy has changed so much,” 
Hansen said in January during a talk 
that was part of the Humanities in 
Medicine series. 
Change in health strategy faces 
formidable obstacles in Cuba, where 
universal health care has been a 
cornerstone of social policy since the 
1959 revolution that brought Fidel 
Castro to power, Hansen said. Cuba 
eradicated polio, diphtheria and other 
diseases endemic to other Latin 
American nations. The island has 
twice the number of doctors per 
capita as the United States and signifi¬ 
cantly lower infant mortality rates 
than its Caribbean neighbors. Even 
after Cuba lost its principal financial 
patron with the breakup of the Soviet 
Union, the government continued to 
invest in health care and promote a 
small biomedical industry. Although 
fuel, food, housing and consumer 
goods remain scarce, the government 
points to health care as a benefit of 
the revolution. 
Cuba’s centralized, authoritarian 
approach to public health allowed it 
to report one of the lowest incidences 
Helena Hansen’s 
research in Havana, 
left, on Cuban HIV 
policy showed the 
potential for higher 
rates of infection. 
of HIV in the hemisphere. In 1997, 
Cuba had 1,609 cases of HIV and 600 
cases of AIDS in a population of 11 
million—compared to more than 
21,000 cases of AIDS in Puerto Rico, 
which has a third the population. 
Cuba banned foreign blood products 
and monitored its population for 
diseases that indicated the presence 
of HIV. Surveillance was so precise 
that health officials could say with 
certainty that AIDS came to Cuba 
in 1985, carried by a bisexual theater 
worker who had traveled to New 
York and several soldiers returning 
from Africa. 
“The decision to quarantine HIV- 
infected citizens reflected a classic 
approach to public health that Cuba 
had exercised with success,” Hansen 
said. But, by 1996, despite the con¬ 
tainment strategy, HIV infection was 
increasing. Popular tourist spots in 
Havana and elsewhere in Cuba, 
Hansen said, are witnessing a phe¬ 
nomenon unseen since the days of 
dictator Fulgencio Batista—the emer¬ 
gence of street hustlers called 
jineteros. Today’s sex workers come 
from diverse backgrounds and can be 
college students, doctors or lawyers 
who occasionally turn to prostitution 
to obtain U.S. dollars and access to 
scarce consumer goods, Hansen said. 
In response to pressure from inter¬ 
national human rights organizations, 
Cuban health officials have relaxed 
their quarantine. People with HIV 
are advised, rather than required, to 
spend six months in a sanatorium to 
learn, among other things, safe sex 
and behavior modification, but the 
country has not yet embarked on a 
comprehensive AIDS education pro¬ 
gram. Monitoring of HIV-positive 
people and the tracing of their sexual 
contacts remain the mainstays of cur¬ 
rent policy. Scarcity of condoms and 
a culture of aversion to condoms limit 
their use. The simple possession of 
a condom, Hansen said, can label a 
woman as a prostitute plying the tour¬ 
ist trade. And the illegality of prostitu¬ 
tion and strong stigma of homosexual¬ 
ity drive underground two groups at 
risk for infection. Although the gov¬ 
ernment supports one official AIDS 
prevention group run by HIV-positive 
Cubans, it is illegal for other groups to 
organize without official sanction. 
Nevertheless, Hansen said, gay men 
report that recent government promo¬ 
tion of tourism has created a more 
liberal atmosphere that allows gay 
clubs and hotels to operate. 
“A toxic mismatch may be occurring 
in Cuba,” she said, referring to the 
high social and geographical mobility 
of Cubans in the face of inadequate 
HIV prevention programs. She notes 
that when it comes to AIDS, revolu¬ 
tionary ideas and a centralized medical 
bureaucracy may be at odds with the 
realities of a changing society. 
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Raiding the reservoir 
AIDS Researcher David Ho reports on “hidden HIV” 
and potential new avenues of attack. In 1996, when Time magazine 
named David Ho, M.D., as its man 
of the year, people with AIDS were 
enjoying the first glimmers of hope 
for long-term survival, thanks to the 
combination therapies he and others 
helped develop. They were living 
longer, and the new treatments kept 
many with HIV from developing full¬ 
blown AIDS. 
Three years later, however, that op¬ 
timism has waned as the limitations of 
those therapies have become apparent. 
Although mortality due to AIDS has 
decreased five-fold over the last several 
years, the new treatments don’t work 
for everyone. Strains of HIV are now 
resistant to the medications. And sur¬ 
vival means a life ruled by rigorous 
adherence to an unforgiving schedule 
of foul-tasting pills. 
Ho, director of the Aaron 
Diamond AIDS Research Center in 
New York City, described the next 
steps in the battle against AIDS at 
the first T.S. Lin Memorial Lecture, 
sponsored by the Department of 
Pharmacology.-In his talk, Advances 
and Obstacles in HIV Therapy, Ho said 
that studies have found that although 
some patients have apparently unde¬ 
tectable levels of HIV, pools of the 
virus remain, lodged in immune cells 
called memory Cd4 lymphocytes. 
“The level of replication of the virus, 
we think, is exceedingly low,” Ho said. 
“One has to come up with a strategy 
that would facilitate the decay of the 
reservoir.” His approach, still under 
study, is to activate the immune 
system’s resting Cd4 cells to keep the 
pool of virus in check. “We think it 
would be very difficult to drive this 
pool to zero,” he said. “We could 
drive it sufficiently low that we could 
ask the immune system to clean it up 
and keep it under control.” 
The lecture series honors Lin, 
a pharmacology research scientist 
who died in 1992 and collaborated 
with William H. Prusoff, Ph.D., 
professor emeritus of pharmacology, 
to develop the anti-retroviral com¬ 
pound d4T as a treatment for AIDS. 
Marketed as Zerit, d4T has helped 
to prolong many thousands of AIDS 
patients’ lives. Ho was introduced 
by Yung-Chi Cheng, Ph.D., the Henry 
Bronson Professor of Pharmacology 
and Medicine, who helped develop 
3TC, another AIDS treatment. 
David Ho, center, 
director of the 
Aaron Diamond 
AIDS Research 
Center in New 
York, gave the 
first T.S. Lin 
Memorial Lecture 
at the Department 
of Pharmacology. 
Here, he is joined 
by Yung-Chi Cheng 
and William 
Prusoff. 
Graduate students 
celebrate common ground 
at research symposium 
Toiling away in a highly specialized 
branch of scientific research, a graduate 
student may feel isolated at times, 
however well the work is going. But 
across the University, there is a larger 
community of scholars, many working 
on similar problems. To enhance com¬ 
munication, some 200 Yale graduate 
students in the biological and biomedical 
sciences gathered in early February to 
exchange ideas across department lines. 
The fourth annual Graduate Stu¬ 
dent Research Symposium brought 
together students from the 12 core 
bioscience departments at Yale to dis¬ 
cuss their work. “We are all in related 
fields,” said Helen A. Seow, a doctoral 
candidate in pharmacology and one of 
the symposium organizers, “but once 
you get into a department you are 
very separate. There are people who 
do things very similar to what I do, 
but they’re across campus.” 
During the conference, 11 students 
presented talks on their research in 
progress. In addition, representatives 
of pharmaceutical and biotechnology 
firms were present at a career forum 
and on panels discussing topics such 
as Where Do You Go After Yale? and 
What Else Can You Do With Your 
Ph.D.?Other speakers included Susan 
Hockfield, Ph.D., dean ol the Gradu¬ 
ate School of Arts and Sciences and 
professor of neurobiology at the medi¬ 
cal school, and Eric S. Lander, D.Phil., 
professor of biology at the Massachu¬ 
setts Institute of Technology and di¬ 
rector of the Whitehead Institute/ 
MIT Center for Genome Research. A 
panel on careers in science communi¬ 
cations included Douglas Starr, co-di¬ 
rector of the science journalism pro¬ 
gram at Boston University, and Peter 
Brown, Ph.D., editor of The Sciences 
magazine, published by the New York 
Academy of Sciences. 
Since the first conference in 1996, 
graduate students have found many 
new vehicles for communication, in¬ 
cluding the Combined Program in 
the Biological and Biomedical Sci- 
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ences, which this year met its goal of 
linking all the relevant Yale depart¬ 
ments. The greater sense of commu¬ 
nity has been noticeable, said Eliza¬ 
beth Doherty, a Ph.D. candidate in 
the Department of Molecular Bio¬ 
physics and Biochemistry and chair 
of this year’s gathering. “Students find 
there has been a lot more integration 
around campus,” she said. 
In Macedonia refugee camp, 
students serve as volunteers 
As the exodus of ethnic Albanians 
from Kosovo continued this spring, a 
team of student emissaries left lor 
neighboring Macedonia on April 22 to 
work in a refugee camp served by the 
medical relief organization Doctors of 
the World. Margaret Bourdeaux, Seth 
Goldbarg, Vivian Lombillo, Sharon 
Chekijian, Aaron Covey and Anya 
Szeglin were accompanied by their 
preceptor, Pamela Perry, M.D., assis¬ 
tant professor of surgery (emergency 
medicine), and by Emine Alijaj, R.N., 
P.A.-C., a physician associate in the 
Emergency Department at Yale-New 
Haven Hospital who was born in 
Kosovo and speaks Albanian. 
The students traveled as volunteers 
and made themselves available to 
distribute blankets and oral rehydration 
fluids, set up tents, dig ditches and 
change bandages. Before their departure, 
the group consulted with faculty on 
medical and psychological issues, as 
well as the culture shock they can 
expect to encounter in the camp and 
upon their return. The students 
planned to stay in Macedonia for four 
weeks before returning to New Haven. 
Elective C-sections found 
to reduce HIV transmission 
to infants 
An international study has found that 
elective caesarean sections, coupled 
with anti-retroviral therapy, can 
reduce the incidence of HIV transmis¬ 
sion from mother to infant to 2 percent, 
a nearly io-fold decrease compared to 
mothers who received neither treat¬ 
ment. The study, in which a team 
from Yale participated, was published 
in April in the New England Journal of 
Medicine. The principal investigator 
for the Yale team, Warren A. 
Andiman, M.D., professor of pediat¬ 
rics and epidemiology, said the study 
by the International Perinatal HIV 
Group could change approaches to 
delivery of infants of HIV-positive 
mothers. 
“My feeling is that the usual prac¬ 
tice in the United States will be to do 
a C-section,” Andiman said. “Obste¬ 
tricians will have to think of compel¬ 
ling reasons not to provide caesarean 
sections for their patients with HIV." 
Physicians were already using elec¬ 
tive C-sections to prevent transmis¬ 
sion of other infectious diseases, such 
as herpes simplex. “It has been long 
held that being born vaginally poses a 
risk,” said B. Joyce Simpson, R.N., 
M.P.H., pediatric HIV coordinator at 
the Pediatric AIDS Care Program, and 
co-leader of the Yale study. But when 
it came to vertical transmission of 
HIV, no single study, either in the 
United States or in Europe, included a 
sample large enough to provide statis¬ 
tically significant results. Moreover, 
most data did not distinguish between 
controlled, elective C-sections and 
emergency C-sections, which are al¬ 
most as likely as vaginal delivery to re¬ 
sult in HIV infection in the infant. To 
prevent transmission of HIV, the C- 
section must be done before labor has 
begun and membranes have ruptured, 
Andiman said. 
The National Institute of Child 
Health and Human Development or¬ 
ganized the international study, which 
included mother-child pairs who were 
studied prospectively, some beginning 
in 1982. It was comprised of 15 study 
sites in the United States and Western 
Europe, including Yale’s Prospective 
Longitudinal Cohort Study. More 
than 8,500 cases were reviewed to en¬ 
sure that all data conformed to the 
study’s strict guidelines. They found 
that elective C-section, without anti¬ 
retroviral therapy, reduced the inci¬ 
dence of HIV transmission from 19 
percent to 10 percent. Elective C-sec¬ 
tions combined with anti-retroviral 
therapy, including AZT given during 
pregnancy and at delivery, reduced the 
rate of transmission to 2 percent. 
Outlook for Y2K: partly cloudy but no hurricanes in sight 
The medical school’s computer infrastructure and information as well as tools that allow users to test 
processor-controlled medical devices are largely in their own hardware and software. Testing experts for 
good shape for the turn of the millennium, according biomedical equipment and other Y2K resources are 
to an analysis by the school’s Year 2000 Steering also available through ITS-Med. The school has hired 
Committee. While the school’s Information Technology PricewaterhouseCoopers to assist with business 
Services division (ITS-Med) has overseen the inven- continuity planning. The dire predictions associated 
tory and risk assessment phase of planning for prob- with the millennium bug are for the most part exag- 
lems that could occur on January 1, 2000, the indi- gerated, said the division’s associate director, Susan 
vidua! owners of equipment and systems are primarily Grajek. “The impact will be neither a big nothing nor 
responsible for their own testing and troubleshooting. a catastrophe, but more likely a number of localized 
An extensive web site [http://info.med.yale.edu/ breakdowns,” she said. “That’s why it’s important for 
computing/year2000/] contains up-to-the-minute people to assess and plan ahead now.” 
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“First aid” for medical students 
Yale’s student editors weigh in with advice for the boards. 
Every spring second-year medical 
students across the country pre¬ 
pare for the first of three exams 
collectively known as “the boards," 
with a great deal riding on the out¬ 
come. At most medical schools, stu¬ 
dents must pass Step i, the first of the 
three tests that comprise the United 
States Medical Licensing Exam, before 
they can proceed to their clinical 
training in the third and fourth years. 
And board scores are a yardstick by 
which applications to residencies are 
measured. “If you do poorly on this 
exam, it can make it difficult to get 
into the residency program you want,” 
said Antony Chu, one of several Yale 
medical students who played a role 
in publishing this year’s edition of 
the leading guidebook to the exam. 
“Basically, it can have a major impact 
on your career.” 
Chu, a senior student co-editor of 
the book, spent hundreds of hours last 
year shaping and writing First Aid for 
the USMLE Step i. Published in Janu¬ 
ary by Appleton and Lange, it is a stu¬ 
dent-written guide that helps medical 
students focus their preparation for 
the boards. Divided into three parts, it 
offers a description of the exam, 
“high-yield" facts that apply to a 
Students at 
Yale reviewed, 
revised and 
edited the 
latest edition 
of First Aid for 
the USMLE 
Step 1, the 
leading guide 
to board 
exams. 
variety of exam topics and a guide to 
resources for study. “Essentially every 
medical student in the country who is 
taking the exam will have this book,” 
said Chu. 
The 1999 edition counted on the 
work not only of Chu, but several 
other writers, editors and reviewers af¬ 
filiated with Yale. Medical student co¬ 
editor Esther Choo revised sections of 
the book and contributors included 
M. Vaughn Emerson, Ronald Yap and 
Amy Nuernberg. William Stewart, 
Ph.D., associate professor of surgery, 
was one of several faculty reviewers. 
Tao T. Le, M.D., a third-year resident 
in internal medicine at Yale, was one 
of the book’s three primary authors. 
Because the exam this year is being 
offered via computer at educational 
testing centers instead of lecture halls, 
the book has changed some of its ad¬ 
vice, said Le. “The exam is no longer a 
pencil and paper exam,” Le said. “The 
guide is now computer-oriented; stu¬ 
dents need to know what buttons to 
push, how to navigate in Windows.” 
When the guide emerged in 1990 as 
a 100-page book that sold for $12, it was 
written and self-published by students 
at the University of California at San 
Francisco. In 1992, Appleton and Lange 
picked it up, expecting to sell 12,000 
copies over three years. It sold 9,000 in 
its first year alone, said Jessica Hirshon, 
an associate editor at Appleton and 
Lange, adding that the book now sells 
about 30,000 copies a year. 
For the Step 1 guide, Chu and 
Choo supervised the work of seven 
student contributors and seven other 
students who reviewed material. 
The students’ incentive, Chu said, was 
not money. “They got a small stipend, 
but in terms of the hours they put in, 
it’s nothing,” he said. “The spirit of 
this book is a reflection of the Yale 
System. It’s about students helping 
each other grow." 
Digital imaging center comes to library 
Students, residents and faculty members can now create 
presentation graphics, put videotapes of lectures online 
and design their own web sites at a new Digital Imaging 
Center located in the medical library. Judy Spak, instruc¬ 
tional technology coordinator at the library, said students 
are also using the equipment to prepare graphics for their 
theses. The new center, comprised of three state-of-the- 
art computers in the Computer Resource Laboratory, a 
digital camera, color printer, color scanner, and a full 
suite of imaging and graphics software, was the gift of 
Martin E. Gordon, M.D. ’46, and his wife, Evelyn Gordon. 
Gordon, who heads the Associates of the Cushing/ 
Whitney Medical Library, demonstrated the new equip¬ 
ment at a reception in November. 
(/) 
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Apoptosis gene suggests new target for chemotherapy Yale scientists who identified a gene that enables cancer cells to evade one 
of the body’s mechanisms for weeding out mutations have refined their 
understanding of the gene and suggested potential new avenues for 
cancer treatment. 
Their findings, published in a December cover story in the journal Nature, show 
that the gene, called survivin, is concentrated on the mitotic spindle, a cell compo¬ 
nent that is central to the process of cell division. “Survivin was absolutely unde¬ 
tectable in normal tissues, but we found it over-expressed in all the most common 
human cancers,” said Dario C. Altieri, M.D., associate professor of pathology 
and leader of the study. Survivin inhibits apoptosis, the programmed death of cells, 
thereby allowing mutated cells to survive. 
Survivin, a gene that inhibits the 
programmed death of cells, can be 
seen in red on the actin cytoskeleton 
of a tumor cell, in green. 
Because it is present at mitosis, the gene may also be the link 
between two processes researchers have long believed were con¬ 
nected, apoptosis and cell cycle regulation. In normal tissue, 
survivin is expressed only during embryogenesis and fetal devel¬ 
opment, where it is believed to play a role in controlling apoptosis 
to maintain homeostasis and organ and tissue development. 
In its recent findings the team built on its 1997 discovery and 
cloning of survivin. “We are providing some mechanistic implica¬ 
tions for why cancer cells might have selected this particular gene 
for survival,” said Altieri, who collaborated on the project with Pier 
C. Marchisio, M.D., Ph.D., of the S. Raffaele Scientific Institute in 
Milan. The next step, Altieri said, is to identify survivin antagonists 
that would increase the effectiveness of chemotherapy by 
removing survivin’s protective function on the mitotic apparatus. 
Unveiling of protein 
structure could yield 
tumor-starving drugs 
In a finding that could result 
in more effective angiogen¬ 
esis blockers, biochemists 
at Yale and Cornell have dis¬ 
covered the three-dimensional 
structure of a protein linked 
to blood vessel growth. 
Researchers believe the 
protein, MetAP-2, enables 
endothelial cells in the lining 
of blood vessels to respond 
to growth factors. When the 
drugTNP-470 blocked the 
activity of the protein in 
tumor-bearing mice, new 
blood vessels failed to grow, 
thereby starving the tumor. 
In the Nov. 13 issue of 
Science, Craig M. Crews, ' 
Ph.D., assistant professor of 
molecular, cellular, and 
developmental biology, and 
his colleagues published a 
“snapshot” of human MetAP- 
2, both alone and bound to 
fumagillin, the parent com¬ 
pound ofTNP-470. “If we can 
get a snapshot of how one 
drug binds to a particular 
protein, we will know to what 
part of a protein a drug 
must bind,” said Crews. With 
such knowledge, he adds, 
pharmaceutical companies 
can more easily find drugs 
that might inhibit MetAP-2 by 
a similar mechanism. “Know¬ 
ing how the drug binds to its 
target is an important step 
in tweaking the chemical 
structure, like carving a key 
to mesh with a lock, in order 
to make future versions of 
fumagillin-based drugs even 
more effective." 
Salmonella vector 
overcomes an 
obstacle 
A year ago, scientists at Yale 
and Vion Pharmaceuticals 
reported success in experi¬ 
ments that used a modified 
salmonella bacterium as a 
vector to attack tumors in 
mice. Now the researchers 
have found a way to reduce 
the risk of potentially fatal 
septic shock in humans, 
making the mutated salmo¬ 
nella a candidate for cancer 
therapy. “You can eliminate 
the main culprit that induces 
septic shock from bacteria,” 
said David Bermudes, Ph.D., 
assistant professor (adjunct) 
of medicine and associate 
director of biology at Vion, 
which is funding the re¬ 
search. Bermudes, K. Brooks 
Low, Ph.D., and John M. 
Pawelek, Ph.D., who have 
collaborated on the salmo¬ 
nella experiments, removed 
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from the bacte¬ 
rium a gene es¬ 
sential to the bio¬ 
synthesis of lipid 
A, or endotoxin, 
which induces 
septic shock. Their 
findings were pub¬ 
lished in the January issue 
of Nature Biotechnology. 
The mutated salmonella, 
tested in mice and pigs for 
safety, has been shown to 
reduce tumor growth in mice 
by more than 90 percent. 
Injected directly into the 
blood stream, the bacterium 
suppresses, but does not 
completely eliminate, tumors 
through a process the 
scientists have yet to deci¬ 
pher. Phase I clinical trials 
are expected to begin 
this year. 
A simple test to 
predict presence 
of Alzheimer’s 
Dementia often goes unrec¬ 
ognized in elderly people be¬ 
cause tests for it are diffi¬ 
cult and time-consuming. 
Yale geriatricians have de¬ 
vised a fast and simple 
screening method to identify 
those at risk for dementia 
who might be candidates for 
more elaborate testing. 
In the “time and change" 
test, developed by a team 
led by Sharon Inouye, M.D., 
associate professor of 
medicine, patients have 
two tries in 60 seconds to 
tell the time on a clock face 
set to 11:10 and two tries 
in three minutes to extract 
one dollar in change from a 
selection of three quarters, 
seven dimes and seven 
nickels. “The test is not 
designed to replace stan¬ 
dard tests,” said Inouye, 
“but to be used as an initial 
screening to identify people 
who should be evaluated 
more thoroughly with more 
sensitive tests.” A study of 
the test was published 
in the Journal of the Ameri¬ 
can Geriatrics Society in 
December. “Based on our 
results, the test could 
reduce the percentage of 
patients with unrecognized 
dementia from 44 to 19 
percent,” said Inouye. 
NEW BOOKS 
A Dream of the Heart: The Life of John H. Gibson, Jr., Father 
of the Heart-Lung Machinery Harris B. Shumacker Jr., M.D., 
associate professor of surgery (’46-48), Fithian Press, 1999. 
Care of the Psyche: A History of Psychological Healing by 
Stanley W. Jackson, M.D., professor emeritus of psychiatry, 
Yale University Press, 1999. 
Felix d'Herelle and the Origins of Molecular Biology by 
William C. Summers, M.D., professor of therapeutic 
radiology and molecular biophysics and biochemistry, 
Yale University Press, 1999. 
Hitler: Diagnosis of a Destructive Prophet by Frederick C. 
Redlich, M.D., professor emeritus of psychiatry, Oxford 
University Press, N.Y., 1999. 
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Researchers discover 
odor receptor genes 
in fruit flies 
In a finding with profound 
implications for con 
trolling insect 
pests that 
spread disease 
and cause crop 
blights, scientists at Yale 
have identified 16 odor re¬ 
ceptor genes in fruit flies. Al¬ 
though researchers had 
searched for at least 15 
years, this is the first time 
anyone identified those 
genes in insects. “The rea¬ 
son people have looked so 
long is that insect olfaction 
is tremendously important in 
the real world," said John R. 
Carlson, Ph.D., associate 
professor of molecular, cellu¬ 
lar, and developmental biol¬ 
ogy at Yale, and leader of 
the study. The finding, re¬ 
ported in the February issue 
of Neuron, could help scien¬ 
tists develop agents that 
would disrupt insects’ ability 
to smell, making it harder for 
them to mate or target hu¬ 
man, animal or plant hosts. 
Carlson's laboratory is fur¬ 
ther exploring its discovery 
by breeding fruit flies with the 
odor receptor genes either 
missing or misexpressed. 
Also important, 
Carlson said, was 
the method used to 
search for the genes. 
Junhyong Kim, Ph.D., as¬ 
sistant professor of ecology 
and evolutionary biology, de¬ 
veloped a computer program 
that used a search algorithm 
to scour the Berkeley Droso¬ 
phila Genome Project for 
putative odor receptor 
genes. “It identified a large 
number of candidate genes 
that were likely to encode 
proteins with transmem¬ 
brane domains,” Carlson 
said. Previous research had 
led them to believe odor 
receptor genes would con¬ 
tain seven transmembrane 
domains. The algorithm, 
which can be adapted to 
identify channels, transport¬ 
ers and other membrane 
proteins needed for the nor¬ 
mal function of a cell, can be 
used for other projects, 
Carlson said. 
Medicines 10 Greatest Discoveries by 
Meyer Friedman, M.D., B.A. ’31 and 
Gerald W. Friedland, M.D., Yale 
University Press, 1998. 
Pediatric Radiation Oncology by Edward 
C. Halperin, M.D. ’79, Lippincott Will¬ 
iams & Wilkins, Philadelphia. The third 
edition was printed in English in 1998 and 
the First edition in Russian in 1999. 
Proteins, Enzymes, Genes: The Interplay of 
Chemistry and Biology by Joseph S. Fruton, 
Ph.D., Eugene Higgins Professor Emeritus of Molecular 
Biophysics and Biochemistry, Yale University Press, 1999. 
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A running conversation abou 
Forty-two years ago, a group of Yale 
pediatricians and child psychiatrists 
began meeting to discuss medical cases 
that crossed into the psychological realm. 
Both disciplines are still learning from 
this unique collaboration. 
By John Curtis 
Harold Bornstein knew the woman he called Mary 
from her birth until her death almost 30 years 
later, first as a pediatrician, then as a friend and 
adviser to her family. A difficult adolescence led her to 
drink and drugs, and in 1986, when she had a child, she 
and her son tested positive for HIV. Her family turned 
to Bornstein for help in handling the resulting medical 
and social problems. 
He, in turn, sought advice from a group of col¬ 
leagues with whom he had long discussed complex cases. 
The group, which calls itself the Compleat Pediatricians, 
was founded in 1957 on the notion that its members 
would benefit from a better understanding of the psy¬ 
chological and social aspects of their young patients' 
lives. The patients, too, they believed, would benefit 
from their increased knowledge of psychology. In the 
beginning, eight pediatricians and a child psychiatrist/ 
psychoanalyst met weekly to discuss cases involving a 
range of issues, from sleep disturbance and toilet train- 
John Curtis is a staff writer. 
Group members gather twice 
a month over coffee and 
donuts to discuss challeng¬ 
ing cases that involve issues 
such as moodiness, self¬ 
esteem. puberty and divorce. 
Left John Schowalter, a 
psychiatrist and professor 
in the Child Study Center, 
usually leads the Thursday 
morning discussion group. 
Center William Stableford, a 
psychologist, presents a case 
to Harold Bornstein, Carter 
Stilson and Albert Solnit. 
Right Carter Stilson listens 
as John Scholwalter 
discusses a case. 
:hildren 
ing to the management of wild behavior, anxiety and 
depression. Before each conference, the child psychiatrist 
and pediatrician on the case often would have met 
with the patient and family and worked together on a 
treatment plan; later, they would report on the case to 
their colleagues. 
Last October, Bornstein, M.D. ’53, H.S. ’56, and sev¬ 
eral of his colleagues illustrated the model they devised 
by describing Mary’s case at grand rounds in Fitkin Am¬ 
phitheater. Breaking from the familiar norm of a lecturer 
disseminating knowledge with notes and slides, they 
engaged in a bit of collective remembering, approaching 
the lectern one by one to reconstruct the case. As the 
story unfolded, the physicians and nurses who had 
participated joined in the discussion from around the 
amphitheater. By the end of the hour, grand rounds 
closely resembled one of the conferences this group of 
physicians holds twice a month. 
Pediatrician and child psychiatrist working together 
was a model quite different from the usual course of 
treatment, in which the pediatrician would refer a case 
to a psychiatrist, who would then resolve it indepen¬ 
dently. “It is rare that a pediatrician and a child psychia¬ 
trist sit down together and discuss patients,” says Robert 
LaCamera, M.D., who trained at Yale in the 1950s and is 
one of the group’s founders. 
This meeting of the minds can be traced to a paper 
published in 1954 in the journal Pediatrics. The authors 
were Albert J. Solnit, M.D., now commissioner of 
Connecticut’s Department of Mental Health and Addic¬ 
tion Services, and the late Milton J.E. Senn, M.D., who 
was then chair of the Department of Pediatrics and 
director of the Yale Child Study Center. Together, Solnit 
and Senn argued that knowledge of human behavior and 
society should be incorporated formally into the teach¬ 
ing of pediatrics. The patient, they wrote, “should be 
considered as a human being in a family setting, not a 
diseased organ or system.” Senn established the Child 
Study Center in 1948 as the successor organization to 
Arnold Gesell’s Child Development Clinic and was 
succeeded as director in 1966 by Solnit, who remains on 
the faculty and is a regular participant in the Compleat 
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“Their accomplishment has been to stress what should seem obvious, 
but is very often overlooked. Anyone taking care of children has to 
deal with issues relating to the family and to the child’s social 
environment.” 
Pediatricians. Donald J. Cohen, M.D., is the current 
director of the Child Study Center. 
Over the years, the group has influenced the prac¬ 
tice of pediatrics at Yale by integrating the theoretical 
and clinical insights from psychoanalysis and child psy¬ 
chiatry as Senn envisioned. “I think there’s a much 
broader concern today about psychosocial issues relating 
to children and the importance of behavioral health,” 
says pediatrics chair Joseph B. Warshaw, M.D. “Their ac¬ 
complishment has been to stress what should seem obvi¬ 
ous, but is very often overlooked. Anyone taking care of 
children has to deal with issues relating to the family and 
to the child’s social environment.” The model developed 
at Yale has been replicated at medical schools and com¬ 
munity practices in 14 states. 
The group now numbers 18 and includes nurses and 
a psychologist. They meet two mornings a month over 
coffee in a conference room named in Senn’s honor, be¬ 
neath the gaze of distinguished psychiatrists whose por¬ 
traits line the walls. The meeting resembles less a formal 
presentation than a casual, but enthusiastic, conversation 
among old friends. 
LARGE PROBLEMS AND SMALL 
Assessing the collaboration in a 1968 article for 
The International Journal of Psycho-Analysis, Solnit 
noted that members were better prepared both for the 
handful of complex cases that came their way as well 
as more routine matters touching on psychology: Is a 
child’s moodiness part of his personality or a cause for 
concern? How do parents talk with their children about 
death, or sex? How do they adjust to the changes sur¬ 
rounding puberty? 
About 15 years ago, LaCamera recalled, he sought 
his colleagues’ advice on how to respond to a situation 
that had not arisen before in his practice. The divorced 
mother of two adolescent girls felt uncomfortable with 
their father’s request that his daughters visit him in 
his new home, which he shared with his male partner. 
The discussion with his colleagues reinforced 
Although the group first 
included only pediatricians 
and psychiatrists, a psychologist 
and a nurse have joined 
its ranks. 
Left Jane Milberg, a nurse at 
the Yale Health Plan, checks 
her notes while presenting 
a case. 
Right Robert LaCamera, one of 
the group's founding members, 
makes a point as Robert 
Kramer listens. 
1 4 
LaCamera’s own feeling that the girls would benefit 
from seeing, rather than imagining, their father in his 
new lifestyle. “The mother still had some reservations,” 
LaCamera said, “but it turned out well and the kids 
had a good time.” 
In other instances, discussion makes it clear that 
a case from the clinic is clearly beyond the purview 
of either pediatrics or child psychiatry. Jane Milberg, 
M.S.N., looked to the group for suggestions that would 
help a io-year-old boy with abdominal problems that 
seemed to have no medical basis. She recommended a 
high-fiber diet to address his physical condition, but 
over time it emerged that his difficulty was very likely 
related to a wrenching family situation and a dispute 
over custody. “This is really law and Jane is a nurse, not 
an attorney,” said John E. Schowalter, M.D., a psychia¬ 
trist in the Child Study Center who frequently moder¬ 
ates the discussions. The group concurred with Milberg’s 
decision to refer the case to a social worker with exper¬ 
tise in custody matters and advise the boy’s father to 
obtain legal advice. 
The tale of Mary and her son also required psycho¬ 
logical and social insights. She would live only six and a 
half years after her son was born and she could provide 
no stable home for him. “Mary was in and out of 
institutions, jails and hospitals with great regularity,” 
Bornstein told the audience at grand rounds. Mean¬ 
while, difficult decisions had to be made about the boy’s 
future. Although he no longer presented traces of HIV, 
the stigma of AIDS had ruled out the family’s plan to 
place the baby for adoption. Mary’s older sister, who had 
The Compleat Pediatricians now includes a mix of original members 
and others who have joined since the group was founded in 1957. 
At a recent meeting were Harold Bornstein, Albert Solnit and William 
Stableford, seated, and Dennis Bekeny, Robert Kramer, Robert 
LaCamera and Carter Stilson, standing. 
another son, took him into her home. The next step was 
explaining the topsy-turvy social structure to the boy. 
“The decision was made that he should know that his 
mother was indeed his mother, but that functionally, his 
aunt and uncle were his parents,” said Bornstein. The 
boy has fit into his new family, which has legally 
adopted him. 
At grand rounds, the discussion bounced around the 
room, drawing in members of the group and others in¬ 
volved in the case, including Warren A. Andiman, M.D., 
professor of pediatrics and epidemiology who specializes 
in pediatric AIDS, and Joyce Simpson, R.N., pediatric 
HIV coordinator in the AIDS care program. Warshaw 
summed up the discussion with a question. “How,” he 
asked Bornstein, “did this end up helping you be a more 
effective pediatrician?” 
“It was very helpful to have experienced colleagues 
expressing their feelings,” Bornstein responded. “In 1986 
AIDS was a very fearsome disease. HIV-positive children 
were not allowed to go to school. They were isolated. 
With support from our group, I was much more com¬ 
fortable in dealing with the baby who was thought to be 
infected at that time.” 
Schowalter added that the collaboration is more 
than a typical consultation. “It’s a synergy when the 
group really gets to know each other,” he said. “A lot of 
the support comes from pediatricians who bring in their 
decades ol experience. Because we have all been together 
so long, it really is a collaboration where both sides give 
to each other.” SUE] 
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We are pleased to announce 
that in October, we will 
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professional billing service. 
Please take a copy of this 
information card to learn 
how we are striving to 
improve service for you. 
The Doctors and Stall of the Yale Faculty Practice 
A visitors guide and other materials have been 
introduced to emphasize service in the Yale 
Faculty Practice. 
A survey sent to every patient treated is used to 
gauge satisfaction and identify potential problems. 
A new computer system has improved billinj 
services and the collection of fees. 
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Keeping physicians and staff informed about 
developments within the practice and beyond 
has also been a priority. 
A manual prepared last year sets standards for 
use by all clinicians and staff. 
A newsletter keeps physicians up to date vl 
the complex federal requirements governin 
billing and payments. 
:nts can visit a website to find their way 1; :ong the 650 physicians and 200 clinical pro¬ 
grams of the Yale Faculty Practice. 
I y a I e 
~ faculty practice 
St 
St 
Good communication with referring physicians 
is vital to the practice and is facilitated by a 
directory of Yale physicians. 
P A T I E N CARE 
Doctors, patients and the 
bottom line 
Once, a Yale doctor could comfortably juggle clinical care, teaching and research without 
worrying too much about the business of medicine. Those days are gone. 
By John Curtis 
On a Monday evening in February, two dozen Yale 
physicians are clustered around tables, puzzling 
over a series of management problems. They 
range from the ordinary to life-threatening: How can 
parking spaces at a new building be allocated most fairly 
among the staff? How can a search-and-rescue operation 
be completed without squandering scarce resources? 
Management professor Victor Vroom, Ph.D., has led the 
group through the processes those in charge might use 
to resolve these and other issues, then broken the class 
into small groups for discussion. 
All of the participants in the course—junior faculty, 
service chiefs and department chairs included—have 
given up one evening a week from January to early April 
with the goal of honing their leadership skills and help¬ 
ing colleagues, as well as themselves, adjust to the chang¬ 
ing requirements of academic medicine in the late 1990s. 
None of the problems raised at this evening’s session is 
specific to medicine, but that is precisely the point, says 
John Curtis is a staff writer. 
Stephen Rimar, M.D., HS ’83-87, the course director 
and medical director of the Yale Faculty Practice. 
Answers to many administrative issues facing doctors, 
he adds, can be found in the experience of other organi¬ 
zations. “What medicine is going through,” Rimar says, 
“is not unique.” 
The idea of training physicians in management is 
just one indication of a culture shift under way within 
the Faculty Practice, which represents more than 650 
faculty physicians and provides care to thousands of 
patients throughout the region. When it was established 
in 1981, it was essentially a billing office that provided 
service to the school’s clinical departments. But as the 
health care environment has grown more complex, the 
Faculty Practice has evolved into something quite differ¬ 
ent from its original incarnation. Now it coordinates the 
clinical activities of 17 medical school departments, ne¬ 
gotiates contracts with insurers and managed care orga¬ 
nizations, ensures compliance with a host of government 
requirements and has become the focal point for ensur¬ 
ing that patients are well served. And while it clearly is a 
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“In the absence of a system that treats patients efficiently, courteously 
and with compassion, there will be fewer and fewer patients coming 
our way.” 
business and must be run like one, it is a business that 
exists for a larger purpose. “The clinical activity of 
our faculty is an essential part of both teaching and 
research,” says Dean David A. Kessler, M.D. “How 
that clinical enterprise is managed has a very large 
impact on the school as a whole.” 
SUPPORTING THE CORE MISSIONS 
While managed care, with its eye firmly on the bottom 
line and a thirst lor measurable results, is perhaps the 
most visible influence affecting faculty practices at the 
nation’s 125 medical schools, it is by no means the only 
one. It’s true that insurers have cut reimbursement rates 
and thrust themselves into the medical decision-making 
process to the dismay ol physicians. But the federal gov¬ 
ernment has added complexity as well, imposing regula¬ 
tory requirements highlighted by several well-publicized 
audits ol medical school billing operations around the 
country. Perhaps more importantly, patients have better 
access than ever before to the latest information and 
treatments, and increasingly regard medicine from the 
viewpoint of consumers. As a result, physicians are being 
urged to pay closer attention to the details ol their prac¬ 
tices and to regard patients not only as people in need ol 
care, but as people who deserve a level ol service taken 
lor granted in the for-profit sector. 
How do these trends affect the academic environ¬ 
ment in which medicine is practiced at Yale? “Since me¬ 
dieval times, the purpose ol a university has always been 
clear—to teach and to expand knowledge,” says David 
Leffell, M.D., HS '86, a dermatologic surgeon who be¬ 
came director of the Faculty Practice and associate dean 
for clinical affairs on Jan. 1. “Our challenge is to develop 
a plan that allows us to support those missions effec¬ 
tively when there are enormous pressures. The overhead 
costs and the realities of medical billing compliance no 
longer make it possible to see a few patients in morning 
clinic and talk at length with medical students about 
those interesting cases. We have to be more creative 
about how clinical teaching is done.” 
Several initiatives reflect the changing nature of the 
practice. Last year, it drew up a book of practice stan- 
'ards that address administrative issues ranging from 
relationships with referring physicians to telephone and 
waiting-room etiquette. It introduced a newsletter for 
Students in the Yale Management Program for Physicians, which 
graduated its first class of 21 in April, used management tools for 
clinical problem-solving. Topics ranged from the feasibility of opening 
a satellite office to organizing the necessary resources to provide cru¬ 
cial intervention for stroke patients around the clock. 
physicians and staff that reinforces the customer-service 
ethos with such articles as Chopping Down the Phone Tree 
and Practice Checkup. And it has engaged in a number of 
bridge-building activities, such as a retreat in March for 
managers front the clinical departments and their coun¬ 
terparts in the Faculty Practice. 
Leffell, who set the stage for these efforts as the 
practice’s medical director over the past three years, 
has spent the winter and early spring holding strategy 
sessions, setting goals with fellow administrators and 
faculty, and monitoring the implementation of a new 
computer billing system. He and his colleagues argued 
for and won the right for the Faculty Practice’s board of 
governors to approve its own budget, which previously 
had been determined by the central administration. “It’s 
an important step forward,’’ he says, “because it allows 
us to set priorities and focus resources on improving 
clinical services.” 
PUTTING PATIENTS FIRST 
Those improvements, Leffell contends, are essential not 
only to the success of the practice but to the school as a 
whole. “In the absence of a system that treats patients 
efficiently, courteously and with compassion, there will 
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“Since medieval times, the purpose of a university has always been 
clear—to teach and to expand knowledge,” says practice director 
David Leffell. “Our challenge is to develop a plan that allows us to sup¬ 
port those missions effectively when there are enormous pressures.” 
While there has been a steady increase in new 
patient volume at Yale over the years, managed care 
does have the potential to limit patient access to Yale 
providers in the future. “In the old days,” says Leffell, 
“patients could go to the doctor they chose and physi¬ 
cians could refer patients to physicians at Yale lor 
tertiary care without limitation. That has changed, 
and we have to be prepared for the possibility that 
contracting limitations will affect our patient flow.” 
Five years ago, the practice appointed Ellen Skinner 
as its first director of managed care and marketing. 
“My role was to come in and organize a system for man¬ 
aged care contracting on behalf of the physicians that 
are full-time faculty,” she says, adding that the practice 
participates in 50 insurance plans. “When I first started 
in this position, less than 5 percent of our business was 
managed care and almost 35 percent was commercial 
indemnity, where you send in a bill and get paid that 
amount,” Skinner says. “Today we are down to about 
be fewer and fewer patients coming 
our way,” he says. “And without 
patients, there is no medical school. 
They’re critical to both teaching 
and research.” 
The school also has had to recog¬ 
nize long-standing traditions that at 
times may run counter to the new 
culture. University professors the 
world over are typically valued more 
for their individualism and academic 
talent than for their ability to func¬ 
tion as institutional players. In aca¬ 
demic medicine, success in research is 
often a quicker path to promotion 
than a good bedside manner and skill 
with patients. And at Yale, as else¬ 
where, individual departments that 
generate much of their own income 
have become accustomed to their own 
ways of doing things. “We are moving 
from a primarily entrepreneurial, de¬ 
partment-based practice to something 
that will end up being more cohe¬ 
sive,” says Joseph B. Warshaw, M.D., 
deputy dean for clinical affairs and 
chair of the Department of Pediatrics. 
Yale’s clinical operation is important to the educa¬ 
tional and research missions of the school in a number 
of ways. Clinical income provides close to 25 percent 
of the medical school’s annual operating revenue of 
approximately $500 million, and, with its constant flow 
of patients, the practice serves as a primary learning 
environment for medical students. Because medical 
school departments were flush for so many years with 
fee-for-service clinical revenue, physicians could leave 
administrative and financial details to others while they 
concentrated on medicine and teaching. 
A CHANGED WORLD 
Those days are gone. In the new world of health care, 
physicians are seeing more patients and collecting 
smaller fees. The arithmetic is simple. “Under managed 
care the reimbursements have gone down, but our over¬ 
head at Yale has not,” says Jean L. Bolognia, M.D. ’80, 
HS ’80-85, professor of dermatology and a leading expert 
in the management of melanoma and pigmented lesions. 
Six months ago, she began seeing patients an hour ear¬ 
lier each morning to add time to her clinical schedule. 
But, she adds, “there are only so many ways you can 
expand. Spending less time per patient was a less 
acceptable option.” 
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25 percent commercial and 46 percent of our business 
is managed care.’’ 
But more than simple participation in plans was 
needed. Ol the 650 physicians in the faculty plan, all 
but three full-time and 10 part-time doctors are special¬ 
ists providing tertiary care. About 90 percent ol their 
patients come as referrals from other physicians, and 
Yale’s ability to contract with the greatest number of 
insurers is important tor patient flow. The school has 
benefited in these negotiations from an expanding net¬ 
work of relationships developed by the Faculty Practice 
and from its participation in the 1,100-member Yale 
Independent Physicians Association, which represents 
all the physicians with attending privileges at Yale-New 
Haven Hospital. 
Along with the economic landscape, the regulatory 
environment has also changed. Physicians not only are 
seeing more patients, but are spending more time 
documenting those patient visits, says Judy Harris, the 
practice’s compliance officer. “When I audit one of 
those services,” she says, “I am looking for 98 different 
components to one office visit or consultation. The basis 
for this documentation is very valid. It has just been 
taken overboard.” 
Harris created a billing-compliance newsletter and 
an online tutorial to keep physicians informed, and 
faculty who wish to bill for clinical services must pass a 
quiz. “When they see what the documentation require¬ 
ments are for them," she says, “they complain that it 
adds a tremendous amount of time to their work every 
day.” This extra effort could cut into teaching time if 
other solutions aren’t found. 
As part of the move towards centralization, the 
Faculty Practice hopes to shift billing-compliance review 
from the individual departments to an expanded unit 
within the Faculty Practice. If all goes as planned, its 
staff of auditors will increase from one to six as of July 1. 
Compliance is paramount, given the fines levied against 
medical schools for inadequate physician documentation 
as part of the Physicians at Teaching Hospitals audits. 
The federal Department of Health and Human Services 
scrutinized millions of documents at Penn, Dartmouth, 
Yale and other schools, and imposed fines and restitu¬ 
tion as high as $30 million. Yale came through its audit 
without penalty. 
STANDARDIZING BILLING AND SERVICES 
Not every aspect of its billing operation has fared so well 
in recent years. Over the past two decades, as the details 
of reimbursement and regulation have become vastly 
more complex, the practice’s billing and collection sys¬ 
tems found it difficult to keep up. Last year, the federal 
government contended that the school had failed to 
return overpayments from insurers promptly. The school 
acknowledged problems with its administrative systems 
and resolved the matter in a settlement. It also installed 
a new computer system last October to handle the com¬ 
plex requirements of the practice's administrative, billing 
and collection functions. “The implementation was on 
time and under budget, and all the early indications 
are that we’re ahead of where we expected to be,” says 
Leffell. “But this is an area of administration we have to 
watch closely.” 
Fixing these problems was a major step forward, says 
Irwin Birnbaum, who became chief operating officer in 
July 1997. “To pursue our mission, we have to have a 
professional business operation supporting our clinical 
activities,” he says. “Accurate billing and timely collec¬ 
tion are critical to the health of the school.” 
The operation’s success hinges on a number of 
factors. Each payment to the school depends on correct 
documentation of the service performed by the physi¬ 
cian, a daunting task given the more than 10,000 pos¬ 
sible billing codes. “It’s imperative that the coding is 
correct and that services are properly documented,” says 
Marianne Dess-Santoro, the executive director of patient 
financial services and the person in charge of imple¬ 
menting the new system. “There is a lot of activity 
that goes into collecting those dollars.” 
In the midst of constantly changing claim submis¬ 
sion rules, the new system keeps tabs on which insur¬ 
ance plan or plans are providing coverage for each 
patient, whether the patient has a referral from a physi¬ 
cian, and whether the insurer has paid the right amount. 
“For the first time,” says Dess-Santoro, “we can see right 
away if a reimbursement from an insurance carrier is 
“No one has questioned the quality of medical treatment. The 
question is how long are patients kept waiting in the waiting room? 
How hard is it to get an appointment? Does the doctor call the 
referring doctor back?” 
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The Faculty Practice management team includes Marianne Dess-Santoro, executive director of patient financial services; Ellen Skinner, director of 
managed care and marketing; Judy Harris, medical billing compliance officer; and Diana Rogers, associate director of managed care and marketing. 
below what our contract with the carrier allows.” The 
system can also provide information on the clinical 
productivity of faculty. And, it has helped make the basis 
for physician charges more rational by standardizing 
fees for similar services that are provided by different 
departments throughout the practice. “It is much better 
from a patient perspective because there is uniformity,” 
Dess-Santoro says, “and it is much easier to negotiate 
managed care contracts now because we have a 
common fee schedule.” 
That uniformity is also transferring to other areas. 
No matter where they receive their care at Yale, patients 
must be treated with equal efficiency and courtesy, 
Leffell believes. Clinical care, more than research or 
teaching, is the face the public sees. “No one has ques¬ 
tioned the quality of medical treatment,” he says. “The 
question is how long are patients kept waiting in the 
waiting room? How hard is it to get an appointment? 
Does the doctor call the referring doctor back?” In addi¬ 
tion to the practice standards book and the newsletter, 
the practice publishes a referral guide that is distributed 
to physicians across Connecticut and in parts of Rhode 
Island, New York and Massachusetts. The practice’s 
extensive web site (http://info.med.yale.edu/yfp) 
includes these resources and other useful information 
for physicians, staff and patients. 
The practice standards, while they may seem focused 
on administrative minutiae, ultimately will lead to better 
medicine. “The more we can improve access for patients 
and ensure that the visit runs smoothly, the more it will 
improve patient-doctor communication,” says Katherine 
C. McKenzie, M.D., assistant professor of medicine and 
one of three full-time general practitioners in the Faculty 
Practice. “Patients who feel well cared for, at every level 
of their experience, will benefit.” 
Medical director Rimar, who is responsible for lead¬ 
ing the implementation of the new standards, is con¬ 
vinced they will help recruit new patients to the practice 
as well as retain them. “Most of our patients come to us 
as referrals from other physicians, and communication 
with the patient and the referring physician is very im¬ 
portant,” he says. Working with doctors in the school’s 
17 departments and more than 200 clinical programs, 
the practice is identifying areas where communication 
may in fact break down. There has been some resistance, 
Rimar notes, among doctors who interpret marketing as 
advertising and business as a preoccupation with the 
bottom line. “Patients don’t want their doctors to be 
business people and doctors don’t want to be business 
people,” he says. But the issue, he adds, is not business 
but management—understanding what resources are 
available, how to obtain them and how to keep the 
practice moving towards its goal. 
The managers themselves, chairs of the departments 
facing centralized governance, recognize the need to 
change. “The environment is changing in health care,” 
says Gary E. Friedlaender, M.D., chair of the Depart¬ 
ment of Orthopaedics and Rehabilitation, “and the way 
in which we work together requires enhanced organiza¬ 
tion in the departments. I am convinced we are going to 
be a better and more nurturing environment for our 
patients, our faculty and the students.” Explicit, how¬ 
ever, in the move towards centralization is a loss of 
autonomy in certain administrative areas, says Benjamin 
S. Bunney, M.D., chair of the Department of Psychiatry. 
“If the practice is going to be able to compete in the 
open marketplace for a contract, we can’t have each 
department trying separately to get its oar in the water. 
We have to be able to trust people to contract for us in 
a way that allows us to all pull together.” 
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"Patients don't want their doctors to be business people and doctors don’t want to be business 
people," says Stephen Rimar. As medical director for the Yale Faculty Practice, Rimar’s goal is to 
help physicians learn how to apply management tools to their practices. 
BACK TO BASICS 
What happens to medical education in the midst of all 
these changes? Within the practice, Leffell says, teaching 
continues much as it always has. “The majority of the 
teaching that goes on in medical school in the second 
two years happens at the bedside, not in the classroom,” 
he says, noting that he is always accompanied in his 
practice by a resident, and often by a student. “To teach 
the science and art of medicine is really why we are 
here,” he says. 
“You can make the case,” says deputy dean 
Warshaw, “that by teaching students and house staff to 
consider cost-benefit issues, we are teaching them how 
to practice better medicine. If we can teach them that 
this test for $10 is better than a CT scan, or that a pedia¬ 
trician measuring someone’s head with a tape measure 
can provide as much information as $1,000 worth of 
°sting, that’s better medicine.” 
Back at the Yale Management Program for Physi- 
, the faculty members enrolled in the evening class 
working toward solutions that, in addition to ad¬ 
vancing their abilities as managers, 
may be of immediate benefit to 
Yale’s clinical operations. A depart¬ 
ment chair is developing an incen¬ 
tive plan lor clinicians that will 
help balance the budget. A lab 
director is thinking through a 
process to identify and correct 
problems in a range of areas, 
from technology implementation 
to employee relations. A clinic 
chief is looking at the feasibility 
of opening a satellite office outside 
New Haven. 
One of the most interesting 
problems—and one that demon¬ 
strates how important management 
is to the well-being ol patients— 
has been raised by Pierre B. Fayad, 
M.D., a neurologist who treats 
stroke patients. Getting the right 
medication to stroke patients 
within a six-hour window makes 
an enormous difference in their 
recovery, but it also requires an 
expensive allocation and coordina¬ 
tion oi services, staff and other 
resources. How can Yale’s cere¬ 
brovascular center direct an ad¬ 
equate number of patients to its 
services to make the investment 
practical? “The management tools I will be acquiring 
here,” Fayad says, “will be helpful in developing a pro¬ 
gram to achieve those goals.” That is Rimar’s hope, 
and one that he sees as realistic as physicians acquire 
the management skills they will need to survive and 
provide better patient care. “You can be an outstanding 
clinician—the greatest doctor in the world—and still 
go out of business,” he says. 
As Leffell observes, the reconfiguration of the 
practice is a work in progress. Behind the plans, how¬ 
ever, is a vision of the practice as a teaching center that 
also provides the best in clinical care and research. 
“Our identity as one of the world’s great medical schools 
defines a niche for us that no one else in our region 
has. It helps us focus on our competencies and our 
strengths. It allows us to make decisions about growth 
in a strategic fashion. Recognizing that we can’t be all 
things clinical to all people, we have to identify where 
we have the greatest critical mass of talent, research 
ability, educational skill and clinical expertise. That’s 
where we focus.” Q2] 
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INTERVIEW 
‘We have a remarkable 
community here’ 
Susan Hockfield, the new dean of the Graduate School, talks about the collegial and 
interdisciplinary nature of Yale, the direction of teaching and scholarship in 
a changing world, and her own research as a neurobiologist. 
A year after leaving Georgetown 
with a Ph.D. in anatomy, Susan 
Hockfield experienced a moment 
that would delight any young scientist. 
She interviewed at a prestigious research 
institute and impressed its Nobel Prize¬ 
winning director well enough to land a 
job as a staff investigator. The year was 
1980, the institute was the Cold Spring 
Harbor Laboratory, and the director 
wasn’t just any Nobel Prize winner, but 
James D. Watson, Ph.D., who discovered 
the structure of DNA in 1953 along with 
Francis Crick and Maurice Wilkins. 
Hockfield spent five years at Cold 
Spring Harbor pursuing research in the 
biology of the nervous system before 
joining Yale’s neurobiology faculty in 
1985. Last July 1, she became the 17th 
dean of the Yale Graduate School of 
Arts and Sciences. She is the first 
Graduate School dean to come from the medical school 
faculty, and her appointment is emblematic of a growing 
connection between Cedar Street and the central campus. 
At the School of Medicine, doctoral students in neurobiology, 
genetics, cell biology, physiology, pharmacology, pathology, 
immunobiology and microbial pathogenesis receive their 
degrees from the Graduate School, which recently created 
a program in the biological and biomedical 
sciences to enhance recruiting of 
students and better coordinate training 
and scholarship. 
Hockfield, 47, was director of gradu¬ 
ate studies for her department between 
1986 and 1994 and remains engaged 
in research. Her recent work has delved 
into the molecular mechanisms that 
allow brain tumors known as gliomas 
to spread through the brain, making 
effective treatment exceedingly difficult, 
and often impossible. Last spring she 
and colleagues published findings in 
The Journal of Neuroscience that 
suggested for the first time how one 
molecule may facilitate the unimpeded 
movement of glioma cells throughout 
the brain. 
As dean, Hockfield oversees a 
community of 2,300 students and 760 
faculty members, taking the reins at a time of intense dis¬ 
cussion about graduate education. She manages 65 Yale 
departments and programs, oversees faculty appointments 
and promotions in the natural and social sciences, and 
spends one day a week in her own laboratory on the fourth 
floor of Sterling Hall of Medicine. She spoke to Yale Medicine's 
editor, Michael Fitzsousa, for this article in late February. 
Neurobiologist Susan Hockfield became 
dean of the Yale Graduate School of Arts 
and Sciences last July. “When you run a 
lab, it’s a small-scale organizational chal¬ 
lenge. I honestly didn’t know how that kind 
of close cooperation would translate to 
the larger scale of the Graduate School,” 
she says. “I found that it does.” 
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You became dean of the Graduate School last July, after 
more than a dozen years as a medical school faculty 
member in neurobiology. What did you find when you 
arrived in the new job? 
I had been closely involved with the Graduate School for 
eight years when I was director of graduate studies, then 
not quite so closely from 1994 until last spring. I was de¬ 
lighted to see that it had undergone a substantial trans¬ 
formation. Until just a few years ago, the school’s func¬ 
tions were almost purely administrative. Under [previous 
dean] lorn Appelquist, a number of programmatic ini¬ 
tiatives were begun, and when I took office three new 
programs were already in place. One was the McDougal 
Center, which serves as a place for students to gather for 
academic and non-academic affairs. The second was the 
Office of Teaching Fellow Preparation and Develop¬ 
ment. We also have a new Office of Graduate Career 
Services, which had been in existence less than a year 
when 1 took over. These initiatives really mark a change 
in how the Graduate School provides service to the 
graduate students and our faculty. 
'bat are the overriding issues in graduate education 
ay, both here and outside of Yale? 
I he career paths that our graduates follow today are 
more diverse than they have ever been. I see this as a 
wonderful opportunity, but it also challenges the way in 
which we think about graduate education. In all fields, 
it’s no longer the case that someone with a Ph.D., even 
from Yale, will necessarily become a professor at an 
institution of higher learning. Because of this, we need 
to re-examine our programs continually to make sure 
that we are equipping our students optimally for the 
work they will do. 
What has been responsible for this broadening of career 
interest outside of academia? 
In the life sciences, there has been an explosion in interest, 
and an explosion of possibility, in what science can 
actually do. We’ve seen a lot of growth in biotech and 
the pharmaceutical industry, and it’s wonderful that our 
Ph.D.s are participating in that new direction. In the hu¬ 
manities and social sciences, university expansions in the 
1960s and early ’70s produced more opportunities for 
Ph.D.s in the academy than today. What is increasingly 
appreciated, however, is that the skills our students 
develop en route to a Ph.D. are in high demand elsewhere. 
To get a Ph.D., a student has to have learned the 
skills of focused creativity—not just being creative, but 
putting that creativity to a purpose. It requires high levels 
of critical analysis and the ability to communicate ex¬ 
tremely well. The scholarship component of the Ph.D. 
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involves compiling huge amounts of data that no one 
before has put into any kind of order. And the challenge 
of the doctoral student is to organize that data so that it 
tells a story that makes sense and answers questions that 
have not been answered before. In an age when the 
economy is increasingly information-based—when we 
are simply awash in data—people with these skills are 
invaluable in the interpretation of information and the 
communication of that new knowledge to other parts 
of the society. 
Several years ago, Yale created the Combined Program 
in the Biological and Biomedical Sciences, or BBS, to 
streamline its programs and enhance the recruitment 
of top students. What has been the impact of this? 
The effect has been enormous. The idea wasn’t so much 
to streamline programs, but to provide an umbrella or¬ 
ganization for research and education. The revolutions 
in molecular biology and other technologies have broken 
down the walls between departments and disciplines in 
the life sciences, and students increasingly want to avail 
themselves of all of the information that is out there. 
They also want the opportunity to work with faculty 
who may be in different departments. So the BBS was an 
obvious solution to the needs of graduate education. 
What exactly did it do? What was the new structure that 
it brought in? 
A student who is interested in pursuing graduate educa¬ 
tion in the biological or biomedical sciences now enters 
one program. There are different tracks, so the student 
will identify the area of greatest interest—neuroscience, 
for example, or genetics and development. But even 
after entering in a track, the student can still move from 
one track to another, so there is flexibility. The BBS per¬ 
mits graduate students to fully participate in an extremely 
rich educational enterprise that involves all the biologi¬ 
cal and biomedical scientists at Yale. In addition to serv¬ 
ing the graduate students well, it has had the secondary 
consequence of bringing together faculty, who are very 
collegial and collaborative to begin with. The BBS pro¬ 
vides yet another way for them to interact. Applications 
to this program are up about 20 percent over last year. 
What is your view of the efforts at Yale and other 
universities to unionize graduate students who serve 
as teaching assistants? 
This is a national effort fueled by unions interested in 
increasing their support base, both in health care and 
education. We here at Yale feel very strongly that a labor 
relationship is not the relationship best suited to the 
education of our graduate students. 
Since becoming dean, you’ve announced several 
initiatives to improve graduate student life in general. 
What has been done? 
We want to recruit the very best graduate students to 
Yale, and we want to be sure that Yale can make com¬ 
petitive offers. Last summer we improved health cover¬ 
age for students. Another change we made was in the 
structure of our stipends. In many departments, the 
stipend that a student was oftered upon entering remained 
the stipend for that student throughout four years. 
What that meant was that each year’s entering class had 
a higher stipend than the class that entered the year before. 
Now all students receive at least the same base stipend, 
which is at a higher level than we’ve offered before. 
Building a sense of community in the Graduate 
School is very important. We began a number ol 
programs last fall to that end, starting with one called 
Take a Faculty Member to Lunch. Then we added Take a 
Student to Lunch. We provide a free lunch when a 
student brings a faculty member (or vice versa) to eat at 
the Hall of Graduate Studies dining hall. That has 
turned into a successful program. We now call it FEAST, 
for Free Eating Attracts Students and Teachers. 
We also initiated a series of multidisciplinary lectures, 
called In the Company of Scholars. At least once a month 
we have a lecture from one of our faculty members, with 
a format that is designed to be accessible to graduate 
students and faculty throughout the University. 
Jonathan Spence, Sterling Professor of History, gave the 
first lecture. There were people in the audience from 
physics, math, psychology and the medical school, because 
in our community there is a tremendous desire to learn. 
We really are, as George Pierson said, a company of 
scholars. We are interested in learning, and in learning 
from one another. Phis is the tradition of Yale, which is 
fostered by our commitment to teaching. It requires us 
always to be learning and creates an environment where 
curiosity can dominate over competition. 
One of the first things I did when I became dean 
was to start an e-mail list so that I can communicate 
with all the graduate students. And I do so with some 
regularity. Hopefully not so much as to be a pest, but 
enough so that students feel that they know what’s 
going on in the graduate school. We also initiated a 
monthly newsletter that highlights activities throughout 
the University and the town that are of particular interest 
to graduate students. 
Since the 1970s, you have pursued research in the 
nervous system and its molecular underpinnings. 
What questions are you trying to answer? 
As the brain develops, there are some intriguing processes 
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that occur. There’s a time in brain development, called 
the critical period, when the connections between nerve 
cells are refined based on how those nerve cells are 
actually working. The period of plasticity when those 
connections can be rearranged is circumscribed, and, 
for reasons that are very poorly understood, a plastic 
brain becomes nonplastic at a particular stage in devel¬ 
opment, after which the connections are much harder 
to modify. 
One of the main questions in my lab has been, 
What are the molecular substrates that change the plas¬ 
tic brain to a nonplastic brain? We’ve identified a family 
of proteins in the extracellular matrix, the space around 
the cells, that are first expressed at the end of these 
periods of plasticity and appear to play a role in their 
closure. In looking at the brain as it changes during 
this process, we identified a protein expressed early in 
development that, we think, facilitates the movement 
of glial cells. We also discovered that this protein is re¬ 
expressed at very high levels in brain tumors. One of 
the hallmarks of primary brain tumors is that the tumor 
cells can move around the brain with great facility, and 
that’s the reason why these tumors are so fatal. We’re 
now working to understand how this particular protein 
increases the motility of glioma cells, with the idea that 
if we could somehow stop tumor cells from moving 
around, we might be able to reduce the lethality of 
these devastating tumors. 
Did you ever imagine such a practical application for 
your research when you began working in that area? 
No, 1 didn’t. And 1 think this is really one of the great 
wonders of biological science today. The tools are so 
powerful; they allow you to look into basic biological 
processes and search relatively quickly for possible 
relevance in clinical processes. 
Are you still active in the lab? 
I set aside Fridays to work there. I have a strong and 
mature group of graduate students, post-docs and 
research technicians, and they are continuing their 
work on our projects. They know that they can talk 
to me at any time, and we e-mail back and forth and 
talk on the phone. 
What excites you most in the field, both in your area 
of research and other areas of neurobiology? 
rn 1980, when I first started my own lab at the Cold 
pring Harbor Laboratory, there weren’t many people 
who seriously considered that there would be a clinical 
application of the work we did. We were all pretty much 
esigned—and perfectly happy—to be carrying on 
with something that was very basic science. I remember 
suggesting in conversation that the things I was studying 
then might not be relevant clinically for another 20 
years, and that’s not the case for work being undertaken 
today, fhe number of rational therapies that are available 
now in neurology and the number of diagnostic tools 
that we have compared to where we were 20 years ago 
are really quite fantastic. We can discover things that 
we never imagined being able to approach. 
When I received my Ph.D. in 1979, there was a 
criticism that there wasn’t any biology in neurobiology. 
And by and large it was true—the things that people 
studied in neurobiology were pretty much divorced 
from the rest of biology. Since 1980, that has changed 
dramatically. The techniques of molecular biology 
that were in their infancy in the 1970s have become 
extremely sophisticated and now allow us to look at 
multicellular organisms, complex tissues, and to make 
very precise evaluations of what’s happening over 
different periods of time. There are so many things 
that I learned as facts in graduate school that have 
proved to be wrong in the last 20 years. It’s a remarkable 
privilege to be working in a field where the pace of 
discovery is breathtaking. 
Tell us about your life outside of Yale. What do you do 
when you’re not at work? 
My husband, Thomas Byrne, is a clinical neurologist. 
We have a seven-year-old daughter. Our lives are an in¬ 
terwoven mixture of Yale and non-Yale. My husband’s 
interest in neuroscience and neurobiology is an impor¬ 
tant piece of our lives. His subspecialty is neuro-oncol¬ 
ogy, and it was our conversations about glioma that led 
to my last discovery of a protein expressed in glioma. 
It wouldn’t have happened if I hadn’t been talking to a 
clinician during the course of the experiments. 
Otherwise, our life revolves around the life of a 
seven-year-old. These are pretty demanding things 
we’ve taken on. I play tennis, my husband swims, my 
daughter does ballet. They join me every Thursday night 
for dinner in the Hall of Graduate Studies dining room. 
My daughter spends time here in my office sometimes, 
and with my husband in his office. So we see these 
activities as family activities and not isolated from 
our lives. 
What is the environment for women now in graduate 
education? 
I can address it best from my experience in the biological 
sciences, where I have enjoyed a richly interesting career. 
There are many kinds of job opportunities that afford 
increasing levels of flexibility for women. There are a lot 
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of women scientists today. That was not the case when 
I started out, although I have to say it never deterred 
me. I just entered a field at a time when the opportuni¬ 
ties were beginning. 
With a distinguished research career, you could have 
continued on that path without taking on a challenge 
such as administering the Graduate School. Why were 
you interested in doing so? 
I’m absolutely committed to graduate education. 
I think it’s enormously important. I think that 
excellence in higher education in the United States is 
what has driven the United States’ leadership both in 
economics and in intellectual property. We have seen 
remarkable growth in many areas, and I think that 
graduate education has played an important role in that. 
Being able to serve Yale and help guide graduate educa¬ 
tion is a wonderful opportunity. 
I also feel it was a privilege to be able to get a Ph.D. 
and enter into this company of scholars, this intellectual 
life of the mind. I think it’s important that people who 
believe in it strongly support it. 
What is the most important lesson you’ve learned 
so far as a dean? 
Well, I’ve learned a heartening lesson. When you run a 
lab, it’s a small-scale organizational challenge in that 
you have some scientific problems that you want to 
address and you have to get people to think together 
about those problems and their potential solutions. 
I honestly didn’t know how that kind of close coopera¬ 
tion would translate to the larger scale of the Graduate 
School. I found out that it does. The most gratifying 
experience I’ve had as dean is seeing how willing people 
are to put their efforts to the cause of making graduate 
education better at Yale. Nothing has given me greater 
pleasure than seeing students, faculty, administrators 
all come together to work toward the good. We have a 
remarkable community here. HS 
Hockfield with members of her lab team, which investigates the 
factors that influence brain development. Their recent discovery of 
a protein that facilitates the movement of glial cells (inset) has 
implications for the treatment of brain tumors known as gliomas. 
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THE SENSES 
An education in taste 
A conversation with Linda Bartoshuk, an expert on the physiology of taste, 
and Jacques Pepin, celebrity chef and cookbook author, explores the 
many facets of taste. 
Taste is one of the most fundamental yet most com¬ 
plex of all human experiences. It of course begins 
on the tongue, but it also embraces all of the other 
senses as well as each individual’s genetic makeup and 
life experience. In many ways, taste is as unique as the 
individual. Nonetheless, there are certain universally 
appreciated tastes. But what does taste mean for two 
people who have devoted their professional lives to 
studying it from very different perspectives? On behalf 
of Yale Medicine, contributing editor Marc Wortman 
invited renowned chef and author Jacques Pepin and 
Linda Bartoshuk, a leading authority on the biology of 
taste and on the treatment of oral pain, to share their 
views on taste over lunch at the Union League Cafe, one 
of Connecticut’s most noted French restaurants. 
Born in France, Jacques Pepin, M.A., was raised 
around fine food at his parents’ restaurant near Lyon. 
Fie was the personal chef to three French heads of state, 
including Charles de Gaulle. He is the author of a number 
of groundbreaking books on French culinary technique, 
as well as cookbooks published in conjunction with the 
cooking shows he has hosted on public television over the 
past 10 years. Holder of a master’s degree in 18th-century 
French literature, he is a faculty member at Boston Univer¬ 
sity. He lives near New Haven and has provided the School 
of Medicine and Yale-New Haven Hospital with frequent 
fund-raising and other assistance. 
Born in South Dakota, Linda Bartoshuk, Ph.D.. has 
been a member of the faculty since 1971. Her research 
has opened up broad new avenues in the study of the 
physiology and genetics of taste. Her more than 100 
articles on the subject have established the importance 
of the genetic basis of taste preference and its impact 
on health in many areas. She has demonstrated the 
significant anatomical differences, most importantly taste 
bud density, underlying taste preferences. Her work with 
taste has also improved the treatment of oral pain in 
cancer patients and people with neurological damage 
resulting in loss of taste. Bartoshuk was a contributor to 
The Yale Guide to Children’s Nutrition [Yale University 
Press, 1997], 
The following excerpt from their two-hour conversation 
begins with a discussion of the artistry that goes into ex¬ 
ceptional cooking and its parallels in the realm of science. 
NOT ON THE MENU 
L B : Part of being a great chef is obviously learning and 
experiencing and repeating dishes over and over. 
J P : Exactly. It’s never using the recipe. That’s why a 
chef must understand the food. If you’re able to taste a 
dish somewhere, and you say, “Gee, that’s a really good 
idea,” that’s all you need to know. But if I do a recipe for 
the New York Times or a new cookbook, then I have to 
say how long it stays in the oven and how hot the oven 
should be, because the editors ask. They’ll say, “How 
long was it in the oven?” “Well, 35 minutes,” I answer. 
Now I am stuck with those 35 minutes, and it will prob¬ 
ably never happen to be 35 minutes for someone else. 
The fact of writing the recipe down destroys the recipe 
by definition. Because as you write it down, you tell 
people, “This is the way it has to be done.” It’s never 
the way it has to be done. It just happened to be the way 
I did it this time because the chicken looked a certain 
way and I reacted to its look. And then I increased or 
reduced the heat or I added a cup of water because the 
situation demanded it. And yet the chicken will never 
react exactly this way the next time, and the adjustments 
will be different. The important thing is the taste at the 
end of cooking. 
It is hard to get someone to understand that this 
is what professional chefs do. You have to change the 
recipe each time to get to the same taste, because 
nothing is ever the same. You have to go beyond the 
recipe to understand how the food works. 
L B : That’s why it’s an apprenticeship to learn to be a 
good cook. 
J P : Sure. In the laboratory, how could you give some¬ 
body the formula for science? I mean, could you provide 
a recipe for thinking through a problem? 
LB: In a sense, it’s the same thing. The difficulty with 
doing basic research is you tend to want to purify the 
experience to the point where you can study it in a 
laboratory under great control. And that’s all well and 
good. But you then take the richness out of it, and it’s 
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no longer like real experience. On the other hand, the 
expert uses judgment at every step in order to make 
certain that you get to something at the end. For ex¬ 
ample, suppose I am testing a group of patients and 1 
want to learn something about them. The nature of the 
patient determines how I’m going to interact with the 
patient. I might have someone who’s extremely anxious 
or cognitively impaired and really can’t lollow what I’m 
trying to do. And I'm going to change the whole way 
I behave. Some of my students will get upset because 
I’m not rigidly doing it the same every time. They’ve 
learned in hooks that to do science you have to be rig¬ 
idly the same. And I say, “No, you have to make sure 
that people comprehend at essentially the same level.” 
J P: To understand, you have to interpret. You have to 
recognize an innate pattern in the making of each recipe. 
And I suppose, to a certain extent, what you do is the 
same—because even after you’ve tested a group of 
patients, you have some data that applies directly to 
each person on that particular day, but will not be the 
same on another day with the same person, and it will 
be different with someone else. So to a certain extent, 
the result of those tests has to be looked at with an 
open mind and as a guideline. 
L B: That’s right. What makes one expert better than 
another is the ability to have insight about what vari¬ 
ables are going to really matter, and to control the ones 
that are really going to matter. And that’s one of the 
reasons why you get inferior science. Genuinely inferior 
science occurs because people don’t have a feel for what 
needs to be controlled. 
J P : That’s why you get inferior dishes, also, because 
cooks believe too much in a structured recipe. It’s never 
the way it has to be done. 
THE VARIETIES OF TASTE 
L B : Can you imagine a particular flavor in your mind? 
That is a rare gift. Most people cannot do that. 
J P: As a professional chef, I believe I can do that. I can 
formulate a recipe in my head and “taste” it on my 
tongue. I know it’s going to taste this way. After 
50 years of cooking professionally, I am technically good 
enough to control the food, although you never control 
it entirely. I did three recipes at home last night. And I 
knew more or less what they would taste like. After a bit 
of a correction here and there, I got pretty close to what 
I imagined. 
Shall we order? I think I’m going to have that tuna. 
It looks great. 
L B : I’m having what you're having. Can I suggest since 
the artichoke induces a taste effect in some people, 
that we have that artichoke bisque? Some people are 
genetically sensitive, so that after they eat artichokes 
things taste intensely sweetened for a period of time. I 
get it incredibly, which is why I started working on it. 
J P : It’s interesting, because we shouldn’t serve wine with 
artichoke, likewise we shouldn’t serve it with asparagus. 
L B: The same compound is found in asparagus; it’s an 
isomer of chlorogenic acid. There is tremendous genetic 
variation in our ability to taste. One thing that we’ve 
learned in the last few years is that these genetic varia¬ 
tions are much greater than we suspected before. For 
example, a supertaster has many times the number of 
taste buds and is tasting two or three times the intensity 
of sweetness from ordinary sugar as a nontaster, like me. 
The supertaster can find broccoli too bitter and hot 
peppers too spicy. The nontaster won’t react to these 
tastes nearly as much. 
You also have some genetic variation in olfaction. 
But even more important than the genetic variation, 
you have life-span variation. Olfaction begins to decline 
at about 40 years of age, and it declines quite steadily. 
We don’t know if that’s a true age effect or if it's due to 
pathology, because your olfactory system is so exposed 
to viral illness. 
In any case, as you age, your ability to smell is less¬ 
ening steadily. And your ability to taste is not, not nearly 
so much. The main effect of aging on taste, we think, 
happens to women at menopause. The ability to taste 
bitter is a poison detection system. And it looks as if the 
body has arranged it so that women vary in their ability 
to taste bitter, depending on whether they are protecting 
a fetus. There’s variation with the menstrual cycle, and it 
appears to make women heightened responders to bitter 
early in pregnancy so that they become very good poison 
detectors. Once you’ve been pregnant, you’re always a 
little more sensitive to bitter than you were before. At 
menopause, it falls off a cliff, and women become much 
less sensitive to bitter than they were. 
J P : Would that be what they call species adaptive 
behavior? 
L B : Yes. It is very adaptive for the species. Then you 
might ask, “Why would you want genetically different 
groups of bitter tasters?” As a nontaster, I can barely 
taste some bitters, and a supertaster, as I suspect you 
are—we ll find out—is exquisitely sensitive to bitters. 
The answer appears to be that there’s a selective advan¬ 
tage to either group, depending on the environment 
you find yourself in. If you’re in a really dangerous 
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To taste or not to taste 
How individuals experience taste 
varies greatly, which explains 
why some people like broccoli 
and others flee at its very mention. 
An industrial chemist named Arthur 
Fox documented one basis for taste 
preference in 1931 while working with a 
compound called phenylthiocarbamide 
(PTC) for the DuPont Co. After the 
chemical was released accidentally 
into the air one day, a colleague re¬ 
marked how bitter it tasted. Fox had 
noticed nothing. 
Investigating further, the two scien¬ 
tists concluded that people fell into 
one of two groups: tasters and 
nontasters of PTC. Fox reported the 
findings later the same year in Science 
News. "The geneticists jumped right 
in," says Linda Bartoshuk, Ph.D., “and 
by the next year, two family studies 
had been done dividing the world 
between tasters and nontasters. The 
research showed that the nontasters 
had two recessive genes.” 
Bartoshuk began exploring the 
subtleties of taste in the 1970s as a 
Yale faculty member and investigator 
at the John B. Pierce Laboratory. She 
took Fox’s notion one step further, 
coining the term “supertaster" after 
identifying a third group of subjects 
whose taste buds were so numerous 
and so densely packed that foods 
such as grapefruit, coffee and dark 
green vegetables were overwhelm¬ 
ingly bitter. According to Bartoshuk, 
who uses a compound known as 
PROP (a thyroid medication) in her 
studies, the world falls into three 
groups: 25 percent nontasters, 
50 percent medium tasters and 
25 percent supertasters. 
What’s the significance of her 
results? “The taste world you live in 
affects your food preferences,” she 
says. “The foods you choose to eat 
are associated with risk factors, and 
there are consequences to eating a 
high-sweet, high-salt, low-fiber diet. 
Being a supertaster also predisposes 
you to oral pain, another area we’re 
investigating.” Bartoshuk and her 
colleagues developed a taffy containing 
capsaicin, the substance that gives 
jalapeno peppers their fire, and proved 
it effective in relieving oral pain in 
cancer patients. 
Long-standing research by taste sci¬ 
entists has established links between 
taste and sexual maturation (girls who 
are tasters mature six months earlier, 
How we taste 
Supertaster 
Supertasters have many more fungiform 
papillae than the rest of the population. The 
papillae are smaller and more densely packed. 
on average, while boys are delayed six 
months), depression (tasters are more 
prone) and alcoholism (nontasters are 
more at risk). But those studies pre¬ 
date the discovery of the supertaster. 
“There’s work to be redone,” says 
Bartoshuk, "and there are many other 
avenues still not explored.” A colleague 
is working out the molecular biology of 
PROP sensitivity, a step forward that 
may lead to new pain therapies and a 
better understanding of taste disor¬ 
ders, diet and nutrition. 
Nontaster 
Nontasters—the label refers to the inability to 
taste a chemical known as PROP—have many 
fewer papillae and are less sensitive to bitter. 
Taste buds in the fungiform papillae contain pores that direct taste stimuli to the 
nervous system and brain. They are capable of distinguishing among four categories: 
salty, sweet, bitter and sour. The other components of flavor are delivered to the 
brain by olfactory and tactile stimuli. 
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“Affective memories are more important for us than the memories 
of the brain,” says Pepin. 
environment with a lot of poisons, the supertaster has 
the advantage. The supertasters will survive and the 
nontasters are likely to die oil. But in a safe environ¬ 
ment, where you have a lot of plants that are actually 
safe, but taste bitter, like certain mushrooms, the 
nontaster has the advantage, because the nontaster 
will eat that mushroom and have a bigger lood world, 
rhe supertaster will avoid it. In the modern world, we 
suspect that this might be a health risk. For example, 
right now, one ol my colleagues, Adam Drewnowsky, 
believes that women are at greater risk for breast cancer 
il they’re supertasters because they avoid certain bitter¬ 
tasting Iruits and vegetables that protect them from 
cancer. We think the same thing might be true in colon 
cancer. In the modern era, we have to reassess. 
EATING THROUGH THE NOSE 
L B : This soup is wonderful. 
J P : As a nontaster, are you missing something that 
a supertaster might be experiencing when tasting 
this soup? 
L B : No. This is primarily olfactory. There’s very little 
genuine taste here. Maybe a little salt. But for the most 
part, this is entirely olfactory. Notice that as you swal¬ 
low, you get the bouquet. This is the second biological 
function ol the nose. It’s called retronasal olfaction. 
You swallow and chew, and the air, with all the odors in 
it, is pumped up into your nose. Your nose is perceiving 
the odor the entire time you’re eating. The brain uses 
smell and taste together to create flavor. Perceptually, 
you believe the olfactory experience is coming from 
your mouth, because taste and smell are both perceptu¬ 
ally localized by touch. If your mouth is feeling the 
food, the olfactory sensation will seem to be localized 
in the mouth. 
1 P : I see the world ol smell affecting memory. That’s 
very important, because the effect ol memory improves 
the taste of a glass of wine or a soup. It’s much more 
powerful when the memory of an event comes through 
the senses, particularly smell. II you asked me, “Where 
were you on such and such a date in 1978?’’ my brain 
may be able to recall the details, but the recall will be 
dry and unemotional. On the other hand, the memory 
of the senses has the element of surprise; it affects you 
deeply in an intimate way, when you don’t expect it at 
all. You walk through a room, and all of a sudden you 
smell something and you’re 5 years old again. That smell 
enables you to relive something through your senses in a 
much deeper and clearer way than something that is 
brought about deliberately by your brain. For a chef, 
and certainly for food critics, this memory of taste and 
smell is important. Affective memories are more impor¬ 
tant for us than the memories ol the brain. 
L B : Let me step back for a minute, because there are 
many things going on there. Taste is very dilferent. 
The emotional effect ol taste is not acquired at all. It’s 
all present at birth. In fact, it’s present before birth. 
You’re born loving sweet and hating bitter. And your 
experience has very little to do with that. Taste is first 
of all sweet, salty, bitter and sour. These are what we 
perceive through the taste buds. The taste buds also 
have another sensory role. They’re surrounded by nerve 
fibers responding to pain, temperature and touch. 
If you’re a supertaster you are born with a different 
anatomy. You have fungiform papillae, which are the 
little structures that hold taste buds. You have many, 
many more of them il you are a supertaster. It is like 
reaching up and feeling something with 500 fingers as 
opposed to 50. The texture that a supertaster feels is 
quite different. 
Then there’s smell. Smell is iced tea, lemon, roast 
beef—much more complex and subtle than taste. The 
way we learn smells is particularly interesting in the light 
of what you’ve been talking about. When you’re born, 
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you have the capacity to smell a tremendous number of 
different molecules, but they don’t mean anything to 
you. Perhaps the mother wears a certain perfume, and so 
the baby learns to recognize that particular mixture of 
odors, because the perfume is complex, as many things 
are. The baby recognizes it after repeated pairings, and 
now that perfume takes on tremendous positive valence, 
because it’s associated with comfort, with the mother. 
That memory, once learned, will stay in your brain 
for your lifetime. If you were to walk into a room years 
after you ever smelled it and smell it again, you’d be 
flooded with the feelings associated with that memory 
of when you were young. And with your exquisite expe¬ 
rience as a chef, you’ve built up a library of experiences 
far more complex and subtle than I have. You learn 
those things when you’re very young, and they’re very 
powerful. They control your pleasure. 
J P : Taste can be experienced in different ways. I always 
say that food critics should be blind, so they can tell you 
what’s good or not good. But, unfortunately, very often 
they are influenced by many other things: the presenta¬ 
tion of the food, the setting and so on, which make it 
so subjective. On the other hand, the food can be many 
things. It can be something simple, straightforward and 
tasty, or it can be a symphony of different tastes. For 
example, when you do a pork chop, you want it to taste 
like pork, and it’s good. Now if I take that pork and 
grind it and put cognac, white wine and shallots with it 
and different types of seasonings, too, I do a pate. The 
pate now is delicious. But it does not taste like pork any 
longer. It’s more of a mixture of different tastes, culmi¬ 
nating in the taste that we call pate. 
If, as they do in France, you cook apple with butter 
and sugar on top of a dough, you have an apple tarte. If 
you make an apple pie in the American style, with cin¬ 
namon, nutmeg, mace and butter, you have lost the taste 
of apple but have created another taste with this combi¬ 
nation. So you have transcended the taste of apple and 
created a symphony by combining different ingredients. 
L B : We know a lot about the pleasure that is associated 
with those experiences, believe it or not. One of the 
amazing things about olfaction is it has this ability to 
take components and relearn them in combination. 
An apple, cinnamon. Your brain learns a template that’s 
a holistic sort of map of this, and you learn it as a new 
whole. The apple pie is a new template. It’s not the same 
as the apple template mixed with the spice template. 
Here’s the important property of olfaction: Those 
templates acquire pleasure. The more templates you 
have, the more pleasure you can acquire. Because of the 
way olfaction works, as soon as you can identify an odor, 
you acquire the emotional valence—that is, it’s either 
good or bad—based on your experience. The acquisition 
of affect to olfaction is very vivid, very powerful and 
very hard to lose. 
THE LOVE OF CALORIES 
J P : One way of learning about food is to go to have 
the real McCoy—a dish the way it is supposed to be 
prepared—so that you can put that in your taste 
memory and draw from it eventually. You learn that’s 
the way it should taste. I remember going to China 
many, many years ago. 1 knew a fair amount of Chinese 
cooking at that time, but when I was in China 1 was 
exposed to ingredients and tastes that I had never experi¬ 
enced, and some of these tastes were pretty weird. So I 
asked, “Is it supposed to taste this way? Is this for real?" 
I tasted these dishes several times, trying to put them 
somewhere in my taste memory so I could draw from 
them at a later time. Often, tastes that are not pleasant 
to start with eventually grow on you. 
L B : But see, that taste to the Chinese has been paired 
with all kinds of reinforcing experiences, including 
calories. One of the main ways to make something loved 
is to pair it with calories. It’s a survival mechanism. And 
that’s why we all love high-fat food. The problem is that, 
in the short term, eating calories, salt and sugar is very 
good for you. In the long term, it leads to chronic dis¬ 
ease. We live in a culture that has learned they’re bad for 
us, but our brains are living in a world where they are 
good for us. 
J P : And there’s a paradox there. 
L B : That’s a paradox. And you can’t solve it. There’s no 
free lunch here. One of the problems our culture has to 
solve is, “Are we really going to ask people to eat foods 
that they were not evolved to love and tell them they are 
healthy?’’ That’s not easy. So how do you do it? How do 
you trick people into learning to like things that have 
less fat, less sugar, less salt? Part of it has to be social 
conditioning. 
J P : I feel that the conditioning is extremely important 
when you are small, because it will stay with you for 
the rest of your life. I like asparagus fresh and lightly 
steamed. My wife was born in New York City, and as a 
child she was served canned asparagus by her mother. 
She now loves fresh asparagus, too, but she still has that 
taste for canned asparagus because that taste is associated 
with her youth. 
Likewise for me, a Frenchman who’s now an Ameri¬ 
can, I learned how to make an apple pie with cinnamon, 
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nutmeg and mace, and I now like it. But it will never 
have the same resonance for me that it does for my wife, 
because it’s something she had when she was a child. 
For me, a piece of crunchy baguette with dark chocolate, 
which is what I ate as a snack after school as a child, is 
still a true delight. While my wife likes bread and choco¬ 
late now, it will never mean the same thing for her as 
it does for me because she never had it as a child. 
L B : You know, there’s a name for that. It’s called 
comfort food. 
J P : Yes, of course. 
L B : See, ordinarily I wouldn’t try this type of food, a 
tuna tartare or an artichoke soup. But because you know 
it’s interesting and you ordered it, it takes on very special 
positive characteristics for me. I look at it and say, oh, 
this is going to be interesting. I approach it with a 
completely different attitude. 
J P : It’s true. And it works both ways. When I had a 
restaurant, many people came because they knew me 
and liked me. For these people, even if I screwed up 
and the food was ordinary, they still loveci it. They were 
conditioned; they liked me, and I could do no wrong. 
Then we had the reverse. We had a guest who would 
say, “Let’s see what the big famous chef can do. Let’s 
see what the big deal is.” Each time he tasted something, 
regardless of how good it was, he would question it and 
find fault with it. There’s nothing you can do. 
I am going to guess that you are going to taste this 
paper as bitter, and that, if we photograph your tongue, 
your fungiform papillae are going to be just side by side. 
J P : You just put it on your tongue? 
L B : Just put it in your mouth. 
J P : Oh boy! Very bitter. 
L B : See, I told you. You have all the earmarks of a 
supertaster. 
J P : It’s disgusting. 
L B : Absolutely nothing for me. 
J P : Oh boy, it was really bitter. 
L B : No taste. It’s genetic, purely genetic. You are prob¬ 
ably carrying two dominant genes for this characteristic 
and I carry two recessive. 
J P : There is also a recessive gene? 
L B : Yes, yes. Not surprisingly, it seems to have a big 
effect on people’s lives. For instance, we visited the 
culinary school at Johnson & Wales and tested students. 
They were virtually all supertasters. Men are more likely 
to be nontasters; it is women who are more likely to 
be supertasters—probably to protect the fetus. Yet 
most of the students were men. Finding all these male 
supertasters who are experts at food is extremely interest¬ 
ing, and this is not an accident. You were born to it. 
J P : And learned to love the experience of taste. 
With Union League Cafe Chef Jean-Michel 
Gammariello. "The meal,” says Pepin, 
“was wonderful.” 
L B : And to share that love. H31 THE PROP TEST 
L B : We need to find out if you’re a supertaster. Let’s try 
this simple test we’ve devised. This piece of filter paper 
has 1.6 milligrams of a chemical 
called propylthiouracil, or PROP, 
on it. If you were being treated for 
thyroid disease, you would take 200 
milligrams per day of this chemical, 
so this paper contains really a trivial 
amount. Let me demonstrate. What 
will happen when I taste it is abso¬ 
lutely nothing. I don’t have enough 
taste buds. It will taste just like paper 
to me, and, if we photograph my 
tongue, we will see that my fungi¬ 
form papillae are so widely spaced 
that they look like polka dots. 
in neurophysiology. 
Gala Dinner and 30th Reunion of Downs Fellows 
Contact: Carolyn Grantham-Millman, M.RH. ’84, 
oordinator of Alumni Affairs, Epidemiology and Public Health, 
60 College St., P.O. Box 208034, New Haven, CT 06520-0834 
m-. -i. & 
Yale School of Medicine 
Alumni Reunion Weekend 
Return to Yale for a reunion celebration June 4 and 5. Take a 
walk down College Street and memory lane, reconnect with 
old friends, enjoy a New England style clambake — revisit 
and reminisce. This year’s event includes special programs on 
medical education, international health and the career of 
neurophysiologist and medical historian John Farquhar 
Fulton, as well as a preview of the Congress Avenue Building. 
Programmatic Review of the 
New Congress Avenue 
Building Project 
Yale Surgery: 1949 to 1999 
Medical Education and 
Curriculum Review at Yale 
Annual Meeting of the 
Association of Yale Alumni 
in Medicine 
Dean’s Reception 
John Farquhar Fulton, M.D. 
Centennial 
Celebration/Symposium 
Tours of the medical center 
and library, Fulton Estate, 
historic New Haven, and Yale 
Center for British Art 
Association of Yale Alumni in Medicine 
Office of Alumni Affairs 
P.O. Box 7613, New Haven, CT 06519-0613 
203. 785-4674 203. 737-5153 Fax 
Association of Yale Alumni in Public Health 
Celebrating Shared Linkages to Global Health 
Friday, June 4 
The theme of this year’s program provides an opportunity to 
reflect on what we currently know about the effects of 
globalization on the health field. Highlights include: 
International Action Can Make a Difference 
Joshua Cohen, M.D., MPH ’59, former Chief of Medical Care 
and Advisor on Health Policy of the World Health Organization 
Global Health as a Reflection of Challenges 
in the U.S. and Abroad 
EPH Alumni/Downs Fellows Panel 
Global Health and the Mission of PAHO 
Keynote Speaker: Sir George Alleyne, M.D., 
Director, Pan American Health Organization 
John Farquhar Fulton, M.D 
Centennial 
Celebration/Symposium 
A panel of the world s foremost 
authorities on Fulton will examine the 
life and contributions of this eminent 
medical historian and pioneer 
FACULTY NEWS 
Rimar appointed 
medical director of 
Yale Faculty Practice 
Stephen Rimar, M.D., HS 83-87, vice chair for 
finance and administration in the Department of 
Anesthesiology, has been appointed medical director 
of the Yale Faculty Practice, the organization that manages 
the clinical activities of more than 650 Yale physicians. 
Rimar, a 1977 graduate of Yale College who received his 
medical degree from George Washington University, is 
board certified in pediatrics and anesthesiology and was 
chief resident of the Pediatric Primary Care Center at Yale 
before joining the faculty in 1988. Fie founded the section 
of pediatric anesthesia and was the first medical director of 
the pediatric surgery center. He has taken an active leader¬ 
ship role in a range of Faculty Practice initiatives including 
credentialing, finance, marketing, compliance and 
telemedicine. 
According to David J. Leffell, M.D., HS ’84-87, director 
the Yale Faculty Practice and associate dean for clinical af¬ 
fairs, Rimar’s appointment is a major step forward for the 
practice. “Dr. Rimar is a highly skilled administrator, clini¬ 
cally active physician, and strong leader who will help guide 
our academic physician organization,” he said in making 
the appointment. 
The Faculty Practice is the group practice of the faculty 
of the Yale School of Medicine, who provide care in a broad 
range of specialties. As medical director, Rimar hopes to 
make physicians more familiar with the business side of 
running a practice. 
According to Leffell, Rimar is responsible for the 
implemention of the practice standards that were developed 
to ensure a uniformity of service in all Faculty Practice 
departments. He also directs the Management Course for 
Physicians, which was designed to cultivate physician lead¬ 
ers and managers within the school and practice, and 
recently graduated 21 students in its first class. 
FACULTY N 
George K. 
Aghajanian, M.D., 
professor of psychiatry 
and pharmacology, re¬ 
ceived the 1998 Lieber 
Prize for Schizophrenia 
in October from the National Alliance 
for Research on Schizophrenia and 
Depression at a gala dinner in 
New York. 
Vincent A.T. 
Andriole, M.D., HS 
professor of medicine, 
received the 1998 
Bristol Award in 
Vincent Andriole November at the Infec_ 
tious Diseases Society of America’s an- 
lal meeting in Denver. The award is 
granted in recognition of a career re¬ 
flecting major accomplishments and 
contributions through teaching in an 
area of infectious diseases. Andriole 
also received the Lawrence Paul 
Garrod Award from the British Soci¬ 
ety of Antimicrobial Chemotherapy at 
its annual meeting in November in 
Manchester, England, at which time 
he delivered the Farrod Lecture. 
Amy Arnsten, Ph.D., research scien¬ 
tist in neurobiology, Ralph E. 
Hoffman, M.D., associate professor of 
psychiatry, and Scott W. Woods, 
M.D., associate professor of psychiatry 
and diagnostic radiology, received 
1998 Independent Investigator Awards 
from the National Alliance for Re¬ 
search on Schizophrenia and Depres¬ 
sion. They each will receive $50,000 a 
year for two years for their research. 
James L. Boyer, M.D. ’78, professor 
of medicine, received the Distin¬ 
guished Achievement Award in 
November from the American 
George 
Aghajanian 
Association for the Study of Liver 
Diseases in honor of his ongoing 
scientific contributions to the field 
of liver diseases and to the scientific 
foundations of hepatology. 
Yung-Chi Cheng, 
Ph.D., the Henry 
Bronson Professor of 
Pharmacology and 
medicine, received the 
American Society for 
Yung-Chi Cheng pbarmac0|0gy ancJ 
Experimental Therapeutics Award in 
Experimental Therapeutics for 1999. 
The award, funded by Hoffman- 
LaRoche Inc. is given annually for the 
purpose of recognizing and stimulat¬ 
ing outstanding basic laboratory or 
clinical research that has had, or 
potentially will have, a major impact 
on the pharmacological treatment of 
disease. Past recipients from Yale are 
Alan C. Sartorelli, Ph.D. in 1986; 
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William H. Prusoff, Ph.D. in 1982; 
and Joseph R. Bertino, M.D. in 1970. 
Jennifer A. Doudna, Ph.D., professor 
of molecular biophysics and biochem¬ 
istry and assistant investigator at the 
Howard Hughes Medical Institute, 
was one of 17 researchers honored by 
the National Academy of Sciences. 
Doudna received a $15,000 Award for 
Initiative in Research for her pioneer¬ 
ing studies, which have enabled the 
determination of complex RNA struc¬ 
tures, especially those of ribozymes, 
through X-ray crystallography. The 
award, established in 1981 by AT&T 
Bell Laboratories in honor of William 
O. Baker, is supported currently by 
Lucent Technologies. 
In October, Stephen C. Edberg, 
Ph.D., professor of laboratory medi¬ 
cine and medicine, was appointed 
United States delegate to the Codex 
Alimentarious Commission (CAC). 
Edberg was chosen lor his internation¬ 
ally recognized work in the field of 
microbial health risk assessment. The 
CAC is the body of the United Na¬ 
tions that generates standards and 
regulations for the international 
movement of food, agriculture and 
drinking water. 
John A. Elefteriades, 
M.D., professor of sur¬ 
gery and chief of the 
section of cardiotho- 
racic surgery, delivered 
an invited address on 
Surgical Revasculari¬ 
zation for Failing Hearts during the ple¬ 
nary sessions of the American Heart 
Assoc-iation's 71st Annual Meeting in 
Dallas in November. Elefteriades also 
spoke on this topic in October at the 
Post-Graduate Course of the Ameri¬ 
can College of Surgeons in Orlando. 
John 
Elefteriades 
Gerald 
Friedland 
Gerald H. Friedland, 
M.D., professor of 
medicine and epidemi¬ 
ology, was honored on 
World AIDS Day in 
December with the 
Connecticut Depart¬ 
ment of Public 
Donaghue Foundation selects five 
investigators for long-term support Five researchers have been 
awarded $ioo,ooo-a-year, 
five-year grants from the 
Patrick and Catherine Weldon 
Donaghue Medical Research 
Foundation. The foundation’s first 
awards through the Donaghue 
Investigator Program for Health- 
Related Research were announced 
in November. The researchers are: 
Mark B. Gerstein, Ph.D., assistant 
professor of medicine, who will con¬ 
duct a large-scale analysis of gene 
sequences and protein structures that 
will be relevant to understanding the 
molecular basis of diseases that have 
been genetically characterized. 
Sharon K. Inouye, M.D., M.P.H., 
associate professor of medicine, who 
will study ways to reduce delirium and 
functional decline in hospitalized 
older persons with the goal of reduc¬ 
ing the length of hospital stays and 
improving health outcomes. 
Zeev Kain, M.D., associate profes¬ 
sor of anesthesiology and pediatrics, 
who will identify children who are 
prone to preoperative anxiety and 
seek ways to decrease their stress and 
improve long-term outcomes. 
David Rimm, M.D., Ph.D., 
assistant professor of pathology, who 
will study adhesion protein expression 
as a predictor of cancer metastasis. 
Discovery of new biological markers 
in breast or melanoma tumors can 
greatly enhance early treatment of 
cancer patients. 
Stephen Strittmatter, M.D., Ph.D., 
associate professor ol neurology, will 
investigate axonal regeneration after 
spinal cord injury. Results could have 
major positive implications for victims 
of spinal cord injury and stroke. 
Health’s 10th annual AIDS Leadership 
Award. Friedland was honored for 
his work in research, administration 
and policy development, as well ■ 
as for providing exceptional 
patient care. 
Siegfried J. Kra, M.D., associate 
clinical professor of medicine, con¬ 
ducted a symposium on hypertension 
in October in Windsor, Conn., 
sponsored by Zeneca Pharmaceuticals. 
John M. Leventhal, M.D., professor 
of pediatrics and a member of the 
Child Study Center faculty, received 
the 1998 Research Award from the 
Ambulatory Pediatric Association, 
which represents almost 2,000 pediat¬ 
ric academic generalists in the United 
States. Leventhal received this award 
for his research on risk factors for 
child abuse and for his enthusiastic 
mentoring of medical students and 
fellows pursuing research on child 
abuse and developmental and behav¬ 
ioral pediatrics. 
Richard R Lifton, M.D., Ph.D., chair 
of the Department of Genetics and 
professor of medicine, genetics, and 
molecular biophysics and biochemis¬ 
try, delivered two lectures as part of 
the 1998 Holiday Lectures on Science 
for high school students sponsored 
by the Howard Hughes Medical 
Institute. The lectures— Telltale 
Genes: Charting Human Disease and 
The Kidney’s Tale: of Salt and Hyperten¬ 
sion—were broadcast live via satellite 
throughout the United States 
and Canada and internationally via 
the Internet. 
Stephen E. Malawista, 
M.D., professor of 
medicine, was awarded 
an honorary doctorate 
(Docteur Honoris 
Causa) by the Universite 
Rene Descartes in Paris 
in December. Malawista is known for 
his work on motile and killing lunc- 
tions of white blood cells in the con¬ 
text of the inflammatory response, the 
Stephen 
Malawista 
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With an eye for detail, an expert 
on the lung shares his life’s work 
By John Curtis 
In a basement office in Brady 
Memorial Laboratory, the evidence 
of a half-century of lung cancer 
research clutters the shelves, pours 
from filing cabinets and covers the 
desk and nearly every flat surface. 
The remaining spaces are filled with 
a few unremarkable pieces of office 
furniture, several microscopes and 
drawers of slides, and a sign that 
thanks visitors for not smoking. 
Although semi-retired at age 85, 
Raymond Yesner, M.D., continues to 
teach the craft and science of pathol¬ 
ogy while documenting the knowl¬ 
edge he has amassed during 53 years 
on the Yale medical faculty. In 
November 1997, Lippincott-Raven 
published his Atlas of Lung Cancer; 
a compendium of knowledge and 
insights gleaned from a life spent 
studying diseases of the lung, particu¬ 
larly cancer and tuberculosis. Yesner, 
professor emeritus and senior research 
scientist in pathology, is “the premier 
authority on the pathology of lung 
cancer,” according to the book de¬ 
scription; its pages contain some 450 
photographs and conclusions based on 
his work with more than 25,000 cases. 
Yesner’s keen understanding of the 
lung and its vulnerabilities has won 
him praise in medical circles as well as 
the emnity of the tobacco industry 
that he has testified against in legal 
proceedings. Outside the courtroom, 
he recalled in an interview, industry 
agents followed his movements in a 
fruitless search for a way to discredit 
him. “If I had any skeletons in the 
closet,” he said, “they were interested 
in uncovering them.” 
Last November, he was honored 
with a Yale professorship in his name. 
In announcing the news—and the ap¬ 
pointment of pathology chair Jon S. 
At a ceremony in November, Dean David Kessler announced the creation and endowment of the 
Raymond Yesner Professorship in Pathology. Yesner's wife, Bernice, and children Steven and 
Donna applaud the announcement. 
Morrow, M.D., as the first incum¬ 
bent—Dean David A. Kessler, M.D., 
praised Yesner for his accomplish¬ 
ments as a scientist and his skill with 
students. “Dr. Yesner,” the dean said, 
“is particularly known for providing 
the kind of support and encourage¬ 
ment that comes with great teachers.” 
Morrow also offered kind words for 
Yesner. “He has been a mainstay of the 
pathology program. He has taught le¬ 
gions of residents. He remains intel¬ 
lectually active,” Morrow said in a 
recent interview. “I marvel at the re¬ 
markable contributions he has made 
over the years.” 
Born in 1914, Yesner spent his 
youth mostly in New England. 
The family’s travels took them from 
Georgia, where he was born, to 
Maine, where his father ran a general 
store catering to lumberjacks who ar¬ 
rived on skis, to New York City, where 
he excelled as a pupil and skipped two 
grades. When the family settled in 
Massachusetts, Yesner attended 
Boston Latin School and proceeded 
on to Harvard on a scholarship, then 
to Tufts Medical School. 
Through it all, he developed an in¬ 
terest in writing that persists. He has 
published hundreds of articles in 
medical journals, ranging from land¬ 
mark studies of lung disease to an ac¬ 
count of his visit to hospi¬ 
tals and clinics in Kenya. 
Resisting the computer 
age, he still writes by 
hand, although he is 
working on the CD-ROM 
edition of his lung cancer 
atlas. “I like to see things 
in long hand and let them 
marinate for a little bit,” 
he said, “in case I want to 
change them.” 
Yesner came to Yale as 
an assistant professor in 
1946, shortly after he 
mustered out of the Army 
and began a career at the 
Veterans Administration 
in West Haven. In 1974, 
he retired from govern¬ 
ment service and devoted 
himself to teaching at 
Yale, an activity he still 
enjoys. “This past week¬ 
ly end I supervised two au- 
3 topsies and have just gone 
o over them with a resi¬ 
dent,” he said during the 
interview several months ago. “This 
kind of teaching, which is done one- 
to-one over a microscope, is the best 
kind of teaching.” 
It is during these sessions that 
Yesner feels he can not only discuss 
what is being observed in the labora¬ 
tory, but also shape the views of his 
students and the future practice of his 
discipline. He rallies energetically in 
favor of the autopsy, all too rarely per¬ 
formed in this day and age, he believes, 
j “In order to understand disease 
you have to be able to follow cases 
from biopsy to autopsy,” he said, 
using a writer’s analogy to make his 
point. “The autopsy is the last chapter 
of an individual’s life. This is a very 
important thing.” 
mechanism of action of colchicine, 
the pathogenesis of gout, and the dis¬ 
covery and elucidation of Lyme disease. 
Bruce McClennan, 
M.D., professor of 
diagnostic radiology, 
was elected to the 
Board of Directors 
of the Academy of 
Radiology Research 
in November. The academy’s focus is 
on radiology as a discipline commit¬ 
ted to research and the translation of 
research advances into higher-quality 
and more cost-effective patient care. 
McClennan is secretary of the Ameri¬ 
can Roentgen Ray Society. 
Ira S. Mellman, 
Ph.D., professor of 
cell biology and 
immunobiology and 
director of the Pro¬ 
gram in Biological 
and Biomedical Sci¬ 
ences, was named editor-in-chief of 
the Journal of Cell Biology (JCB) in 
March by Arnold Levine, Ph.D., presi¬ 
dent ofThe Rockefeller University. 
Mellman replaces Norton B. Gilula, 
Ph.D., of the Scripps Research Insti¬ 
tute, who had served as editor-in-chief 
since 1981. The journal was founded in 
1955 by several of the field’s pioneers, 
including former Yale professor and 
Nobel laureate George Palade, M.D. 
Yale faculty members currently serving 
on its editorial board include Pietro 
DeCamilli, M.D., Graham Warren, 
Ph.D., Keith Joiner, M.D. and Arthur 
Horwich, M.D. Mellman, a senior 
editor at JCB for the past year, says 
new initiatives are planned for the 
journal, including enhanced web ac¬ 
cess, video links and a unique system 
for online peer review. 
James R. Merikangas, M.D., HS ’71- 
72, lecturer in psychiatry, was elected 
president of the American Academy of 
Clinical Psychiatrists in October at its 
annual meeting in New Orleans. 
Sara C. Rockwell, Ph.D., professor of 
therapeutic radiology and pharmacol¬ 
ogy, received the John Yuhas Award in 
Bruce 
McClennan 
Ira Mellman 
October from the University of Penn¬ 
sylvania in recognition of her out¬ 
standing research in radiation biology. 
The award was presented to Rockwell 
after she delivered the John Yuhas Me¬ 
morial Lecture on Radio resistance and 
Drug Resistance: The Importance of 
the Cellular Environment. 
Martin W. Sklaire, M.D., clinical pro¬ 
fessor of pediatrics, was presented the 
1998 Milton J.E. Senn Award by the 
American Academy of Pediatrics in 
recognition of his achievement in the 
field of school health. Sklaire, also a 
school physician in the Madison, 
Clinton, Hamden and Saybrook 
school systems in Connecticut, has 
been in private practice in Madison 
for over 30 years. 
Brian R. Smith, M.D., professor of 
laboratory medicine, pediatrics and 
medicine (bone marrow transplanta¬ 
tion), has been appointed assistant 
chief of laboratory medicine at Yale- 
New Haven Hospital. 
Frans J.Th. Wackers, M.D., professor 
of diagnostic radiology and medicine 
and director of cardiovascular nuclear 
imaging, was awarded the Eugene 
H. Drake Award in February by the 
American Heart Association’s New 
England Affiliate. In March, he re¬ 
ceived the 1999 Distinguished Service 
Award from the American Society of 
Nuclear Cardiology. 
Eiji Yanagisawa, M.D., clinical profes¬ 
sor of surgery (otolaryngology), pre¬ 
sented two video programs in October 
during the Motion Picture Session in 
Otorhinolaryngology at the Clinical 
Congress ol the American College of 
Surgeons in Orlando. In November, 
he was an invited lecturer at the 50th 
Anniversary Congress oi the Japan 
Bronco-Esophagological Society held 
in Kobe. Yanagisawa also presented a 
video program with Dewey A. Christ¬ 
mas, M.D., HS ’70, last July at the 
1998 European Rhinologic Society and 
International Symposium of 
Infection and Allergy of the Nose in 
Vienna, receiving a second place award 
in the international competition. 
STUDENT NEWS 
A vision realized 
Student sees a need for AIDS education program in India and fills it. 
When first-year medical 
student Vivek Murthy 
completes his medical 
training and begins his career as a 
physician, he plans to continue a 
philanthropic venture he started as a 
freshman in college. If he is successful, 
he may well become the Paul Newman 
of the health products world, channel¬ 
ing profits from commercial enter¬ 
prises into a charitable foundation 
that supports health education and 
other initiatives in developing coun¬ 
tries and underserved communities in 
the United States. 
As an undergraduate at Harvard, 
Murthy launched VISIONS World¬ 
wide Inc., a non-profit organization 
that has about 200 students working 
on AIDS prevention and community 
health projects. Its AIDS prevention 
program has sent American college 
students to India to help high school- 
age students organize local AIDS edu¬ 
cation and prevention efforts. Also in 
India, VISIONS has worked with a 
hospital to identify village women for 
training in nursing and community 
health. In the Boston area, VISIONS 
has linked student volunteers to HIV 
Vivek Murthy 
service agencies. VISIONS also pub¬ 
lishes an annual journal and holds an 
annual conference. 
The organization’s AIDS education 
project in India started with six stu¬ 
dent emissaries in the summer of 1995; 
this summer 22 students are expected 
to go abroad. While in India, student 
volunteers meet with groups of students 
and hold workshops that use perfor¬ 
mance and role-playing to underscore 
the message of AIDS prevention. 
The concept of VISIONS grew 
from Murthy’s experience as a student 
in Florida, where he started a peer 
education program in which high 
school students mentored middle 
school students. At Harvard he 
decided to address the growing 
problem of AIDS in India, the 
country with the highest number 
of HIV-positive people, 4.1 million, 
according to UNAIDS. 
VISIONS Worldwide [P.O. Box 
24-8315, Coral Gables, FL 33124] now 
has seven chapters in India and the 
United States, including three in the 
Boston area, at Tufts, MIT and 
Harvard. The students who travel 
to New Delhi, Bombay, Bangalore 
and Sringeri for peer education work 
must raise at least $2,000 towards 
their expenses. They train in Florida 
for two weeks, learning to teach 
and facilitate discussions while 
becoming more familiar with the 
culture of India. 
On Martin Luther King Day, an affirmation of ideals 
In song, speeches and verse, students and faculty at the 
medical school honored the Rev. Martin Luther King Jr.’s life 
and beliefs as well as the new generation that will continue 
his struggle. “We can say humbly, honestly and without 
despair,” said Forrester A. Lee, M.D., associate professor 
of medicine and assistant dean for multicultural affairs, 
“that so much remains to be done. It is time to pass on 
the legacy of Dr. King to the next generation.” Speakers 
included the Rev. Frederick J. Streets, Yale University chap¬ 
lain; Erin Armstead, a Yale College senior; Charles Warner, 
left, a senior at Hill Career High School; and Richard 
Lyn-Cook, right, a fourth-year medical student. 
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Murthy’s goal in starting the orga¬ 
nization, he said, was “to generate 
change in local communities that 
would be sustainable, involve local 
leadership and create a mutually ben¬ 
eficial partnership between students 
in the United States and India.” 
He targeted high school-age students 
because, although HIV infection is 
spreading fastest among 15- to 24- 
year-olds, they seldom perceive them¬ 
selves to be at significant risk. Said 
Murthy: “Young people don’t always 
relate what they hear about HIV and 
AIDS to themselves. Our goal is to 
personalize HIV in a way that will 
make individual prevention more 
effective and that will motivate stu¬ 
dents to create and support commu¬ 
nity AIDS activities.” 
From left Duffy, Davies, 
Nuernberg, Styliano- 
poulos and Angoff 
Three students 
recognized 
At a ceremony in May, students re¬ 
ceived awards for writing and commu¬ 
nity service. 
Claire Styliano- 
poulos, a first- 
year student, 
accepted the 
Novartis Phar¬ 
maceuticals 
Corp. Award on 
behalf of COVS, 
the Committee 
on Volunteer 
Services, which she chairs. The prize, a 
io-volume set of the Netter Atlas, rec¬ 
ognizes community service by stu¬ 
dents. Third-year students Amy 
Nuernberg and Ryan Davies shared 
this year’s Lerner Award for creative 
writing. Davies was honored for his 
essay on the marvels of the human 
body as seen by a student in the oper¬ 
ating room. Nuernberg was recog¬ 
nized for a song she composed about 
end-of-life issues called I Have to Go. 
Professor Thomas Duffy and Associate 
Dean Nancy Angoff presented the 
awards at the final student-faculty tea 
of the year in the Beaumont Room. 
Auction raises $25,000 for the 
homeless and hungry 
The sixth annual Hunger and 
Homeless Auction organized by 
students last November raised 
more than $25,000 for local charities, 
including soup kitchens, food delivery 
agencies and a homeless shelter for 
women and children. 
Items on the block included lunch 
at the United Nations with Secretary- 
General Kofi Annan, a four-day 
sojourn at the Maine cottage of 
Deputy Dean Robert H. Gifford, 
M.D., H.S. ’67, and a dessert a month 
for six months. Two associate deans, 
Ruth Katz, J.D., M.P.H., and Nancy 
R. Angoff, M.D. ’90, H.S. ’90-93, 
M.P.H. ’81, successfully bid for roles in 
the second-year show presented 
in February. 
A four-day stay for up to six people 
in the Martha’s Vineyard home of 
Keith A. Joiner, M.D., professor 
of medicine and epidemiology, and 
Jo Ellen Schweinle, M.D., assistant 
clinical professor of medicine, fetched 
the highest price, $1,550. The design 
and construction of a tree house 
came in second at $1,400. Richard 
Donabedian, M.D., professor of 
laboratory medicine, hesitated not a 
second in bidding $500 for a promise 
of full attendance at a lecture from 
Top Richard Donabedian bid $500 for full 
attendance by the Class of 2001 at one of 
his lectures. 
Above Dave Kharbanda made a successful 
bid on a tour of the United Nations and lunch 
with Secretary General Kofi Annan. 
the Class of 2001. “I didn’t know we 
were that bad,” joked Kebba Jobarteh, 
a member of the class and one of the 
organizers of the auction. Other 
organizers were Michael Fehm and 
Kathy Witgert. 
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UA transforming experience” 
Internships guide public health students 
as they contemplate the road ahead. 
Sue Lin Yee and Mindy Perilla, with colleagues on the 
steps of the Chinese Academy of Preventative Medicine 
in Beijing, where they spent last summer in public 
health internships. 
Each summer, public health stu¬ 
dents abandon the classroom 
and enter the world of business, 
health, law or politics to blend practi¬ 
cal experience with their textbook 
studies. Summer internships may take 
them down Interstate 95 to a health 
care firm in Norwalk, Conn., or to 
Washington, Geneva or China to 
work at federal or international agen¬ 
cies. Last summer, 74 students worked 
on projects at home and abroad. 
One organized a database for a 
study of dementia among older Latino 
residents in California. Another wrote 
summaries of information on repro¬ 
ductive health for the World Health 
Organization in Geneva. A third stu¬ 
dent created financial models for 
health care companies at an invest¬ 
ment banking firm on Wall Street. 
“The internships allow students to 
gain practical experience and get an 
idea of balancing theory and practice. 
It makes their studies come alive,” said 
Christy Bergheim, director of the 
EPH Office of Career Services, which 
helps place students in the program. 
“It is a transforming experience. They 
really come back professionals.” Stu¬ 
dents must complete their internships 
between the first and second years of 
the two-year M.P.H. program. Students 
research their internships indepen¬ 
dently, then discuss their plans with 
an adviser, who must approve them. 
Brooke Courtney worked for the 
Latino Council on Alcohol and To¬ 
bacco, one of about 50 public health 
organizations working for passage of 
tobacco legislation in Washington. 
Her job was to develop fact sheets, in¬ 
form Senate staffers about issues and 
keep members of the Latino council 
n-to-date on developments on 
Capitol Hill. “It was an incredible 
experience,” said Courtney, whose 
concentration is in health policy and 
international health. “It gave me a 
really good understanding of 
the policy process, how law¬ 
making works, and how in¬ 
terest groups affect policy.” 
Tobacco was also the 
topic for Sue Lin Yee, who 
went to China, where a 
third of the world’s cigarettes 
are smoked. She studied 
anti-tobacco campaigns in 
China and assessed the atti¬ 
tudes of public health work¬ 
ers toward smoking. “Not all 
people in health were non- 
smokers,” Yee notes. Never¬ 
theless, she found that 
health workers, as well as the 
general public, considered 
smoking a serious problem. 
She surveyed doctors, nurses 
and other health profession¬ 
als, and found a majority 
preferred prevention pro¬ 
grams aimed at adolescents 
over cessation programs for 
current smokers. They also 
favored student-generated 
smoking awareness pam¬ 
phlets rather than after¬ 
school programs. 
“I think the most impor¬ 
tant thing I learned from the 
internship was how to deal 
with the unexpected when working in 
a foreign environment,” Yee said. 
“Often we go into the field with great 
expectations and very specific objec¬ 
tives, but we later discover that, for 
whatever reasons, we cannot meet our 
goals. Then it’s important to keep try¬ 
ing and to be firm, but if this fails, try 
to make the most out of the situation 
and make the appropriate changes in 
future research.” 
That was also the lesson for 
Mindy Perilla, who worked on several 
projects in China. One took her to 
Inner Mongolia where she investi¬ 
gated neonatal tetanus, a disease that 
can be prevented by hygienic birthing 
methods and immunization of pro¬ 
spective mothers. Perilla found her in¬ 
ternship particularly challenging be¬ 
cause she speaks no Chinese. “This is 
what international work is really like,” 
her preceptor told her when they dis¬ 
cussed the frustrations of research. 
“It’s easy to overlook the impact that 
realities of life, resources, communica¬ 
tion and culture can have when plan¬ 
ning a project, even when doing so 
with experienced individuals ‘in-coun¬ 
try,’” Perilla said. “Expectations and 
outcomes can be quite different.” 
Unity, an undergraduate 
group of Korean drummers 
performed at the Grannum 
Jamboree in January. 
Sherri Sandifer accompa¬ 
nied Nduka Amankulor, a 
first-year medical student 
who sang spirituals at the 
jamboree. 
The sounds of a gospel choir, Chilean and Cuban 
poetry, Korean drums and native American chants 
filled Harkness Auditorium on Jan. 15 as students held 
a jamboree to raise money for minority youth in New 
Haven. The money will go to a scholarship fund for 
students who participate in the Health Professions 
Recruitment and Enrichment Program (HPREP), which 
ran from January to April. HPREP is a national program 
created by the Student National Medical Association 
(SNMA) to expose young people to career opportuni¬ 
ties and encourage them to go to college. At Yale, 
medical students taught 
classes on Saturday mornings 
on topics ranging from domes¬ 
tic violence to career opportu¬ 
nities in the health profes¬ 
sions. “What is unique about 
Yale is that students are com¬ 
mitted to this type of activity,” 
said David LaBorde, a second- 
year medical student and vice 
president of the local chapter 
of the SNMA. 
Sherri Sandifer brought down the 
house with her performance of an 
original song about men, women 
and relationships. 
A world of possibilities 
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Your Fiftieth 
Reunion— 
Making it 
Count 
Over 1,300 graduates are 
receiving income from their 
gifts to Yale. 
Many of these gifts were 
made in connection with 
a Fiftieth Reunion. 
As this milestone rapidly 
approaches for the Class 
of 1949, please reflect upon 
the role a Yale education 
has played in your life 
during the half-century 
since your graduation. 
A life income gift 
may enable you to 
commemorate your 
Fiftieth more splendidly 
than you thought possible. 
w 
Yale University 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521 
800-445-6086 
fax: 203-432-7901 
development, plannedgiving 
@ yale.edu 
40’s 
Aaron Beck 
Aaron T. Beck, M.D. 
’46, received the Life¬ 
time Achievement 
Award from the Asso¬ 
ciation lor the Ad¬ 
vancement of Behavior 
Therapy, (AABT), at its 
32nd annual convention last Nov¬ 
ember. Widely recognized as one of 
the founders of cognitive therapy, 
Beck has developed models for the 
treatment of depression, anxiety, panic 
and other disorders over a period of 
more than 50 years. The AABT cited 
his work for its “enormous impact on 
the methodology practiced by 
clinicians, far beyond the reach of 
those who adhere only to the tenets 
of cognitive and behavioral thera¬ 
pies,” adding that his approach has 
been described as the fastest growing 
psychotherapy in the world. 
David K. Geddes, M.D., HS '48-49, 
of Santa Ana, Calif., writes to say 
that he is still practicing psychiatry 
at age 78 and teaching residents and 
students at the University of Califor¬ 
nia, Irvine College of Medicine. 
Jack L. Strominger, 
M.D. ’48, was one of 
two recipients of the 
1999 Japan Prize, 
awarded in Tokyo by 
the Science and 
Jack Strominger Technology Founda¬ 
tion of Japan in April. Strominger is 
the Higgins Professor of Biochemistry 
in the Department of Molecular and 
Cellular Biology at Harvard Univer¬ 
sity and will share the $430,000 prize 
for deciphering the 3D structure of 
human histocompatibility molecules 
with Harvard colleague Don Wiley, 
Ph.D. The award underlines the rapid 
advances made in molecular immu¬ 
nology in the last three decades. 
50’s 
George L. Becker Jr., M.D., HS 58- 
62, of Franklin Lakes, N.J., received 
the Honorary Distinguished Alumni 
Award from the Department of 
Neurological Surgery at Columbia 
University, College of Physicians and 
Surgeons, in the summer 1998. 
In October, the Wharton Health 
Care Management alumni honored 
William L. Kissick, M.D. ’57, HS 
’58-61, of Philadelphia, with a 
scholarship in his name. 
Myron Lotz, M.D. ’58, continues to 
work with charities and hospitals in 
San Miguel de Allende, Guanajuato, 
Mexico, that assist with family 
planning, hunger relief and medical 
care for needy children. Lotz writes, 
“This is a beautiful area with lots of 
arts and crafts and cultural events. 
Come on down. It’s fun.” 
Leon G. Smith Jr., M.D., HS ’59-62, 
director of medicine and chief of 
infectious diseases at Saint Michael’s 
Medical Center in Newark, N.J., 
received the Jubilee Medal Pro Meritis 
for distinguished service within the 
Archdiocese of Newark Health Care 
Apostolate and was honored by the 
Archbishop of Newark at a special 
mass held in the Cathedral Basilica of 
the Sacred Heart. He has also been 
honored with the dedication of the 
Leon G. Smith Infectious Diseases 
Institute at Saint Michael’s Medical 
Center. According to background 
information published by the medical 
center, Smith will lead the institute in 
its mission “to impact countless lives 
in the world-especially those of the 
impoverished and the neglected in the 
battle against infectious diseases.” 
60’s 
Malin R. Dollinger, M.D. ’60, of 
Palos Verdes Estates, Calif., writes 
that after 24 years in a private practice 
of medical oncology and serving as 
vice president of medical affairs at the 
John Wayne Cancer Institute in Santa 
Monica, Calif, he is devoting time to 
4 4 SPRING 1999 
a second-opinion cancer practice and 
consulting. He also enjoys playing his 
Wurlitzer pipe organ. 
Phillip Gorden, M.D., HS 61-64, 
director of the National Institute 
of Diabetes, Digestive and Kidney 
Diseases, has announced his intention 
to step down from the post when a 
successor is named. Gorden plans to 
rejoin the National Institutes of 
Health intramural program. 
70’s 
Edward L. Marut, M.D. ’74* of 
Winnetka, Ill., is the medical director 
of the Highland Park Hospital IVF 
Center, which ranks in the top 10 of 
all centers in the United States for 
pregnancy success rates, according to 
the data published by the Centers for 
Disease Control in February. 
David B. Moyer Jr,, M.D. ’72, a 
Navy medical corps captain, has 
retired after 26 years in the service. 
He was the Navy Surgeon General’s 
consultant for allergies, tobacco and 
health issues. Moyer is now at the 
Kaiser Hospital in Oakland, Calif. 
Jeffrey C. Faig, M.D. 
’80, is presently chief 
resident in obstetrics 
and gynecology at 
Kaiser Medical Center 
in San Francisco. He 
also completed an 
endocrinology fellowship at Stanford 
and an internal medicine residency at 
the University of California, San 
Francisco. Dr. Faig plans to practice 
obstetrics and gynecology in North¬ 
ern California next year. 
90’s 
Jill Fischer, M.D. ’97 and Michael 
Fischer, M.D. ’97, are proud parents 
of a son, Benjamin Jeremy, born Dec. 
20. He has an older brother, Jacob. 
Jill is in her second year of pediatric 
residency at Massachusetts General 
Hospital and Michael in his second 
80’s 
Jeffrey Faig 
year oi primary care/internal medi¬ 
cine residency at Brigham and 
Women’s Hospital. The obstetrics 
resident on-call when they arrived at 
the hospital for the delivery was class¬ 
mate Wendy Kuohung, M.D. ’97. 
Louluo Hong, M.P.H. 92, was 
named assistant director for Wellness 
Education at the Louisiana State Uni¬ 
versity (LSU) Student Health Center 
in September. She also received her 
Ph.D. in educational leadership and 
research from LSU in December. 
A May wedding is planned with 
Christopher J. Aamadt, a paramedic 
with Acadian Ambulance. 
Lauren D. Hyman, 
M.D. ’94, has joined 
the staff of The West 
Hills (Calif.) Hospital 
& Medical Center and 
the medical practice of 
Lauren Hyman Linda Katz, M.D., 
Ob/Gyn. Hyman also served as an 
instructor at a homeless shelter for 
pregnant women in Los Alamitos. 
Elan D. Louis, M.D. ’89 and Vinita 
Sehgal, M.D. ’90, announce the birth 
ol their son, Ravi Jonah Sehgal Louis, 
born Sept. 25. Louis and Sehgal are 
currently assistant professors of 
neurology and nephrology at the 
College of Physicians and Surgeons, 
Columbia University. 
Scot Phelps, M.P.H. ’95, received his 
juris doctor degree from Brooklyn 
Law School in May 1998, and passed 
both the New York and New Jersey 
bar exams. He has been appointed 
assistant professor of emergency 
medicine at George Washington 
University. 
Stacy M. Susman, M.P.H. ’91, a 
health-care management consultant 
at PricewaterhouseCoopers in New 
York, and Thomas J. Kuhn, senior 
vice president and general counsel 
of USA Networks Inc., were married 
on Jan. 31 at Cipriani Wall Street in 
New York. 
Is Yale 
University 
In Your 
Will? 
High estate tax rates 
significantly lower 
the cost of making 
a bequest to the 
University. 
If you will be at least 
65 years old as of 
June 30 of your next 
reunion year, notify¬ 
ing the University of 
your Will provision 
will allow us to count 
your generosity in 
your reunion gift. 
w 
Yale University 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521 
800-445-6086 
fax: 203-432-7901 
development, plannedgiving 
@yale.edu 
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OBITUARIES 
ERICA PIFER BATE 
Erica Pifer Bate, M.P.H. 82, died on 
Jan. 2 in London. She was 71. 
Born in England, she graduated 
with honors from London University. 
In 1953, she married Alan Pifer, the 
American director of the newly estab¬ 
lished Fulbright Scholarship Program. 
They later moved to the United States 
where she returned to school and 
earned her master’s degree in hospital 
administration from Yale. During her 
career she was employed as a senior 
administrator at Bridgeport Hospital. 
She also served as president of the 
Norwalk Hospital Volunteers and as a 
trustee of the hospital and the Educa¬ 
tional Foundation of America. She 
divorced in 1994 and moved back to 
England where she married John Bate, 
a childhood friend. 
EDWARD N. BRENNAN 
Edward N. Brennan, M.D. ’55, died 
June 25, 1998, at home in Greenwich, 
Conn., of cancer. 
After graduation from the School 
of Medicine, Brennan served as a 
teaching fellow in psychiatry at 
Harvard University from 1956 to 1959 
and trained at Columbia University’s 
Psychoanalytic Clinic for Training and 
Research. He also served as a captain 
in the Air Force from 1959 to 1961 at 
Eglin Air Force Base in Florida. Brennan 
was an associate professor at Colum¬ 
bia and had an active practice in New 
York City and Greenwich, Conn. 
KATHERINE L. BURNHAM 
Katherine L. Burnham, M.P.H. ’70, died 
Nov. 20 of breast cancer. She was 52. 
Burnham was born in New York 
City and graduated from Hiram Col¬ 
lege in Ohio. She received a master’s 
degree in public health from Yale and 
attended Duke University Medical 
School, where she received her 
physician’s assistant degree. In 1978, 
she moved to Portland, Ore., where 
she practiced as a physician’s assistant 
for Kaiser Permanente. 
ALBERT C.K. CHUN-HOON 
Albert C.K. Chun-Hoon, M.D. ’57, 
died March 12, 1998, at St. Francis 
Hospice in Hawaii. He was 66. 
Chun-Hoon graduated from 
Bowdoin College in Maine, and, after 
receiving his Yale medical degree, 
trained as a resident at Baylor Univer¬ 
sity. He served in the Army Medical 
Corps in Okinawa and returned to 
Hawaii in i960 to practice medicine. 
Chun-Hoon served on the Hawaii 
Medical Service Association Board for 
more than 20 years and as its chair¬ 
man from 1984 to 1987. He helped 
launch and was the first medical direc¬ 
tor of the WorkComp Hawaii Insur¬ 
ance Co. Inc., which underwrites 
workers’ compensation coverage for 
employers in Hawaii. He also was a 
professor of surgery in orthopaedics at 
the University of Hawaii and served 
on the medical staff of the Queen’s, St. 
Francis and Kuakini medical centers. 
NORMAN L. CRESSY 
Norman L. Cressy, M.D. ’39, died Jan. 
25 at the Wildflower Health Care 
Center in Greenville, R.I. He was 85. 
A 1935 graduate of Yale College, 
Cressy served as a lieutenant colonel in 
the U.S. Army Medical Corps and 
played a role in the Army’s efforts to 
identify and control viral pneumonia. 
Following a post-war fellowship at Yale, 
he became a fellow of the American 
College of Physicians while serving on 
the staff at the Veterans Administration 
Hospital in Newington, Conn. 
In 1949, he moved to Northampton, 
Mass., and practiced internal medi¬ 
cine. Cressy joined the staff of Uncas- 
on-Thames Hospital in Norwich, 
Conn., in 1953 where he was apointed 
superintendent and medical director. 
He retired in 1974. During his career, 
he also served as an associate clinical 
professor at the School of Medicine, 
where he was recognized for his work 
in pulmonary diseases and oncology. 
MARCIA FITE 
Marcia Fite, M.D. ’37, died Jan. 20 at 
the Gregory Wing Nursing Home in 
Boothbay Harbor, Maine. She was 87. 
Born in Poughkeepsie, N.Y., Fite 
graduated from Vassar College and re¬ 
ceived her medical degree from the 
School of Medicine in 1937. Most of her 
career was devoted to clinical research. 
STORER P. HUMPHREYS 
Storer P. Humphreys, M.D. ’32, died 
Dec. 28 at the Anna Jaques Hospital 
in Newburyport, Mass. He was 93. 
In 1928, Humphreys graduated 
from Norwich University in North- 
field, Vt. After receiving his medical 
degree from Yale, he continued his 
studies at McGill University and Neu¬ 
rological Institute in Montreal. He 
served his residency as a neurological 
surgeon at Massachusetts General 
Hospital and became an associate on 
the hospital’s neurological team. 
Humphreys served with both the 
Canadian and the U.S. Army Medical 
Corps and retired from the Army 
as a colonel. 
WILLIAM H.E. KEELER 
William H.E. Keeler, M.D., M.P.H. 
’58, died Dec. 10 at the Licking Me¬ 
morial Hospital in Newark, Ohio. 
He was 79. 
Keeler received his medical degree 
from New York Medical College and 
his master’s of public health degree 
from Yale. He served in the U.S. Ma¬ 
rine Corps as a medic in the Pacific 
Theater during World War II. 
Keeler was a retired medical officer 
for the U.S. Postal Service and a former 
health commissioner in Marion City, 
Ohio, where he was affiliated with the 
Frederick C. Smith Clinic. 
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WILLIAM KESSEN 
Child psychologist William Kessen, 
Ph.D. ’52, died Feb. 13. He was 74. 
Kessen graduated from the Univer¬ 
sity of Florida in 1948 and went on to 
Brown, where he received his Sc.M. 
degree in 1950. After earning his Ph.D. 
at Yale, he began his career as a 
postdoctoral fellow in the Yale Child 
Study Center. He was named the Eu¬ 
gene Higgins Professor of Psychology 
in 1976 and became a professor of pe¬ 
diatrics in 1978. 
Kessen chaired the Department of 
Psychology at Yale from 1977 to 1980. 
He also served as acting secretary of the 
University during the fall of 1980 and 
acting master of Calhoun College in 
the spring of 1989. He retired in 1997. 
Kessen’s research centered on the 
behavior of children in the first years 
of life. His work led him to many 
parts of the world including China, 
where he led one of the first delega¬ 
tions following the re-establishment of 
U.S. diplomatic relations. 
PAUL F. MCALENNEY 
Paul F. McAlenney, M.D. ’29, died Dec. 
23 at Pomperaug Woods Health Center 
in Southbury, Conn. He was 94. 
McAlenney graduated from Catho¬ 
lic University of America in 1925. Af¬ 
ter earning his M.D. from Yale, he be¬ 
gan his career as an associate clinical 
professor of pediatrics at Yale from 
1932, remaining on the faculty until 
1974. He headed the Department of 
Pediatrics at St. Raphael’s Hospital in 
New Haven from 1950 to 1964. 
RUTH CORTELL MEDINE 
Ruth Cortell Medine, M.D. ’48, died 
Dec. 21. She was 84. 
Medine graduated from Wellesley 
College and the University of Chi¬ 
cago. While pursuing her medical 
degree at Yale, she also studied thyroid 
function as a research fellow in 
pharmacology. Medine served as asso¬ 
ciate medical director of the Metro¬ 
politan Life Insurance Co. 
ETHAN R. NADEL 
Ethan R. Nadel, Ph.D., died Dec. 26 
of cancer at his home in Guilford, 
Conn. He was 57. 
A native of the Washington, D.C., 
area, Nadel received a bachelor’s de¬ 
gree from Williams College and a 
Ph.D. in environmental physiology 
from the University of California at 
Santa Barbara. He then continued 
with postdoctoral studies at the Pierce 
Laboratory in New Haven and was 
appointed assistant professor of 
epidemiology at the Yale School oi 
Medicine in 1970. 
Nadel was an authority in the area 
of human thermoregulation during 
exercise and heat exposure. In 1986 he 
became a consultant on the M.l.T. 
Daedalus Project, which took human- 
powered flight to a new level with a 
successful non-stop flight in 1988 
between the Aegean islands of Crete 
and Santorini. 
During his tenure as director of 
the Pierce Laboratory from 1989 until 
last year, Nadel planned and oversaw 
the expansion and major renovation 
of the laboratory’s facilities and helped 
increase the research staff to a level 
of 25 scientists and postdoctoral fellows. 
He also strengthened the relationship 
between the laboratory and the medi¬ 
cal school, inviting medical and 
graduate students to use Pierce facilities 
and expertise to complete their training. 
CHARLES J. PETRILLO 
Charles J. Petrillo, M.D. ’38, died Dec. 
31 at his home in Clinton, Conn. 
He was 84. 
Petrillo was born in West Haven 
and graduated from Yale College in 
1935. After completing medical school 
at Yale, he practiced otolaryngology 
in New Haven from 1947 to 1985. 
Petrillo served on the school's clini¬ 
cal faculty in otolaryngology from 
1950 until his death. He was also an 
associate section chief of otolaryngol¬ 
ogy at Yale-New Haven Hospital. 
Petrillo was active in the Associa¬ 
tion of Yale Alumni in Medicine, serv¬ 
ing as a class secretary for many years. 
He was a former president of the New 
Haven Medical Society, the American 
Rhinologic Society, and American 
Diopter and Decibel Society. 
IN MEMORIAM 
The School of Medicine has received 
notification of the deaths of the 
following persons: 
Muriel H. Bagshaw, M.D. ’51 
February 9, 1998 
Erica Pifer Bate, M.P.H. ’82 
January 2, 1999 
Eleanor Clay Bigley, M.D. ’51 
January 23, 1998 
Katherine L. Burnham, M.P.H. ’7° 
November 20, 1998 
Nicholas W. Fenney, M.P.H. ’46 
January 9, 1999 
Storer P. Humphreys, M.D. ’32 
December 28, 1998 
William H.E. Keeler, M.D., M.P.H. ’58 
December 10, 1998 
Harriet P. Leach, M.D. ’35 
May 25, 1998 
Paul F. McAlenney, M.D. ’29 
December 23, 1998 
Ruth Cortell Medine, M.D ’48 
December 21, 1998 
Charles J. Petrillo, M.D ’38 
December 31, 1998 
Donald A. Pious, M.D. ’56, HS ’57-59 
September 6, 1998 
Charles F. Scholhamer, M.D. ’42 
October 2, 1998 
H. Yale Tyler, M.D., Med ’35 
November 28, 1998 
John H. Wentworth, M.D. ’39 
June 21, 1998 
Mabel Wilson, Med ’29 
April 28, 1998 
Abrahim I. Zafar, M.D. ’96 
October 10, 1998 
The designation Med. indicates that the 
deceased attended the School of Medicine 
for a portion of his or her education. 
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Face to face with Ray 
In the clinic and on film, an exceptional patient is a teacher without peer. 
Over the last four years, I have listened to 
hundreds ol patient stories as a medical 
student taking histories. Not all stories 
are equal in their impact, and some are so pro¬ 
found that one begins to see patients differently. 
The story of Ray has stayed with me lor lour 
years and will, 1 think, color my experience with 
every patient. 
I first encountered Ray in the dermatology 
clinic in the Yale Physicians Building. I poked 
my head in, greeted him, and closed the door. 
I stood there for what seemed an eternity, mouth 
agape, as I gawked at the lesions that lestered on every inch 
ol his skin. Tumors the size of goli-balls appeared to be 
in a sort of limbo, not sure whether to remain embedded 
under the skin or to bud out. “Are you okay? Ray asked 
self-effacingly, and I sat down in the chair usually occupied 
by the patient. 
Ray had a severe and untreatable case of neurofibromato¬ 
sis. The scheduled 15-minute visit turned into a two-hour 
conversation in which he recounted the endless ways it had 
changed his life. A normal kid growing up in a normal New 
Haven family, Ray had hoped to be a photographer running 
around New York City like the famous Weegee. His dreams 
faded when bumps the size of marbles began parasitizing his 
skin during adolescence. The doctors told him, “You have 
the elephant man’s disease—just bad luck.” Now, as then, 
there is no cure. The best medicine can do is manage the 
complications, which is why Ray has had more than 40 sur¬ 
geries to remove fibromas that had become inlected. Fifty 
years alter diagnosis, alone and reclusive, Ray’s otherwise 
monotonous existence oi television and videotapes is inter¬ 
rupted by a call inviting him to come to clinic and meet 
some students, which he enjoys doing in the hopes of edu¬ 
cating us. “I want you all to be good docs,” he continually 
reminds us. 
It is difficult not to have a changed perspective on the 
doctor-patient relationship, and a greater capacity for empa¬ 
thy, after meeting and talking with Ray. His greatest fear is 
that others will fear him, out of misplaced anxiety that he 
might be contagious. 
Last summer while shopping at the market and covered 
from head to toe with a very long raincoat, Ray encoun¬ 
tered a new cashier. When she saw him she 
shrieked, drawing the attention and stares of 
a crowd of onlookers as Ray pleaded with her 
to accept his io-dollar bill. She placed his 
change on a napkin, and a very nervous Ray 
dropped the money on the floor. Embarrassed 
once again, he ran from the store, leaving his 
groceries and money. “It’s the unforeseeable 
reaction that I live with on a daily basis,” he 
says as he stares at the floor. He never looks 
you in the eye. 
Ray affected me and has helped to make me 
a better doctor. Soon alter I met him, I wondered how his 
story might help other medical students be good docs, too. 
A film about his life would say it all. After a meeting with 
Ray and one ol his dermatologists, Irwin Braverman, M.D., 
we all agreed to make a documentary recounting Ray’s 
battle with this horrible disease. The film would be used to 
teach medical students and residents the profound impact 
that disease can have on patient lives, not only physically 
but socially as well. 
With encouragement and direction from mentors at 
the medical school, I began work on Illness As Experience. 
The half-hour film took a year to make, with resources 
and financial support from the school, the Yale Film Studies 
Department and outside grants. Ray’s story unfolds in inter¬ 
views with him and Dr. Braverman detailing the pervasive 
presence of neurofibromatosis in his life. The film is being 
shown at more than 100 medical schools and residency 
programs throughout the country as part ol their humani- 
ties-in-medicine and ethics curricula. 
Ray’s altruism towards young doctors, as he shares his life 
with us in the clinic and on the screen, goes beyond words. 
I occasionally view the documentary, and it is admittedly an 
unsettling experience; even the thought of briefly viewing 
the world through the eyes of a severely disfigured man is a 
vicarious experience most would rather not have. For many 
Yale students who meet Ray, however, it is a voyage we 
rarely forget. 
Angelo Volandes is a fourth-year medical student graduating 
in May. He will begin his residency training in primary care 
this summer at the University of Pennsylvania. 
By 
Angelo Volandes 
48 SPRING 1999 
n
e
a
s
e
 
s
e
n
d
 
a
d
d
it
io
n
al
 
in
fo
rm
at
io
n
 
o
n
 
th
e 
c
o
n
fe
re
n
ce
s 
c
h
ec
k
ed
 
a
t 
le
ft
. 
te
le
ph
on
e 
a
r
e
a
 
c
o
de
: 
( 
z s 
n O 
CD 
3: O 
> X 
K> 
n o 
n 00 
/ o 
Cl K> 
H 
CW 
OJ 
n 
tn 
D 
> 70 
on 
H 
S 
n 
H 
DD H< 
O £ on n 
H tn 
g Z 
O 3 
c H 5 n 
H £ 
tn h 
> 
Z ^ 
o 
n 
z 
S o 
0 o 
n 
O 
T1 
z 
H 
Z 
C 
Z R 
n 2 
5 G 
n z 
O n 
n 
> 
n 
n 
O 
C 
n 
5 
o 
z 
r 1 20
 c
e
n
ts
 
postage
 
here
 
Continuing Education at Yale 
August 7 - 8 
Saturday - Sunday 
Spinal Canal Endoscopy 
Course Directors: Lloyd Saberski, M.D. 
and James Rosser, M.D. 
Temple Medical Center, 40 Temple Street, 
New Haven 
September 15 -19 
Wednesday - Sunday 
PA Conference 
Course Director: Christiane Nockels 
Omni Hotel, New Haven 
October 23 
Saturday 
Diabetes 
Course Director: Rosa Hendler, M.D. 
Omni Hotel, New Haven 
c 
D 
September 17 
Friday 
The Yale Glaucoma Symposium 
Sheraton Four Points, Waterbury 
September 25 
Saturday 
Asthma Update for the New Millennium 
Course Directors: Alia Bazzy-Asaad, M.D. 
and Gabriel Haddad, M.D. 
Foxwoods Resort & Conference Center, 
Ledyard, Conn. 
October 29 
Friday 
Changing the Risk: Women and 
Heart Disease 
Course Directors: Teresa Caulin-Glaser, 
M.D. and Frans J.Th. Wackers, M.D. 
Fitkin Amphitheatre, New Haven 
November 5 
Friday 
Osteoporosis 
Course Director: Karl Insogna, M.D. 
New Haven Lawn Club 
E October 15 Friday 
Second Annual Frisbee Stem Ceil 
Symposium 
Course Director: Edward Snyder, M.D. 
Omni Hotel, New Haven 
F October 21 - 23 Thursday - Saturday 
Yale Conference on Women’s Health 
and Fitness 
Course Director: Peggy DeZinno 
Omni Hotel, New Haven 
November 6 - 7 
Saturday - Sunday 
Spinal Canal Endoscopy 
Course Directors: Lloyd Saberski, M.D. 
and James Rosser, M.D. 
Temple Medical Center, 40 Temple Street, 
New Haven 
November 12 
Friday 
Yale Ophthalmology Cornea Update 
Yale Eye Center, Boardman Building, 
Room 307, New Haven 
For information, contact the Office of Postgraduate and Continuing Education, Yale University School of Medicine, 
333 Cedar Street, P.O. Box 208052, New Haven, CT 06520-8052; Tel: (203) 785-4578 
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“Our trip to Santa ^e surpassed our expectations in terms ofi faculty, program and 
companionship. YOhat an experience!’ —Maureen & Harold Bernstein ’53 MD 
Join Yale faculty and 
interesting fellow 
travelers on Yale 
travel/study programs Association 
of Yale Alumni 
Over forty educational 
adventures offered each 
year. Call 1-800-456-925 
for your AYA Passport 
listing them 
a: 
—"——■— 1 1 1 . ,:a*r 
elemedicine on Mt, Everest, page^ i Second-vear showoffs. ■Mm I Bar k to Africa. .. Pine 
Yale Medicine 
KOSOVO 
JOURNAL 
Hardship and hope 
through the eyes of 
six Yale medical 
students 
On the cover: Children in the Senekos refugee 
camp near the Kosovo border in the former 
Yugoslav Republic of Macedonia found them¬ 
selves homeless and, in many case*,, separated 
from family members and loved ones, yak 
volunteers organized recreational activities in- ; 
eluding soccer and volleyball leagues* hikes 
in the countryside and a theatrical production 
of Gndmila complete with props and cos® 
tumes scavenged in the marketplace in Skopjet 
“If you make the kids happy, it makes the 
community a whole lot better, observed one 
of the medical students who worked in the 
camp, For excerpts from the volunteers 
journals, see page 26. 
12 The Show Must Go On 
By John Curtis 
For a true insider’s view of the School of Medicine 
(or a glimpse of the faculty wearing tights), buy 
yourself a ticket to the Second-Year Show, an an¬ 
nual exercise in institutionalized irreverence. Even 
as The Show turns 50 this year, it retains all the 
energy and spunk of its youth. 
20 The Many Worlds 
of Nozipo Maraire 
By Cathy Shufro 
When Nozipo Maraire returns to Zimbabwe next 
year, she will be one of seven neurosurgeons in a 
nation of 11 million people and quite possibly the 
first black female neurosurgeon on the African 
continent. She goes home after seven years of train¬ 
ing at Yale and one critically acclaimed novel. 
A ‘Crisis of the Spirit’ in Kosovo 
By Emine Alijaj, Margaret Bourdeaux, Sharon 
Chekijian, Aaron Covey, Seth Coldbarg, Vivian 
Lombillo, Pamela Perry and Anya Szeglin 
As ethnic Albanians fled Kosovo by the hundreds of 
thousands this spring, eight Yale volunteers traveled 
to neighboring Macedonia with the international re¬ 
lief organization Doctors of the World. In the refugee 
camp at Senekos, they triaged new arrivals, surveyed 
the camp population’s medical and nutritional needs, 
organized youth programs and comforted thousands 
displaced from their homes. 
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ON CAMPUS 
A case study in corporate resuscitation 
O Managed-care executive Norman C. Payson, M.D., described 
"The Rise, Collapse and Resurrection of Oxford Health Plans Inc.” 
for graduates of the Yale Management Course for Physicians in 
April. The Connecticut-based health insurer “is off the ventilator, 
it is out of the ICU, but it is still an inpatient,” said Payson, who 
was brought in to revive the ailing company as its CEO last year. 
He was a fitting choice for the graduation ceremony, which 
marked the end of a course designed to impart management 
skills so doctors may better cope with medicine’s new regulatory 
and financial environment. Payson started his career as a physi¬ 
cian, became CEO of a 120-physician group practice, then headed 
a managed care company before taking over as CEO of Oxford. 
The company became the darling of Wall Street in the early 
1990s as it offered customers a choice of insurance plans and 
sought affiliations with top doctors and hospitals. After a series 
of poor business decisions, its quarterly profits of $34 million, 
Payson said, fell to quarterly losses of $45 million a year later. 
Its stock plummeted, investors sued and regulators intervened. 
To survive, the company jettisoned its management, secured 
new investments and pulled out of unprofitable markets. Now, 
Payson said, Oxford’s recovery is a work in progress. "Hope¬ 
fully,” he said, “the patient will be able to go home soon.” 
Shades of gray in the human genome 
O Nobel laureate Baruch S. Blumberg, M.D., Ph.D., discussed 
environmental and genetic factors of the hepatitis B virus and 
related liver diseases during a talk on May 24. "It is very diff¬ 
icult, if not impossible, to assign a value to a gene in terms of 
good or bad,” Blumberg said. "Those terms are polarized and 
very often they can only be used in the context of other factors 
that are involved.” 
His talk,"DNA Polymorphisms and Clinical Phenotypes: 
A New Era for Genome Epidemiology,” was the second annual 
Genaissance Pharmacogenetics Lecture. Blumberg shared the 
1976 Nobel Prize in Medicine with D. Carleton Gajdusek, M.D., 
for their discoveries concerning new mechanisms for the origin 
and dissemination of infectious diseases. Blumberg was hon¬ 
ored for his discovery of the hepatitis B virus. 
2 
“Lost Boys” author weighs in on Littleton 
O Access to weapons, violent role models in the media, spirit¬ 
ual emptiness and a history of trouble are among the risk factors 
that can precipitate teen violence, said James Garbarino, Ph.D., 
director of the Family Life Development Center and professor of 
human development at Cornell University. Garbarino’s talk on 
May 6, “Lost Boys: Pathways to Violence,” came two weeks after 
the high-school massacre in Littleton, Colo., that left 15 dead, 
including two high-school gunmen. 
“[The cause] is not one thing, it’s an accumulation of risk 
factors,” Garbarino said during the second in a series of lectures 
marking the opening this fall of the Neison and Irving Harris 
Building of the Child Study Center. “With one or two risk factors, 
kids do fine. With three or four risk factors they go over the line.” 
But Garbarino saw cause for optimism in the tragedy. "This is 
obviously a time of despair, but also an opportunity to help 
people mobilize in caring, thoughtful ways,” he said. 
Biology’s new world 
Q DNA sequencing and genome-mapping have moved bio¬ 
logy into a new world where researchers try to keep pace with 
the explosion of information and ideas, Nobel laureate Walter 
Gilbert, Ph.D., told a standing-room-only audience of graduate 
students, postdocs and researchers in May. 
"By the time you start graduate school,” he said, "there is 
only 10 percent of the information about DNA that will be 
known by the time you get your Ph.D. A few years ago it was 
possible to get a thesis by cloning a gene. Today it is impossible. 
You have to do something more.” 
Gilbert, a microbiologist at Harvard who invented DNA 
sequencing, delivered the seventh annual Edward A. Adelberg 
Lecture in Genetics. He shared the 1980 Nobel Prize in chem¬ 
istry with Frederick Sanger for their work in determining base 
sequences in nucleic acids. 
— John Curtis 
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LETTERS 
FROM THE EDITOR 
An evolving Yale Medicine 
You may notice a few improvements 
in this issue of Yale Medicine: cleaner 
typography, more extensive use of 
color, an additional feature or two and 
the lively touch of designers Peter 
Johnson and Kristin Tomsits of the 
Yale RIS Design Department. During 
the course of the next several issues, 
we will be fine-tuning the magazine’s 
content and presentation with the 
goal of creating a more attractive, bet¬ 
ter organized, and, ultimately, more 
informative publication. 
While the core mission of Yale 
Medicine remains unchanged, we 
would like to hear from readers as we 
reconsider its format. What do you 
like about the magazine? What could 
be better? What could be added to 
make Yale Medicine more useful and 
enjoyable? Please share your thoughts 
by writing to us at the address on the 
masthead or by e-mailing me directly 
at michael.fitzsousa@yale.edu. 
Meanwhile, we have added content 
to our Web site, including back issues 
from the past two years and supple¬ 
mental material that you won’t find in 
the magazine. A video clip, edited 
from interviews with three of the stu¬ 
dents who traveled to Macedonia, 
accompanies our cover story at 
info.med.yale.edu/ymm. We’re also 
seeking student-show memorabilia, 
which we will digitize and make avail¬ 
able on the Web; see the timeline on 
pages 14-17, and please help us fill in 
the missing years. 
While you’re online, please take 
a fresh look at the school’s overall site, 
info.med.yale.edu/ysm, which has 
been redesigned by Patrick Lynch with 
the help of a school-wide committee. 
You may also want to visit Yale Univer¬ 
sity’s retooled front door on the Web 
at www.yale.edu—one of the first pro¬ 
jects overseen by new University Print¬ 
er John Gambell. An accomplished 
designer and senior critic at the School 
of Art, John became university printer 
last August, continuing a long Yale 
tradition in graphic design and typog¬ 
raphy. He has provided valuable coun¬ 
sel as the School of Medicine refocuses 
its publications. Stay tuned for 
future developments. 
Michael Fitzsousa 
How to reach us 
Yale Medicine welcomes news and commentary. 
Please send letters to the editor and news items to 
Yale Medicine, P.O. Box 7612, New Haven, CT 06519-0612, 
or via electronic mail to ymm@yale.edu, and include 
a daytime telephone number. Submissions may be 
edited for length, style and content. 
1999-2000 
Association of Yale 
Alumni in Medicine 
Officers 
Gilbert F. Hogan, M.D. ’57 
President 
Frank R. Coughlin Jr., M.D. ’52 
Vice President 
Peter N. Herbert, M.D. ’67 
Secretary 
Nicholas M. Passarelli, M.D. ’59 
Past President 
Executive Committee 
Susan J. Baserga, M.D. ’88, Ph.D. ’88 
Arthur C. Crovatto, M.D. ’54 
Mary V. Digangi, M.D. ’64 
John W. Foster Jr., M.D. ’71 
Robert J. Kerin, M.D. ’47 
Francis M. Lobo, M.D. ’92 
Jocelyn S. Malkin, M.D. ’51 
Dwight F. Miller, M.D. ’56 
Romeo A. Vidone, M.D. ’57 
Christine A. Walsh, M.D. ’73 
Ex-officio 
David A. Kessler, M.D. 
Dean 
Donald L. Kent, M.D. ’72 
Chair, YSM Alumni Fund 
Samuel D. Kushlan, M.D. ’35 
YSM Bequest and Endowment Officer 
Representatives to the 
Association of Yale Alumni 
Daniel L. Arons, M.D. ’67 
Joseph F.J. Curi, M.D. ’64 
M. Felix Freshwater, M.D. ’72 
Benjamin E. Lyons, M.D. ’38 
Donald E. Moore, M.D., M.P.H. ’81 
Valerie E. Stone, M.D., M.P.H. 84 
AYAM Representative, 
Medical School Council 
Peter N. Herbert, M.D. 67 
YALE MEDICINE 3 
SCOPE 
Satcher’s message of prevention 
In visit to Yale, surgeon general cites public health challenges 
Human behavior, according to 
Surgeon General David Satcher, M.D., 
Ph.D., is the most important factor 
in the public health challenges facing 
the nation. In conversations with 
students and in a speech to library 
associates this spring, Satcher said 
that smoking, poor nutrition and 
physical inactivity are responsible for 
hundreds ot thousands of deaths each 
year. Hall ol all deaths derive Irom 
Surgeon General David Satcher warned that 
smoking, diet and physical inactivity contribute 
to hundreds of thousands of deaths each year. 
nine behaviors, he said in his keynote 
address, “Toward a Balanced Com¬ 
munity Health System: Opportunities 
and Challenges,” delivered March 24 
at the 51st annual meeting of the 
Associates ol the Cushing/Whitney 
Medical Library. And medicine ex¬ 
pends a disproportionate amount of 
its resources on treatment oflate-stage 
disease rather than health promotion 
and disease prevention, he said. 
Treatment, he pointed out, fails to 
reach all social groups and classes 
equally. “We have the most sophisticat¬ 
ed health care system in the world,” 
he said. “Yet there are tremendous dis¬ 
parities on the basis of race and eth¬ 
nicity. An African-American baby born 
in this country is two times as likely 
to die in the first year ol life as a 
majority baby.” 
Over lunch he took questions from 
medical, public health and nursing 
students who had traveled abroad on 
research fellowships or spent time 
working in inner-city hospitals and 
homeless shelters. What, asked Kebba 
Jobarteh, did Satcher think about con¬ 
troversial AZT trials designed to reduce 
vertical transmission of HIV in the 
Third World? “We were criticized by 
people I respect a lot,” answered 
Satcher, who, as director of the Centers 
lor Disease Control and Prevention, 
endorsed the trials that used placebos in 
a control group. The study found that 
use of AZT could reduce the spread of 
AIDS from pregnant mother to child, 
even il the first dose is administered 
during labor. “That controversial study 
is saving thousands ol lives every day,” 
Satcher said. 
Did he foresee, asked Rachel Lovins, 
any changes in the nation's health insur¬ 
ance system? “There is no way we are 
going to control costs as long as we fo¬ 
cus on treatment of patients after they 
are sick,” he said. “There is not enough 
incentive for health promotion and 
disease prevention.” Satcher expressed 
hope that frustration with the current 
system would pave the way for his 
balanced approach. 
Yale delegation brings high-tech care to remote corner of Peru 
Two Yale plastic surgeons traveled to 
the Peruvian Amazon in March, where 
they performed about 80 operations 
lor people in need of corrective sur¬ 
gery. John A. Persing, M.D., chief of 
the section of plastic surgery, and 
Joseph Shin, M.D., HS ’97, assistant 
professor of plastic surgery, went as 
part of Interplast, an agency that sends 
doctors around the world to do chari¬ 
table work. Their trip to Iquitos, Peru, 
a port on the Amazon accessible only 
by air or water, was sponsored by the 
Ronald McDonald House. Interplast 
was founded in 1965 by Yale alumnus 
Donald R. Laub, M.D. ’60, HS ’63, 
now at Stanford University. 
The surgeons each spent a week in 
Iquitos, part of a team of 16 people 
that included nurses, an obstetrician- 
gynecologist and a pediatrician. Of 
the 80 operations Persing and Shin 
perlormed, most were for cleft lip and 
palates. They also operated on burn 
patients and removed a tumor on the 
nose of a 90-year-old woman. “We 
try to serve the needs of the local pop¬ 
ulation,” said Shin, “although the em¬ 
phasis is on cleft palates and congenital 
malformations.” This was Shin’s sec¬ 
ond trip on behalf of Interplast and 
Persing’s fifth since 1993. 
As part of their program they are fol¬ 
lowing up on their patients’ recoveries 
via information sent by local doctors on 
the Internet. Two Web sites, http:// 
www.wiredMD.com and http:// 
yalesurgery.med.yale.edu, carry the 
information. Part of the doctors’ 
mission is to provide training to local 
physicians, both during their visit 
and afterwards over the Internet. “The 
initial goal,” says Persing, “is to provide 
service for people who would not be 
able to afford care. The secondary goal 
is to magnify our effect by teaching 
local surgeons how to do the work.” 
4 SUMMER 199 
Telemedicine proves its mettle on Mt. Everest 
Jim Williams/Professional Mountain Guides 
In May 1998, a team of Yale physicians trekked to the 
slopes of Mt. Everest to provide medical support for climb¬ 
ers and to conduct research on the body’s response to high 
altitude and thin air. They brought along equipment to re¬ 
cord how fast climbers’ hearts pumped and how well their 
lungs worked in those extreme conditions on the world’s 
highest mountain. 
At the core of the expedition was a system to transmit 
that information from climbers high on the mountain to 
the expedition’s makeshift medical center at the Everest 
Base Camp at 17,500 feet, and then around the globe to 
New Haven. 
This spring, a second Yale team returned to Everest to 
continue the work of that first expedition and quickly 
found an opportunity to prove the value of telemedicine 
in an emergency. On May 14, as physicians on the moun¬ 
tain were beginning their daily videoconference with col¬ 
leagues in New Haven, a climber stumbled into the medical 
tent, wheezing and coughing. The climber had reached 
Everest Camp Four, at 26,000 feet above sea level, before 
turning back with breathing difficulties that worsened even 
as he descended into the fuller air of lower altitudes. 
Tests showed that his blood oxygen was low and that little 
air was moving through the lower part of his lungs. Sus¬ 
pecting either pneumonia or the potentially fatal condition 
known as high-altitude pulmonary edema, his physicians 
Real-time communication between Mt. Everest and New Haven enabled Yale 
physicians on both sides of the connection to consult on emergency cases. When 
a climber returned to the Everest Base Camp with a retinal hemorrhage, images 
from a fundoscopic exam (inset) were transmitted to Yale, where the chair of 
ophthalmology was able to view them and discuss treatment with the 
expedition team. 
used the expedition’s electronic network to consult in real 
time with their colleagues in New Haven. They sent ultra¬ 
sound images of the climber’s lungs, along with digitized 
blood smears and sputum samples, to Yale for further analy¬ 
sis, and the diagnosis of pneumonia was confirmed. The 
clinical data traveled the 15,000 miles in an instant—by satel¬ 
lite from Base Camp to a relay station in Malaysia, then to 
the United States and onto Yale via the Internet. 
After two days of antibiotics, oxygen and an IV to treat 
dehydration, the climber left the medical tent. “He was able 
to walk down to lower altitudes, where he continued to 
improve,” said Richard Satava, M.D., of the Commercial 
Space Center for Medical Informatics and Technology at 
Yale, which was responsible for the expedition. Yale’s partners 
in the expedition were the Explorers Club and Millennium 
Healthcare Solutions Inc. Olympus America was a major 
sponsor of the expedition. Ronald C. Merrell, M.D., former 
chair of surgery, was the driving force behind the school’s 
telemedicine efforts. 
continues on next page 
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Telemedicine continued 
The consultation that spanned an ocean and two conti¬ 
nents proved the viability ot the communications techno¬ 
logy, which is being developed for the National Aeronautics 
and Space Administration. “We are hoping that the success 
of this year will be enough to encourage NASA to put some 
ol these things on the space station and the mission to Mars,” 
Satava said. 
The expedition’s research also expanded knowledge of 
the effects of hypoxia on the cardiovascular system. Previous 
studies concentrated on the pulmonary system, Satava said. 
“We now have specific measurements about how the heart 
and blood vessels adapt to low oxygen,” he said. 
Last year’s lesson was that a telemedicine station in remote 
terrain could transmit to a medical center thousands of miles 
away, said Peter Angood, M.D., program director for the Yale 
Surgical Critical Care program, and a member of the support 
team at Yale. But during that first expedition the technology 
was not always successful. Personal status monitors, designed 
to measure climbers’ temperature, heart rate, breathing and 
location, often failed to transmit the information to Base 
Camp. This year climbers successfully repositioned repeaters, 
the line-of-sight devices that transmit data from the climbers’ 
monitors to Base Camp. Upgraded personal status monitors 
proved better able to transmit data to Base Camp than last 
year. On May 12 three climbers wore them on a trek to Camp 
One at 21,000 feet, while the Yale support team monitored 
them in real time. 
Physicians on the team again opened a clinic at Base 
Camp, where they treated routine high-altitude ailments — 
headaches, insomnia and gastrointestinal disorders —as well 
as medical emergencies such as frostbite and physical injuries. 
The expedition team included a resident in ophthalmology 
who conducted research into the effects ol high altitude on 
sight. “Surprisingly,” said Angood, “there is very little good 
research on what happens to the eyes in high altitude. With 
the pressure changes the contours of the eyeball itself 
change.” On May 18, M. Bruce Shields, M.D., chair of 
ophthalmology and visual science, consulted with the resi¬ 
dent, Jennifer Grin, M.D., on a case of retinal hemorrhage. 
A video fundoscopic exam had revealed the hemorrhaging, 
and Shields also identified venous congestion in the retina. 
In addition to caring for sick and injured climbers, the team’s 
physicians conducted regular tests on a core group of seven 
climbers. Every other day the climbers went through a 90- 
minute exam that measured, among other things, cardiac 
output, oxygen saturation, mental and visual acuity and cog¬ 
nitive lunctions. The tests started before the team members 
left the United States so their physiological measurements at 
sea level could be compared with readings in the mountains. 
The team’s medical devices included a small camera that fits 
under the tongue and reveals how small blood vessels change 
shape and caliber. 
The next step in the project is, Satava said, “up in the air.” 
An expedition to Everest, or another remote site, depends 
on the results of this year’s research and the availability of 
corporate support. “There are other environments that simi¬ 
lar concepts and ideas could be tested out on,” Angood 
said. “It doesn’t have to be Everest.” 
CIRA events focus on the ethics and science of HIV 
An impromptu debate over the case of 
NuShawn Williams, an upstate New 
York man accused of infecting at least 
nine women with HIV, explored the 
legal and public health consequences of 
criminalizing sexual behavior linked to 
deliberate HIV infection. The debate 
took place at “Using Law to Regulate 
Neal Nathanson: 
The greatest threat 
to progress in HIV 
research is compla¬ 
cency bred by recent 
clinical successes. 
HIV infection is still 
devastating devel¬ 
oping countries, par¬ 
ticularly in Africa. 
Behavior: AIDS and the Criminal¬ 
ization of Sex,” a symposium sponsor¬ 
ed by the Law, Policy and Ethics Core 
of the Center for Interdisciplinary Re¬ 
search on AIDS (CIRA). Some states 
already have laws on the books that 
make it a crime to expose others to 
HIV infection through sex or blood 
donations. Williams, already in prison 
on drug charges, pleaded guilty to two 
counts of reckless endangerment for 
exposing women to HIV, and one 
count of statutory rape for his relation¬ 
ship with a 13-year-old. 
Leslie Wolf, J.D., M.P.H., an assis¬ 
tant professor of medicine at the Cent¬ 
er for AIDS Prevention Studies at the 
University of California San Francisco, 
set forth arguments in favor of and 
against criminalization of HIV trans¬ 
mission. She suggested that criminal¬ 
ization of HIV transmission may be 
appropriate, but only if statutes are 
drafted to target a narrow range of 
cases and to minimize negative effects 
on public health efforts. 
In the ensuing debate, Scott Burris, 
J.D., professor of law at Temple Uni¬ 
versity, noted that issues of race and 
poverty were missing from her discus¬ 
sion. “Criminalization of HIV expo¬ 
sure is fine in principle,” Burris said, 
“but impossible in any social setting." 
The following day CIRA, in col¬ 
laboration with the Yale AIDS Pro¬ 
gram, held AIDS Science Day ’99 to 
highlight AIDS research at Yale. Neal 
Nathanson, M.D., director of the 
Office of AIDS Research at the Nat¬ 
ional Institutes of Health, delivered 
the conference’s keynote address, 
“AIDS Research and the Global Epi¬ 
demic.” “Right now in the developing 
world there are 30 million people liv¬ 
EPH inaugurates grand rounds series 
Connecticut’s $3.6 billion share of the 
nationwide tobacco settlement should 
be used to fund public health and anti¬ 
smoking programs, the state’s attorney 
general, Richard Blumenthal, told fac¬ 
ulty and students during a talk April 14 
at the Department of Epidemiology 
and Public Health. “We have an op¬ 
portunity to use this money in a way 
that literally will save lives,” he said, 
noting that some in government would 
rather use the money for politically 
desirable programs such as property tax 
relief or increased public school fund¬ 
ing. “We continue to face this industry 
that will go on marketing to kids and 
we have to figure out how to counter 
it,” Blumenthal added, posing a chal¬ 
lenge to his audience in Winslow Aud¬ 
itorium. “I am inviting you to think 
about this problem.” 
Blumenthal was the final speaker in 
an inaugural series of public health 
grand rounds that began in December 
with a talk on drug policy by Thomas 
Zeltner, the director general of the 
Swiss Federal Office of Public Health. 
Other speakers were Barry S. Levy, 
M.D., M.P.H., former president of the 
American Public Health Association, 
and Frank Ruddle, Ph.D., Sterling 
Professor of Biology. “We want to give 
ing with HIV/AIDS,” Nathanson said, 
“and almost all of them will be dead in 
10 years and they will be replaced by 
60 million people.” Although drug 
therapies may help stem the spread of 
AIDS, a vaccine remains elusive, he 
said. Once candidate vaccines are iden¬ 
tified, he continued, it could take five 
years to evaluate their efficacy. “The 
future of AIDS research depends on 
convincing the world that it is im¬ 
portant to sustain research.” 
Presentation topics included needle 
exchanges, prenatal HIV counseling 
and testing, and drugs users’ social net¬ 
works. Gerald Friedland, M.D., direc¬ 
tor of the Yale AIDS Program, cau¬ 
tioned that more study is needed on 
the pharmacokinetic interactions 
between anti-HIV drugs and drugs 
employed in drug-abuse treatment 
programs. “Methadone may alter the 
pharmacokinetics of antiretroviral 
drugs and, conversely, antiretroviral 
agents may alter the disposition of 
methadone and other opiate substitu¬ 
tion therapies,” Friedland said, adding 
that very little data on these interac¬ 
tions is available, and this is an active 
area of research at Yale. 
our students the opportunity to hear 
from practitioners of public health in 
the community, the state and the 
nation, as well as experts 
from fields related to public 
health,” said Michael H. 
Merson, M.D., dean of pub¬ 
lic health, adding that the 
roster of speakers will reach 
beyond physicians and 
researchers to include govern¬ 
ment officials, such as 
Blumenthal, whose duties 
touch on public health issues. Merson 
said he hopes to have up to five grand 
rounds each academic year. 
YALE MEDICINE 7 
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Non-traditional medicine is complementary, not alternative, 
says alumnus who headed NIH office 
Although he once headed the Office of Alternative Medicine 
at the National Institutes ol Health, Joseph J. Jacobs, M.D. 
’77, HS '80, says he never liked the term. "It conjures up this 
mutually exclusive range ol either/or decisions that patients 
have to make,” he told a crowd of about 60 people in the 
Beaumont Room at the School ol Medicine in April. 
He prefers to look at acupuncture, herbs, macrobiotics, 
massage, biofeedback, t’ai chi and other regimens as comple¬ 
ments, rather than alternatives, to conventional medicine. 
Many patients see in alternative medicine a holistic approach 
they feel is lacking in traditional medicine, he said. “What is 
not so important is whether this group of alternative medi¬ 
cines have any efficacy,” he said, noting that they may offer 
hope to patients. “Patients trust us with their bodies and 
should not be afraid to trust us with their beliefs. We must let 
our patients know we are not only listening to them, but 
hearing them as well.” 
During his talk on alternative medicine in April, part ol the 
Humanities in Medicine lecture series, he described his own 
initiation into the world ol alternate beliefs. Jacobs, a mem¬ 
ber of the St. Regis Mohawk tribe who grew up in Brooklyn, 
spent his early years as a physician on a Navajo reservation in 
New Mexico. Those formative personal and professional 
experiences have made him particularly sensitive to his 
patients’ belief systems, which he says can be as important to 
healing as the latest med¬ 
ical technology. A physi¬ 
cian colleague on an 
Apache reservation once 
described to him how a 
tubercular patient looked 
at his X-ray, then chanted 
and danced before allow¬ 
ing conventional treatment 
to begin. “When immi¬ 
grants come into your clin¬ 
ic, what is their belief 
structure?” asked Jacobs, 
now medical director for 
the Medicaid and correc¬ 
tions systems in the state 
of Vermont. “How is it 
going to influence the way 
we deliver health care?” 
Patients’ belief systems can be as impor¬ 
tant to healing as the latest medical 
technology, says Joseph Jacobs. 
Cancer Center 
chosen for 
breast cancer 
study 
The Yale Cancer Center will partici¬ 
pate in a national trial to determine 
the effectiveness of two drugs in pre¬ 
venting breast cancer. The STAR Trial, 
also known as the Study of Tamoxifen 
and Raloxifene, began this spring and 
will involve 22,000 post-menopausal 
women at increased risk for developing 
breast cancer. The National Surgical 
Adjuvant Breast and Bowel Project 
(NSABBP) is conducting the study. 
Tamoxifen, which has been in use 
for 20 years to treat cancer, also has 
been found effective in preventing 
breast cancer. In a previous trial the 
NSABBP found a 49 percent decrease 
in invasive breast cancer among wo¬ 
men who received tamoxifen therapy. 
The new study will seek to determine 
whether raloxifene is also effective in 
preventing breast cancer and whether 
it results in fewer side effects than 
tamoxifen. Raloxifene was recently ap¬ 
proved by the FDA to prevent osteo¬ 
porosis in postmenopausal women. 
Grant will support 
musculoskeletal 
research 
A biologist who isolates a gene linked 
to the musculoskeletal system, regard¬ 
less of where on campus he or she 
works, will have increased access to 
resources for research, thanks to a 
$1.98 million, five-year grant from 
the National Institute of Arthritis, 
Musculoskeletal and Skin Diseases. 
The grant to the School of Medicine 
will fund the new Yale Core Center 
for Musculoskeletal Diseases. The cen¬ 
ter will encourage research into muscu¬ 
loskeletal disorders such as osteoporosis 
and provide financial and technical 
support, as well as the expertise of its 
members. The center currently has 
25 affiliated researchers, most of them 
at the medical school. 
“There is an appreciation that mus¬ 
culoskeletal disorders, in particular 
osteoporosis, are emerging as a major 
health concern,” said Karl L. Insogna, 
M.D., associate professor of medicine, 
director of the new center. “There 
is a need for a more comprehensive 
approach to understanding the patho¬ 
genesis of these diseases and other 
musculoskeletal disorders.” 
SUMMER 19 9! 
What’s in a yam? Clues to fertility, a student discovers 
White yams, a staple of the diet of the Yoruba people of 
southwestern Nigeria, may play a role in the society’s high 
incidence of fraternal twinning, according to a student’s 
research. “You see families consuming yams three or four 
times a day,” said Obinwanne Ugwonali, M.D. ’99, whose 
thesis on the link between yams and fertility was one of five 
to garner awards this year on Student Research Day (See page 
42). “I think this project will lead us to understanding more 
about the mechanisms of the human reproductive system, 
specifically the reason why we are typically monotocous 
rather than polytocous like other animals,” he said. 
Ugwonali’s adviser, Frederick Naftolin, M.D., professor and 
chair of obstetrics and gynecology, said the research is the 
cornerstone of a group of related studies of yam intake and 
genetic predisposition to multiple births now under way at 
Yale and Harvard and in Nigeria. In addition to the biologi¬ 
cal and anthropological aspects, the study has medical appli¬ 
cations, Naftolin said. “We don’t know why normally mono¬ 
tocous women become polytocous, but multiple pregnancy is 
the most common cause of prematurity, which is the major 
cause of perinatal morbidity and mortality,” he said. 
Ugwonali’s interest in yams and fertility started when he 
worked in Naftolin’s lab the summer before he entered med¬ 
ical school. Naftolin asked him to investigate why humans are 
monotocous, and a Medline search led Ugwonali to informa¬ 
tion about the high rate of twinning in Nigeria. Although 
some Nigerian tribes have rates of fraternal twinning ranging 
from 20 to 30 pairs per thousand births, it peaks among the 
Yoruba at 41.6 per thousand. “I’m from Nigeria and I didn’t 
know this before,” said Ugwonali, who is a member of the 
Ibo tribe. For African-Americans the rate is 15 per thousand, 
and for Caucasians in the United States and the United 
Kingdom it is between 10 and 11 per thousand. Among the 
Yoruba, twins symbolize a duality of blessings and burdens 
that is celebrated in hardwood carvings. 
In 1996 Ugwonali went to Nigeria on a Downs fellowship 
to begin his research. After analyzing age, socioeconomic fac¬ 
tors and other variables, Ugwonali focused on diet. 
Demographic and scientific studies conducted in the early 
1970s pointed to white yams as the culprit in the mystery of 
multiple births in southwestern Nigeria. Ugwonali inter¬ 
viewed people about their eating habits and made his own 
observations. “We suspected environmental factors,” he said. 
“The only factor that ended up being different from the ones 
we controlled was yams.” In laboratories at Yale and in 
Nigeria, he fed rats a diet of yams and saw the average size 
of their litters double from about four to about nine. 
Obinwanne Ugwonali has correlated the high incidence of fraternal twinning 
among the Yoruba people of Nigeria with the consumption of white yams. 
“Our hypothesis is that yams act as anti-estrogens,” he 
said, noting that he hasn’t investigated the precise chemical 
link between yams and fertility and has yet to isolate an anti¬ 
estrogen from yams. Anti-estrogens fool the brain into think¬ 
ing there is insufficient estrogen, causing it to release more of 
a hormone called gonadotrophin and increase the ovulation 
rate, he said. 
Ugwonali, who began his residency in orthopaedics at 
Columbia-Presbyterian Medical Center in New York, plans to 
continue his research in Brazil, where many Yoruba were 
brought as slaves in colonial times. He wants to determine if 
the high incidence of multiple births persists there among the 
Yoruba, who have maintained elements of their language, 
religion, cultural identity and diet, including consumption of 
white yams. 
YALE MEDICINE 
A glimpse inside the brain 
New imaging techniques allow physicians to peer 
inside the brain to measure how mental and emo¬ 
tional stress provoke physical reactions, such as the 
shrinking of the hippocampus in response to trau¬ 
ma or changing levels of chemical messengers dur¬ 
ing depression or panic. A symposium in March, 
Honors in anatomy 
“Neuroscience i999: Breakthroughs in Brain 
Imaging of Neuropsychiatric Disorders,"offered 
a glimpse of promising new methodologies. 
This was the third annual symposium sponsored 
by the Connecticut Mental Health Center, the 
Department of Mental Health and Addiction 
Services of the State of Connecticut, the 
Department of Psychiatry and the National 
Alliance for the Mentally III. Above, associate 
professor Robert Malison found that cocaine 
addiction increases the density of binding 
sites for cocaine in the brain, and that the 
density persists even after patients stop using 
cocaine. This SPECT image shows cocaine 
binding sites in a healthy human brain. 
SUMMER 
More than 60 students from New Haven's Career High School received 
diplomas in May for their successful participation in anatomy and biol¬ 
ogy programs at the medical school. Milca Sanchez, a junior, received 
her diploma from Forrester A. Lee, M.D., associate dean for multicultur¬ 
al affairs. Standing with them (from right) were Career High School 
science teacher Shirley Neighbors, William B. Stewart, Ph.D., associate 
professor of anatomy and coordinator of the program at Yale, and 
Charles Williams, the principal of Career High School. 
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SCOPE FINDINGS 
Yale researchers find ways to ward off delirium in hospitalized 
patients and eliminate home hazards for the elderly 
In separate studies, Yale 
geriatricians have found two 
ways to help the elderly 
maintain their physical and 
cognitive function. One 
study surveyed the homes of 
elderly people for physical 
hazards that can be easily 
eliminated. The other de¬ 
monstrated the efficacy of 
a program to prevent del¬ 
irium in elderly hospital¬ 
ized patients. 
Thomas M. Gill, M.D., 
associate professor of medi¬ 
cine, conducted the study 
on home hazards such as 
poor lighting, exposed elec¬ 
trical cords, throw rugs and 
insufficient bathroom grab 
rails or stairway banisters. 
Gill believes the potential 
for disabling accidents can 
be decreased by assessing 
potential hazards in the 
home and correcting them. 
The delirium study ex¬ 
amined the effects of the 
Elder Life Program, design¬ 
ed to ward off delirium 
among elderly hospitalized 
patients through a mix 
that includes conversation, 
exercise and memory aids. 
The program has been 
found to reduce symptoms 
by 40 percent, according 
to a study published in 
the March 4 issue of the 
New England Journal 
ofMedicine. 
The study, according to 
leader Sharon Inouye, 
M.D., M.P.H. ’89, assoc¬ 
iate professor of medicine, 
compared an intervention 
group with a control group, 
which had a higher rate of 
delirium. The Elder Life 
Program is the first major 
clinical program designed 
to prevent rather than treat 
delirium. It focuses on six 
risk factors for delirium — 
vision loss, hearing impair¬ 
ment, dehydration, sleep 
deprivation, cognitive im¬ 
pairment and immobility 
from prolonged bed rest. 
Trained volunteers took 
patients for walks three 
times a day, talked about 
current events and offered 
warm milk rather than 
sedatives to induce sleep at 
night. A bedside bulletin 
board lists names of doctors 
and nurses, as well as a 
schedule of daily tests 
and activities. 
Patients served by the Elder Life Program were 
much less likely to become disoriented during the 
course of their hospital stay. 
Estrogen treatment increases 
brain activity in mature adults 
Magnetic stimulation offers relief 
to schizophrenia patients 
In a study of 46 post¬ 
menopausal women, Yale 
researchers found that estro¬ 
gen therapy stimulated 
activity in areas of the brain 
that deal with the type of 
short-term memory used in 
common, everyday tasks. “It 
is significant that there was 
a change,” said Sally E. 
Shaywitz, M.D., leader of 
the study and professor of 
pediatrics and in the Child 
Study Center. “It shows 
that there is flexibility in 
the neural circuitry in 
mature adults.” The study, 
she said, suggests that estro¬ 
gen affects brain organiza¬ 
tion for memory in post¬ 
menopausal women. The 
findings were published in 
the Journal of the American 
Medical Association in April. 
Pulsing a magnetic field 
into the brain can tem¬ 
porarily reduce or stop the 
imaginary voices heard by 
schizophrenic patients, Yale 
researchers reported at the 
May meeting of the 
American Psychiatric 
Association in Washington. 
The investigational treat¬ 
ment, transcranial magnetic 
stimulation (TMS), 
involves placing an electro¬ 
magnetic coil on the scalp, 
then turning current on 
and off to create a pulsing 
magnetic field which is 
directed at the temporo¬ 
parietal cortex. This brain 
region plays a critical role 
in processing speech. Half 
Functional magnetic resonance imaging shows the effect of estrogen on 
the memory’s ability to retrieve stored information. The regions numbered 
2 through 5 indicate increased activity associated with estrogen. 
oi the study’s 12 participants 
reported clinically signifi¬ 
cant reductions in their hal¬ 
lucinations following TMS. 
These improvements were 
sustained for periods rang¬ 
ing from several days to six 
weeks. The study is continu¬ 
ing with an additional 20 
patients, said Ralph 
Hoffman, M.D., deputy 
medical director of the Yale 
Psychiatric Institute, who 
led the study. “Patients will 
get a more extended course 
of TMS. Starting this sum¬ 
mer we are going to be 
doing our own neuroimag¬ 
ing studies to better under¬ 
stand what TMS is doing in 
the brain,” Hoffman said. 
YALE MEDICINE II 
TRADITIONS 
In 1949, Yales fourth-year medical students set the stage for institutionalized irreverence 
with the Four Years for What Follies, a collection of questionable skits, songs and dance 
numbers. Haifa century later, students are still poking fun at their professors and peers. 
BY JOHN CURTIS / PHOTOGRAPHS BY PETER CASOLINO 
Imagine Deputy Dean for Education Robert H. Gifford, 
M.D., HS ’67, (the real one) and dozens of his clones (sec¬ 
ond-year students in white coats and wigs) prancing around 
the stage in Harkness Auditorium and singing to the tune of 
the 1970s musical Fame: 
Remember my name, 
FAME. 
I’ll be the dean forever, 
Students will learn how to rhyme. 
People at Yale Med will treasure 
The Gijffor a very long time. 
That bit of surreal fantasy was the seed from which sprang 
Live and Let Diagnose, a James Bond-style spoof performed in 
February by the second-year Class of 2001. Gifford’s twice- 
delayed retirement, which has become a running gag over the 
last two years, was a recurrent theme throughout the show, as 
was this second-year class’s apparent reluctance to attend basic 
science lectures. Add song, dance, a ridiculous story line and 
large doses of irreverence and you have the latest installment 
in a stage tradition that has endured for 50 years. 
The plot revolved around the scheme of an evil professor 
(Greta Galore) to remain head of her curriculum subcommit¬ 
tee. By cloning and controlling Dean Gifford, she plans to 
orchestrate her reappointment. Meanwhile, the diabolical Dr. 
No, a deadly lecturer in child psychology, has spiked the stu¬ 
dents’ food with Y-agra, a drug that compels them to attend 
class. To the rescue come James Bond and Ana Phylaxis, stu¬ 
dents in the M.D./Ph.D. program, which is universally 
regarded as a home for the “socially challenged” but is really a 
school for spies. Like its predecessors, the show poked fun at 
a variety of targets, including, but not limited to: deans of all 
ranks, faculty members with unintelligible accents, anatomy 
professors, the ignorance of first-year students and the arro¬ 
gance of the third-year class. 
After polling alumni and faculty in a highly unscientific 
survey, Yale Medicine has concluded that The Show is a tradi¬ 
tion that dates to at least 1949, when the graduating class got 
the ball rolling with the Four Years for What Follies. The show 
remained a staple of the fourth year for the next two decades 
before evolving into a second-year tradition. Fifty years later, 
this exercise in sanctioned irreverence has become a fixture of 
student life almost as hallowed as the student thesis require¬ 
ment — despite major lapses in taste, the occasional resent¬ 
ment of faculty and one dean’s threat to ban the show. 
From its Origins 50 years ago as the fourth-year follies to this year’s James Bond- 
inspired spoof the student show has found humor in the Yale System of medical 
education and paid special homage to the most admired faculty members. 
(Right) Jeffrey Miller donned a wig and sang "I’ll be the dean forever” in his 
portrayal of the ever-retiring Robert Gifford. 
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THE SHOW 1 o 1 
To appreciate the show, there are things you must know. 
First, although a familiarity with medical terms is handy, it 
is not as essential as an intimate knowledge of the medical 
school personalities being lampooned. Keeping up with gos¬ 
sip also helps, as shows tend to draw their plots from current 
events and intrigues. It’s good to have seen last year’s show, 
since it will be the butt of at least a few snide cracks. 
It’s also best to see the show on a Saturday night. Absent at 
Friday night’s performance are the hooting, cheering, catcalls 
and the inevitable attempt by first-year students to sabotage 
the production. The audience response —first- and third-years 
don’t take their skewerings lightly —is as much a part of the 
show as whatever nonsense is happening on stage. 
The show also has its drawbacks — sophomoric humor, 
incomprehensible inside jokes and uneven singing, acting and 
dancing. And, at times, it seems the performance will go on 
forever, or until midnight, which is nearly as bad. What is 
it about this variety show that has made it last? What makes 
students drop other activities to write scripts and rehearse 
songs and dance numbers as early as October of the 
second year? 
“It has a wonderful social function,” said Gifford. “Years 
later, as the students look back on medical school, they have 
John Curtis is a staff writer for Yale Medicine. Peter 
Casolino is a photographer in New Haven. 
long since forgotten what they learned in anatomy, but they 
will not forget a single line of the lyrics they sang in the 
second-year show. It brings the class, usually, very close 
together. It is a revelation to the students the amount of 
talent that exists in a group of ioo people.” 
The producers of Live and Let Diagnose were similarly 
effusive in praise of their cast and crew. “Our choreographers 
have danced for years, our music directors studied music and 
our writers were born funny,” said Jennifer Wang, who co¬ 
produced the 1999 show with classmate Jordan Prutkin. 
Professors know better than to schedule important lectures 
the week of the show. “It is pretty all-consuming,” recalled 
Susan J. Baserga, M.D. ’88, Ph.D., now an assistant professor 
of therapeutic radiology and genetics, of her class show. 
Damn Yalies told the story of a medical strident who sold 
his soul to the devil in exchange for a passing grade on 
the boards. 
“If they worked as hard on their studies as they do on the 
show they would all be getting a Nobel Prize,” said Gifford. 
But he adds, “It plays such a valuable role in the socialization 
of medical students, it is probably worth the irritation it pro¬ 
duces in the faculty when students don’t go to class.” 
Brainstorming for this year’s show began in October, when 
students submitted ideas for skits and a team of four writers 
shaped them into a coherent format. By the end of December 
they had a rough draft. Editing and polishing continued, and 
the script was ready for rehearsal by the middle of January. 
A SECOND- [AND FOURTH-] YEAR SAMPLER 
Over the past 50 years, student 
productions have parodied every 
facet of medical school life, from 
the ever-present food vendors on 
Cedar Street to the peccadilloes of 
the financial aid office. Always in 
the crosshairs are faculty members 
and the Yale System. Faculty tar¬ 
gets have included John P. Peters, 
Averill Liebow, Milton Winternitz, 
Howard Levitin and, in recent 
years, Robert afford, Nancy An- 
goff, David Kessler, Angela Holder, 
Arthur Crovatto, Margretta Sea¬ 
shore and Frank Bia. 
i 14 
Always Frank Bia, it seems. 
What did he do? 
In fact, Bia actively encourages 
the students to mock him. "I 
would feel left out if they didn't," 
he said. "I make it very clear to 
medical students that one of 
their major obligations is to 
put on a good show,”And they 
oblige, often with the most 
biting wit. 
Among the highlights of 
past years’shows are the tid¬ 
bits that follow. 
1949 
Four Years for What Follies 
[Fourth Year] 
“How Many Liters, Dr. Peters?” 
made fun of the tendency of 
John P. Peters, M.D„ to speak in a 
very low voice. The show opened 
to an overture,"We’re Doctors 
Out of Yale.” Skits included 
“Continental Bow-Wows” and 
“Super-Duper Rounds.” 
1954 
Not As a Doctor 
[Fourth Year] 
These lyrics, sung by John Cole, 
Jack Gariepy and Ed Ransenhofer 
to music borrowed from Gilbert 
and Sullivan’s The Mikado, lam¬ 
pooned Averill Liebow, M.D., a 
pathologist noted for his de¬ 
mands on students. (CPC stands 
for clinical pathology conference.) 
If you want to know what this is, 
it's a medical CPC 
Where we give the house staff 
the biz, for there’s no one so 
wise as we! 
We pathologists show them how, 
Although it is too late now. 
Our art is a sacred cow! 
And, poking fun at the Yale 
System, to the tune of “Fugue for 
A month later, rehearsals were daily events, starting at about 
5 p.m. and continuing late into the night. 
FROM FORCEPS TO FOLLIES 
Although shows are more elaborate these days, with more 
songs and dance numbers —and a new wrinkle, scenes on 
video —the basic formula harks back to what appears to have 
been the first show in modern memory, 1949 ’s Four Years for 
What Follies (A Tragedy in Four Years). That collection of skits 
lampooned faculty targets such as John Paul, M.D., who was 
portrayed singing “I Am the Very Model of a Modern Epi¬ 
demiologist’' to music from Gilbert and Sullivan’s H.M.S. 
Pinafore. Metabolism pioneer John P. Peters, M.D., was tar¬ 
geted for his tendency to conduct his rounds in such a low 
voice that students circled around him and leaned in to cap¬ 
ture the great man’s every word. A skit had a gaggle of white- 
coated students moving around Peters as a single body. One 
of the songs asked, “How many liters, Dr. Peters?” 
The man behind that show was William G. Anlyan, M.D. 
’49, who wrote the script, provided piano accompaniment 
and directed the show on his way to becoming chancellor 
of Duke University Medical Center 15 years later. At Yale, 
Anlyan had led a vocal quartet called The Forceps, featuring 
singers Bi, Tri, Quadri and Contra. He decided to expand on 
the singing group and stage a class show. “It was great fun. 
It’s the thing that everyone remembers most,” he said. 
Classmate William D. Bevis, M.D. ’49, said the cast included 
Preparations for the show include 
planning sessions, script meetings 
and a lot of rehearsal time. Michael 
Sherling, one of the show's musical 
directors, rehearses a song with 
Jennifer Wang and Caroline Harada 
(above right); Sherling sets up his 
keyboard during a sound check 
(right). The practice pays off 
at showtime (above) as Jeanne 
Triant and Jeff Miller join in a 
swing dance number in the 
show's final performance. 
Tinhorns” from Guys and Dolls; 
You needn’t take exams. 
You never have to cram. 
About the boards, you see, 
we don’t give a damn. 
You fail— 
The tale 
Will stay quiet here at Yale. 
The Class of 1954 also made 
fun of Dr. Peters’ speaking man¬ 
ner to the tune of the chorus of 
“Oh, Susanna.” 
J.P. Peters, 
We greeted him with cheers. 
But he whispered sweet 
nothings in 
Our eager, upturned ears. 
Crovatto appeared in his class 
show not as a doctor, but as a 
nurse. Student shows have 
made him a regular target, most 
recently in 1998’s The Rx Files. 
1959 
Title unfit for publication 
[Fourth Year] 
The Class of 1959 struggled to find 
lyrics from their fourth-year show, 
featuring Nicholas Passarelli and 
John Marsh, that might be suitable 
for publication. “Failing at the 
task,” Marc Schwartz wrote in a 
memo (below) to Yale Medicine, 
“and unwilling to risk disqualifying 
the medical; school from any grants 
it might receive from funding 
organizations overseen by 
Congress, we regretfully decline 
your invitation." 
1964 
The Senior Show 
[Fourth Year] 
Set to the music of Carl Orff’s 
“Carmina Burana,” these lyrics 
poked fun at Paul Beeson, then 
the chairman of medicine, who 
was rumored never to use his 
first name. 
Attila was not called Mr. Hun. 
I don't think that was done 
In the year 45,3. 
So, fellows when you call me 
Just take a chance and 
Paul me. 
I’ll make it worth your while. 
Faculty and administrators, long the 
fodder for student wit, began par¬ 
ticipating in the show a decade ago 
when Leon Rosenberg was dean. 
(Clockwise from top) This year, Jose 
Miranda, disguised as Dean David 
Kessler, a.k.a. Special K, leapt onto a 
table in a scene depicting a meeting 
of students in the M.D./Ph.D. 
Program; Karlee Gifford joined her 
husband onstage, much to his sur¬ 
prise, as he promised that this year 
he really would retire; Kessler 
danced with Associate Dean Ruth 
Katz as they portrayed the hand¬ 
some prince and Cinderella in a 
dance version of the fairy tale. 
nursing students. “The student nurses were just as inspired as 
the medical students,’’ he recalled. “They sang and they wrote 
lyrics for the songs.” 
Although the tradition would last half a century, its earlv 
years were rocky. In the 1950s, then-Dean Vernon W. 
Lippard, M.D., threatened to ban the shows altogether unless 
students cleaned up their act. One production featured stu¬ 
dents with water bottles inside their costumes pretending to 
urinate onstage. “The shows got more and more obscene,” 
said Arthur Ebbert, M.D., professor emeritus of medicine 
and former deputy dean. Even the manner of collecting 
money was in questionable taste. “They didn’t sell tickets, but 
at intermission they would collect money by passing a bed- 
pan around and you dropped your dollar in the bedpan.” 
The show survived the dean’s warning, but interest waned 
and some classes chose not to do a show. When the Class of 
1959 presented its own bawdy offering, it was the first in a 
few years. The 1959 production, which told the tale of an 
astronaut who is mistaken for a patient, roasted faculty, par¬ 
ticularly in the departments of pediatrics and obstetrics and 
gynecology. “There were a lot of references to the posterior 
fornix,” recalled John Poglinco, M.D. ’59. 
By the mid-1960s, a similar revue that celebrated the end 
of a second-year pathology course began to eclipse the fourth- 
year show as the main student production. “What happen¬ 
ed,” recalled Thomas Lentz, M.D. ’64, now a professor of cell 
biology and assistant dean of admissions, “was the fourth-year 
show died out. Students didn’t want to get involved. They 
1969 1972 
Cuaiac Positive 
[Second Year] 
The Class of 1972 also poked fun at 
the Yale System with this song to 
the tune of “There Is Nothing Like a 
Dame,”from South Pacific. 
When we first considered Yale, 
We were anxious all to come. 
They had something new to offer 
Called the New Curriculum. 
It was novel and heroic 
To put Yale back on the map. 
But what did we get? 
The same old CRAPlI! 
We have tennis matches Monday. 
We spend Tuesday at the track. 
We have mixers with the nurses 
And we wind up in the rack. 
Every Thursday on the 
golf course, 
Every Friday at the pub— 
That's why it‘s called 
The Country Club!!! 
1978 
Waiting for Fallot 
[Second Year] 
In 16 skits, the Class of 1980 target¬ 
ed classmates whose parents were 
on the faculty, student recruiting 
practices and the "new” curricu¬ 
lum. The title refers to tetralogy of 
Fallot, a common form of congeni¬ 
tal heart disease. 
1989 
Minimally Competent 
[Second Year] 
The Class of 1991 mocked the facul¬ 
ty in "Yalehouse Rock,” to the tune 
Of the Elvis Presley standard: 
Bill Stewart was bangin’on the 
ol’leg bone. 
Ed Cretin's blowin'on 
his microphone. 
Anatomy is dancin’— 
Barber says it don’t matter. 
If you can't find a partner, 
use a cadaver. 
Let’s rock. Everybody, let's rock. 
Everybody in the whole 
Cedar block 
Was dancin'to the 
Yalehouse Rock. 
To the tune of The Who’s 
“Pinball Wizard”: 
Ever since I was in med school, 
afraid to be on call, 
Examining the organs, 
I really had a ball. 
Eyeing all the patients, 
I'd wait for them to fall. 
That young path professor 
sure seems to know it all. 
He’s a path lab wizard, 
Naming that disease, 
He’s a path lab wizard, 
He does it with such ease. 
How do you think he does it? 
I don’t know. 
What makes him so cool? 
How to Succeed in Medicine 
Without Really Trying 
[Second Year] 
This class stressed scholarly pur¬ 
suits and their second-year show 
included a scene of runners 
sprinting to overcome the hurdle 
of the medical boards. 
were applying for residencies and finishing their theses." 
A number of factors coincided in the late 1960s to drop 
the curtain on the fourth-year show. During the clinical years 
classes dispersed as students who had once traveled no farther 
than Yale-New Haven Hospital began rotations throughout 
the state. The social ferment of the times —the Vietnam War 
and the Civil Rights movement —led students away from the 
frivolity of a show. It also led them to reject authority, at 
times with unpleasant consequences. Once-good-humored 
jibes became personal and vicious. “The faculty stopped 
going,” Lentz said. “First they stopped taking their spouses, 
then they stopped going themselves." Members of the Class 
of 1974 fought among themselves over nasty attacks that 
found their way into Proctalgia Fugax (loosely translated as 
Pain-in-the-Butt), a collection of sketches set to an operetta 
and centered on a clinical pathology conference. “The things 
that were in bad taste or caustic we didn’t want to put in,” 
said Richard A. Cazen, M.D. ’74, director of that second-year 
show and now a gastroenterologist in San Francisco. 
Over the years the bitterness subsided, and in 1983 the 
graduating class demonstrated their school spirit by resusci¬ 
tating two lost traditions, the yearbook and the abandoned 
fourth-year show. The class’s 1983 production. Still Crazy 
After All These Years, had alumni reminiscing about medical 
school, with each recollection segueing into a skit, said Peter 
Blier, M.D. ’83, Ph.D. ’87, a pediatrician and rheumatologist 
in Springfield, Mass. One skit had the cast singing “Rounds, 
rounds, go to rounds, I go to rounds,” to the tune of the 
Beach Boys’ “I Get Around.” 
But the second-year show, which had weathered the stormy 
’60s and 70s, would ultimately prevail. It began to resemble 
a Broadway production, say faculty, and, as classes achieved a 
balance of men and women, it lost much of its vulgarity. 
Faculty and alumni, however, lament the loss of the fourth- 
year show. Clinical professors, with whom students spend 
their last two years, are now spared the withering ridicule 
accorded their colleagues in the basic sciences. “When you 
work in the wards with faculty, you learn a lot about their 
personalities and peccadilloes,” said Sherwin B. Nuland, 
M.D. ’55, HS ’61, who played a leading role in his class show 
as a hapless patient. “There’s nothing like being in an operat¬ 
ing room with a professor of surgery at three in the morning 
when crucial decisions are being made.” To say that the show 
is irreverent, said Nuland, “is like saying the flag is red, white 
and blue.” But that very irreverence is a sign of affection and 
comfort, he added. “When you’re comfortable with the facul¬ 
ty you feel free to lampoon them,” he said. His show had a 
patient going from service to service at the medical school 
and finding himself in worse shape after each visit. At show’s 
end he is struck by a car. The diagnosis? “The patient’s a little 
run down,” Nuland said. 
To be lampooned in the show is the highest honor. “We’re 
told that faculty come to the show because they know they’re 
going to be made fun of,” said 1999 co-producer Wang. “The 
ones with the accents, the ones who are heads of certain 
courses, the ones that are very much characters always end up 
To the tune of 
"The Lion Sleeps Tonight": 
In the rectum, the Itchy rectum, 
The pinworm crawls tonight. 
In the bedsheets, the 
fertile bedsheets, 
The pinworm breeds tonight, 
CHORUS: Itchy anus, itchy anus, 
itchy anus, itchy anus. 
Drop your skivvies, here comes 
the Scotch tape, 
We'll diagnose it right. 
Watch out pinworm,you 
vile pinworm, 
Frank Bio’s on his way. 
CHORUS: He's on his way. He’s 
on his way. He's on his way. 
He’s on his way. 
1998 
The Rx Files [Second Year] 
The Class of 2000 borrowed the 
music from "Don’t Worry, Be 
Happy” to lampoon the food 
vendors on Cedar Street. 
Bean curd make your 
mouth a-water? 
You get two pieces for a quarter. 
No Creasy, No Oily. 
The Yaki Soba on my right, 
Eat it,you get a parasite. 
No Creasy, No Oily. 
They also mocked Dean Kessler, 
newly arrived at Yale after seven 
years as head of the Food and Drug 
Administration.They sang "FDA 
Dropout” to the tune of “Beauty 
School Dropout” from Crease, 
Your story’s too long to tell, 
a premed done too well. 
You took on the delinquents in D.C. 
Your future’s very clear now, 
you’ve got a med career now. 
We’re gonna help you make the 
world smoke-free. 
Kessler took it in good 
humor and even appeared 
in the show, imitating Irish 
preener Michael Flatley in 
a number titled “Deans of 
the Dance.” 
—John Curtis 
THANKS FOR 
THE MEMORIES | 
If you have photographs, pro¬ 
grams, posters, lyrics, recordings 
or other memorabilia from past 
shows, please consider adding 
them to the collection of the 
Cushing/Whitney Medical 
Library. Materials that are sub- 
I mitted will be digitized and 
posted on our Web site 
(http://info.med.yale.edu/ymm) 
with this article. Send your sub¬ 
missions to: 
John Curtis, Staff Writer 
Yale Medicine 
Yale University 
School of Medicine 
P.O. Box 7612 
New Haven, CT 06519-0612 

in it.” One scene in the 1999 show paired associate deans 
Ruth Katz, J.D., M.P.H., and Nancy Angoff, M.P.H. ’81, 
M.D. ’90, HS ’90-93, (who accommodated the second-year 
class by playing themselves) in a sweetly sung duet to the 
tune of Paul McCartney and Stevie Wonder’s “Ebony and 
Ivory.” The two deans turned in a respectable performance of 
“Empathy, Not Rivalry” and made fun of themselves in the 
process: “She’s uptight and 1 am touchy-feely,” sang Angoff. 
To which Katz replied: “I balance the budget while she runs 
group therapy.” The audience loved it. 
PROFESSORS, PRANKS AND PARTING SHOTS 
According to Gifford, faculty participation started in the early 
1990s when faculty members pulled a prank on the students. 
Then-Dean Leon E. Rosenberg, M.D., HS 63, Gifford and 
others jumped up from their seats in the audience, feigned 
anger at being ridiculed and began singing their outrage to 
the tune of the Beatles’ “Let It Be” with lyrics written by 
Alvan Feinstein, M.D., HS ’54. “We each had a verse, then 
we all sang the chorus,” Gifford recalled. “It brought the 
house down.” It was faculty’s first and only appearance in the 
show until Gifford and then-Dean Gerard Burrow, M.D. ’58, 
made another appearance a few years later as a pair of gam¬ 
blers taking their chances at Foxwoods Casino in hopes of 
erasing the school’s deficit. Students also began offering roles 
for sale in the annual Hunger and Homelessness Auction, and 
faculty bid for the privilege of appearing in the show. 
This year Dean David A. Kessler, M.D., joined Katz, 
Angoff and Gifford in the cast. On the night of their rehears¬ 
al the deans bought pizzas for the cast and joined them for 
dinner. Then, Jennifer Lucero directed a dance number 
involving all four deans. Gifford recited a spoonerized version 
of Cinderella while Katz danced the title role. Angoff was the 
fairy godmother and Kessler played the “prandsome hi nee.” 
“I can’t believe I paid $300 for this,” said Katz, who shared 
the bid with Angoff at the homelessness auction last 
November. Students Tara Lagu and Aaron Covey pranced 
around the stage as the “sticked wepsisters.” 
Rehearsals intensified, becoming longer and more frequent 
as opening night approached. On Saturday night, the show’s 
final performance, producers were on the lookout for the 
first-year prank, a traditional effort to sabotage the show. This 
year, however, a prank came from an unusual source —the 
third-year class. During the first act a hissing sound emanated 
from the audience, then a balloon carrying a banner that read 
“Diagnose This” wafted up to the ceiling. 
Mike Fehm and Hany Bedair, in full costume, rehearse before the Saturday night 
show. (Inset) To the tune of the Village People song YMCA, the Class of 2001 put 
Lynne Wootton’s annual profile of the incoming class to music and dance. 
Portraying new students were, from left to right, Aaron Covey, Dan Hoit, Seth 
Coldbarg, Jeanne Triant and Jessica Mega. 
The second-year performers also played a trick on Gilford. 
The script called for him to announce that, unlike past years 
when the administration had asked him to delay his retire¬ 
ment in order to take on one more task, he was really leaving 
at the end of the academic year. On Saturday night his wife, 
Karlee, emerged from the wings, and asked, “Do you prom¬ 
ise?” Her unexpected appearance startled Gifford, and in the 
next scene he flubbed his lines, turned away from the audi¬ 
ence, and started over. 
The show ended with the entire Class of 2001 joining in a 
medley of songs — among them, one to the tune of the 
Sinatra classic “New York, New York.” 
Start washing your hands and wearing your gloves, 
Learn how to use that stethoscope and draw 
some blood. 
With clinical pearls that we learned in school. 
Now we can find the optic disk and cidture stool. 
I got accepted here, but ojfthe wait list, dear, 
My heart’s with you, Yale Med, Yale Med. 
With the medical boards offered on a flexible schedule at 
designated computer sites this summer, the second-year show 
represents the class’s last shared effort before students move 
on to clinical studies and two years of rotating clerkships. “It 
takes on more importance as the last class activity,” Prutkin 
said. “This is the last time that we are all working together, 
all doing something together.” 
“It’s nice to have an activity that is fun and that people 
can bond over,” said Wang. “It’s good to see your classmates 
when they’re not under tension, when they’re having fun.” VM 
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PROFILE 
Most neurosurgical 
residents are happy just 
to learn their craft, help 
humanity and survive 
seven years of very long 
days. Zimbabwe’s Nozipo 
Maraire has other things 
on her mind as well. 
m muc mug in usiemuer. me neurosurgeon ana me opnmaimoiogis 
have searched for three hours without finding the tumor on the 
15-month-old boy’s optic nerve, a giioma that has already blinded 
the toddler in one eye and threatens his sight in the other. Because 
it is the same pearl white as the surrounding tissue and lies hidden 
somewhere behind the eye, it is hard to find. Reluctantly, the two 
doctors decide they must drill farther into the boy’s frontal bones 
Nozipo Maraire has been watching this from the sidelines. As the 
chief resident neurosurgeon, she had begun by assisting with the 
procedure but ceded her place at the operating table when the oph 
thalmoiogist was called in to help. For the last three hours, Maraire 
has watched the surgery on a video screen linked to the operating 
microscope. Now she asks to take another quick look for herself. Sh< 
steps onto the stool, peers into the microscope—and this time find 
the tumor. She guides the stainless steel instruments with 
to free it from the nerve. After two hours of painstaking v 
Maraire lifts out a glioma the : 
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For J. Nozipo Maraire, M.D., HS ’92-99, the operating 
room is a world apart, a place where little else intrudes as 
surgeons, nurses and technicians focus on the delicate work 
of opening the skull and fixing what’s wrong inside. “There’s 
a closeness you share with people here. It’s almost a kind of 
clandestine fraternity,” she says, wearing a blue surgical cap, 
her smooth black hair pulled back above a high forehead. 
Part of the culture is the balance between the seriousness of 
the situation—how macabre it really is — and yet you’re able 
to talk about the baby you just had, your lives, your friends. 
Time is suspended.” 
Amid the repartee of the operating room, Maraire concen¬ 
trates almost single-mindedly on the work of her hands. She 
has used this ability to focus outside the OR as well, extend¬ 
ing her influence far beyond hospital walls. In the little free 
time granted a surgical resident, she has written a critically 
acclaimed novel, served on the board of an international 
development agency, pursued her master’s degree in public 
health, and laid the groundwork for a partnership between 
Yale and the medical institutions of her native Zimbabwe. 
When she returns there next year, the 34-year-old Maraire 
will be one of seven neurosurgeons in the southern African 
nation of 11 million people. (Her 77-year-old counterpart at 
Pariranyetwa Hospital in the capital city of Harare is “count¬ 
ing the days until I get there,” Maraire says.) She will be only 
the second woman to have completed neurosurgical training 
at Yale since its program began in 1925, and she believes 
she will be the first black female neurosurgeon on the 
African continent. 
Maraire was five years old when she told her father she 
wanted to be a neurosurgeon. She had only the vaguest 
notion of what one did, but liked the idea because “it sound¬ 
ed like the most difficult thing I could find to do.” Her 
mother is a pediatrician; her father, now deceased, was a col¬ 
lege professor, banker and tobacco farmer. Nozipo grew up 
in Harare, attended elite private schools, then earned her 
undergraduate degree at Harvard before studying medicine at 
Columbia. Though her choice of career originated as a dare 
to herself, it has proven satisfying to Maraire. She feels drawn 
to the intellectual challenge of working out the puzzle of 
1 
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what afflicts a patient: asking good questions, listening care¬ 
fully, visualizing the neuroanatomy, doing research. She rec¬ 
ognizes that the problems treated by neurosurgeons lie at the 
core of the patient's identity. 
"What is wrong with them, and what are you going to do 
about it? What do they want done? You know you are going 
to do something that affects their body and, worse yet—in 
our case—their brain, which is at the center of how they 
function,” Maraire says with a trace of a British accent. “If 
you affect someone’s memory, it affects their ability to inter¬ 
act with their children, to get around town, to find their way 
home, to remember what they left the house for. You almost 
have a dread when you first meet a patient because you know, 
initially, more than they do about how they will be affected.” 
On a different day, writing notes in the recovery room, she 
glances toward a gurney where a curly-haired man in his 40s 
is stirring back to consciousness. She has just completed sur¬ 
gery to release fluid pressure caused by an inoperable brain 
tumor. She asks the man to squeeze her hand, then continues 
holding it. 
“Surgery’s all done!” Maraire says in a loud voice. “You’re 
doing great. You just have to wake up.” She has to strain to 
keep a grip on his hand because she is very short. (“Say I 
claim to be five feet tall,” she teases jovially when asked her 
height on another occasion.) Watching the man drinking 
orange juice from a paper cup in the recovery room a half- 
hour later, she says, “I didn’t know him yesterday, and when 
he’s finished I may never see him again. It’s just for the 
moment. He trusts me completely. It’s amazing.” 
For her part, Maraire throws herself into the process of 
diagnosing problems and working out a treatment plan. In 
the course of talking through these issues with patients, she 
says she has experienced “an intimacy you don’t encounter 
anywhere else.” She also recognizes, and tries to resist, the 
impulse to shield oneself from the patient’s pain. “There’s a 
vulnerability in really allowing yourself to feel things,” she 
says. “For me it wouldn’t be meaningful without it. It helps 
the quality of what I do. I can only hope it helps the patient.” 
With a few patients, she has had to overcome racial stereo¬ 
types. There was the patient who was on the phone when she 
entered his hospital room to introduce herself as his surgeon. 
The patient told the person on the other end, “Hold on. 
The cleaning lady just came in.” 
Patients do respond to Maraire, and her medical colleagues 
clearly enjoy her company as well. She teases them by using 
exaggerated formality at times. (“Yes, doctor. Yes, sir.”) She 
laughs at their bad puns. She joins in the irreverent banter 
while maintaining her focus as she performs a procedure. 
Operating room nurse Paul Bruch, R.N., has spent years 
Cathy Shufro is a freelance writer in Connecticut and a 
tutor in the Bass Writing Program at Yale. Frank Poole is 
a photographer in New Haven. 
trying to sleuth out Maraire’s first name. (She uses only the 
initial “J.”) Bruch’s technique for venturing new guesses is 
intimately tied to the surgical process itself. At the end of 
each case, as Maraire dresses the patient’s incisions, Bruch 
uses Bacitracin ointment in a fine-tipped tube to write “J” 
names on the gauze he prepares for her. 
“I’ve tried Juanita, Jebedia, Jessica, Jewel, Jacqueline. ... I’ve 
been doing it for seven years,” Bruch says in mock despair. 
Maraire smiles and keeps her own counsel. 
Early evening. Maraire has spent 12 hours in surgery and the tod¬ 
dler’s case is still in progress. She leaves the OR, slips the paper surgi¬ 
cal mask off her face, and walks briskly downstairs to pathology, 
carrying the child's optic tumor in a sterile cup. Pathology will check 
to see that a margin of healthy brain tissue surrounds the glioma, 
showing that the entire tumor has been removed. As Maraire awaits 
the results, she notices stacks of glossy Christmas catalogs in the 
waiting area. She begins constructing a story in her mind. She imag¬ 
ines a play for children, in which a scholarship student in Zimbabwe 
visits the home of a wealthy classmate and recognizes the difference 
between material wealth and a rich family life. Maraire has no paper 
for making notes. She rehearses the ideas in her mind so that she 
will remember enough to record them when she gets home. 
When Maraire’s day as a neurosurgical 
resident ended, often after midnight, she 
turned to her writing. The result was 
Zenzele: A Letter for My Daughter, a 
critically acclaimed first novel that has 
been translated into 13 languages. 
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Ideas for stories often emerge when she is most consumed 
by her work as a doctor. “I’m so full of neurosurgery and it’s 
like a release valve that allows me to escape.” Writing provid¬ 
ed this kind of liberation early in her residency, when she 
wrote Zenzele: A Letter for My Daughter (Crown, 1996; Delta 
paperback edition, 1997). She borrowed the key to an empty 
computer room, and at midnight, or 2 a.m., or whenever her 
day finally ended (and her call began), she wrote for two 
hours. She says her need to write outweighed her need to rest, 
and she often got by on three hours’ sleep. Zenzele, listed in 
the New York Times Book Review as one of the notable books 
of 1996, has been translated into 13 languages. 
The book takes the form of a letter from a wise Zimbab¬ 
wean mother to her daughter at Harvard. The mother uses 
her life story and stories of family and friends to illustrate the 
struggle of Shona people to preserve the strong aspects of 
their culture: respect for elders and a feeling of obligation to 
the community. She warns her daughter Zenzele of the perils 
of severing roots to her culture. In poetic language, the moth¬ 
er tells how the older generation suffered under and resisted 
colonial rule in Rhodesia (the name for Zimbabwe until inde¬ 
pendence from Britain in 1980). 
“Since I’ve written the book,” Maraire says, “I’ve met a lot 
of young Africans who’ve told me it’s the first time they’ve 
read a book in which they recognize themselves, the genera¬ 
tion of children who made the transition from pre-independ¬ 
ence to the struggle for independence and the post-independ¬ 
ence era, and the ensuing cynicism that inevitably followed. 
“We remember apartheid, when we weren't allowed to shop 
in certain stores. ... We’re lost between the traditional African 
culture and the modern culture. We don’t know how to 
incorporate them, and there are no role models. The world is 
so Western, and we want to retain our core identity.” 
Maraire’s second novel, well under way, tells the story of a 
return from the West: a Zimbabwean woman orphaned by 
the brutal assassination of her family escapes to the United 
States. Years later, she goes back to Africa to confront her past 
and the meaning of home. 
The struggle of Maraire’s fictional characters to reconcile 
African and Western values reflects Maraire’s own enduring 
interest in the analogous challenge facing Third World soci¬ 
eties: how to adopt Western ideals and technologies selective¬ 
ly. While an undergraduate at Harvard, Maraire organized a 
campus group to place students with international agencies 
like Oxfam. She took a year off from college to work on 
AIDS education for the World Health Organization in 
Geneva. There she worked closely with the late Jonathan 
Mann, M.D., a visionary advocate for global AIDS policy. 
Now she serves on the board of directors of the Manhattan- 
based nonprofit group South North Development Initiative, 
which finds innovative ways to provide capital to African 
and Latin American businesses considered too risky by 
conventional investors. 
Maraire has retained her connections to home during her 
surgical residency. She found grant money for a fellowship 
that will allow American neurosurgeons to visit Zimbabwe, 
and she is the only African serving on a committee, led by 
missionaries, hoping to establish a second medical school in 
Zimbabwe. When she was invited to speak at the Zimbabwe 
International Book Fair this summer, she used her honorari¬ 
um to establish an award for a young female African writer. 
It’s 10 p.m. when Maraire has completed the optic glioma case and 
“tucked the patient in.”The prognosis for the little boy is excellent: 
the tumor has been removed and biopsied, and it is not malignant. 
His physicians will need to watch him closely, but they don’t expect 
the tumor to recur. Maraire does rounds, checking on eight surgical 
patients on the neurosurgical intensive care unit and then another 
32 on the neurosurgery ward. When she gets home, she writes until 
midnight, recording the ideas that struck her while she waited in 
pathology. Before sleeping, she phones her husband, Allen Chiura, 
M.D., a urologist in Delaware. 
Allen Chiura was a childhood friend whom she met again 
by chance five years ago in Heathrow Airport in London. 
(He was traveling from Zimbabwe to Philadelphia; she from 
Ethiopia to New York.) Maraire had thought she wouldn’t be 
caught dead making the conventional choice by marrying 
someone from her upper-class social circle in Zimbabwe. But 
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she and Chiura found that their common frame of reference 
gave them a deep understanding of each other. She says they 
“shared a time not too many people have shared, living in a 
country going through the transition from colonialism to a 
time of independence. We made sense to each other." She 
saw that broadening her horizons by dating men from differ¬ 
ent cultures had, paradoxically, imposed limitations. She 
compared it to living in a single room of a mansion. “Meet¬ 
ing Allen, it was like the whole house was open. Light 
came in.” 
Marriage to a Zimbabwean will make it easier for Maraire 
to transmit to her children what she most values in the Shona 
worldview: feeling linked to one’s ancestors. “There’s a sense 
that you have the benefit of other spirits. You’re not so alone. 
There’s a sense of some continuum. That continuum is with 
you and maybe — who knows — gives you wisdom 
and insights.” 
Maraire and Chiura have celebrated two weddings. Their 
families gathered in May 1998 in a traditional Shona kuroora. 
The kuroora ceremony joins the extended families of bride 
and groom. This union is symbolized by ritualized gift-giving 
and role-playing in which the groom’s parents, siblings, aunts 
and uncles show appreciation to the bride’s family for raising 
her. Chiura’s family paid Maraire’s family a lobola, or dowry 
— a “hefty” one because Maraire is a well-educated profession¬ 
al. Then in April of this year, they were married in a large 
Roman Catholic wedding in Zimbabwe. The reception, 
attended by 1,600 guests and a writer for Martha Stewart 
Living, was held at the botanical gardens in Harare. 
The wedding also solved the mystery that has plagued 
operating-room nurse Paul Bruch for the last seven years. 
Engraved on the invitation that arrived at his home in 
late winter was Maraire's full name. The “J.” stands 
for Jacqueline. 
At seven the next morning, on a warm day for December, Maraire 
arrives at Union Station in New Haven. Briefcase in hand, she is 
heading to Manhattan for the annual meeting of South North 
Development Initiative. She serves on the agency’s eight-member 
board, which includes bankers, business leaders, an environmental 
activist and a high-level United Nations administrator. Sitting in the 
conference room overlooking Rockefeller Center, they hear a report 
on a plum farm in western Argentina that South North is trying to 
save from bankruptcy. The discussion turns to South North’s social 
rationale for preserving the farm, the largest employer in a small 
town. Maraire raises some philosophical questions, asking whether 
the agency is doing enough to differentiate itself from conventional 
venture capitalists and lenders by emphasizing its mission of 
empowering poor people. 
After the board meeting, Maraire takes a rare evening away to 
meet Chiura and attend a friend’s wedding reception in Philadelphia. 
By midnight she will be back in New Haven and on call. She seems 
almost embarrassed to admit that she will take a few months off 
before beginning a fellowship in New York in June. Not completely 
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Settling in the United States and leaving Zimbabwe behind is “not even an option, "says Maraire, who will return home with husband Allen Chiura after completing a fellowship in Nev. 
off—Maraire will be writing the thesis for her master’s degree in 
public health at Yale. She will develop a system for measuring 
quality of life for patients with cerebrovascular disease. 
Maraire’s next big project would affect lives on a larger 
scale. She hopes to create a foundation that will “galvanize 
civil society” in southern Africa. Her aim is to build cultural 
centers, museums and theaters in the region (Zimbabwe, 
South Africa, Namibia, Botswana, Mozambique, Zambia, 
and Malawi). She sees the foundation as “an instrument to 
improve the quality of life for southern Africans” in the 
broadest terms: providing grants to support innovation in 
medicine, public health, the arts, engineering and scientific 
research. For lack of money to carry out their ideas, southern 
Africans “have become culturally impoverished when we are 
culturally rich.” Maraire has envisioned this project for a long 
time —she wrote her first proposal for a foundation while 
an undergraduate. 
After Maraire completes her fellowship this December with 
pediatric neurosurgeon Fred J. Epstein, M.D., in New York, 
she and Chiura will return home. Many of their patients in 
Zimbabwe will have AIDS. (The United Nations estimates 
that at least one in five Zimbabweans between 15 and 49 is 
living with HIV or AIDS.) The epidemic has devastated peo¬ 
ple of every social class —Maraire says their parents tell her 
and Chiura that they attend as many as three funerals a week. 
She has no choice but to accept the perpetual risk that any 
patient could infect her. “You double glove. You take precau¬ 
tions. What are you going to do? You have to treat people,” 
says Maraire. “It’s not that it’s not scary. It’s scary.” 
Settling permanently in the United States is “not even an 
option,” she says. She feels a strong tie to her home that she 
attributes in part to her parents’ example. They were always 
raising money or collecting clothes for the revolutionary 
forces fighting to overthrow the government of Rhodesian 
Prime Minister Ian Smith. Even when her father’s academic 
appointments took the family abroad to live, Maraire says, 
“it never occurred to my parents that they were not 
going home.” 
The strength of her commitment to return home was 
important to the Yale neurosurgeons who chose her, over 100 
other candidates, for a single slot in the residency program in 
1992. The committee immediately recognized that “if we 
wanted to make a difference in the world, this is the person 
to take on,” recalls Alain de Lotbiniere, M.D., associate pro¬ 
fessor of neurosurgery. “It was obvious that we had to take 
her. She’s an exceptional individual. I don’t expect to train 
anyone else like her in my lifetime.” 
The department’s chair, Dennis Spencer, M.D., HS ’72-76, 
says that, in his experience, surgeons trained at Yale are often 
unwilling to return to places that lack the sophisticated tech¬ 
nology they have come to rely on in the United States. 
Maraire’s challenge will be to adapt neurosurgical techniques 
to use the limited equipment in Zimbabwe. For instance, the 
university hospital in Harare just received its first operating 
microscope as a result of Maraire’s efforts. 
Yale will help her to handle difficult cases by establishing a 
videoconferencing link between New Haven and Harare, 
allowing Maraire and colleagues to confer with Yale physi¬ 
cians even while doing surgery. (A video camera can be aimed 
through the microscope to show detail.) Spencer plans to visit 
Zimbabwe to help train surgeons in advanced techniques and 
to provide any other help Maraire requests. “Her promise 
when we brought her into the program was that she would 
bring her training back to the people of Zimbabwe,” Spencer 
says. “My promise to her was to make that dream happen 
and to continue to be a bridge between the United States 
and Zimbabwe.” 
Spencer says that knowing Maraire has inspired him to 
make more effort to extend his work in epilepsy to develop¬ 
ing countries, teaching medical and surgical approaches that 
do not require expensive equipment. He foresees that Maraire 
will have to choose between two routes: becoming the main¬ 
stay for neurosurgery in Zimbabwe, case by case, “living in 
the hospital,” or taking a broader approach by setting up pro¬ 
grams to improve medicine in Zimbabwe and to train “more 
Nozipos.” He predicts she will choose the latter. 
Maraire agrees. She imagines a life for herself that includes 
time in the operating room, time establishing her foundation, 
time with the children she hopes for. She plans for her future 
by picturing how she wants to live—what she calls “doing the 
visioning thing.” Observing that people often complain about 
their lives without recognizing that they are choosing those 
lives, Maraire recommends that people slow down and think: 
“I want my life to be like this. How can I construct the life I 
want?” This long-established practice of envisioning her goals 
has been confirmed by her experience in practicing medicine, 
in what she calls “this constant encounter with death.” She 
says, “I have a sense that at any time this moment could 
be cut short. I think, as a result, I live more fully. Time is 
so precious.” 
Maraire says her drive and her ability to get things done 
derive from her assumption that she can accomplish whatever 
she chooses to undertake, even when she can claim no special 
expertise in a field. “I don’t feel, ‘I can’t do that. Somebody 
else should do that,’ ” she says. Maraire believes her lack of 
inhibition about tackling projects grows, in part, out of com¬ 
ing from the Third World, where fewer people have the edu¬ 
cation and the connections to get things done. “If you have 
the opportunity to do something, you have to seize it.” 
Although Maraire has reached two of the goals she set in 
her twenties —becoming a surgeon and writing a book—she 
feels frustrated that she hasn’t accomplished more. “The more 
you do, the more you feel needs to be done,” she says. “I feel 
a responsibility because I’ve had so much opportunity. I’ve 
had a privileged life.” ym 
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Nail polish for a young girl. A scrap of paper with a child’s weight and height written on it. An origami bird 
that flapped its wings. A stage production of Cinderella for an audience of 400. 
In the accounts that follow, six Yale medical students, a physician associate and an emergency room physician 
evoke these images as they recount what they saw, heard, did and felt in the four weeks they spent at the 
Senekos refugee camp in Macedonia in April and May. Their stories tell of the seemingly little things that 
offered comfort to emotionally fragile people, as well as the projects they undertook to improve life in 
the camp. Our first day in Senekos refugee camp: a sea of white tents and somber 
J - —     . , ...nA   — ——————— 
The group traveled to Macedonia in late April to work with ethnic Albanians forced from their homes in neigh¬ 
boring Kosovo. The trip was organized by the Dean’s office under the auspices of Doctors of the World, an 
international relief organization. Chosen by lottery from more than 100 volunteers, the students arrived expect¬ 
ing to be put to work at any number of tasks, from digging latrines to handing out blankets to changing band¬ 
ages. “We went with the understanding that we were not going to practice medicine,” said Aaron Covey. “We 
went with the understanding that we would do anything that would be needed to help. 
With most of the refugees’ material and medical needs in the hands of others, the students devised a unique 
role for themselves at Senekos, which grew from an initial population of 800 to more than 6,000 in the month 
they were there. “As a medical student,” said Margaret Bourdeaux, “you’re not constrained by your professional 
role. You have the luxury and the privilege and the time to sit and talk with people and not have a goal, not 
need something from them. I think that was extremely special, yet it is difficult to convey to people how impor¬ 
tant that is.” Everyone here is looking for a lost relative or friend. 
From the very beginning, the group plunged into personal contacts with the people they had come to help. A 
key was the presence in the group of Emine Alijaj, R.N., P.A.-C. ’96, an ethnic Albanian who left Kosovo with 
her family when she was four years old and who now works as a physician associate in the Emergency 
Department at Yale-New Haven Hospital. At a camp called Stenkovac, an hour’s drive from Senekos, she was 
reunited with the cousins she had last seen on a railroad platform 27 years earlier. I was absolutely hysterical, 
crving and crying,” Alijaj said of the reunion. Two days later, her relatives left for a refugee camp in France. The 
students’ visit with the family, early in their stay, influenced their view of their role in the camps. Just being 
part of their lives,” said Sharon Chekijian, “is often enough.” 
The students came to know the inhabitants of Senekos through a tent-to-tent survey of medical needs and a 
similar assessment of the nutritional status of children in the camp. These visits not only helped them establish 
a rapport with the refugees, but brought patients to the camp clinics for treatment. “We identified a lot of 
health problems and health needs that would never have shown up in the clinic had we not been there to refer 
people and encourage them to go there,” Bourdeaux said. A lot of it was like being a small-town doctor. You 
knew where everyone lived, so you could go make house calls.” 
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While Alijaj and Pamela Perry, M.D., had duties in the camp clinic, the students saw to other needs and con¬ 
cerns. Some camp inhabitants had tasks and chores to occupy their days; children under 15 attended school in a 
nearby town and mothers washed clothes, cooked and cleaned their tents. But men and older children often 
had nothing to do except think about what they had lost and wonder what lay ahead. The medical students 
organized soccer and volleyball leagues for 15- to 18-year-olds. “There was a sense of camaraderie within these 
teams,” Covey said. “People enjoyed being a part of it and it was important for this age group.” 
Seth Goldbarg organized a theater production, with children in the camp acting out the story of Cinderella. 
“I thought it would be a really good idea to begin community-building activities to involve a spectrum of peo¬ 
ple,” he said. The play had a therapeutic benefit that reached beyond those actively involved in the production, 
said Chekijian, who added: “If you make the kids happy, it makes the community a whole lot better.” 
Moments of happiness, however, often gave way to memories of war. When Covey gave children crayons and 
paper, they drew pictures that “showed a lot of burning houses, tanks in villages, sometimes dead bodies,” 
he said. The war just across the border in Kosovo became real not only through the children’s drawings, but 
through the stories the medical students heard often in the camp. When a young man recounted how Serbian 
paramilitaries took his family from their home, ordered them to lie down, then shot his father and two broth¬ 
ers, Goldbarg said, “I just thought of my parents and sister lying in the front yard in the grass.” 
le faces of new arrivals in the camp, who disembarked from buses in a state of exhaustion, dehydration and 
confusion, also reflected those horrors. “There was an older woman, about 75 years old, and she got off the bus 
■■ 
md just stood there and looked around,” said Bourdeaux. “I walked up and offered her a glass of water and she 
waved it away. I offered her a Kleenex and she grabbed it and burst into tears and she grabbed me and just 
.. 'V‘r 
stood there crying and holding on for dear life. 
e see battered souls in need of healing. 
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“Your first reaction is you don’t want to see this person cry. But that is really the first step in healing for them, 
just to have permission to be sad and angry and to think about what they re going to do next. This is not a 
medical crisis. It’s a crisis of the spirit. Giving people a sense that they exist is the most important thing to 
do there.” The volunteers’ observations, edited from their journals and letters, follow. 
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A ‘CRISIS OF THE SPIRIT 
PAMELA PERRY, M.D. 
ASSISTANT PROFESSOR OF SURGERY (EMERGENCY MEDICINE) 
The dean’s office sent an e-mail today, seeking a faculty member to accompany a group of 
medical students to Macedonia to assist with relief efforts. When I asked myself, “Why drop 
everything and go to Macedonia for four weeks?” the answer was clear as a bell: If my family 
were suffering from the atrocities forced upon the ethnic Albanian people of Kosovo, I would 
expect the world to stop and help. 
The planning for the trip complete, yesterday we were on our way: New York to Brussels, to 
Vienna, to Thessaloniki, to Macedonia (roughly 24 hours of traveling). Finally, we’re here. Our 
accommodations are sufficient: a rented, four-bedroom house in the capital city of Skopje. I 
will be rooming with Anya, a first-year medical student. I haven’t had a roommate since I was 
15! Group spirits are at a high. We will commute an hour by car 
to the camp with volunteer drivers from Doctors of the World. 
EMINE ALIJAJ, R.N., P.A.-C ’96 
PHYSICIAN ASSOCIATE, EMERGENCY DEPARTMENT 
YALE-NEW HAVEN HOSPITAL 
Yesterday we made our way to Stenkovac, the largest Albanian refugee 
camp in Macedonia, to look for my cousins. (I was born in Kosovo in 
1968 and lived there until I was four, when my family emigrated to 
the United States.) 
How we were going to get into the camp —and how we were to find my cousins there 
among 20,000 refugees—was a mystery to us, but somehow we did it. Sharon was able to get 
the number of the tent where my cousins were staying, and we walked through the camp call¬ 
ing out their last name, “Avdiu.” A woman approached us thinking we were long-lost family 
coming to rescue her. When she realized that we were looking for someone else by the same 
name, the expression on her face changed to utter disappointment. I wished I could have been 
the family member she had hoped for. 
And then I found my cousin Bashkim, whom 1 last saw 27 years ago when he accompanied 
my family to the train station in Kosovo. We cried and embraced as if the time had not gone 
by. He told me of his family’s journey from Kosovo four weeks ago. Now they are living in a 
tent, 15 people in all. They welcomed all of us, and, within a few minutes, everyone in the Yale 
group felt like an Avdiu, despite not being able to say much that would be understood. When I 
saw my cousins, my first thought was, “Thank God they are alive.” Then I thought, “God, 
how could this have happened to all the Kosovar Albanians?” 
In Senekos, Yale students triaged new arrivals to the camp. Ethnic Albanians fleeing Kosovo were transported from the 
Macedonian border in buses, often arriving exhausted and dehydrated. Set against rolling hills and the mountains that form 
the border with Kosovo, the camp had a population of only 800 when the students arrived in late April. It grew to more 
than 6,000 in the month that followed. At the much larger Stenkovac refugee camp an hour away, the Yale group located 
Emine Alijaj's cousin, Bashkim Avdiu (embracing Alijaj in photo), and his family. Conversation was difficult but student 
Aaron Covey entertained the children with origami. 
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APRIL 26 On the road from Skopje we had seen other refugee camps, kilometers of white tents stretched 
along the base of the lush, green mountains bordering Kosovo. But it was muddy in Stenkovac, 
where we went in search of Emine’s cousins. 
The Macedonian police guarding the camp looked at our American passports and let us in, 
to our great relief. Emine and I talked our way into the camp’s administrative area, where the 
lists of refugees and their tent assignments within the camp were kept. The people working in 
this makeshift office hardly looked up, perhaps from fear that they would have to answer the 
endless questions fired at them by the crowd of refugees. Everyone here is looking for a lost 
relative or friend, or seeking asylum in France, Belgium or elsewhere. 
We caught the attention of one of the workers, who looked up reluctantly and seemed to 
notice that we were somehow different from the others. It’s that difference —our sense of self— 
that allows us to walk out of camp unchallenged at the end of the day and to ask questions 
when we need answers. It empowers us with confidence. Every single refugee —doctors, 
lawyers, teachers, farmers and children alike —seems to have been stripped of it. 
The relief worker returned minutes later, surprising us with the tent numbers of Emine’s 
cousins. We headed off as a group, followed by a crowd of people. After Emine was reunited 
with her cousin Bashkim, other family members appeared and the group of us from Yale were 
surrounded by 20 Albanian refugees, curious and excited. We had not expected that on our 
first evening we would find an instant connection to these people we had never met, whose 
culture and language were so different from ours. As our communication was limited to a 
mixture of French, Albanian, and English, Aaron taught us all the international language 
of origami. 
Bashkim handed me a business card from the time that he spent away from his family in 
Switzerland. “I worked for 12 years to make a home and now nothing is left,” he said. "It is 
all gone.” As we learned later, most refugees don’t even have pictures of the lives that they left 
behind. But Emine’s teenage cousins had rescued two little albums, which they meticulously 
narrated as they turned the pages showing classmates, family members and vacations to the 
Adriatic. We are thankful to Emine for sharing her family with us. The experience was in¬ 
valuable in influencing our view of our role here. We don't need to be medical students, 
doctors, volunteers, relief workers or foreigners. Just being part of their lives at this point is 
often enough. 
PAMELA PERRY, M.D. 
Our first day in Senekos refugee camp. Initial impression: a sea of white tents and somber 
faces. We had driven by the camp the day before but were asked not to enter without ID cards, 
so we didn’t go in. I have met so many beautiful people! The children are incredible. A lot of 
the doctors seem to have a certain bedside etiquette that surpasses any 1 have witnessed at 
home. It is refreshing to see people who take care of others merely because they want to and 
not because of the prestige attached to it. I met a neurosurgeon working in the Senekos clinic 
who could have left for America weeks ago but chose to stay and help his people. He’s working 
as an internist! 
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Yes, mind-body therapies are effective in treating illnesses 
related to stress. But 1 could not have imagined their applica¬ 
tion in a situation such as Kosovo. Given what the refugees 
entering Senekos had been through, 1 doubted they would 
have felt like sitting quietly and meditating on the inspiration 
and expiration of their breath. Wouldn’t it have been pre¬ 
sumptuous of us to ask them to take their minds to a more 
peaceful place, just days after they had watched their homes 
burned down and family members assaulted by Serb 
paramilitary troops? 
To my utter surprise, then, I found myself participating in 
a stress-reduction workshop on my first day in the camp. 
James Gordon, M.D., a Georgetown University psychiatrist 
and an expert on mind-body therapy, led the session. His 
audience was a small group of refugees from Kosovo in their 
teens and early 20s. When I arrived. Dr. Gordon was describ¬ 
ing the fight-or-flight response to acute stress. 
“What happens to your body it you realize that a tiger is 
chasing after you?” he asked. “My heart races,” replied a 
teenage boy. “My eyes open wide and I start breathing fast,” 
said another. Dr. Gordon explained the physiology of stress in 
terms that seemed to reassure his young audience. The mes¬ 
sage was that this tension and continued alertness to danger 
were normal, despite the discomfort associated with them. 
Further, they might be able to influence these sensations by a 
conscious effort. 
Dr. Gordon led his group in an exercise of guided imagery 
to demonstrate how the body responds physiologically to a 
particular mental picture. “Close your eyes and imagine a 
lemon in front of you,” he said. “Now, slice it with a sharp 
knife and then place it into your mouth. Bite down on its 
juicy texture. What do you feel?” 
Some were refreshed by the image. Most felt their salivary 
glands activated by the sourness of the lemon that hovered in 
their mind’s eye. “You see, our bodies respond to mental 
images. This can be an effective way to calm your body dur¬ 
ing stressful times,” Dr. Gordon said. “Not by imagining 
lemons, necessarily. But taking one’s mind to a more peaceful 
place can be relaxing physiologically.” 
Never has a lemon seemed so instrumental to me. 
EMINE ALIJAJ, R.N., P.A.-C 
' " Bashkim and the rest of the Avdiu family have left Stenkovac 
for another temporary home in Lyon, France. He was reunit¬ 
ed with his parents, brothers and sisters who are in France 
and Switzerland. They are all well. 
AARON COVEY 
CLASS OF ’01 
Every child in the camp between the ages of 6 and 14 is 
waiting at the gated entrance of our refugee camp. Today 
is the first day that these children will attend school while 
in Senekos, and I am the unofficial photographer! 
The town that surrounds our camp is largely ethnic 
Albanian, and local officials have agreed to let the refugees 
use the schoolhouses for four hours each weekday. For many 
of the 300 or so children, it is their first day of school ever. 
Under recent law, most Kosovar Albanians were not permit¬ 
ted to attend school in their homeland. 
1 followed the children as they sang their way to school. 1 
tried to sing along to make the children laugh. It worked. 
They were excited and eagerly waved as 1 took pictures. Some 
held up the two-finger symbol for “Free Kosovo” for my cam¬ 
era. They were accompanied by older residents of the camp 
who had been teachers or teachers-to-be back in Kosovo. I 
went to a couple of classrooms and, unintentionally, disrupt¬ 
ed them. The children tried to get me to take their photo¬ 
graph instead of paying attention to their teachers. 
I peeked in another door to see if I would be disturbing 
another class in progress. I wasn’t. I did not even see an adult 
in the room. 1 thought I could get some good pictures here. 
When I opened the door, these 6- to 7-year-old children 
started cheering. They had recognized me as the American 
who made balloon animals, sang and played ball with them. 
I took some photos, but still no one arrived to teach the 
children. “Hello,” I said. 1 said it a few more times, cupped 
my ears and stretched my neck until they said hello back. 
Then “Goodbye!” I left the classroom. I went back in again. 
... “Hello!” I did this a few more times and soon found 
myself teaching English. A man who I recognized from the 
camp poked his head in and nodded for me to keep teaching. 
At least that’s what I think he said. It’s what I wanted to hear! 
I taught the things that I had myself learned in Albanian 
this past week. “How are you?” Si je? “Good morning.” Mir 
minges. It was difficult to know whether the children actually 
learned any English, and, after two and a half hours I was 
Arrangements were made for the children to attend school in buildings outside the camp, in the village of Senekos. Aaron Covey tagged along as photographer 
and soon found himself teaching English. Later the children made drawings with crayons and paper. Many of the pictures showed villages under attack and homes 
cire. A few days later, one of the children in the camp sat with Anya Szeglin to have her nails painted. Before long, a crowd had gathered and Szeglin found 
elf busy decorating 50 sets of nails. "This was something normal and civilized," she wrote in her journal, “something completely frivolous that fulfilled more 
izn a basic human need." 
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feeling mentally drained. Relief came in the form of crayons 
and paper, brought by the organizer of the program. The 
children drew whatever they liked. After this, the class was 
dismissed back to the camp. I accompanied them with the 
pictures in hand, again singing songs. 
I had lost myself in the fun of teaching and I felt energized 
the rest of the day, knowing how much the children enjoyed 
it. Yet that night, my perspective changed a bit while looking 
through the drawings that they made. 
Most children draw what is on their minds. In this case, 
almost all drew their homes and villages. Some of these 
images included burning houses, tanks and warplanes, even 
dead bodies. The pictures reminded me that I wasn’t teaching 
kids at home, nor was I just having fun. These 6- and 7-year- 
olds are living through an indescribably awful time. While 
balloons, singing, and drawing will never erase the horror 
these children have witnessed, 1 hope that what we are doing 
at the camp has helped start their healing. 
SHARON CHEKIJIAN 
The camp has grown over the last four days from 800 inhab¬ 
itants to 2,300. It is run by Mercy Corps International and is 
the smallest of all nine camps. It is rumored to be the clean¬ 
est and the most hospitable, too. The clinic or “Ambulanta” 
is a structure composed of two large tents joined by a canvas 
waiting room. 
The clinic is staffed by three ethnic Albanian doctors, who 
are themselves refugees from Kosovo, and two American 
physicians. There are four Kosovar nurses on staff, as well as 
several interpreters. Currently there are few acute problems. 
Most medical problems are chronic in nature; diabetes, 
hypertension, heart disease and pulmonary problems pre¬ 
dominate. Medications are adequate, but the supply is limit¬ 
ed. New influxes of refugees introduce occasional acute 
considerations of dehydration, diarrhea, upper-respiratory 
infections, and minor trauma. 
Two evenings ago, Emine, Seth and Aaron remained at the 
camp overnight to assist with the arrival of a new group of 
refugees who came by bus after spending days at the border 
camp at Blace. They arrived exhausted, dehydrated and dis¬ 
oriented. A triage area was set up and the sickest were given 
seats, taken to the clinic and evaluated for treatment. 
ANYA SZEGLIN 
CLASS OF ’02 
I brought five jars of nail polish to the camp yesterday to 
paint little girls’ fingernails. They loved it. It might seem like 
a trivial thing to do when we have issues of overcrowding 
and shortages of clothes, diapers, and sanitary pads. A few 
days earlier I was talking with a 14-year-old girl named 
Havishe, who had told me that her hands were once beau¬ 
tiful in Kosovo, but have become ugly from her travels to 
Macedonia and living in the camp. I then noticed that many 
of the little girls (between 3 and 10 years old) had just scant 
remains of blue and green nail polish. I thought they might 
enjoy it. 
I found Havishe and asked if she would like her nails 
painted. She was delighted. We sat down beside a tent and 
1 asked her to choose a color from the bottles that 1 had 
brought. I was soon mobbed by 20 other people —small chil¬ 
dren and their parents, as well as an elderly woman and man. 
They had come to watch. When I was finished, I asked if 
anyone else wanted her nails painted. The response was over¬ 
whelming. I painted over 50 people’s nails over the next 
few hours. 
The strangest response was from the fathers. They kept 
saying, “Bravo! Bravo!” My reading of these events is that 
here in the midst of a refugee camp—where they have been 
degraded by being forced to leave their homes and flee for 
their safety, where there is no hot water and the few clothes 
they have are dusty and dirty —this was something normal 
and civilized, something completely frivolous, something that 
fulfilled more than a basic human need such as food, shelter 
or clothing. 
I asked the elderly woman who had been watching whe¬ 
ther she would like her nails painted. The man with her 
shook his head discouragingly. She shook her head, too, and 
lowered her gaze. From what I could gather in my small 
Albanian vocabulary, the man didn’t think she should have 
her nails painted because she was finished, too old; it wasn’t 
important for her to feel pretty. The woman, I think, felt 
ashamed by this and thus agreed with the man. I insisted that 
I paint her nails. The smile on her face was priceless. In that 
one gesture, I conveyed that she was worth it. 
In medical school when we are learning the physical exam, 
we are taught about the power of touch. Touch can calm you. 
It lets you know that someone notices your pain. When I talk 
to the refugees, I try to touch them. Sometimes I am afraid 
to touch them, especially when 
we first arrived, but I know they 
need to be touched. My need to 
help them overwhelms my fear 
of being too personal with some¬ 
one I met just five minutes ago. 
It is one of the most powerful 
experiences to hear someone’s 
✓ 
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story of devastation and when they are weeping to reach out and gently squeeze their arm, or 
hold their hand, or put your arm around their shoulders. You cannot help but weep yourself. 
You do not need an interpreter for that. When they see you crying, the storyteller knows that 
you understand the pain that they have been through. When you listen to their story, you take 
some of the pain away. 
SETH GOLDBARC 
CLASS OF 'ol 
MAY 5 As medical students, we tend to fixate on the care that we can give to treat an illness, to cure 
an infection, to ease the pain of a disease. Here in Senekos we see battered souls in need of 
healing. We meet children starved for attention and parents struggling to do all they can for 
their families. Fifteen-year-olds have become the heads of households. Old men weep as their 
sons tell their stories to us. 
We are with a group of refugees who have survived the physical trauma of the flight from 
Kosovo and the border crossing into Macedonia. They have before them many long, hot days 
confined to a fenced-in camp with only their few possessions as diversion. Passports and 
papers confiscated, homes looted and burned, relatives missing, and their country in turmoil, 
the people of Senekos seem to survive by living in the moment. 
Without a sense of identity, how can they begin building community? No one can predict 
when this crisis will end or what will happen when it does. With this in mind, I have been 
speaking with my Yale classmates about trying theater here. They agree that it might be a good 
way to bring people together and get them to use their talents within the confines of Senekos. 
may 8 Kadrush is a 28-year-old teacher who is thrilled by the idea of putting on a play. He seemed 
skeptical at first, but he picked out Cinderella (La Perhitura in Albanian) from among several 
children's books and has gathered together three university students who were begging for 
something constructive to occupy them. They wrote the script, cast eight children in the roles 
and are about to begin rehearsals in one of the unoccupied vaccination tents above the camp. 
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The man pictured above left rented out his home to workers who were documenting human rights abuses in Kosovo for the 
Organization for Security and Co-operation in Europe. When they left, he fled his village, fearing retribution from his 
Serbian neighbors. He told Sharon Chekijian that he spent several days in hiding, living on his tractor out in the countryside 
and sneaking back to his cousin’s home at night to collect food and supplies. He later drove the tractor to the border and 
entered Macedonia as a refugee. 
Many of those fleeing the violence crossed the border at Blace (above center), where a silent crowd of refugees awaited per¬ 
mission to enter Macedonia, a former Yugoslav republic that is now an independent state. The somber mood gave way to 
elation in Senekos, especially among young people, but the joy was at times short-lived. 
Chekijian encountered the woman at left while assisting with a tent-to-tent survey of the camp population's medical 
needs. The woman had lived in a small farming village in Kosovo for all of her go years. "I lived through World War I and 
World War II but this was worse," she told Chekijian. "This time it was so bad that even the cows ran away." 
YALE MEDICINE 33 
MARGARET BOURDEAUX 
CLASS OF ’02 
What happens to a dream deferred? 
Does it dry up 
like a raisin in the sun? 
Or fester like a sore — 
And then run? 
Does it stink like rotten meat? 
Or crust and sugar over — 
like a syrupy sweet? 
Maybe it just sags 
like a heavy load. 
Or does it explode? 
—Langston Hughes 
Technically, I had spent my day collecting data for a nutritional assessment of the pediatric 
population of the Senekos Refugee Camp. But that description, while accurate, belied the real¬ 
ity of the task: bending on one’s knees in the muddy gravel and reading off the weights and 
heights of squirming, indignant children who would not be still for too long. The weighing 
and measuring of these refugee children had also proved unexpectedly therapeutic for their 
mothers—women with hardened faces and creases around their mouths, mothers deeply wor¬ 
ried about their children. They insisted that I write their children’s measurements down for 
them on slips of brown, recycled paper. It took some time for me to understand their eagerness 
for this documentation: These little slips of paper were the only written proof that their chil¬ 
dren existed. Birth certificates, baby pictures and immunization records had all been burned, 
stolen or left behind in the course of their forced exodus. And what documentation it was! 
Slips of paper that recorded the physical space their children occupied in this world—space 
that had almost been violently denied them. Every centimeter a defiance! Every kilogram hope 
for future growth. 
Hope, in fact, was what 1 needed now. I was talking with Gazmend, one of 
our interpreters, in Kapan An, an Albanian-owned bar tucked away in the 
Turkish section of Skopje, the capital of Macedonia. Gazmend had just 
returned from a meeting with a Kosovo Liberation Army commander who 
turned up in Skopje two days ago. Gazi was set on joining the KLA when his 
work with us was finished. Through persistent, heated discussion, I had been 
able to cast some doubt in Gazi’s mind about his plan, but I was afraid this 
meeting would seal his resolve. It turned out quite the opposite—the KLA 
commander had been very discouraging. “He said that if I joined the KLA I 
would be dead in two weeks,” Gazmend reported. “Go somewhere and study, 
learn something that will help rebuild our country,” he had told Gazmend. I was relieved, but 
not as much as I thought I would be. Gazmend’s face was in his hands as he mulled over the 
commander’s advice. “But who cares if I die?’’ he finally exploded. “At least I will have done 
something!” 
I understood Gazmend’s desire to fight. Seven years ago, just after he finished his second 
year of medical school at age 20, Serb soldiers knocked on his door and informed him that he 
had been conscripted into their army and that he was to come with them immediately. He 
grabbed the conscription notice from their hands and ran —and kept running for two years 
before settling in the western Kosovo town of Pec and opening a dress shop. After Kosovar 
businesses were deemed illegal by the Serb government in late 1997, Gazmend went to work in 
Kosovo for the Office of Security and Co-operation in Europe, an organization that docu¬ 
mented human rights abuses. Working out of Pristina, he donned a bulletproof vest and drove 
through combat zones investigating atrocities. Six weeks ago his American boss had entered 
the office and announced that he and the rest of the expatriate staff had to evacuate due to the 
Gazmend (above left), an interpreter for the group who was eager to fight for a free Kosovo but unsure of the wisdom of 
doing so, had lost everything as well. Weighing a young child in his family’s tent, Margaret Bourdeaux collected data for an 
assessment of the nutritional status of the children in the camp. Parents, many of whom had been stripped of their identity 
papers and other documents while leaving Kosovo, were eager to have their children’s measurements recorded and set 
down on paper. Opposite page: A 14-year-old child’s drawing of his village documents its destruction. 
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escalating violence. He wished all the Kosovars luck finding their way out ol the country. 
Gazmend packed up his mother and father and sent them ahead to Macedonia. He followed 
weeks later after a brutal journey through burned villages, sniper fire, and the burial of a travel 
companion who did not survive. 
But Gazmend did not want to fight, as I had thought. He wanted to contribute, to do 
something that mattered. Gazmend would much rather face the Serb military than the cold 
terror of a wasted life. He was 27. He had no diplomas, no transcripts, no way of leaving 
Macedonia, no way of working after his job with us was finished. He was a talented leader and 
resourceful thinker, and he knew it. But what now? As I looked at Gazmend and at the other 
young refugees who populated the darker corners of the bar, I wished 1 could give them slips 
of paper with the measurement of their potential in the world written upon them. How does 
one treat this kind of stunting, this malnutrition of the soul? 
The KLA commander was right: go study, go learn how to write constitutions, create school 
systems, care for the sick, and heal communities. However, these young refugees cannot create 
the opportunities to learn these skills out of thin air. Educational opportunities can be provid¬ 
ed only by those of us in the international community who care enough to do so. And as I 
look at Gazmend considering his choice between a future of violence and a future of dreams 
deferred, I know that we do not have much time. 
PAMELA PERRY, M.D. 
The students are really proving what they are made of. Their work is important, useful, and 
they appear to be deeply moved by the experience. The depth of Emine’s emotion must be 
incredible. We have found three sets of her relatives, each very loving and caring. The concept 
of family among ethnic Albanians reminds me so much of my own parents and nine siblings. 
I think everyone is now realizing how short four weeks really is. The weather is HOT, and 
we are expecting more refugees at Senekos any day. I am having a ball with the kids. Moussa is 
by far my favorite. He is an 11-year-old boy who witnessed a Serbian soldier cutting an 
Albanian man’s throat. Moussa has had nightmares for three weeks. When he sees me coming, 
he wants to arm-wrestle or play whatever game I have in mind. He reminds me so much of 
my nephew Max. 
SETH GOLDBARC 
We bought red and purple sheets of material in Skopje yesterday, and a seamstress in the 
camp is making costumes. We have a crown for the princess and we found a plastic sword in 
the old market in Skopje. Today, volunteers built a crude but sturdy stage over a drainage 
Keeping young people engaged was a primary goal of the Yale students, who had few set duties at the camp and the 
freedom to be inventive. Seth Coldbarg cleared the way for a young director and his cast of eight children to put on a 
production o/Cinderella (left), securing an outdoor location for the stage and organizing prop-hunting trips to the Mac¬ 
edonian capital of Skopje. With few structured activities, the 15- to 18-year-olds in the camp had little to do until the 
medical students organized soccer and volleyball games. They set up leagues and arranged for the use of a sports facility 
several kilometers from the camp. Pamela Perry (right), the preceptor and only physician in the Yale group, befriended a 
young relative of Emine Alijaj. 
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Walking outside the camp, students Sharon Chekijian and Vivian Lombillo noticed a group of villagers resting and talking 
in a back garden, and were invited in to chat. The local people, during the course of a month, had watched their tiny 
Senekos grow to accommodate thousands of homeless Kosovars from across the border. With no language in common, the 
villagers conversed with the Yale students with smites and gestures and said goodbye with a gift of eggs. 
S 
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ditch from scrap plywood, the most visible location in the camp. Erfan, my invaluable assistant 
and friend, even strung up a curtain from one of his family’s blankets. Kadrush and the stu¬ 
dents helped design the flyers that we put up to advertise the performance. The names of the 
actors and writers are proudly written on every sheet, which we posted on the community 
bulletin boards. 
may 19 Hundreds of people, mostly children, watched La Perhitura today while the sun set behind the 
stage over the snowy mountains of the Kosovo border. Every face wore a smile as Cinderella, 
with a beautiful dress and flowers in her hair, slipped her foot into the glass (or in this case, 
black plastic) slipper. Ramadan, who played the prince’s young steward and, at age 14, has an 
incredible command of English, promised that this was only the beginning of dramas in 
Senekos and that he personally intends to direct one every two weeks. 
EMINE ALIJAJ, R.N., P.A.-C 
Today Vivian and I returned to Stenkovac and found two more of my cousins. They are hop¬ 
ing to come to New York to see my family. Last week, I met another cousin, Mergim, and his 
wife and children. They are living in an apartment in Skopje. [Mergim returned to Kosovo to 
find his home destroyed. He planned to return to Macedonia in late June and then make the 
journey to Kosovo one final time.] 
PAMELA PERRY, M.D. 
We are going home. I cannot believe the time has come to leave! Last night was so emotional. 
I stayed up until 3 a.m. with Moussa’s family, talking, dancing and laughing. My final goodbye 
at the camp was so emotional! After hugging all of the kids who walked me to the gate, I start¬ 
ed crying and we all just stood there weeping for what seemed like ages! Moussa would not let 
go of my hand. He was so sweet. I hate saying goodbye. YM 
A month after the group’s return, Emine and Margaret returned to 
Senekos to spend the summer working in the camp. Emine took a 
three-month leave of absence from her job in the YNHH Emergency 
Department to work with Doctors of the World. Margaret returned 
as a Wilbur Downs fellow investigating malnutrition in the refugee 
population and exposure to diarrhea and upper-respiratory infections. 
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FACU LTY NOTES 
O U.S. Department of Health and 
Human Services Secretary Donna E. 
Shalala has named Kim Bottomly, 
Ph.D., professor of immunobiology 
and dermatology, as one of five 
appointees to the National Advisory 
Allergy and Infectious Diseases 
Council, the principal advisory body of 
the National Institute of Allergy and 
Infectious Diseases. Bottomly’s research 
focuses on the factors that regulate 
CD4 T-cell differentiation and func¬ 
tion, especially as regards the pathogen¬ 
esis of asthma. Bottomly has served on 
the NIH Immunobiology Study 
Section and on several committees of 
the American Association of 
Immunologists. 
Thomas E. Brown, Ph.D., assistant 
clinical professor of psychiatry, was the 
keynote speaker in February for the 
National Attention-Deficit/Hyper¬ 
activity Disorder (ADHD) Conference 
in Stuttgart, Germany. Brown also pre¬ 
sented the Department of Psychiatry 
grand rounds at the Goethe University 
Medical School in Frankfurt. His topic 
was “Working Memory and Executive 
Function Impairments in ADHD.” 
The following Yale faculty have been 
elected to membership in the Conn¬ 
ecticut Academy of Science and 
Engineering: Yung-Chi Cheng, Ph.D., 
Henry Bronson Professor of Pharm¬ 
acology and director of the develop¬ 
mental therapeutics program at the 
Cancer Center; David A. Kessler, 
M.D., dean of the School of Medicine 
and professor of pediatrics, medicine 
and public health; Michael H. Merson, 
M.D., dean and professor of epidemi¬ 
ology and public health; Dieter G. 
Soil, Ph.D., professor of molecular bio¬ 
physics and biochemistry; and Peter B. 
Moore, Ph.D., the Eugene Higgins 
Professor of Chemisty and professor of 
molecular biophysics and biochemistry. 
O Myron Genel, M.D., professor of 
pediatrics, received the Abraham Jacobi 
Memorial Award in April at the annual 
meeting of the American Academy of 
Pediatrics. The award is presented by 
the Academy and the American 
Medical Association to “a pediatrician 
who has made notable contributions to 
pediatrics on a national level.” Genel 
(at left in photo with AAP President Joe 
Alpert) received the award in part for 
his efforts to bridge the gap between 
the pediatric specialty and the general 
medical community. 
O I he School of Medicine has received 
a $500,000 unrestricted cardiovascular/ 
metabolic research grant from Bristol- 
Myers Squibb, to be supervised by 
Richard Lifton, M.D., Ph.D., chair of 
genetics, professor of genetics and med¬ 
icine (nephrology) and a Howard 
Hughes Medical Institute investigator. 
Lifton’s research in hypertension has led 
to the identification of more than a 
dozen genes that regulate blood pres¬ 
sure. The grant was announced on 
March 31 at a reception for Lifton, (pic¬ 
tured with Bristol-Myers Squibb’s 
Anders Hedberg, left) who leads a team 
of researchers who have found muta¬ 
tions in genes that alter blood pressure 
by changing salt and water reabsorption 
in the kidney. 
Lawrence C. Kaplan, M.D., associate 
professor of pediatrics and director of 
the Disabled Child Care Program and 
the Center for Children with Special 
Health Care Needs, was chosen one of 
30 fellows for Zero to Three’s Leaders 
for the 21st Century program. Zero to 
Three is a national nonprofit organiza¬ 
tion of pediatricians and child develop¬ 
ment specialists. 
Paula Kavathas, Ph.D., associate pro¬ 
fessor of genetics and immunobiology, 
and William B. Stewart, Ph.D., associ¬ 
ate professor of surgery and chief of the 
section of anatomy and experimental 
surgery, were honored with Ivy Awards 
in May. The Elm and Ivy Awards are 
given in recognition of efforts to 
strengthen the relationship between 
Yale and the city of New Haven. 
Kavathas created the Science Education 
Outreach Program to strengthen sci¬ 
ence education in New Haven. Stewart 
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helped to establish a program of bring¬ 
ing students from Career High School 
to anatomy laboratories at the medical 
school, where they are taught by med¬ 
ical student volunteers. 
The National Alliance for Research on 
Schizophrenia and Depression 
(NARSAD) has announced the recipi¬ 
ents of its 1999 Distinguished and 
Young Investigator Awards. From Yale, 
Kenneth K. Kidd, Ph.D., professor of 
genetics and psychiatry, received the 
Distinguished Investigator Award. The 
recipients of the Young Investigator 
Awards were: assistant professors of 
psychiatry Walid M. Abi-Saab, M.D., 
J.D.; Aysenil Belger, Ph.D.; Robert 
Berman, M.D.; Jingshan Chen, M.D., 
Ph.D.; Cheryl M. Corcoran, M.D.; 
Benjamin Druss, M.D., M.P.H.; 
Masahiro Fujita, M.D., Ph.D.; and 
Gerard Marek, M.D., Ph.D.; instructor 
in psychiatry C. Bruce Baker, M.D.; 
postdoctoral fellows in psychiatry 
Gerard Sanacora, M.D., Ph.D.; Kelly 
A. Stein, Ph.D.; Nicholaas P.L.G. 
VerhoefF, M.D., Ph.D.; and Erica 
Weiss, M.D.; postdoctoral fellow in 
genetics Naoya Murakami, M.D., 
Ph.D.; and assistant professor of neu¬ 
rology David S. Russell, M.D., Ph.D. 
Richard W. Kim, M.D., surgical resi¬ 
dent in cardiothoracic surgery, was 
named a Baxter Research Fellow for 
1999-2000 by the Thoracic Surgery 
Foundation for Research and 
Education for his research investigating 
new techniques in gene therapy and 
cardiac transplantation. 
Sunita Maheshwari, M.D. (M.B.B.S.), 
clinical instructor in pediatrics (cardiol¬ 
ogy), was awarded the Laennec Society 
Young Clinician Award by the 
American Heart Association in 
November at its 71st annual meeting in 
Dallas. The award was given for the 
best clinical presentation in a special 
session of the Laennec Society for 
Clinical Cardiology that was conduct¬ 
ed at the meeting. 
Richard A. Marottoli, M.D., associate 
professor of medicine (geriatrics), 
received an Outstanding Research 
Award in the Field of aging and health 
care for seniors and long-term care in 
May for his research identifying risk 
factors associated with driving safety 
and interventions for the older driver 
and their families. 1 he award was pre¬ 
sented as part of a celebration of Older 
American’s Month hosted by 
Connecticut Community Care Inc. 
W. Ian McDonald, Ph.D., professor 
adjunct of neurology, presented the 
Helen Wilshire Walsh Lecture titled 
“The Dynamics of Multiple Sclerosis” 
in June at Yale. Ms. Walsh was a sup¬ 
porter of neurology research and had a 
long-standing interest in improving the 
lives of people with disabilities. Mc¬ 
Donald has made many contributions 
to the diagnosis and understanding of 
multiple sclerosis and has used magnet¬ 
ic resonance imaging and spectroscopy 
to probe its evolution in humans. 
Lynne J. Regan, Ph.D., professor of 
molecular biophysics and biochemistry, 
was awarded the fourth annual Herbert 
W. Dickerman Award from the New 
York State Department of Health’s 
Wadsworth Center. She was selected 
for the award in recognition of her 
achievements in elucidating rules 
underlying protein folding, as well 
as for her contributions in the areas 
of protein design and prediction. 
Regan visited the center this spring, 
presented a lecture and met with staff 
scientists. The Wadsworth Center is 
devoted to the biomedical and 
environmental sciences. 
Stephen G. Waxman, M.D., Ph.D., 
professor and chair of neurology and 
professor of pharmacology and neuro¬ 
biology, was given the Wartenberg 
Award, the highest honor bestowed 
by the American Academy of Neuro¬ 
logy. The award was presented in 
April at the annual meeting in Toronto. 
Waxman is founding director of the 
PVA/EPVA Neuroscience Research 
Center at the VA Connecticut Health¬ 
care Systems West Haven campus. 
Q Robert M. Weiss, M.D., professor of 
surgery (urology) and in the Cancer 
Center, has been appointed interim 
chair and chief of the Department of 
Surgery. Weiss has served on the faculty 
for more than 30 years, most recently 
as chief of the section of urology. 
He is the recipient of an NIH Merit 
Award, a trustee of the American Board 
of Urology and a member of 
the American Association of Genito¬ 
urinary Surgeons. Weiss succeeds 
Ronald Merrell, M.D., who will 
chair the Department of Surgery at 
the Medical College of Virginia 
in Richmond. 
NEW BOOKS 
Understanding Cancer: A Patient's 
Guide to Diagnosis, Prognosis, 
and Treatment, by C. Norman 
Coleman, M.D. ’70, The Johns 
Hopkins University Press 
(Md.), 1998. 
W.gb Style Guide: Basic Design 
Principles for Creating Web Sites, 
by Patrick J. Lynch, director, Yale 
Center for Advanced Instructional 
Media, and Sarah Horton, Yale 
University Press, 1999. 
Henry F.du Pont and Winterthur: A 
Daughter’s Portrait, by Ruth D. Lord, 
research affiliate in the Child Study 
Center, Yale University Press, 1999. 
Recursive Partitioning in the Health 
Sciences, by Heping Zhang, Ph.D., 
associate professor of public health 
and in the Child Study Center, and 
Burton Singer, M.D., Springer-Verlag 
(N.Y.), 1999. 
Prescriptions for Living, by Bernard S. 
Siegel, M.D., HS ’6i, HarperCollins (N.Y.), 
1998; paperback edition, Fall 1999. 
STUDENT NEWS 
The Match goes online, 
but students prefer 
old-fashioned envelopes 
The Internet proved no match for snail mail as scores of stu¬ 
dents gathered in Harkness Hall on Match Day, March 18, to 
receive the plain white envelopes that would tell them where 
they’d been accepted for residencies. Rather than wait until 
i p.m. and find out by logging on to a computer, students 
preferred to share their joys, and occasional disappointments, 
with their classmates at noon. 
The medical school, said Cynthia Andrien, assistant dean 
for student affairs, has no plans to change the annual rite of 
passage for medical students. “I think the Kin is the 
envelopes,” Andrien said as she prepared to deliver them to 
students. Accompanied by Nancy R. Angoff, M.P.H. 81, 
M.D. ’90, HS ’90-93, associate dean for student affairs, 
Andrien wheeled a cart bearing the letters into the mailroom 
shortly before noon. 
A few minutes later she stepped out and students poured 
in, only to emerge a moment later, tearing open their 
envelopes. “Oh, my God!” shouted Nnemdi Kamanu, who 
matched at her first choice, primary care medicine at the 
University of San Francisco - General Hospital. She hugged 
Clovene Campbell, who also matched at her first choice, a 
residency in pediatrics at Massachusetts General Hospital. All 
92 students in the class found residencies, Andrien said, and 
73 percent matched to their first choice and 97 percent 
1999 residency placements 
for Yale medical students 
The Office of Student Affairs has provid¬ 
ed the following list, which outlines 
the results of the National Resident 
Matching Program for Yale's medical 
school graduates. Some names appear 
twice because the graduate is entering 
a one-year program before beginning 
a specialty residency The transitional 
designation is a one-year program 
with three-month rotations in 
different specialties. 
CALIFORNIA 
Alameda County Medical Center, 
Oakland 
Danica Barron, emergency medicine 
California Pacific Medical Center, 
San Francisco 
Victoria Cross, rnedicine 
Cedars-Sinai Medical Center, 
Los Angeles 
Kristin Boger, internal medicine 
Santa Clara Valley Medical Center, 
San Jose 
Yvonne Lui, transitional 
UCLA Medical Center 
Jason Merritt, internal medicine 
Karen Purcell, obstetrics and gynecology 
Lisa Skinner, internal medicine 
Maie St. John, surgery, otolaryngology 
UCLA - Neuropsychiatric Institute 
Michael Brodsky, psychiatry 
UCLA - San Fernando Valley, Sepulveda 
Robert Chiang, medicine 
David Cershfield, medicine 
University of California - Los Angeles 
David Cershfield, neurology 
University of California - 
San Francisco 
R. Alison Adcock, psychiatry 
MarieI Eliza, surgery 
Jessica Haberer, internal medicine 
Alexander Kao, anesthesiology 
University of San Francisco - 
General Hospital 
Nnemdi Kamanu, internal medicine/ 
primary 
CONNECTICUT 
Greenwich Hospital 
Alexandra Cohen, medicine 
Hospital of Saint Raphael, New Haven 
Jeffrey Hart, transitional 
Alexander Kao, medicine 
Yale-New Haven Hospital 
Senai Asefaw, internal medicine 
Kristen Aversa, obstetrics & gynecology 
Deena Berkowitz, pediatrics 
Tamar Braverman, internal medicine 
John Chang, internal medicine 
Holly Craig, internal medicine 
Caroline Dumont, psychiatry 
Lawrence Etter, medicine 
Jeffrey Hart, ophthalmology 
Eric Hughes, internal medicine 
Zachary Leitze, orthopaedics 
M. Grey Maher, surgery, urology 
Nicole Rabidou, internal medicine 
Richard Torres, pathology 
Steven Williams, surgery 
Meher Yepremyan, medicine 
DISTRICT OF COLUMBIA 
George Washington University 
Minh Tran, neurosurgery 
National Capital Consortium 
Jon Meyerle, internal medicine 
HAWAII 
University of Hawaii, Honolulu 
Matthew Lawrence, medicine 
ILLINOIS 
McGaw Medical Center - Northwestern 
Univ., Chicago 
Kenneth Kim, plastic surgery 
MARYLAND 
Johns Hopkins Hospital, Baltimore 
Kerri Cavanaugh, internal medicine 
Daniel Rothbaum, surgery, 
otolaryngology 
Johns Hopkins Hospital, Sinai, GBMC, 
Baltimore 
Camille Hylton, ophthalmology 
Johns Hopkins University, Baltimore 
Michael Schlosser, surgery, 
neurosurgery 
University of Maryland, Baltimore 
Joshua Broder, emergency medicine 
MASSACHUSETTS 
Beth Israel Deaconess Medical Center, 
Boston 
Cyrus Komer, internal medicine 
Debby Lin, internal medicine 
Alison Zimon, obstetrics & gynecology 
Boston University Medical Center 
John Carr, internal medicine 
Jennifer Chiu, internal medicine 
Dennis Lee, dermatology 
Ruth Potee, family practice 
Brigham & Womens Hospital, Boston 
Jesse Flaxenburg, internal medicine 
Lifei Guo, plastic surgery 
Michelle Pinto, internal medicine 
Jeong Yoon, surgery 
Cambridge Hospital 
Suruchi Chandra, medicine 
Jerry Doshen, internal medicine/ 
primary 
Carney Hospital, Boston 
Beth Murphy, medicine 
Harvard Medical School 
Jeong Yoon, urology 
Massachusetts Eye & Ear Infirmary, 
Boston 
Matthew Lawrence, ophthalmology 
Massachusetts General Hospital, 
Boston 
Clovene Campbell, pediatrics 
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matched to one of their top three choices. “No one went 
below their fourth choice,” she said. 
Nationally, according to the American Association of 
Medical Colleges, 94 percent of medical school seniors 
received a first-year residency program, with 80 percent 
matching at one of their top three choices. 
Notification via the Internet was a novelty this year, and no 
doubt useful to far-flung applicants. But not all availed them¬ 
selves of the computer service, even if it involved a lengthy 
trip. “There is something giddy about being here and seeing 
so many smiles,” said Steven Jacoby, who came from New 
York City to learn he was accepted for a residency in internal 
medicine at Columbia-Presbyterian Medical Center there. 
“There was no way that I was going to sit alone in Boston 
and log onto the Internet to discover where my residency 
training would take place,” said Ruth Potee, who drove to 
New Haven to be with her classmates for the ceremony. She 
was accepted at her first choice —a residency in family prac¬ 
tice at Boston Medical Center, the first such offering 
in the city. “I like the idea of being in a new program,” 
Potee said. “You get to blaze your own trail.” 
Nina Eisenberg, pediatrics 
Daniel Kamin, pediatrics 
Rosemarie Pezzullo, pediatrics 
Michelle Sanders, pediatrics 
Sujatha Singaracharlu, pediatrics/adult 
and child psychiatry 
Massachusetts General 
Hospital/McLean, Boston 
Suruchi Chandra, psychiatry 
Beth Murphy, psychiatry 
New England Medical Center, Boston 
Eloisa Falzarano, pediatrics 
Tufts/New England Eye Center, Boston 
Meher Yepremyan, ophthalmology 
NEW YORK 
Einstein/Montefiore Medical Center, 
Bronx 
Alison Days, pediatrics/primary 
Hospital for Special Surgery 
John Koski, orthopaedics 
Long Island Jewish Medical Center, New 
Hyde Park 
Tamara Koss, medicine 
The Mount Sinai Hospital, New York 
Richard Lyn-Cook. medicine/pediatrics 
Deborah Steinbaum, pediatrics/primary 
New York Presbyterian Hospital - 
Columbia 
Steven Jacoby, internal medicine 
Tamara Koss, dermatology 
Obinwanne Ugwonali, orthopaedics/ 
research 
New York Presbyterian Hospital - 
Cornell 
Christopher Aiken, psychiatry 
Deanna Chin, diagnostic radiology 
John Koski, surgery 
Sandra Santiago, diagnostic radiology 
YALE MEDICINE 
New York University Medical Center 
Alexandra Cohen, dermatology 
Yvonne Lui, diagnostic radiology 
St. Vincents Hospital, New York 
Deanna Chin, medicine 
Sandra Santiago, transitional 
SUNY - Health Science Center at 
Brooklyn 
Victoria Cross, dermatology 
Grace Korting, obstetrics & gynecology 
NORTH CAROLINA 
Duke University Medical Center, Durham 
Lawrence Etter, dermatology 
OHIO 
Cleveland Clinic Foundation 
Lee Akst, surgery, otolaryngology 
The University Hospital, Cincinnati 
JoAnne McDonough, 
emergency medicine 
OREGON 
Oregon Health Sciences University, 
Portland 
John Rugge, family practice 
PENNSYLVANIA 
Albert Einstein Medical Center, 
Philadelphia 
Camille Hylton, transitional 
Allegheny University Hospitals, 
Philadelphia 
Alison Portnoy, emergency medicine 
Children's Hospital of Pennsylvania, 
Philadelphia 
Tanya Froehlich, pediatrics 
Hospital of the University of 
Pennsylvania, Philadelphia 
Dennis Lee, medicine 
Joshua Pierce, general surgery 
Angelo Volandes, medicine/primary 
Wills Eye Hospital, Philadelphia 
Robert Chiang, ophthalmology 
University Health Center - Pittsburgh 
Daniel Hall, general surgery 
Paul Leong, surgery, otolaryngology 
TEXAS 
Baylor College of Medicine - Houston 
Sherri Sandifer, pediatrics 
VERMONT 
University of Vermont / Fletcher Allen, 
Burlington 
Ursula McVeigh, internal medicine 
VIRGINIA 
Portsmouth Naval Medical Center 
Scott Hines, transitional 
WASHINGTON 
University of Washington Affiliated 
Hospitals, Seattle 
Matthew Mealiffe, internal medicine 
Shahram Salami, general surgery 
Meena Thayu, pediatrics 
Students greeted the news of 
their placements with smiles, hugs 
and tears. 
Clovene Campbell and Michelle 
Sanders learned they were both 
accepted for pediatrics residencies 
at Massachusetts General Hospital 
in Boston. 
Cynthia Andrien, assistant 
dean for student affairs, distributes 
the notification letters shortly 
before noon. 
0 Leo Otake, a student in the 
M.D./Ph.D. program, hugs Heather 
Nye, a 7998 graduate who post¬ 
poned her match until this year. 
Lynda Kauls, who graduated last 
year, returned to celebrate with 
friends Matthew Mealiffe and Bruin 
Rugge, who started medical school 
with her. 
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Pioneer in G proteins 
urges students toward 
careers in research 
The speaker at this year’s Student Research Day warned his 
audience of the perils of spending too much time in the lab. 
“It is very addictive,” Robert J. Lefkowitz, M.D., cautioned 
students when he delivered the 12th Annual Farr Lecture 
in May. “One doesn’t realize one is addicted until one is put 
in withdrawal.” 
His tongue-in-cheek warning couldn't have come on a 
better day, one that celebrates Yale’s long tradition of stud¬ 
ent research. The school’s thesis requirement, which sets 
Yale apart from other medical schools, began in 1839, said 
John N. Forrest Jr., M.D., HS 70, professor of medicine and 
director of the Office of Student Research. “What makes it 
work,” Forrest said, “is the faculty-student pairs. It’s a great 
synergy.” 
Lefkowitz, professor of medicine and biochemistry at Duke 
University Medical Center and an investigator for the 
Howard Hughes Medical Institute, described “G Protein- 
Coupled Receptors and Their Regulation’’ in his speech. He 
said he moved between clinical work and research before set¬ 
tling on research as a career. His groundbreaking work on G 
protein-coupled receptors in 1970 has led to the development 
of precise and effective drugs. “Drugs which target these 
receptors,” he said, “either as agonists or antagonists, proba¬ 
bly represent the largest and most useful class of therapeutic 
agents. Understanding the properties of these receptors in 
molecular detail holds great promise for developing novel tar¬ 
gets and novel therapeutic strategies.” 
This year 62 students displayed posters or made oral 
presentations of their research projects, which ranged from 
studies of informed consent in pediatric emergency cases 
to novel methods of gene therapy. “It is not the number of 
research projects that is important,” said Dean David A. 
Kessler, M.D., “it is the effort towards gaining knowledge, 
towards asking fundamental questions. That is what this 
day is all about. Curriculum changes will come and go, but 
what we celebrate here today is part of who we are and 
what we do.” 
Five students delivered oral presentations of their award¬ 
winning theses: Obinwanne Ugwonali, “The Role of White 
Yams in the Increased Incidence of Multiple Births in 
Southwestern Nigeria”; Angelo Volandes, “Film Documen¬ 
tary as Ethnography: Tempering Medical Ethics with Patient 
Stories”; Senai Asefaw, “Stimulation of Myocardial AMP- 
activated Protein Kinase by AICAR Increases Cardiac Glu¬ 
cose Uptake and Causes GLUT4 and GLUTi Translocation 
(Clockwise) Robert Lefkowitz, who delivered the 12th annual Farr Lecture, listens as Mail 
Maragh describes his research on Student Research Day in May. Maragh's thesis topic 1 s 
osteoclast function and bone mass in knockout mice; Tamara Koss answers a question 
about her research on the breast cancer drug tamoxifen; Students and faculty crowd tjj 
halls of the Jane Ellen Hope Building to view the student poster exhibit. 
In Vivo”; Steven Jacoby, “Analysis of Structure and Function 
in the Na-K-Cl Cotransporter ”; and Maie R. St. John, “The 
Role of LATS in Mammalian Tumorigenesis, Development 
and Cell Cycle Regulation.” 
STUDENT NOTES 
Randy R. Kidd, a history of medicine graduate student, 
received a Prize Teaching Fellowship award for excellence in 
teaching. Undergraduates and faculty nominate graduate stu¬ 
dents for this high honor at Yale. Kidd also will teach an 
independent course, which he designed, titled “The Scientific 
Revolution,” at Yale College in Spring 2000. 
Caroline Harada, a second-year medical student, was hon¬ 
ored with an Ivy Award in May. Harada was chair of the 
Committee Overseeing Volunteer Services (COVS) of the 
University’s health professional schools and was an active vol¬ 
unteer in four programs within COVS. The Elm and Ivy 
Awards are in recognition of efforts to strengthen the rela¬ 
tionship between Yale and the city of New Haven. 
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Student-led course helps clinicians with their Spanish 
Imagine being sick and helpless in a 
hospital, surrounded by strangers in 
white jackets, stethoscopes hanging 
from their necks. Then imagine you 
can't tell them what’s wrong. You speak 
and they look back, uncomprehending. 
They speak and their words are so 
much gibberish. 
That is the case for many patients in 
hospitals that serve large minority and 
foreign communities. To remedy the 
problem, students offer a io-week 
course, once each semester, that teaches 
the rudiments of Spanish for medical 
practitioners. The course is open to 
students in medicine, nursing, public 
health and the Physician Associate 
Program. “When I try to use Spanish,” 
said Michelle Sanders, M.D. ’99, 
“patients really appreciate the effort.” 
Students organized the course about 
six years ago, with support from the 
Office of Student Affairs and the Com¬ 
mittee for the Well-Being of Students. 
This year, the course, under the direc¬ 
tion of fourth-year M.D./Ph.D. stu¬ 
dent Michael Singer, has some innova¬ 
tions. Singer, who studied Spanish in 
high school and as an undergraduate 
at Yale, has created a Web page 
(habibi.med.yale.edu) with a course 
description and tutorials. For the first 
time, the students have been divided 
into beginner, intermediate and 
advanced levels. Singer persuaded the 
student affairs office to increase the 
budget to add a stipend for a second 
teacher, Diana Bojorquez, a medical 
student from California who teaches 
the intermediate course. 
Singer also has offered students a 
chance to apply what they have learn¬ 
ed. For advanced students, a typical 
class includes a textbook lesson in a 
hospital conference room followed by 
a visit to Spanish-speaking patients on 
the wards. The last class of the semes¬ 
ter in April took four students to the 
room of a middle-aged Puerto Rican 
patient. In their halting Spanish, the 
students ascertained that she had come 
to the hospital complaining of stomach 
pains and vomiting that started a few 
days before and that she was diabetic. 
“Do others in your family have dia¬ 
betes?” “Is the pain worse at certain 
times of day or night?” “Do you feel 
better or worse when you eat?” The 
questions continued, veering from her 
condition to her personal and family 
medical history. 
The patient, who also speaks Eng¬ 
lish, had volunteered to meet with 
the students to help them practice 
Spanish. For patients who speak no 
English, the hospital maintains an 
interpreters’ service. 
The students said they have found 
patients receptive to their efforts to 
learn Spanish. Ultimately, they believe, 
it will benefit patients to have care¬ 
givers who speak their language and 
can help them feel more at ease in an 
unfamiliar and perhaps frightening 
environment. “They really appreciated 
that we were making an effort to 
communicate with them in their own 
language,” said Marjorie Trotter, who 
is in her first year of the Physician 
Associate Program. 
Education gets high marks, but students worry about safety 
While 90 percent of students rated the quality of education 
at the medical school as good or excellent, they also remain 
concerned about security, particularly in parking lots and on 
streets leading to the main campus. The Committee for the 
Well-Being of Students reported its findings from an annual 
survey to the Medical School Council on April 15. The survey 
was based on responses from 277 students in the medical 
school, public health and the Physician Associate Program. 
“Most people are very satisfied with the quality of education,” 
said Ben Smith, co-chair of the committee. “Most students 
view the administration as concerned about them and res¬ 
ponsive to their needs.” 
Although most also gave high marks to security efforts, 
it remained a top concern. Only 58 percent of public health 
students rated security as good or excellent, compared to 95 
percent of PA students and 84 percent of first-year medical 
students. “A lot of us feel our end of campus gets neglected 
at night,” said public health student Kathy Witgert. She said 
public health students would like to see a nighttime foot 
patrol and scheduled bus stop in front of the public health 
building on College Street so students could wait inside, 
rather than on the street. 
A related complaint was the high cost of secure parking 
near the medical school. The report recommended better 
lighting ol parking lots and adjoining roads, more foot 
patrols at night, change machines for parking meters, and 
incentives for car-pooling, such as reduced parking rates. 
Jack Gundrum, director of security for the medical school, 
said that in response to the concerns outlined in the students’ 
report a periodic foot patrol has been added at night to 
LEPH and College Plaza. Parking, however, is a harder prob¬ 
lem to address. “Parking is at a premium,” he said. “There 
is certainly adequate parking, but it comes at a cost.” 
Other topics of concern to students were prices of meals 
at cafeterias, rare instances of discrimination based on gender 
or sexual orientation and verbal abuse on medical rounds. 
The Office of Student Affairs is establishing a program to 
make peer counseling available to students who wish to dis¬ 
cuss verbal abuse or other forms of student mistreatment. 
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Students help students find 
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their way to a college education 
For io weeks this winter and spring, 
high-school students from New Haven 
and nearby communities gave up 
their Saturday mornings to come to 
the medical school to learn about 
HIV, nutrition, drug abuse, domestic 
violence and other health issues. They 
attended a series of lectures prepared 
by minority students like themselves 
and designed to encourage them to 
go to college. “One of the keys to this 
program is the interaction with other 
around the country. “Our predominant 
goal is to get them into college and 
support them in whatever career choice 
they decide.” 
On a Saturday morning in March, 
Karl Lozanne, a second-year medical 
student, stood on the stage in the 
Hope Building auditorium and asked 
40 high school students what they eat 
and how they eat it. “How many indi¬ 
viduals are going to eat their first meal 
at 11 o’clock today?” he asked, referring 
Fourth-year medical student Richard Lyn-Cook discussed nutrition with students from New Haven-area high 
schools this spring as part of the Health Professions Recruitment and Enrichment Program. 
students from backgrounds that are 
similar to theirs,” said David LaBorde, 
a second-year medical student who 
coordinated the program this year. “It 
is something that medical students are 
committed to, to make sure that 
students who come after them have 
the same opportunities they were 
privy to.” 
I he Health Professions Recruitment 
and Enrichment Program (HPREP) 
was created in 1989 by the Student 
National Medical Association and 
started at Yale five years later. “The 
whole idea is to foster mentorships 
between local high school students and 
medical students in the same regions 
and cities,” said Eboni G. Price, a 
fourth-year medical student at Johns 
Hopkins, a member of the SNMA who 
co-chairs HPREP at the national level. 
The program has spread to 60 chapters 
to the pizza and sodas on the menu for 
lunch. Hands shot up all over the audi¬ 
torium. “That’s not healthy,” Lozanne 
said before beginning a talk on the 
basics of healthy eating. After a lecture 
on nutrition and exercise, the students 
had lunch and then broke up into 
small discussion groups. 
Since its inception in 1994, the Yale 
program has also offered tangible help 
to college-bound students, providing 
$18,500 in grants to 13 students. An 
interest in health or medicine is not a 
requirement. The course is designed to 
encourage a range of abilities. “Things 
like critical thinking and writing skills 
have broad applications in any field 
they go into,” said Damani Piggott, 
a second-year student who taught the 
HPREP course this year and served 
as president of Yale’s SNMA chapter 
last year. 
Bohmfalk Prize: 
Dr. James Jamieson (basic sciences) 
Dr. Barry Wu (clinical sciences) 
Healthcare Foundation of New 
Jersey Humanism in Medicine 
Faculty Award: 
Dr. Karen E. Brown 
Dean’s Medical Education Farr 
Prize: 
Dr. Robert H. Gifford 
The Leah M. Lowenstein Prize: 
Dr. Shanta E. Kapadia 
The Francis Gilman Blake Award: 
Dr. Barry Wu 
The Betsy Winters House Staff 
Award: 
Dr. Stephen Kavic 
Parker Prize: 
Michelle M. Pinto 
Miriam Kathleen D 
Ruth A. Potee 
Norma Bailey Bern 
Sherri D. Sandifer 
Dean’s Prize for Co 
Service: 
Alison L. Days 
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At commencement, candidate Dole addresses 
health care concerns 
In a commencement speech that touched on gun control, 
Kosovo and advances in medicine and biology, Elizabeth 
Dole urged the Class of 1999 to devote time to public service 
and to maintain a concern for the needy. 
“Twenty years from now,” said Dole, past president of the 
American Red Cross, former cabinet secretary and current 
presidential candidate, “American physicians will not —must 
not —be practicing the same medicine they are today. 
Meanwhile, however, some things will stay the same. Patients 
will still need to be listened to with concern and attention. 
The helpless will still need our special care.” 
Dole was the graduating class’s choice to deliver the 
keynote address at the medical school’s commencement cere¬ 
mony on May 24. Dean David A. Kessler, M.D., who 
worked with Dole when he headed the Food and Drug 
Administration, praised her commitment to public service, 
noting that as transportation secretary she had made the 
roads safer by requiring additional brake lights on vehicles. As 
leader of the Red Cross, he added, she had transformed the 
hospital, needs a transfusion, that blood is safer because of 
Elizabeth Dole.” 
Although Dole never mentioned her own campaign to win 
the Republican Party’s nomination for the presidency, she 
alluded to it in her speech. The budget of the National 
Institutes of Health should be doubled over the next five 
years, she said. “We should have the same commitment from 
our next president, whoever she may be,” she added. 
Mindiul of her audience, she linked her stands on issues of 
the day to medicine. “For years we have had safety caps on 
medicine that might cause injury to children,” she said, hold¬ 
ing up an aspirin bottle and a gun trigger lock. “Why not 
protect children with safety locks on guns?” 
She also called lor expanded health care coverage to protect 
the 43 million Americans without health insurance and for 
changes in the relationship between physicians and health 
insurers. “We must ensure that our health care providers have 
the freedom and the flexibility to provide the best possible 
care,” she said. 
way the nation protects its blood supplies. “Let there be no 
doubt,” he said, “that when a patient in our hospital, in any 
Healthcare Foundation of New 
jersey Humanism in Medicine 
Student Award: 
Ruth A. Potee 
Campbell Prize: 
Michelle M. Pinto 
Perkins Prize: 
Michelle M. Pinto 
Merck Book Awards: 
Angelo E. Volandes 
Meena Thayu 
Lange Book Award: 
Lawrence Etter 
M.D./Ph.D. Award: 
Alexandra B. Cohen 
Eric A. Hughes 
Connecticut Society of American 
Board of Obstetricians and 
Gynecologists: 
Kristen R. Aversa 
New England Pediatric 
ciety Prize: 
E. Froehlich 
' for Academic Emergency 
: Award: 
Broder 
: Society of American 
>ns Prize: 
iram Salemy 
' A. T. Grannum Award: 
nya 
cut
At Commencement in May, former cabinet secretary Elizabeth Dole was honored 
with the Peter Parker Medal in recognition of her "outstanding leadership and 
dedication to the health and safety of our nation’s citizens, as well as to the 
people of the world." 
Q Dean Kessler sheltered Dole from the rain as they led the 
commencement procession. 
Q Students waited to receive their diplomas under the tent on Harkness Lawn. 
Q Smiles and hugs greeted graduates at the ceremony’s end. 
Obinwanne F. Ugwonali 
Sherri D. Sandifer 
Camille M. Hylton 
Lauren Weinstein Award: 
Paul Huang (posthumously) 
Richard X. Lyn-Cook 
Connecticut Academy of Family 
Physicians Award: 
Ruth A. Potee 
J. Bruin Rugge 
Winternitz Prize in Pathology: 
Danica N. Barron 
Michelle M. Pinto 
Endocrine Society Medical 
Student Achievement Award: 
Ursula A. McVeigh 
The Courtland Van Rensselaer 
Creed Award: 
Richard X. Lyn-Cook 
National Medical Fellowship 
(NMF) James H. Robinson, M.D., 
Memorial Prize in Surgery: 
Obinwanne F. Ugwonali 
ACP-ASIM Internal 
Medicine Award: 
Nicole C. Rabidou 
National Health Service Corps 
Certificate of Recognition: 
Alison L. Days 
Jennifer B. Griffiths 
Hold fast to ideals and integrity, public health students urged 
Graduating public health students listened to speakers including classmate Cari Jo 
Clark and Dean Michael Merson as they waited to receive their diplomas at 
Commencement. (Right) James Jekel received the Award of Excellence in Teaching 
during the ceremony. The hourglass was a playful reference to his habit of using 
an egg timer to keep student presentations brief. 
AWARDS AND HONORS 
Award for Excellence in Teaching: 
James Jekel, M.D., M.P.H. 
SCHOLARSHIPS AND FELLOWSHIPS 
Wilbur C. Downs International 
Travel Fellowships: 
Ibilola Abike Fashoyin 
Rajesh Gupta 
George Levon Melikian 
Timothy Myshrall 
Nicole C. Rabidou 
James A. Hamilton Scholarships: 
Natasha Devi Goburdhun 
Anthony Jerome Giovanni Pacheco 
Kathleen Hara Howe Scholarship: 
Audra Nicole Boscoe 
Mary Florence Ricciuti 
Merit Scholarships: 
Stacey Rebecca Grill 
Sofia S. Kennedy 
Richard H. Schlesinger Fellowships: 
Kathleen Anne Harris 
Anthony Jerome Giovanni Pacheco 
Sarah Helen Stanton 
John Devereaux Thompson 
Scholarships: 
Scott Christopher Durbin 
Katharine Ellen Witgert 
E. Richard Weinerman Fellowships: 
Magdalena Cerda 
Cari Jo Clark 
April Celeste Cohen 
Christina Y. Kim 
Kristin Mattocks 
Pamela S. Nelson 
Thomas Horton Riess 
At a time of great and varied challenges to public health, 
Michael H. Merson, M.D., dean ol public health, urged the 
Class of 1999 to hold fast to its courage and principles. 
“When you accept your diplomas today,” he told the 118 
graduates, “I ask you to remember that you have a new 
responsibility in public health. Class of 1999, be proud to 
be entering a profession that has accomplished so much 
tor our nation." 
Merson offered his 
comments in place of 
Margaret A. Hamburg, 
M.D., Assistant Secretary 
for Planning and 
Evaluation at the federal 
Department of Health 
and Human Services. 
Heavy rains and tog on 
Commencement Day 
made it impossible for 
her flight from Wash¬ 
ington to land in 
New Haven. 
Student speaker Cari 
Jo Clark told her class¬ 
mates upon graduation 
they were no longer 
peers, but colleagues. “We are now a complex network of 
health professionals who will most likely benefit from know¬ 
ing each other,” she said. “The very nature of public health 
has brought us into contact with interesting, inspiring and 
dedicated people.” 
James Jekel, M.D., M.P.H. ’65, Charles Edward A. 
Winslow Professor Emeritus and Lecturer in Public Health, 
received the Award of Excellence in Teaching. As he came 
forward to accept the award he brandished an oversized 
hourglass, a gift from students poking fun at his tendency to 
time student presentations with an egg timer. 
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Pediatric cardiologist Muriel D. 
Wolf, M.D. ’59, HS ’60, was among 
five Yale alumni to receive the Yale 
Medal at a dinner in April. The 
medal is the highest honor bestowed 
by the Association of Yale Alumni in 
recognition of outstanding volunteer 
service to the University. 
“A sense of responsibility leavened by infectious enthusiasm 
characterizes your outstanding contributions to the Yale com¬ 
munity,” reads the award citation, which praises Wolf for her 
leadership as the first woman president of the Yale Club of 
Washington, D.C. “You ensured that the club offered a wide 
spectrum of events and activities appealing to young people, 
minorities, women and alumni of the graduate and profes¬ 
sional schools as well as those of Yale College.” 
The AYA recognized Wolf for her work as president of the 
Association of Yale Alumni in Medicine, as a member of the 
AYA Board of Governors, and as chair of the Committee on 
Women at Yale. 
Wolf, a resident of Washington, D.C., is associate professor 
of pediatrics at George Washington University School of 
Medicine and was recently named senior pediatrician at 
Children’s National Medical Center. 
Retired oncologist Robert W. Frelick, 
M.D. ’44, spent Christmas and New 
Year’s in Honduras, providing medical 
relief in the wake of Hurricane Mitch, 
which devastated a swath of Central 
America late last year. He left his home 
in Wilmington, Del., to travel as a vol¬ 
unteer on a med¬ 
ical mission spon¬ 
sored by Church 
World Services. 
From Dec. 20 to 
Jan. 2, the team 
traveled over back 
country roads 
through deep val¬ 
leys, fording swollen streams to reach 
outlying villages. Throughout, he saw 
the hurricane’s toll of ravaged high¬ 
ways, lost harvests and ruined homes. 
“They had four and a half years’ worth 
of rain in nine days,” said Frelick, who 
before retiring served as a consultant to 
Delaware’s Department of Public 
Health and reviewed oncology 
programs for the National 
Cancer Institute. 
Their mission took them first to El 
Sauce, one of three villages they visited 
in the northwestern corner of the 
country. Traveling with a cook, a driver 
and supplies of food and water, they 
rode in a four-wheel-drive truck, two 
team members up front in the cab, the 
rest in the back on top of the luggage 
and medical supplies. Frelick’s team¬ 
mates included an internist from Los 
Angeles who had worked in Mexico, a 
nurse-clinician who had spent 12 years 
in Guatemala, a nurse from Seattle 
who spoke survival Spanish, a bilingual 
nurse from Indiana whose church took 
care of her four children while she was 
away, and an intensive care nurse from 
North Carolina. 
On arrival they set up a clinic in a 
two-room schoolhouse and started see¬ 
ing patients at 1:30 p.m. By the time 
darkness fell they’d seen 100 patients, 
some of whom had walked for hours to 
reach the clinic. Common ailments 
were bronchitis, asthma, headaches, 
diarrhea, heartburn, dermatitis, 
cataracts, intestinal parasites, malnutri¬ 
tion and anemia. 
That first day set the pattern for the 
trip —a journey over difficult roads, 
setting up a clinic, treating patients 
until dark, sharing a meal of rice and 
beans, then sleeping on camping gear 
in a common bedroom, usually the 
makeshift clinic itself. “Nobody com¬ 
plained about the lack of amenities,” 
Frelick said, adding, “The biggest 
problem they had was my snoring.” 
Medically, however, they lacked the 
support to which they were accus¬ 
tomed. They worked without electrici¬ 
ty, refrigeration or running water, and 
sometimes without supplies such as 
tetanus toxoid or Pepto-Bismol. In one 
clinic the only sink available for wash¬ 
ing hands became useless after it sprang 
a leak. Despite the lack of facilities, the 
team managed to treat patients’ chronic 
diseases. They dispensed medications 
for some ailments and arranged for 
serious cases to be treated in hospitals. 
But throughout the mission Frelick 
wondered whether his patients’ poverty 
would enable them to receive appropri¬ 
ate treatment. He doubted that one 
patient with large varicose ulcers would 
be able to keep her legs clean and ele¬ 
vated. He also wondered whether 
mothers would follow his advice on the 
proper preparation of infant formula to 
prevent diarrhea. 
“I just couldn’t get over how well 
the doctors and nurses worked togeth¬ 
er,” said Frelick, noting that their only 
time off from medical care came on 
New Year’s Day when they made an 
excursion to the ancient Mayan city of 
Copan. “The fact that we could work 
so well together without knowing each 
other ahead of time was really nice.” 
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John P. Ferguson, M.D. ’39, of 
Springfield, Mo., writes to say that he 
is now living in Palm Desert, Calif., for 
five months of the year so that he can 
play more golf; he gets out two or 
more times a week. Ferguson says he is 
enjoying retirement and usually takes a 
cruise or a foreign trip once a year. 
Jack S. Blaisdell, M.D. ’40, continues 
to practice orthopaedics in Sandpoint, 
Ind., and is adjusting to the loss of his 
wife of 61 years, Famie. 
Robert E. Carroll, M.D. ’42, of New 
York City, was selected as the 1999 
Man of the Year by the Culver Military 
Academy in Indiana. Carroll was a 
1934 graduate of the academy. 
Hunter H. Comly, M.D. 43, of San 
Diego, Calif., traveled to Tahiti this 
spring and hopes to take a cruise 
around the world next winter. 
David Geddes, M.D., HS ’48-49, of 
Santa Ana, Calif., is now a clinical pro¬ 
fessor of psychiatry at the University of 
California, Irvine, College of Medicine. 
O Janies A. O’Neill Jr., M.D. ’59, the 
John Clinton Foshee Distinguished 
Professor of Surgery at Vanderbilt 
University School of Medicine, was 
elected in February to serve as presi¬ 
dent of Southeastern Surgical Congress 
at its annual meeting in Tampa, Fla. 
His one-year term will begin in 
February 2000. O’Neill, who is sur¬ 
geon-in-chief at Vanderbilt and chair 
of the section ol surgical sciences, will 
also serve as a member of the 
Congress’s Continuing Medical 
Education Committee. 
O David W. Barry, M.D. ’69, chair¬ 
man and chief executive officer of 
Triangle Pharmaceuticals, received the 
Award for Distinguished Service to 
Industry, Commerce or Education in 
April from the Yale Science and 
Engineering Association. Barry was 
recognized for his work in virology and 
pharmaceutical development — pioneer¬ 
ing the development of the herpes 
drug acyclovir and leading a team that 
discovered AZT, the first treatment for 
HIV. Barry served as deputy director 
of the Division of Virology of the 
National Food and Drug Administra¬ 
tion’s Bureau of Biologies and as vice 
president of research, development and 
medical affairs at Burroughs Wellcome 
in North Carolina before founding 
Triangle Pharmaceuticals in 1995. 
O Allen I. Goldberg, M.D., HS ’68- 
70, served as president of the American 
College of Chest Physicians during 
1998-99. Goldberg is professor of pedi¬ 
atrics and director of the section of 
home health at Loyola University 
Medical Center in Chicago. 
Neal L. Maslan, M.P.H. ’64, was 
recently listed in The Global 200 
Executive Recruiters, a book by Nancy 
Garrison Jenn on the world’s top exec¬ 
utive recruiters, and John Sibbold’s 
new edition of The New Career Makers, 
published by HarperRow. 
O Stephen C. Schimpff, M.D. ’67, 
HS ’67-69, was named chief executive 
officer of the University of Maryland 
Medical Center in March. The medical 
center is a private, nonprofit corpora¬ 
tion encompassing the hospital, chil¬ 
dren’s hospital, cancer center and shock 
trauma center. Schimpff, who previ¬ 
ously headed the cancer center and has 
been the executive vice president of the 
University of Maryland Medical 
System for the last 14 years, is a 
professor of medicine, oncology and 
clinical pharmacy. 
In celebration of the 20th anniversary 
of the founding of the American 
Council on Science and Health 
(ACSH), the journal Technology has 
designated the first volume of 1999 a 
festschrift—a special collection of 
essays in honor of the two ACSH 
founders. They are Elizabeth M. 
Whelan, M.P.H. ’67, and Fredrick J. 
Stare. The volume is entitled 
Human Health. 
After 14 years as professor and chair of 
the Joint Center for Radiation Therapy 
at Harvard Medical School, C. Norman 
Coleman, M.D. ’70, has moved to the 
National Institutes of Health. He is the 
director of the newly established 
continues on page 50 Q 
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"I must have confidence and I must be 
worthy of the great DiMaggio who 
does all things perfectly even with the 
pain of the bone spur in his heel.... Do 
you believe the great DiMaggio would 
stay with a fish as long as I will stay 
with this one? ... I am sure he would 
and more since he is young and strong. 
Also, his father was a fisherman. But 
would the bone spur hurt him 
too much?” 
—from The Old Man and The Sea, 
by Ernest Hemingway, 1952 
Joe DiMaggio (above center) is surrounded by jubilant teammates after winning Came 2 of the 1950 World 
Series, the year before heel spurs forced him to retire from baseball. "If I had met Rock Positano so years 
ago,”he said later, “I never would have ended my career."Positano (below), a podiatrist with a public health 
degree from Yale, became a friend of DiMaggio and organized his memorial service in April at St. Patrick’s 
Cathedral in New York. 
Growing up in Brooklyn’s Bensonhurst 
section, Rock G. Positano, D.P.M., 
M.P.H. ’89, lived in awe of Joe 
DiMaggio, the legendary batter and 
center fielder who started playing with 
the New York Yankees in 1936. Heel 
spurs ended DiMaggio’s career in 1951 
and the “Yankee Clipper” endured the 
discomfort until 1990, when he walked 
into Positano’s office at the Hospital 
for Special Surgery. That visit marked 
the beginning of a personal and profes¬ 
sional relationship that lasted until 
DiMaggio’s death at 84 in March of 
lung cancer. “He took a liking to me,” 
recalled Positano, “and more impor¬ 
tantly, I got him well.” Positano fitted 
a strap he had devised onto DiMaggio’s 
foot to ease swelling and allow healing 
to begin. Years later, Positano recalled, 
he sat in George Steinbrenner’s box at 
Yankee Stadium with DiMaggio and 
others when “Joe took his shoe off, 
pointed to his heel and said, ‘If I had 
met Rock Positano 50 years ago I never 
would have ended my career.’ ” 
DiMaggio, 
he said, not 
only respected 
his compe¬ 
tence, but also 
had a soft spot 
in his heart for 
Yale. 
DiMaggio’s 
son had 
attended Yale 
College and the Yankee slugger count¬ 
ed among his friends A. Bartlett 
Giamatti, the late baseball commis¬ 
sioner and former Yale president. 
Positano, 40, studied public health at 
Yale because of his interest in foot dis¬ 
orders as occupational injuries. 
Positano dined with DiMaggio reg¬ 
ularly as part of a group of five or six 
friends who gathered when the base¬ 
ball great was visiting from his home 
in Florida. DiMaggio, Positano said, 
encouraged him to write his textbook, 
Disorders of the Heel, Rearfoot, and 
Ankle, published recently by Churchill 
Livingstone and which Positano co¬ 
authored with Chitranjan S. Ranawat, 
M.D. Positano was the subject of a New 
York Times profile that focused on his 
friendship with DiMaggio. It ran on 
April 23, the day of the memorial serv¬ 
ice Positano organized at St. Patrick’s 
Cathedral in New York. “It was a 
tremendous undertaking, but I did it 
with great love,” he said. 
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Radiation Oncology Sciences Program, 
which includes a number of responsi¬ 
bilities. One duty will be to serve as a 
special advisor to the director of the 
National Cancer Institute, Yale College 
alumnus Richard Klausner. Coleman 
and his wife, Karolynn, will be living 
in Somerset, Md. 
O Joseph Zaccagnino, M.P.H. 70, 
president and chief executive officer of 
Yale-New Haven Hospital (YNHH) 
and Yale New Haven Health System, 
received the Torch of Liberty Award 
from the Connecticut Anti-Defam¬ 
ation League (ADL). The award, the 
highest honor bestowed by the organi¬ 
zation, was presented at a dinner in 
April attended by 750 of Connecticut’s 
most influential leaders. The ADL rec¬ 
ognized Zaccagnino (center, with Rob 
Leikind and Marvin Lender, right, of 
the ADL) for his efforts and accom¬ 
plishments in the areas of diversity, 
community-building and children’s 
health care. Past recipients of the award 
include Yale University President 
Richard Levin, U.S. Sen. Christopher 
Dodd and YNHH board member John 
Lahey, who is the president of 
Quinnipiac College. 
Michael D. Burg, M.D. ’87, of 
Durham, N.C., writes to say: “After 
more than eight years in a community 
emergency medicine practice, I’m 
engaged in an emergency department 
fellowship and a teaching faculty devel¬ 
opment fellowship at Duke. I’ll be 
transitioning to an academic emer¬ 
gency medicine practice next year.’’ 
Q Robert S.D. Higgins, M.D. 85, 
surgical director of the Henry Ford 
Health System’s Thoracic Transplan¬ 
tation Program, had an incredible year 
in 1998. He was named to an endowed 
chair, earned Medicare approval for the 
lung transplant program he founded at 
Henry Ford in 1993, and led a team of 
surgeons from Henry Ford and Child¬ 
ren’s hospitals in Detroit in their first 
pediatric heart transplant. Higgins also 
performed a transplant last August on 
one of Michigan’s youngest heart recip¬ 
ients, io-week-old Stephanie Gossage. 
E*Ye£Hnfli|N^ra 
Michelle Andrews, M.D., HS ’90, an 
attending physician at the Cincinnati 
Sports Medicine and Orthopaedic 
Center, was elected to the board of 
trustees of the Women’s Sports 
Foundation, a national nonprofit 
organization dedicated to increasing 
opportunities for girls and women in 
sports and fitness. 
Helen L. Egger, M.D. ’91, a postdoc¬ 
toral fellow in mental health service 
systems and research at the University 
of North Carolina at Chapel Hill and 
Duke University Medical Center, was 
chosen as one of 30 fellows for Zero to 
Three’s Leaders for the 21st Century 
program. The two-year Solnit fellow¬ 
ship which honors Yale professor 
Albert J. Solnit, M.D., is funded by 
grants from The Robert Wood Johnson 
Foundation and philanthropist Irving 
Harris. Egger will focus her work on 
developing a tool for diagnosing post- 
traumatic stress disorder in young 
children. Zero to Three is a national 
nonprofit organization of pediatricians 
and child development specialists. 
We re preparing an article on “The Yale System Through the 
Decades’’ and invite letters, thoughts and memories from 
alumni. In particular, we would like to explore which essen¬ 
tial threads of Yale’s approach to medical education have 
remained unchanged over the years, as well as the evolution 
of the tradition from generation to generation. 
Letters should be brief, no more than 250 words, and 
touch on one major facet of the Yale System specific to the 
era in which the author experienced it as a student, faculty 
member or in some other capacity. Please send letters to 
Editor, Yale Medicine, P.O. Box 7612, New Haven, CT 06519- 
0612 [or via e-mail to ymm@yale.edu] and include a daytime 
phone number. A representative selection of essays will be 
published in a future issue. 
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OBITUARIES 
JOHN DONNELLY 
John Donnelly, M.D., ofWest 
Hartford, Conn., died February 18. 
He was 84. 
Born in England, Donnelly received 
his medical degree in 1938 from the 
University of Liverpool Medical School 
and his diploma of psychological 
medicine in 1948 from the Maudsley 
Institute at the University of London. 
In 1949 he joined the staff of The 
Institute of Living in Hartford and was 
named medical director in 1956. From 
1965 until 1984 he was psychiatrist-in- 
chief and chief executive officer of the 
institute. He also served on state and 
national advisory boards and 
chaired a number of task forces for the 
American Psychiatric Association. 
In addition to his position at the 
institute, Donnelly was at the Yale 
School of Medicine as an assistant clin¬ 
ical professor of psychiatry from 1952 
until 1963, an associate clinical profes¬ 
sor of psychiatry from 1963 until 1968 
and a lecturer from 1968 until 1980. 
He also served as professor of psychia¬ 
try at the University of Connecticut 
School of Medicine. 
JOHN C. HOOVER 
John C. Hoover, M.D. ’46, died 
March 16 at the Hackensack 
(N.J.) University Medical Center. 
He was 79. 
Hoover was born in Connecticut 
and was a World War II Army veteran. 
He was a former medical director and 
staff member of the Hackensack 
University Medical Center and a for¬ 
mer president of the Bergen Pines 
Hospital Medical Board in Paramus. 
Hoover lived in Wyckoff, N.J., for 
the past 27 years and was retired from 
his practice as an orthopaedic surgeon. 
ROBERT A. KRAMER 
Robert A. Kramer, M.D. ’55, HS 
’55-56, a prominent pediatrician in 
the Hartford area, died April 23. 
He was 68. 
Kramer was a leader in the treatment 
of behavioral and psychiatric problems 
of adolescents and children. He 
remained an active member of 
The Compleat Pediatricians, a group 
of Yale-affiliated physicians who treat 
medical problems in the context 
of children’s social, family and emo¬ 
tional environments. Kramer was a 
regular participant in the breakfast 
meetings 1 he Compleat Pediatricians 
hold twice a month to discuss cases. 
After graduation from the School of 
Medicine, and a residency in pediatrics 
and a fellowship in child psychiatry at 
Johns Hopkins Hospital, Kramer had a 
private pediatric practice in Baltimore 
until 1968. During his career he was 
vice president for medical affairs and 
medical director at the Newington 
Children’s Hospital, director of the 
division of child and adolescent be¬ 
havior and professor of pediatrics at 
the University of Connecticut School 
of Medicine, and clinical professor 
of pediatrics and surgery (orthopaedic) 
and rehabilitation at the Yale School 
of Medicine. 
Kramer was a founder of the 
Adolescent Drug Dependency Service 
at the University of Connecticut in 
1970 and the Child and Adolescent 
Psychiatric Service at Mt. Sinai 
Hospital (Hartford) in 1974. At the 
time of his death, he was executive vice 
president of the Newington Children’s 
Hospital Foundation, Inc. 
JOHN B. OGILVIE 
John B. Ogilvie, M.D. ’34, died at his 
home in Riverside, Conn., on May 1. 
He was 89. 
Born in New York City, Ogilvie 
graduated in 1931 from Yale College 
and in 1934 from the School of 
Medicine. During World War II, he 
was a captain in the Army’s 9th 
General Hospital Unit from New 
York Hospital, serving as a surgeon 
in New Guinea and the Philippines. 
After completing his residency at New 
York Hospital, Ogilvie moved to 
Stamford, Conn., where he practiced 
general surgery until he retired in 1987. 
During his career he served as sur- 
geon-in-chief at Stamford Hospital 
from 1966 to 1972 and as president of 
the local YMCA from i960 to 1965. 
Ogilvie served on the Development 
Board and the Dean’s Council at Yale 
School of Medicine. 
I he son of Scottish immigrants, he 
remained appreciative of Yale’s generos¬ 
ity to him as an undergraduate and 
medical student. Although he contrib¬ 
uted to other projects, including the 
construction of the Cushing/Whitney 
Library and the Boyer Center for 
Molecular Medicine, his largest gifts to 
the school were for financial aid. He 
made a point of getting to know the 
students who benefited from his 
scholarships, regularly taking them 
to lunch for pep talks. 
His enthusiasm for Yale was such 
that he could rally his classmates dur¬ 
ing fund-raising campaigns, urging 
them to meet the financial challenges 
of both Yale College and the medical 
school. No major fund-raising com¬ 
mittee was established at the medical 
school without his participation. 
During the past 10 years he made 
monthly visits to the alumni and devel¬ 
opment offices to counsel staff on 
securing gifts to the school. He was 
credited with reinvigorating the Associ¬ 
ation of Yale Alumni in Medicine and 
in 1994 became the first recipient of 
the Peter Parker Medal for outstanding 
service to the School of Medicine. 
IN MEMORIAM 
The School of Medici ne has received notifica¬ 
tion of the death of the following persons: 
David G. Borden, M.D. 43, 6.16.98 
Phillip G. Couchmdn, M.D. ’49, 8.15.98 
Norman L. Cressy, M.D. '59,1.25.99 
Wynant Dean, M.D. ’40, 1.25.99 
Robert M. Edwards, M.P.H. ’65, 5.22.99 
Marcia Fite, M.D. '59, 1.20.99 
John C. Hoover, M.D. ’46, 5.16.99 
Rose Iannotta, M.P.H. ’60, 1.14.99 
CarroldK. Iverson, M.D. ’51, 5.10.99 
Moshe Lahav, M.D., HS ’69-92, 9.50.98 
James Peter Murphy, M.D. ’59, 1.15.99 
John Frazier Snyder III, M.D. ’55, 1.24.99 
Robert N. Taylor, M.D. ’50, 9.19.91 
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Our generations 
In i960, a woman entering medicine had all the normal hurdles to 
overcome and then some. So what’s it like for her daughter? 
By Diane K. Shrier, M.D. ’64 
When my oldest daughter, Lydia, was four years old, she 
announced that she wanted to be a nurse when she grew up. 
“Why not a doctor?” I asked. 
“Women can’t be doctors,” Lydia replied. 
This was an idea she had picked up in nursery school, al¬ 
though I, her mother, had practiced medicine her entire life. 
We had a talk, and I mounted a re-education campaign. At age 
10, Lydia was determined to become a physician; today she is 
one, with a promising career in academic medicine ahead of her. 
Since her graduation from medical school in 1991 and her 
residency at Yale, we’ve had the opportunity to compare notes 
about the experiences of women in medicine. Despite signifi¬ 
cant differences in our professional lives — it is clearly much 
easier for women today — there are remarkable similarities 
and many obstacles yet to overcome. 
I grew up in the 1950s when 95 percent of women got their 
M.R.S. along with their B.A. or B.S. and most stayed home to 
raise a family. When I entered medical school in 1960, women 
were openly discouraged from applying and limited by quota. A 
pamphlet handed to many female applicants bore the title “Why 
Would a Nice Girl Like You Want to Become a Doctor?” I was 
warned that no one would marry me, and that if I did manage 
to have a family, my children would be emotionally damaged 
by my career. 
I was determined to prove that I could indeed do it all. 
Fortunately Adam, my husband-to-be, was ahead of his time in 
wanting to be one half of a dual-career couple. We married 
while he was a graduate student at Yale, just after my first year 
of medical school in St. Louis. There was no question in those 
days that I would be the one to transfer, and, despite my break¬ 
ing the quota on women, Yale ultimately accepted me as a 
second-year student. We started our family soon afterward. 
Jonathan was born in my last year of medical school, Lydia 
and Catherine followed during my specialty training, and 
David after I entered practice. We were young and energetic, 
and we managed. 
Others have written about gender discrimination in academ¬ 
ic medicine. For my generation, it was a matter of overcoming 
attitudes that seem ludicrous today, but were taken for granted 
at the time. “You’re taking a man’s place,” we were told, either 
directly or in dozens of more subtle ways. But it has been a won¬ 
derful life and I wouldn’t give up any of it, except perhaps for 
the difficulties in finding and keeping good child care. 
Lydia had a very different experience. As a Yale undergradu¬ 
ate, she knew many young women who were planning careers in 
medicine. About 40 percent of her class at Albany Medical 
College were female. During 
her pediatric residency back at 
Yale, she was strongly men- Lydia and Dianeshrier 
tored by faculty who nurtured 
her ambitions for a first-rank academic career. At Boston 
Children’s Hospital, where she trained in adolescent medicine 
and is now on the Harvard faculty, her division chief is a woman, 
as are the majority of her colleagues. 
Yet, while Lydia tells me I am her role model, I tell her she 
only followed the career half of the model. She is not yet mar¬ 
ried and has no children. She has choices: to marry or not, to 
live with someone or not, to have children or not, to delay hav¬ 
ing children into her 30s or beyond. It’s a different world —and 
in most respects far better for a woman who wants to make 
her own choices. But in some ways it is harder to have so 
many choices. 
One day during a long walk together, Lydia and I talked about 
what could be learned from mothers and daughters in medicine 
and whether this might be a useful group to study. Many male 
physicians have followed in their fathers’ footsteps, and a good 
bit is known about that parent-child pattern. Much less is known 
about the mother-daughter pairing. We’ve located more than 
100 such pairs in medicine around the nation and are embarking 
on a long-term study to learn more about the lives of these 
women physicians of different generations. 
We’re very curious: What has changed over the years for wo¬ 
men in medicine? What has stayed the same? What facilitates or 
inhibits a child following her mother into the field? We also won¬ 
der about the future. Though women now make up nearly one- 
quarter of all physicians in this country, they account for a much 
smaller percentage of leaders in medicine. Is it different for wo¬ 
men whose mothers are physicians? Can these women stand on 
their mothers’ shoulders? Do they have knowledge that can be 
useful to other women in medicine? 
We hope to locate as many mother-daughter pairs as possi¬ 
ble, and we welcome your interest (not to mention the names 
of additional pairs). For Lydia and me, it’s a welcome chance to 
learn a little more about ourselves and our colleagues, and may¬ 
be what we discover will help make life better for all women 
in medicine. 
Diane K. Shrier, M.D. '64, is a clinical professor of psychiatry and pediatrics at 
George Washington University Medical Center and a psychiatrist in private 
practice. She can be reached via e-mail at diane.shriermed.64@aya.yale.edu 
or by fax at 202-965-2942. Her daughter Lydia A. Shrier, M.D., M.P.H., HS 
'91-94, contributed significantly to this article. 
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Continuing Medical Education at Yale 
For information on the following programs, please contact the Office of 
Postgraduate and Continuing Education, Yale University School of 
Medicine, 333 Cedar St., P.O. Box 208052, New Haven, CT 06520-8052 
Tel: (203) 785-4578. Web: http://info.med.yale.edu/CME/ 
September 15-19 
(Wednesday-Sunday) 
The 23rd Yale Physician Assistant Certification/ 
Recertification Preparatory Conference 
Harkness Auditorium 
course director Christiane Nockels, P. A.-C. 
September 17 
(Friday) 
The Yale Glaucoma Symposium 
Sheraton Four Points Hotel 
Waterbury, CT 
course director M. Bruce Shields, M.D. 
September 25 
(Saturday) 
Asthma Update for the New Millennium 
Foxwoods Resort & Center 
Ledyard, CT 
course directors Alia Bazzy-Asaad, M.D. 
Hilary Cain, M.D. 
October 2 
(Saturday) 
Treating Depression through the Life Cycle 
Hope 110 
course director Robert M. Berman, M.D. 
October 6 
(Wednesday) 
Intensive Workshop on the Difficult Airway/Instrumentation 
New Haven 
course director William Rosenblatt, M.D. 
October 15 
(Friday) 
2nd Annual Frisbee Stem Cell Symposium 
Omni Hotel, New Haven 
course director Edward L. Snyder, M.D. 
October 21-23 
(Thursday-Saturday) 
Yale Conference on Women’s Health and Fitness 
Omni Hotel, New Haven 
course director Peggy DeZinno, R.N. 
October 22 
(Friday) 
Diabetes 
New Haven Lawn Club 
course director Rosa E. Hendler, M.D. 
October 29 
(Friday) 
Changing the Risk: Women and Heart Disease 
Fitkin Amphitheatre 
course directors Teresa L. Caulin-Glaser, M.D. 
Frans J.Th. Wackers. M.D., Ph.D. 
November 5 
(Friday) 
Osteoporosis 
New Haven Lawn Club 
course director Karl Insogna, M.D. 
November 12 
(Friday) 
Yale Ophthalmology Cornea Update 
Yale Eye Center, Boardman 307 
course director M. Bruce Shields, M.D. 
Yale Medicine 
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